首页 » 细胞株Cell Lines 97及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 97及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV97
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.点击这里给我发消息

电话:+86-010-53513060. 工作QQ:1843439339

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


http://www.biovector.net


ID   UKRV-Mel-20f

AC   CVCL_C404

DR   Cosmic; 1846713

DR   ESTDAB; ESTDAB-236

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D3S1358: 17

ST   D5S818: 12,14

ST   D7S820: 10,12

ST   FGA: 21,25

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 16,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A721 ! UKRV-Mel-20a

OI   CVCL_C401 ! UKRV-Mel-20b

OI   CVCL_C402 ! UKRV-Mel-20c

OI   CVCL_C403 ! UKRV-Mel-20e

OI   CVCL_C405 ! UKRV-Mel-20h

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-20h

AC   CVCL_C405

DR   ESTDAB; ESTDAB-237

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D3S1358: 16,17

ST   D5S818: 12,14

ST   D7S820: 10,12

ST   FGA: 21,25

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 16,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A721 ! UKRV-Mel-20a

OI   CVCL_C401 ! UKRV-Mel-20b

OI   CVCL_C402 ! UKRV-Mel-20c

OI   CVCL_C403 ! UKRV-Mel-20e

OI   CVCL_C404 ! UKRV-Mel-20f

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-21a

AC   CVCL_A722

DR   BTO; BTO:0005348

DR   Cosmic; 1846715

DR   ESTDAB; ESTDAB-063

RX   PubMed=10594685;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 13,14

ST   D3S1358: 14,17

ST   D5S818: 12

ST   D7S820: 10,11

ST   FGA: 22

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-22

AC   CVCL_A723

SY   UKRV MEL22

DR   Cosmic; 972281

DR   Cosmic; 1846716

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKRV-Mel-22a

AC   CVCL_C661

DR   Cosmic; 1846717

DR   Cosmic; 2163860

DR   ESTDAB; ESTDAB-182

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,12

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 9

ST   FGA: 21,24

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C662 ! UKRV-Mel-22b

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-22b

AC   CVCL_C662

DR   Cosmic; 1846718

DR   ESTDAB; ESTDAB-183

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,12

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: Not_detected

ST   FGA: 24

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C661 ! UKRV-Mel-22a

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-23

AC   CVCL_A724

RX   PubMed=10594685;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKRV-Mel-24

AC   CVCL_A725

DR   ESTDAB; ESTDAB-099

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-25

AC   CVCL_C406

DR   Cosmic; 1846720

DR   Cosmic; 2163861

DR   ESTDAB; ESTDAB-184

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 9

ST   D3S1358: 15

ST   D5S818: 12,13

ST   D7S820: 8,11

ST   FGA: 22

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-27

AC   CVCL_A726

DR   BTO; BTO:0005349

DR   Cosmic; 1846721

DR   ESTDAB; ESTDAB-238

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 7,11

ST   D13S317: 10,12

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 10,13

ST   FGA: 22,23.2

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKRV-Mel-29

AC   CVCL_A727

DR   Cosmic; 1846722

RX   PubMed=10594685;

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-30

AC   CVCL_C407

DR   Cosmic; 1846723

DR   Cosmic; 2163836

DR   ESTDAB; ESTDAB-146

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D3S1358: 14

ST   D5S818: 12,14

ST   D7S820: 10,12

ST   FGA: 21,24

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-31

AC   CVCL_A728

DR   BTO; BTO:0005350

DR   Cosmic; 1846724

DR   ESTDAB; ESTDAB-101

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 9,12

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 10,11

ST   FGA: 24

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-37

AC   CVCL_A729

DR   Cosmic; 1846726

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKRV-Mel-38

AC   CVCL_A730

DR   Cosmic; 2163823

DR   ESTDAB; ESTDAB-112

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,13

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 9,10

ST   FGA: 23

ST   TH01: 8,9.3

ST   TPOX: 8,10

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UKTS8049

AC   CVCL_K960

DR   ECACC; 91032120

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS8660

AC   CVCL_K961

DR   ECACC; 91032121

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ECACC; 91032121; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS8670

AC   CVCL_K962

DR   ECACC; 91031441

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS8695

AC   CVCL_K963

DR   ECACC; 91021102

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UKTS8713

AC   CVCL_K964

DR   ECACC; 91031446

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS8727

AC   CVCL_K965

DR   ECACC; 91021107

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS8740

AC   CVCL_K966

DR   ECACC; 91031437

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS8754

AC   CVCL_K967

DR   ECACC; 91070908

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UKTS8768

AC   CVCL_K968

DR   ECACC; 91031439

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UKTS8770

AC   CVCL_K969

DR   ECACC; 91070910

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ECACC; 91070910; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS8791

AC   CVCL_K970

DR   ECACC; 91032122

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS8792

AC   CVCL_K971

DR   ECACC; 91032123

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UKTS8796

AC   CVCL_K972

DR   ECACC; 91032124

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS8797

AC   CVCL_K973

DR   ECACC; 91032125

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS8802

AC   CVCL_K974

DR   ECACC; 91032126

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS8825

AC   CVCL_K975

DR   ECACC; 91030444

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS8837

AC   CVCL_K976

DR   ECACC; 91021101

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS8840

AC   CVCL_K977

DR   ECACC; 91031438

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS8878

AC   CVCL_K978

DR   ECACC; 91032127

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS8964

AC   CVCL_K979

DR   ECACC; 91070916

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ECACC; 91070916; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS8966

AC   CVCL_K980

DR   ECACC; 91021106

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS8989

AC   CVCL_K981

DR   ECACC; 91031443

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS8992

AC   CVCL_K982

DR   ECACC; 91030401

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9002

AC   CVCL_K983

DR   ECACC; 91031447

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9003

AC   CVCL_K984

DR   ECACC; 91031436

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9019

AC   CVCL_K985

DR   ECACC; 91032128

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9020

AC   CVCL_K986

DR   ECACC; 91070903

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9025

AC   CVCL_K987

DR   ECACC; 91021104

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9034

AC   CVCL_K988

DR   ECACC; 91070905

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS9046

AC   CVCL_K989

DR   ECACC; 91030402

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9050

AC   CVCL_K990

DR   ECACC; 91030403

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS9051

AC   CVCL_K991

DR   ECACC; 91032129

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9074

AC   CVCL_K992

DR   ECACC; 91021103

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9082

AC   CVCL_K993

DR   ECACC; 91031445

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS9087

AC   CVCL_K994

DR   ECACC; 91070901

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ECACC; 91070901; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS9109

AC   CVCL_K995

DR   ECACC; 91032130

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UKTS9110

AC   CVCL_K996

DR   ECACC; 91032131

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UKTS9114

AC   CVCL_K997

DR   ECACC; 91031442

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UKTS9115

AC   CVCL_K998

DR   ECACC; 91032132

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS9142

AC   CVCL_K999

DR   ECACC; 91070909

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9160

AC   CVCL_L000

DR   ECACC; 91032133

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ECACC; 91032133; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS9161

AC   CVCL_L001

DR   ECACC; 91032134

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ECACC; 91032134; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS9175

AC   CVCL_L002

DR   ECACC; 91021105

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UKTS9201

AC   CVCL_L003

DR   ECACC; 91070902

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9204

AC   CVCL_L004

DR   ECACC; 91070906

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ECACC; 91070906; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS9213

AC   CVCL_L005

DR   ECACC; 91070904

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UKTS9225

AC   CVCL_L006

SY   UKTS9225?

DR   ECACC; 91032135

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UKTS9242

AC   CVCL_L007

DR   ECACC; 91031440

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UKTS9260

AC   CVCL_L008

DR   ECACC; 91070907

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UL-1

AC   CVCL_L421

RX   PubMed=23196801;

CC   Doubling time: 20.9 hours (PubMed=23196801).

CC   Breed/subspecies: Labrador Retriever mix.

DI   NCIt; C128121; Canine lymphoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   Ul-F

AC   CVCL_6F96

SY   ULF; Umbra limi Fin

RX   PubMed=6541753;

CC   Group: Fish cell line.

OX   NCBI_TaxID=75935; ! Umbra limi

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Ul-H

AC   CVCL_6F97

SY   ULH; Umbra limi Heart

RX   PubMed=6541753;

CC   Group: Fish cell line.

OX   NCBI_TaxID=75935; ! Umbra limi

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ULA

AC   CVCL_1854

SY   Uppsala Lymphoma Ascites-fluid

DR   BioSample; SAMN03473508

DR   DSMZ; ACC-627

DR   GEO; GSM1374977

RX   PubMed=17487752;

CC   Doubling time: ~40-60 hours (DSMZ).

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 9,10

ST   D13S317: 9,12

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 11

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 17,18

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ULEIi001-A

AC   CVCL_IT81

DR   BioSamples; SAMEA7410418

DR   hPSCreg; ULEIi001-A

RX   PubMed=27789413;

CC   From: Leipzig University Center for Biotechnology and Biomedicine; Leipzig; Germany.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ULF-23

AC   CVCL_5641

SY   Umbra Limi Fin-23

DR   CLO; CLO_0050006

DR   RCB; RCB0568

RX   CelloPub=CLPUB00124;

CC   Group: Fish cell line.

OX   NCBI_TaxID=75935; ! Umbra limi

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ULF-23HU

AC   CVCL_5642

RX   DOI=10.1007/BF02624131;

CC   Group: Fish cell line.

OX   NCBI_TaxID=75935; ! Umbra limi

HI   CVCL_5641 ! ULF-23

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ULK1 KO MEF (SIM)

AC   CVCL_5A52

SY   ULK1-/-ULK2+/+

DR   ECACC; 14050806

DR   Ximbio; 151715

RX   PubMed=23291478;

CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   ULK1 KO MEF (SV40)

AC   CVCL_5A53

DR   ECACC; 14050807

DR   Ximbio; 152609

RX   PubMed=23291478;

CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   ULK1/2 WT MEF (SIM)

AC   CVCL_5A50

DR   ECACC; 14050808

DR   Ximbio; 151714

RX   PubMed=23291478;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   ULK1/2 WT MEF (SV40)

AC   CVCL_5A51

DR   ECACC; 14050804

DR   Ximbio; 152607

RX   PubMed=23291478;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   ULK1+ULK2 DKO MEF (SIM)

AC   CVCL_5A56

SY   MEF Ulk1 -/- Ulk2 -/- (DKO) (SIM)

DR   ECACC; 14050803

DR   Ximbio; 151774

RX   PubMed=23291478;

CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.

CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   ULK1+ULK2 DKO MEF (SV40)

AC   CVCL_5A57

SY   MEF Ulk1 -/- Ulk2 -/- (DKO) (SV40)

DR   ECACC; 14050802

DR   Ximbio; 152608

RX   PubMed=23291478;

CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.

CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   ULK2 KO MEF (SIM)

AC   CVCL_5A54

SY   ULK1+/+ULK2-/-

DR   ECACC; 14050810

DR   Ximbio; 151776

RX   PubMed=23291478;

CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   ULK2 KO MEF (SV40)

AC   CVCL_5A55

DR   ECACC; 14050805

DR   Ximbio; 152610

RX   PubMed=23291478;

CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   ULT-1

AC   CVCL_L784

RX   PubMed=22273270;

CC   Characteristics: Ultra long-lived cell line with a life span of 166 PDL.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0560 ! TIG-1

SX   Female

CA   Finite cell line

//

ID   ULTR

AC   CVCL_8138

RX   PubMed=1311088;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ULTR-hT

AC   CVCL_8139

SY   ULTRhT

RX   PubMed=19767538;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8138 ! ULTR

SX   Female

CA   Transformed cell line

//

ID   UM-1

AC   CVCL_W392

RX   PubMed=10087940;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-2

AC   CVCL_W393

RX   PubMed=10087940;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-3

AC   CVCL_W394

SY   UM3

RX   PubMed=10087940;

RX   PubMed=10936422;

RX   PubMed=15257707;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-6

AC   CVCL_W395

RX   PubMed=10087940;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-AVE1

AC   CVCL_Z825

RX   PubMed=1367156;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7163; ! Aedes vexans

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UM-BGE-1

AC   CVCL_Z332

RX   DOI=10.1016/B978-0-12-470270-7.50008-2;

RX   PubMed=192663;

CC   Group: Insect cell line.

CC   Doubling time: 4.8 days (PubMed=192663).

OX   NCBI_TaxID=6973; ! Blattella germanica

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UM-BGE-2

AC   CVCL_Z333

SY   UMN-BGE-2

RX   DOI=10.1016/B978-0-12-470270-7.50008-2;

RX   PubMed=192663;

RX   PubMed=16593348;

CC   Group: Insect cell line.

OX   NCBI_TaxID=6973; ! Blattella germanica

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UM-BGE-4

AC   CVCL_Z334

SY   UMBGE-4

RX   DOI=10.1016/B978-0-12-470270-7.50008-2;

RX   PubMed=192663;

CC   Group: Insect cell line.

OX   NCBI_TaxID=6973; ! Blattella germanica

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UM-BGE-5 alpha

AC   CVCL_Z335

RX   DOI=10.1016/B978-0-12-470270-7.50008-2;

RX   PubMed=192663;

CC   Group: Insect cell line.

OX   NCBI_TaxID=6973; ! Blattella germanica

OI   CVCL_Z336 ! UM-BGE-5 beta

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UM-BGE-5 beta

AC   CVCL_Z336

SY   UMN-BGE-5beta

RX   DOI=10.1016/B978-0-12-470270-7.50008-2;

RX   PubMed=192663;

RX   PubMed=16593348;

CC   Group: Insect cell line.

OX   NCBI_TaxID=6973; ! Blattella germanica

OI   CVCL_Z335 ! UM-BGE-5 alpha

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UM-CCS-1

AC   CVCL_0J37

SY   UM-CCS1

RX   PubMed=12237889;

DI   NCIt; C3745; Clear cell sarcoma of soft tissue

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-Chor1

AC   CVCL_1D68

SY   UM-CHOR-1; University of Michigan-Chordoma-1

RX   PubMed=27102572;

WW   https://www.chordomafoundation.org/reagents-data/cell-line-repository/um-chor1/

WW   http://ahns.jnabstracts.com/2014/Detail.aspx?ID=57728

WW   http://epostersonline.com/ifhnos2014/node/3423?view=true

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Genome sequenced.

ST   Source(s): PubMed=27102572

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 14

ST   D19S433: 14,16

ST   D21S11: 27,31

ST   D2S1338: 18,20

ST   D3S1358: 18

ST   D5S818: 9,13

ST   D7S820: 11

ST   D8S1179: 12,13

ST   FGA: 19,23

ST   Penta D: 8,9

ST   Penta E: 7

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 15

DI   NCIt; C5412; Clivus chordoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-Chor2

AC   CVCL_5T81

SY   UM-CHOR-2; University of Michigan-Chordoma-2

WW   http://ahns.jnabstracts.com/2014/Detail.aspx?ID=57728

WW   http://epostersonline.com/ifhnos2014/node/3423?view=true

DI   NCIt; C5156; Spinal chordoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-EC-1

AC   CVCL_5972

SY   University of Michigan-Endometrial Carcinoma-1

RX   PubMed=1541432;

RX   PubMed=3349465;

RX   PubMed=8123477;

RX   PubMed=17178626;

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-EC-2

AC   CVCL_X001

SY   University of Michigan-Endometrial Carcinoma-2

RX   PubMed=1541432;

RX   PubMed=2344964;

RX   PubMed=8123477;

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-EC-3

AC   CVCL_X002

SY   University of Michigan-Endometrial carcinoma-3

RX   PubMed=1541432;

RX   PubMed=8123477;

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-FSC-1

AC   CVCL_W199

RX   PubMed=3855324;

DI   NCIt; C6604; Bone fibrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-GCC-1

AC   CVCL_HX25

SY   University of Michigan-Glassy cell Cervix Carcinoma-1

RX   PubMed=1958593;

RX   PubMed=7751322;

DI   NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-HMC-1

AC   CVCL_Y473

RX   PubMed=24035723;

DI   NCIt; C5908; Salivary gland mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-HMC-2

AC   CVCL_Y474

RX   PubMed=24035723;

DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-HMC-3A

AC   CVCL_Y471

RX   PubMed=24035723;

DI   NCIt; C6214; Hard palate mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y472 ! UM-HMC-3B

SX   Female

CA   Cancer cell line

//

ID   UM-HMC-3B

AC   CVCL_Y472

RX   PubMed=24035723;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C6214; Hard palate mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y471 ! UM-HMC-3A

SX   Female

CA   Cancer cell line

//

ID   UM-HPA-1

AC   CVCL_Y475

RX   PubMed=24035723;

DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-Ly(ebv)-17

AC   CVCL_5G90

SY   UM-Lyebv-17

RX   PubMed=2790823;

RX   PubMed=6417595;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7724 ! UM-SCC-17A

OI   CVCL_7725 ! UM-SCC-17B

SX   Female

CA   Transformed cell line

//

ID   UM-RC-11

AC   CVCL_B226

SY   UMRC-11; UMRC11; University of Michigan-Renal Carcinoma-11

DR   Cosmic; 972915

RX   PubMed=7915601;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-RC-2

AC   CVCL_2739

SY   UMRC-2; UMRC2; University of Michigan-Renal Carcinoma-2

DR   CCLE; UMRC2_KIDNEY

DR   Cosmic; 972910

DR   ECACC; 08090511

DR   GEO; GSM374476

RX   PubMed=4038766;

RX   PubMed=7915601;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~24 hours (PubMed=4038766).

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-RC-3

AC   CVCL_2740

SY   UMRC-3; UMRC3; University of Michigan-Renal Carcinoma-3

DR   Cosmic; 972911

DR   ECACC; 08090512

DR   PRIDE; PXD003105

RX   PubMed=4038766;

RX   PubMed=7915601;

RX   PubMed=26972028;

RX   PubMed=27141528;

CC   Doubling time: ~29 hours (PubMed=4038766).

CC   Omics: GPI-anchored proteins analysis by proteomics.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,12

ST   D16S539: 9

ST   D5S818: 9,12

ST   D7S820: 9

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-RC-5

AC   CVCL_B227

SY   UMRC-5; UMRC5; University of Michigan-Renal Carcinoma-5

DR   Cosmic; 972872

DR   Cosmic; 972912

RX   PubMed=4038766;

RX   PubMed=7915601;

CC   Doubling time: ~43 hours (PubMed=4038766).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-RC-6

AC   CVCL_2741

SY   UMRC-6; UMRC6; University of Michigan-Renal Carcinoma-6

DR   BioSample; SAMN03470958

DR   CCLE; UMRC6_KIDNEY

DR   Cosmic; 972873

DR   Cosmic; 972913

DR   Cosmic; 1779196

DR   ECACC; 08090513

DR   GEO; GSM374477

RX   PubMed=4038766;

RX   PubMed=7915601;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-317.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~43 hours (PubMed=4038766).

ST   Source(s): ECACC; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 8,12

ST   D13S317: 12

ST   D16S539: 9,10

ST   D18S51: 18

ST   D19S433: 14,18.2

ST   D21S11: 28

ST   D2S1338: 19,22

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 10,12

ST   D8S1179: 12,13

ST   FGA: 22

ST   Penta D: 7

ST   Penta E: 8

ST   TH01: 6

ST   TPOX: 10

ST   vWA: 18

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-RC-7

AC   CVCL_2742

SY   UMRC-7; UMRC7; University of Michigan-Renal Carcinoma-7

DR   BioSample; SAMN03470957

DR   Cosmic; 972914

DR   ECACC; 08090514

RX   PubMed=4038766;

RX   PubMed=7915601;

CC   Doubling time: ~53 hours (PubMed=4038766).

ST   Source(s): ECACC; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 8,11

ST   D16S539: 11

ST   D18S51: 13,14,19

ST   D19S433: 14,15,16.2

ST   D21S11: 31.2,33.2

ST   D2S1338: 17,25

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 13,14

ST   FGA: 24,25

ST   Penta D: 9,12

ST   Penta E: 7,9

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-1

AC   CVCL_7707

SY   UMSCC-1; UM-SCC1; UMSCC1; SCC-1; SCC1

DR   BTO; BTO:0003138

DR   Cosmic; 1483455

DR   Cosmic; 1530751

DR   Cosmic; 2131858

DR   Millipore; SCC070

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X,Y (PubMed=19760794_passage_4)

ST   Amelogenin: X (PubMed=19760794_passage_150; PubMed=21868764)

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 12,13

ST   D18S51: 18

ST   D21S11: 27

ST   D3S1358: 18

ST   D5S818: 10,13

ST   D7S820: 9,12

ST   D8S1179: 13,16 (PubMed=19760794_passage_4)

ST   D8S1179: 16 (PubMed=19760794_passage_150)

ST   FGA: 18,22 (PubMed=19760794_passage_4)

ST   FGA: 18 (PubMed=19760794_passage_150)

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-100

AC   CVCL_7708

SY   UMSCC-100; UMSCC100

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-101A

AC   CVCL_7709

SY   UMSCC-101A; UMSCC101A

RX   PubMed=15287027;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7710 ! UM-SCC-101B

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-101B

AC   CVCL_7710

SY   UMSCC-101B; UMSCC101B

RX   PubMed=15287027;

CC   Derived from metastatic site: Neck lymph node.

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7709 ! UM-SCC-101A

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-103

AC   CVCL_7711

SY   UMSCC-103; UMSCC103

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-SCC-104

AC   CVCL_7712

SY   UMSCC-104; UMSCC104; University of Michigan-Squamous Cell Carcinoma-104

DR   Millipore; SCC072

RX   PubMed=22162267;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-105

AC   CVCL_0C69

RX   PubMed=25677579;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-106

AC   CVCL_0C70

RX   PubMed=25677579;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-108

AC   CVCL_0C71

RX   PubMed=25677579;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-109

AC   CVCL_0C72

RX   PubMed=25677579;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-10A

AC   CVCL_7713

SY   UM-SCC 10A; UMSCC-10A; UMSCC10A

DR   Cosmic; 948025

DR   Cosmic; 2131859

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=8679156;

RX   PubMed=15287027;

RX   PubMed=19760794;

RX   PubMed=20947470;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9

ST   D16S539: 11

ST   D18S51: 15

ST   D21S11: 30

ST   D3S1358: 17

ST   D5S818: 12,13

ST   D7S820: 9

ST   D8S1179: 13,14

ST   FGA: 22,26

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 19

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7714 ! UM-SCC-10B

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-10B

AC   CVCL_7714

SY   UM-SCC 10B; UMSCC-10B; UMSCC10B; UM-SCC10B

DR   Cosmic; 932287

DR   Cosmic; 948026

DR   Cosmic; 2439751

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=8679156;

RX   PubMed=15287027;

RX   PubMed=19760794;

RX   PubMed=20947470;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Submental lymph node.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9

ST   D16S539: 11

ST   D18S51: 15

ST   D21S11: 30

ST   D3S1358: 17

ST   D5S818: 12,13

ST   D7S820: 9

ST   D8S1179: 13,14

ST   FGA: 22

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 19

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7713 ! UM-SCC-10A

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-110

AC   CVCL_0C73

RX   PubMed=25677579;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-111

AC   CVCL_0C74

RX   PubMed=25677579;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-11A

AC   CVCL_7715

SY   UMSCC-11A; UMSCC11A

DR   Cosmic; 948027

DR   Cosmic; 2131860

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=1958593;

RX   PubMed=3855324;

RX   PubMed=15287027;

RX   PubMed=19760794;

RX   PubMed=16785414;

RX   PubMed=21868764;

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 7

ST   D13S317: 14

ST   D16S539: 12,14

ST   D18S51: 16

ST   D21S11: 28

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 12,15

ST   FGA: 19,24

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 16,17,18

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7716 ! UM-SCC-11B

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-11B

AC   CVCL_7716

SY   UM-SCC 11B; UMSCC-11B; UMSCC11B; UM-SCC11B; SCC11B

DR   BTO; BTO:0005995

DR   Cosmic; 932288

DR   Cosmic; 948028

DR   Cosmic; 1130354

DR   Cosmic; 1317414

DR   Cosmic; 1351517

DR   Cosmic; 2296306

DR   Cosmic; 2131861

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=1958593;

RX   PubMed=3855324;

RX   PubMed=8679156;

RX   PubMed=15287027;

RX   PubMed=16785414;

RX   PubMed=19760794;

RX   PubMed=20947470;

RX   PubMed=21868764;

RX   PubMed=25275298;

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

ST   Source(s): PubMed=19760794; PubMed=21868764; PubMed=25275298

ST   Amelogenin: X

ST   CSF1PO: 7

ST   D13S317: 14

ST   D16S539: 12,14

ST   D18S51: 16

ST   D21S11: 28

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 15

ST   FGA: 19

ST   Penta D: 2.2

ST   Penta E: 8,13

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 16,17,18

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7715 ! UM-SCC-11A

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-12

AC   CVCL_7717

SY   UMSCC-12; UMSCC12

DR   BTO; BTO:0003139

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 13

ST   D18S51: 12,16

ST   D21S11: 29

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 10,11

ST   D8S1179: 14,15

ST   FGA: 23,25

ST   vWA: 16

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-13

AC   CVCL_7718

SY   UMSCC-13; UMSCC13

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 12

ST   D18S51: 14,16

ST   D21S11: 27,28

ST   D3S1358: 16,18

ST   D5S818: 13

ST   D7S820: 8,12

ST   D8S1179: 12,14

ST   FGA: 19,24

ST   vWA: 17

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-14A

AC   CVCL_7719

SY   UM-SCC 14A; UMSCC-14A; UMSCC14A

DR   BTO; BTO:0003140

DR   Cosmic; 948029

DR   Cosmic; 1483458

DR   Lonza; 40

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=8679156;

RX   PubMed=9041179;

RX   PubMed=15287027;

RX   PubMed=19760794;

RX   PubMed=20947470;

RX   PubMed=21868764;

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 15

ST   D21S11: 29

ST   D3S1358: 15

ST   D5S818: 11,14

ST   D7S820: 9,10

ST   D8S1179: 8,13

ST   FGA: 20,21

ST   TH01: 6,8

ST   vWA: 14,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7720 ! UM-SCC-14B

OI   CVCL_7721 ! UM-SCC-14C

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-14B

AC   CVCL_7720

SY   UM-SCC 14B; UMSCC-14B; UMSCC14B

DR   BTO; BTO:0002710

DR   Cosmic; 948030

DR   Cosmic; 2513912

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=8679156;

RX   PubMed=9041179;

RX   PubMed=15287027;

RX   PubMed=19760794;

RX   PubMed=20947470;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 15

ST   D21S11: 29

ST   D3S1358: 15

ST   D5S818: 11,14

ST   D7S820: 9,10 (PubMed=19760794)

ST   D7S820: 9,10,11 (PubMed=21868764)

ST   D8S1179: 8,13

ST   FGA: 20,21

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7719 ! UM-SCC-14A

OI   CVCL_7721 ! UM-SCC-14C

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-14C

AC   CVCL_7721

SY   UM-SCC 14C; UMSCC-14C; UMSCC14C; UM-SCC14C

DR   CLS; 300370/p795_UM-SCC-14C

DR   Cosmic; 932289

RX   PubMed=8679156;

RX   PubMed=9041179;

RX   PubMed=15287027;

RX   PubMed=19760794;

RX   PubMed=20947470;

CC   Derived from metastatic site: Skin.

ST   Source(s): CLS; PubMed=19760794

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 15

ST   D21S11: 29

ST   D3S1358: 15

ST   D5S818: 11,14

ST   D7S820: 9,10

ST   D8S1179: 8,13

ST   FGA: 20,21

ST   Penta D: 12,16

ST   Penta E: 7

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7719 ! UM-SCC-14A

OI   CVCL_7720 ! UM-SCC-14B

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-15

AC   CVCL_7722

SY   UMSCC-15; UMSCC15

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 12

ST   D18S51: 14

ST   D21S11: 31,31.2

ST   D3S1358: 18

ST   D5S818: 12

ST   D7S820: 9

ST   D8S1179: 13,14

ST   FGA: 23

ST   vWA: 17

DI   NCIt; C102872; Pharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-16

AC   CVCL_7723

SY   UMSCC-16; UMSCC16

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 8,10

ST   D18S51: 15

ST   D21S11: 28,29.2

ST   D3S1358: 14

ST   D5S818: 10,12

ST   D7S820: 10,12

ST   D8S1179: 10,14

ST   FGA: 21,24

ST   vWA: 15,17

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-17A

AC   CVCL_7724

SY   UM-SCC 17A; UMSCC-17A; UMSCC17A; UM-SCC17A; SCC17A

DR   BTO; BTO:0004022

DR   Cosmic; 932290

DR   Cosmic; 948031

DR   Cosmic; 1130355

DR   Millipore; SCC074

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=1958593;

RX   PubMed=2790823;

RX   PubMed=3855324;

RX   PubMed=6417595;

RX   PubMed=8679156;

RX   PubMed=15287027;

RX   PubMed=16785414;

RX   PubMed=19760794;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 10,11

ST   D18S51: 17,22

ST   D21S11: 28

ST   D3S1358: 15,18

ST   D5S818: 11

ST   D7S820: 13

ST   D8S1179: 12,13

ST   FGA: 20,22

ST   TH01: 6,8

ST   TPOX: 10,11

ST   vWA: 14,17

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5G90 ! UM-Ly(ebv)-17

OI   CVCL_7725 ! UM-SCC-17B

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-17As

AC   CVCL_9T71

RX   PubMed=1958593;

RX   PubMed=15287027;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7724 ! UM-SCC-17A

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-17B

AC   CVCL_7725

SY   UMSCC-17B; UMSCC17B

DR   BTO; BTO:0002711

DR   Cosmic; 948032

DR   Cosmic; 2296307

DR   Millipore; SCC075

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=1958593;

RX   PubMed=2790823;

RX   PubMed=3855324;

RX   PubMed=6417595;

RX   PubMed=15287027;

RX   PubMed=16785414;

RX   PubMed=19760794;

RX   PubMed=21868764;

RX   PubMed=25275298;

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Neck lymph node.

ST   Source(s): PubMed=19760794; PubMed=21868764; PubMed=25275298

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 10,11

ST   D18S51: 22

ST   D21S11: 28

ST   D3S1358: 15,18

ST   D5S818: 11

ST   D7S820: 13

ST   D8S1179: 12,13

ST   FGA: 20,22

ST   Penta D: 10

ST   Penta E: 5,19

ST   TH01: 6,8

ST   TPOX: 10,11

ST   vWA: 14,17

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5G90 ! UM-Ly(ebv)-17

OI   CVCL_7724 ! UM-SCC-17A

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-18

AC   CVCL_7726

SY   UMSCC-18; UMSCC18

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 9,12

ST   D18S51: 14

ST   D21S11: 29,30

ST   D3S1358: 13,14

ST   D5S818: 11

ST   D7S820: 9

ST   D8S1179: 14,15

ST   FGA: 19,20

ST   vWA: 15,19

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-19

AC   CVCL_7727

SY   UMSCC-19; UMSCC19; UMC19; UMC-19; umc-19

DR   Cosmic; 844589

DR   Cosmic; 877398

DR   Cosmic; 1152493

DR   Cosmic; 2043900

DR   Cosmic; 2439755

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 9,13

ST   D18S51: 10,16

ST   D21S11: 28,30

ST   D3S1358: 14

ST   D5S818: 11

ST   D7S820: 9

ST   D8S1179: 10,12

ST   FGA: 24

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,19

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-2

AC   CVCL_7728

SY   UMSCC-2; UMSCC2

DR   BTO; BTO:0003315

DR   Cosmic; 2043890

DR   Cosmic; 2296304

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

RX   PubMed=21868764;

RX   PubMed=25275298;

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 11,13

ST   D18S51: 18

ST   D21S11: 30,33.2

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 8,12

ST   D8S1179: 12,14

ST   FGA: 19

ST   vWA: 16

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-20

AC   CVCL_7729

SY   UMSCC-20; UMSCC20

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=19760794;

CC   Derived from metastatic site: Neck.

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 8,10

ST   D18S51: 13,15

ST   D21S11: 28,30.2

ST   D3S1358: 14,15

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 12,15

ST   FGA: 18,22.2

ST   vWA: 16,18

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-21A

AC   CVCL_7730

SY   UMSCC-21A; UMSCC21A

DR   BTO; BTO:0002713

RX   PubMed=1958593;

RX   PubMed=15287027;

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 8,9

ST   D18S51: 14

ST   D21S11: 29,32.2

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   D8S1179: 13,14

ST   FGA: 21

ST   vWA: 16,18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L143 ! UM-SCC-21B

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-21B

AC   CVCL_L143

SY   UMSCC-21B; UMSCC21B

RX   PubMed=1958593;

RX   PubMed=15287027;

CC   Derived from metastatic site: Neck lymph node.

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7730 ! UM-SCC-21A

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-22A

AC   CVCL_7731

SY   UMSCC-22A; UMSCC22A; SCC22A; UMC-22a; UMC22a; UM-22A

DR   BTO; BTO:0002714

DR   Cosmic; 948033

DR   Cosmic; 1130357

DR   Cosmic; 2439752

DR   Cosmic; 2513913

DR   Millipore; SCC076

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=1958593;

RX   PubMed=15287027;

RX   PubMed=19760794;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,12

ST   D16S539: 9,11

ST   D18S51: 18

ST   D21S11: 28

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 8,9

ST   D8S1179: 11,13

ST   FGA: 22,24

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 15,18 (PubMed=19760794_passage_16)

ST   vWA: 18 (PubMed=19760794_passage_138; PubMed=21868764)

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7732 ! UM-SCC-22B

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-22B

AC   CVCL_7732

SY   UM-SCC 22B; UMSCC-22B; UMSCC22B; UM-SCC22B; SCC22B; UMC-22b; UMC22b; UMC22B; UM-22B

DR   ChEMBL-Cells; CHEMBL3307244

DR   ChEMBL-Targets; CHEMBL612798

DR   Cosmic; 932291

DR   Cosmic; 948034

DR   Cosmic; 1130358

DR   Cosmic; 1483459

DR   Cosmic; 2131862

DR   Cosmic; 2513914

DR   Millipore; SCC077

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=1958593;

RX   PubMed=8679156;

RX   PubMed=15287027;

RX   PubMed=19760794;

RX   PubMed=20145189;

RX   PubMed=20947470;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Neck lymph node.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,12

ST   D16S539: 9,11

ST   D18S51: 18

ST   D21S11: 28

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 8,9

ST   D8S1179: 11,13

ST   FGA: 22,24

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7731 ! UM-SCC-22A

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-23

AC   CVCL_7733

SY   UMSCC-23; UMSCC23

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=1958593;

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 8

ST   D18S51: 10

ST   D21S11: 29

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 8,13

ST   D8S1179: 10,15

ST   FGA: 20

ST   vWA: 17

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-24

AC   CVCL_7734

SY   UMSCC-24; UMSCC24

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 11,12

ST   D18S51: 15

ST   D21S11: 32.2

ST   D3S1358: 17

ST   D5S818: 13

ST   D7S820: 9

ST   D8S1179: 13

ST   FGA: 18,25

ST   vWA: 16,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-25

AC   CVCL_7735

SY   UMSCC-25; UMSCC25; SCC25; UMC-25; UMC25

DR   Cosmic; 1130359

DR   Cosmic; 2131863

RX   PubMed=19760794;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 10,15

ST   D13S317: 11

ST   D16S539: 10,12

ST   D18S51: 19

ST   D21S11: 27

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 12,13

ST   D8S1179: 13,14

ST   FGA: 21

ST   TH01: 6,9

ST   TPOX: 8,9

ST   vWA: 19

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-26

AC   CVCL_7736

SY   UMSCC-26; UMSCC26

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 11

ST   D18S51: 14

ST   D21S11: 32.2

ST   D3S1358: 16

ST   D5S818: 10,11

ST   D7S820: 7,12

ST   D8S1179: 13,15

ST   FGA: 21,24

ST   vWA: 16,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-27

AC   CVCL_7737

SY   UMSCC-27; UMSCC27

DR   Cosmic; 1483460

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 8

ST   D18S51: 14,16

ST   D21S11: 29,32.2

ST   D3S1358: 14

ST   D5S818: 12,13

ST   D7S820: 8,11

ST   D8S1179: 12,13

ST   FGA: 19

ST   vWA: 17,18

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-28

AC   CVCL_7738

SY   UMSCC-28; UMSCC28

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 12

ST   D18S51: 14

ST   D21S11: 30,32.2

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 13,15

ST   FGA: 23,25

ST   vWA: 18,19

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-29

AC   CVCL_7739

SY   UMSCC-29; UMSCC29

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 8,11

ST   D18S51: 15

ST   D21S11: 28

ST   D3S1358: 14

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 15

ST   FGA: 23,25

ST   vWA: 18,19

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-SCC-3

AC   CVCL_7740

SY   UMSCC-3; UMSCC3; SCC3

DR   Cosmic; 1130350

DR   Cosmic; 1483456

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

RX   PubMed=21868764;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D18S51: 12,15

ST   D21S11: 31.2

ST   D3S1358: 17

ST   D5S818: 11,13

ST   D7S820: 9,10

ST   D8S1179: 14

ST   FGA: 20,27

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-30

AC   CVCL_7741

SY   UMSCC-30; UMSCC30

DR   Cosmic; 2513915

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 13

ST   D18S51: 14

ST   D21S11: 29

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 14,15

ST   FGA: 21

ST   vWA: 16,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-31

AC   CVCL_7742

SY   UMSCC-31; UMSCC31; UMC-31; UMC31

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 10,12

ST   D18S51: 13,18

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 8

ST   D8S1179: 14

ST   FGA: 24

ST   vWA: 17,18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-32

AC   CVCL_7743

SY   UMSCC-32; UMSCC32

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-33

AC   CVCL_7744

SY   UMSCC-33; UMSCC33

RX   PubMed=19760794;

RX   PubMed=21868764;

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 11

ST   D16S539: 10

ST   D18S51: 18

ST   D21S11: 31

ST   D3S1358: 17

ST   D5S818: 10

ST   D7S820: 10

ST   D8S1179: 12

ST   FGA: 19

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-34

AC   CVCL_7745

SY   UMSCC-34; UMSCC34

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 12,13

ST   D18S51: 13

ST   D21S11: 30,31

ST   D3S1358: 15

ST   D5S818: 12,13

ST   D7S820: 10,12

ST   D8S1179: 9,14

ST   FGA: 23

ST   vWA: 15,18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-35

AC   CVCL_7746

SY   UMSCC-35; UMSCC35

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 11

ST   D18S51: 15

ST   D21S11: 36

ST   D3S1358: 17

ST   D5S818: 13

ST   D7S820: 9,11

ST   D8S1179: 11,15,16

ST   FGA: 18.2,26

ST   vWA: 15,18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-36

AC   CVCL_7747

SY   UMSCC-36; UMSCC36; UMC-36; UMC36

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 11,12

ST   D18S51: 20

ST   D21S11: 30

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 9,11

ST   D8S1179: 12,13

ST   FGA: 21

ST   vWA: 17,18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-37

AC   CVCL_7748

SY   UMSCC-37; UMSCC37

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 10

ST   D18S51: 14,17

ST   D21S11: 30

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 11,14

ST   FGA: 20,22

ST   vWA: 18,19

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-38

AC   CVCL_7749

SY   UMSCC-38; UMSCC38

DR   BTO; BTO:0002715

DR   Cosmic; 948035

DR   Cosmic; 2513916

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=1958593;

RX   PubMed=19760794;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 10,11

ST   D18S51: 19

ST   D21S11: 27,29

ST   D3S1358: 18

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 14,15

ST   FGA: 28

ST   vWA: 17,18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-39

AC   CVCL_7750

SY   UMSCC-39; UMSCC39

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 13

ST   D18S51: 16,17

ST   D21S11: 32.2

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 10,11

ST   D8S1179: 14

ST   FGA: 24

ST   vWA: 17,18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-4

AC   CVCL_7751

SY   UMSCC-4; UMSCC4; SCC4

DR   Cosmic; 1130351

DR   Cosmic; 1483457

DR   Cosmic; 2131864

DR   Cosmic; 2296305

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

RX   PubMed=21868764;

RX   PubMed=25275298;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 16

ST   D21S11: 28

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 9,10

ST   D8S1179: 13,15

ST   FGA: 26

ST   TH01: 7

ST   TPOX: 9,10

ST   vWA: 17,18

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-40

AC   CVCL_7752

SY   UMSCC-40; UMSCC40

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 10

ST   D18S51: 12

ST   D21S11: 28,30

ST   D3S1358: 14

ST   D5S818: 10

ST   D7S820: 8,10

ST   D8S1179: 13

ST   FGA: 21,22

ST   vWA: 14,16

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-41

AC   CVCL_7753

SY   UMSCC-41; UMSCC41

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 11

ST   D18S51: 18

ST   D21S11: 29

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 10,12

ST   D8S1179: 14

ST   FGA: 25

ST   vWA: 18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-42

AC   CVCL_7754

SY   UMSCC-42; UMSCC42

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 13

ST   D18S51: 12

ST   D21S11: 29,30

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   D8S1179: 10,14

ST   FGA: 19,20

ST   vWA: 18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-43

AC   CVCL_7755

SY   UMSCC-43; UMSCC43

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 11,13

ST   D18S51: 14,16

ST   D21S11: 32.2

ST   D3S1358: 18

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 13,15

ST   FGA: 20,22

ST   vWA: 14,15

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-44

AC   CVCL_7756

SY   UMSCC-44; UMSCC44

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 12

ST   D18S51: 12,13

ST   D21S11: 30

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 9,13

ST   D8S1179: 13

ST   FGA: 24

ST   vWA: 16,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-45

AC   CVCL_7757

SY   UMSCC-45; UMSCC45

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 10

ST   D18S51: 19

ST   D21S11: 28,30

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 11,14

ST   FGA: 21

ST   vWA: 14,16

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-46

AC   CVCL_7758

SY   UMSCC-46; UMSCC46

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 10

ST   D18S51: 19

ST   D21S11: 30,31.2

ST   D3S1358: 15

ST   D5S818: 10,11

ST   D7S820: 12,14

ST   D8S1179: 13,15

ST   FGA: 21

ST   vWA: 14,18

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-47

AC   CVCL_7759

SY   UMSCC-47; UMSCC47; UM-SCC47; UMSCC047

DR   Cosmic; 1122677

DR   Cosmic; 2131865

DR   Cosmic; 2296309

DR   Millipore; SCC071

RX   PubMed=19760794;

RX   PubMed=21868764;

RX   PubMed=25275298;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Omics: Deep exome analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794; PubMed=21868764; PubMed=25275298

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 8,11

ST   D16S539: 8,13

ST   D18S51: 18

ST   D21S11: 29,30

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 11

ST   D8S1179: 15

ST   FGA: 23,25

ST   Penta D: 9,10

ST   Penta E: 12,13

ST   TH01: 7,9.3

ST   TPOX: 10,11

ST   vWA: 18

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-48

AC   CVCL_7760

SY   UMSCC-48; UMSCC48

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 12

ST   D18S51: 15

ST   D21S11: 29,31.2

ST   D3S1358: 14

ST   D5S818: 12,13

ST   D7S820: 8,11

ST   D8S1179: 13,14

ST   FGA: 18,21

ST   vWA: 17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-49

AC   CVCL_7761

SY   UMSCC-49; UMSCC49

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 12,13

ST   D18S51: 15

ST   D21S11: 27

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 8,9

ST   D8S1179: 12

ST   FGA: 23,26

ST   vWA: 16,20

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-5

AC   CVCL_7762

SY   UMSCC-5; UMSCC5

DR   BTO; BTO:0004023

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 8,11

ST   D18S51: 12,16

ST   D21S11: 31

ST   D3S1358: 17

ST   D5S818: 13

ST   D7S820: 9

ST   D8S1179: 11,13

ST   FGA: 25

ST   vWA: 18

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-50

AC   CVCL_7763

SY   UMSCC-50; UMSCC50

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 11

ST   D18S51: 17

ST   D21S11: 29

ST   D3S1358: 15

ST   D5S818: 9,12

ST   D7S820: 10,12

ST   D8S1179: 13,15

ST   FGA: 21,22

ST   vWA: 16,18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-51

AC   CVCL_7764

SY   UMSCC-51; UMSCC51

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 11

ST   D18S51: 14

ST   D21S11: 29

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 13

ST   D8S1179: 9,12

ST   FGA: 20,21

ST   vWA: 14,15

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-52

AC   CVCL_7765

SY   UMSCC-52; UMSCC52

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 13

ST   D18S51: 12

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 9,12

ST   D8S1179: 13,16,17

ST   FGA: 19

ST   vWA: 16,18,19

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-53

AC   CVCL_7766

SY   UMSCC-53; UMSCC53

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 8

ST   D18S51: 14,21

ST   D21S11: 27,30

ST   D3S1358: 14

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 12,15

ST   FGA: 24

ST   vWA: 17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-54

AC   CVCL_7767

SY   UMSCC-54; UMSCC54; UMC-54; UMC54

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 10,11

ST   D18S51: 14,15

ST   D21S11: 29

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 10,12

ST   D8S1179: 12,14

ST   FGA: 24,25

ST   vWA: 14,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-55

AC   CVCL_7768

SY   UMSCC-55; UMSCC55

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 8,13

ST   D18S51: 16

ST   D21S11: 30,31

ST   D3S1358: 17

ST   D5S818: 12,13

ST   D7S820: 10

ST   D8S1179: 12,14

ST   FGA: 22,24

ST   vWA: 17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-56

AC   CVCL_7769

SY   UMSCC-56; UMSCC56

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-SCC-57

AC   CVCL_7770

SY   UMSCC-57; UMSCC57

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 9,12

ST   D18S51: 17,18

ST   D21S11: 29

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 12

ST   FGA: 23,24

ST   vWA: 16,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-58

AC   CVCL_7771

SY   UMSCC-58; UMSCC58

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 9,13

ST   D18S51: 13

ST   D21S11: 30,32.2

ST   D3S1358: 14

ST   D5S818: 11

ST   D7S820: 9,11

ST   D8S1179: 13,15

ST   FGA: 22,25

ST   vWA: 15,16,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-59

AC   CVCL_7772

SY   UMSCC-59; UMSCC59

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 10

ST   D18S51: 12

ST   D21S11: 28,29

ST   D3S1358: 14

ST   D5S818: 10

ST   D7S820: 11,12

ST   D8S1179: 13,14

ST   FGA: 22

ST   vWA: 15

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-6

AC   CVCL_7773

SY   UMSCC-6; UMSCC6; SCC-6

DR   Cosmic; 1530755

DR   Millipore; SCC073

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794; PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 13

ST   D16S539: 9,12

ST   D18S51: 11,19

ST   D21S11: 28

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 10,11

ST   D8S1179: 11,14

ST   FGA: 23

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 15,16

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-60

AC   CVCL_7774

SY   UMSCC-60; UMSCC60

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 14

ST   D18S51: 12

ST   D21S11: 32

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 9,10

ST   D8S1179: 11

ST   FGA: 19,26

ST   vWA: 14,15

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-62

AC   CVCL_L129

SY   UMSCC-62; UMSCC62

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-63

AC   CVCL_L130

SY   UMSCC-63; UMSCC63

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-65

AC   CVCL_L131

SY   UMSCC-65; UMSCC65

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-66

AC   CVCL_L132

SY   UMSCC-66; UMSCC66

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-67

AC   CVCL_L133

SY   UMSCC-67; UMSCC67

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-68A

AC   CVCL_L134

SY   UMSCC-68A; UMSCC68A

RX   PubMed=15287027;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L135 ! UM-SCC-68B

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-68B

AC   CVCL_L135

SY   UMSCC-68B; UMSCC68B

RX   PubMed=15287027;

CC   Derived from metastatic site: Neck lymph node.

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L134 ! UM-SCC-68A

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-69

AC   CVCL_7775

SY   UMSCC-69; UMSCC69

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 11

ST   D18S51: 15,16

ST   D21S11: 30,32.2

ST   D3S1358: 17,18

ST   D5S818: 11,12

ST   D7S820: 11,13

ST   D8S1179: 10,14

ST   FGA: 20,24

ST   vWA: 16,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-7

AC   CVCL_7776

SY   UMSCC-7; UMSCC7

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 10

ST   D18S51: 14,15

ST   D21S11: 33.2

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 8,12

ST   D8S1179: 12,15

ST   FGA: 20,22

ST   vWA: 16

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-70

AC   CVCL_7777

SY   UMSCC-70; UMSCC70

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 11

ST   D18S51: 18

ST   D21S11: 30

ST   D3S1358: 14

ST   D5S818: 11

ST   D7S820: 12

ST   D8S1179: 14

ST   FGA: 20

ST   vWA: 16,17

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-71

AC   CVCL_L136

SY   UMSCC-71; UMSCC71

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-72

AC   CVCL_L137

SY   UMSCC-72; UMSCC72

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-73A

AC   CVCL_9T70

RX   PubMed=15287027;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7778 ! UM-SCC-73B

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-73B

AC   CVCL_7778

SY   UMSCC-73B; UMSCC73B

RX   PubMed=15287027;

RX   PubMed=19760794;

CC   Derived from metastatic site: Neck lymph node.

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 11

ST   D18S51: 12,14

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 8,9

ST   D8S1179: 13,15

ST   FGA: 21

ST   vWA: 16,19

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9T70 ! UM-SCC-73A

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-74A

AC   CVCL_7779

SY   UMSCC-74A; UMSCC74A

RX   PubMed=15287027;

RX   PubMed=19760794;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 12

ST   D18S51: 17

ST   D21S11: 30,34.2

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 12,13

ST   FGA: 21,26

ST   vWA: 15,16

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7780 ! UM-SCC-74B

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-74B

AC   CVCL_7780

SY   UMSCC-74B; UMSCC74B

RX   PubMed=15287027;

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 12

ST   D18S51: 17

ST   D21S11: 30,34.2

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 12,13

ST   FGA: 21,26

ST   vWA: 15,16

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7779 ! UM-SCC-74A

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-75

AC   CVCL_L138

SY   UMSCC-75; UMSCC75

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-76

AC   CVCL_L139

SY   UMSCC-76; UMSCC76

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-77

AC   CVCL_L140

SY   UMSCC-77; UMSCC77

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-78A

AC   CVCL_L141

SY   UMSCC-78A; UMSCC78A

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L142 ! UM-SCC-78B

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-78B

AC   CVCL_L142

SY   UMSCC-78B; UMSCC78B

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L141 ! UM-SCC-78A

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-79

AC   CVCL_L299

SY   UMSCC-79; UMSCC79

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-8

AC   CVCL_7781

SY   UMSCC-8; UMSCC8; SCC8

DR   Cosmic; 1130352

DR   Cosmic; 2043898

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=1958593;

RX   PubMed=3855324;

RX   PubMed=19760794;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 12

ST   D18S51: 13,15

ST   D21S11: 29,31.2

ST   D3S1358: 14,16

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   D8S1179: 10,13

ST   FGA: 22,23

ST   vWA: 16

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-80

AC   CVCL_7782

SY   UMSCC-80; UMSCC80

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 11

ST   D18S51: 24

ST   D21S11: 31.2

ST   D3S1358: 17

ST   D5S818: 9

ST   D7S820: 10

ST   D8S1179: 13

ST   FGA: 22

ST   vWA: 14,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-81A

AC   CVCL_7783

SY   UMSCC-81A; UMSCC81A

RX   PubMed=9041179;

RX   PubMed=15287027;

RX   PubMed=16785414;

RX   PubMed=19760794;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 9

ST   D18S51: 14,19

ST   D21S11: 33.2

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 10

ST   FGA: 22

ST   vWA: 17

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7784 ! UM-SCC-81B

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-81B

AC   CVCL_7784

SY   UMSCC-81B; UMSCC81B

RX   PubMed=9041179;

RX   PubMed=15287027;

RX   PubMed=16785414;

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X,Y

ST   D13S317: 9,11

ST   D18S51: 14

ST   D21S11: 29

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 10,13

ST   FGA: 20,22

ST   vWA: 17

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7783 ! UM-SCC-81A

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-82A

AC   CVCL_L127

SY   UMSCC-82A; UMSCC82A

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L128 ! UM-SCC-82B

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-82B

AC   CVCL_L128

SY   UMSCC-82B; UMSCC82B

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L127 ! UM-SCC-82A

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-83A

AC   CVCL_7785

SY   UMSCC-83A; UMSCC83A

RX   PubMed=9041179;

RX   PubMed=15287027;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7786 ! UM-SCC-83B

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-83B

AC   CVCL_7786

SY   UMSCC-83B; UMSCC83B

RX   PubMed=9041179;

RX   PubMed=15287027;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7785 ! UM-SCC-83A

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-84

AC   CVCL_7787

SY   UMSCC-84; UMSCC84

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-85

AC   CVCL_7788

SY   UMSCC-85; UMSCC85

RX   PubMed=21868764;

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 12

ST   D5S818: 11,12

ST   D7S820: 9

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C8192; Nasal cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-86

AC   CVCL_7789

SY   UMSCC-86; UMSCC86

RX   PubMed=9041179;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-87

AC   CVCL_7790

SY   UMSCC-87; UMSCC87

RX   PubMed=9041179;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-88

AC   CVCL_7791

SY   UMSCC-88; UMSCC88

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-89

AC   CVCL_7792

SY   UMSCC-89; UMSCC89

RX   PubMed=9041179;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-9

AC   CVCL_7793

SY   UMSCC-9; UMSCC9; UM-SCC9; SCC9

DR   Cosmic; 1130353

DR   Cosmic; 1317413

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=3855324;

RX   PubMed=19760794;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 11,14

ST   D18S51: 13,15

ST   D21S11: 30,31.2

ST   D3S1358: 14

ST   D5S818: 12

ST   D7S820: 8,11

ST   D8S1179: 9,13

ST   FGA: 22

ST   vWA: 17,18

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-90

AC   CVCL_7794

SY   UMSCC-90; UMSCC90

RX   PubMed=9041179;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-91

AC   CVCL_7795

SY   UMSCC-91; UMSCC91

RX   PubMed=9041179;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-92

AC   CVCL_7796

SY   UMSCC-92; UMSCC92

RX   PubMed=19760794;

ST   Source(s): PubMed=19760794

ST   Amelogenin: X

ST   D13S317: 12,14

ST   D18S51: 14,15

ST   D21S11: 29,31

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 11,12

ST   D8S1179: 10,13

ST   FGA: 19,21

ST   vWA: 17,20

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-93

AC   CVCL_7797

SY   UMSCC-93; UMSCC93

RX   PubMed=9041179;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-94

AC   CVCL_7798

SY   UMSCC-94; UMSCC94

RX   PubMed=9041179;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-95

AC   CVCL_7799

SY   UMSCC-95; UMSCC95

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-96

AC   CVCL_7800

SY   UMSCC-96; UMSCC96

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-97

AC   CVCL_7801

SY   UMSCC-97; UMSCC97

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCC-98

AC   CVCL_7802

SY   UMSCC-98; UMSCC98

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCC-99

AC   CVCL_7803

SY   UMSCC-99; UMSCC99

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCP-1

AC   CVCL_4906

RX   PubMed=6378378;

RX   PubMed=14518029;

WW   http://capcelllines.ca/details.asp?id=81

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-SCV-1A

AC   CVCL_0568

SY   UMSCV-1A; University of Michigan-Squamous cell Carcinoma of the Vulva-1A

DR   MCCL; MCC:0000473

RX   PubMed=1777413;

RX   PubMed=1958593;

RX   PubMed=2335395;

RX   PubMed=2758419;

RX   PubMed=8646696;

RX   PubMed=15047230;

CC   Doubling time: 32 hours (PubMed=15047230).

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5973 ! UM-SCV-1B

SX   Female

CA   Cancer cell line

//

ID   UM-SCV-1B

AC   CVCL_5973

SY   UMSCV-1B; University of Michigan-Squamous cell Carcinoma of the Vulva-1B

RX   PubMed=1777413;

RX   PubMed=1958593;

RX   PubMed=2335395;

RX   PubMed=2758419;

RX   PubMed=7599042;

RX   PubMed=8646696;

RX   PubMed=15047230;

CC   Doubling time: 34 hours (PubMed=15047230).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0568 ! UM-SCV-1A

SX   Female

CA   Cancer cell line

//

ID   UM-SCV-2

AC   CVCL_5974

SY   UMSCV-2; University of Michigan-Squamous cell Carcinoma of the Vulva-2

RX   PubMed=1777413;

RX   PubMed=1958593;

RX   PubMed=2758419;

RX   PubMed=7599042;

RX   PubMed=8646696;

RX   PubMed=15047230;

RX   PubMed=17178626;

CC   Doubling time: 58 hours (PubMed=15047230).

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCV-3

AC   CVCL_5975

SY   UMSCV-3; University of Michigan-Squamous cell Carcinoma of the Vulva-3

RX   PubMed=1777413;

RX   PubMed=1958593;

RX   PubMed=7599042;

RX   PubMed=15047230;

CC   Doubling time: 76 hours (PubMed=15047230).

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCV-4

AC   CVCL_5976

SY   UMSCV-4; University of Michigan-Squamous cell Carcinoma of the Vulva-4

RX   PubMed=1777413;

RX   PubMed=1958593;

RX   PubMed=7599042;

RX   PubMed=8646696;

RX   PubMed=15047230;

CC   Doubling time: 56 hours (PubMed=15047230).

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCV-5

AC   CVCL_HX24

SY   UMSCV-5; University of Michigan-Squamous cell Carcinoma of the Vulva-5

RX   PubMed=1777413;

RX   PubMed=7599042;

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCV-6

AC   CVCL_0569

SY   UMSCV-6; University of Michigan-Squamous cell Carcinoma of the Vulva-6

DR   MCCL; MCC:0000474

RX   PubMed=1777413;

RX   PubMed=7599042;

RX   PubMed=15047230;

CC   Characteristics: Contains an integrated HPV16 genome.

CC   Doubling time: 53 hours (PubMed=15047230).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCV-7

AC   CVCL_5977

SY   UMSCV-7; University of Michigan-Squamous cell Carcinoma of the Vulva-7

RX   PubMed=7599042;

RX   PubMed=15047230;

RX   PubMed=17178626;

CC   Doubling time: 37 hours (PubMed=15047230).

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-SCVa-1

AC   CVCL_HX28

SY   UM-SCVA-1 University of Michigan-Squamous cell Carcinoma of the Vagina-1

RX   PubMed=1958593;

RX   PubMed=7599042;

DI   NCIt; C7736; Vaginal squamous cell carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-UC-1

AC   CVCL_2743

SY   UMUC1; University of Michigan-Urothelial Carcinoma-1

DR   EFO; EFO_0006770

DR   BioSample; SAMN03473231

DR   CCLE; UMUC1_URINARY_TRACT

DR   Cosmic; 1927293

DR   Cosmic; 1938699

DR   ECACC; 06080301

DR   GEO; GSM888823

DR   GEO; GSM1574557

RX   PubMed=3761468;

RX   PubMed=6471236;

RX   PubMed=16469639;

RX   PubMed=18812553;

RX   PubMed=19375735;

RX   PubMed=22460905;

RX   PubMed=23401075;

RX   PubMed=25485619;

RX   PubMed=25997541;

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Doubling time: ~26 hours (ECACC).

CC   Omics: CNV analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12,14

ST   D16S539: 9,11

ST   D18S51: 15

ST   D21S11: 28,29

ST   D3S1358: 17,18

ST   D5S818: 13

ST   D7S820: 8,11

ST   D8S1179: 12,14

ST   FGA: 22,24

ST   Penta D: 2.2

ST   Penta E: 7,17

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 14,15

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-UC-10

AC   CVCL_2744

SY   UMUC10; University of Michigan-Urothelial Carcinoma-10

DR   BTO; BTO:0004992

DR   Cosmic; 1082651

DR   Cosmic; 1927297

DR   Cosmic; 1938705

DR   Cosmic; 2037962

DR   ECACC; 08090506

RX   PubMed=16469639;

RX   PubMed=18812553;

RX   PubMed=19375735;

RX   PubMed=23401075;

RX   PubMed=24018021;

RX   PubMed=25997541;

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-UC-11

AC   CVCL_2745

SY   UM-UC11; UMUC11; UC-11; University of Michigan-Urothelial Carcinoma-11

DR   Cosmic; 846279

DR   Cosmic; 1927298

DR   Cosmic; 1938706

DR   Cosmic; 2037963

DR   ECACC; 08090507

DR   GEO; GSM1574591

RX   PubMed=16469639;

RX   PubMed=18812553;

RX   PubMed=19375735;

RX   PubMed=23401075;

RX   PubMed=24018021;

RX   PubMed=25997541;

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-UC-12

AC   CVCL_S992

SY   UMUC12; University of Michigan-Urothelial Carcinoma-12

DR   Cosmic; 1938707

DR   GEO; GSM1574592

RX   PubMed=25997541;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: CNV analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-UC-13

AC   CVCL_2746

SY   UMUC13; UC-13; University of Michigan-Urothelial Carcinoma-13

DR   Cosmic; 846280

DR   Cosmic; 1082652

DR   Cosmic; 1938708

DR   Cosmic; 2037964

DR   ECACC; 08090508

DR   GEO; GSM1574560

RX   PubMed=16469639;

RX   PubMed=18812553;

RX   PubMed=19375735;

RX   PubMed=24018021;

RX   PubMed=25997541;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: CNV analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-UC-14

AC   CVCL_2747

SY   UMUC-14; UM-UC14; UMUC14; University of Michigan-Urothelial Carcinoma-14

DR   BTO; BTO:0004991

DR   Cosmic; 1082653

DR   Cosmic; 1302360

DR   Cosmic; 1938709

DR   Cosmic; 2037965

DR   Cosmic; 2050469

DR   Cosmic; 2057447

DR   Cosmic; 2212695

DR   Cosmic; 2444231

DR   ECACC; 08090509

DR   GEO; GSM1574586

DR   GEO; GSM1574587

RX   PubMed=16469639;

RX   PubMed=18812553;

RX   PubMed=19375735;

RX   PubMed=24018021;

RX   PubMed=25997541;

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C6142; Renal pelvis carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-UC-15

AC   CVCL_R742

SY   UMUC15; University of Michigan-Urothelial Carcinoma-15

DR   Cosmic; 1927299

DR   Cosmic; 1938710

DR   Cosmic; 2037966

RX   PubMed=18812553;

RX   PubMed=23401075;

RX   PubMed=24018021;

RX   PubMed=25997541;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-UC-16

AC   CVCL_2748

SY   UMUC16; University of Michigan-Urothelial Carcinoma-16

DR   Cosmic; 1082654

DR   Cosmic; 1938711

DR   ECACC; 08090510

RX   PubMed=16469639;

RX   PubMed=19375735;

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 11

ST   TH01: 6

ST   TPOX: 8,10

ST   vWA: 15,18

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-UC-17

AC   CVCL_R743

SY   UMUC17; University of Michigan-Urothelial Carcinoma-17

DR   Cosmic; 1927300

DR   Cosmic; 1938481

DR   Cosmic; 1938712

DR   GEO; GSM1574541

DR   GEO; GSM1574590

RX   PubMed=18812553;

RX   PubMed=23401075;

RX   PubMed=25997541;

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-UC-18

AC   CVCL_R744

SY   UMUC18; University of Michigan-Urothelial Carcinoma-18

DR   Cosmic; 2037967

DR   GEO; GSM1574561

RX   PubMed=18812553;

RX   PubMed=24018021;

RX   PubMed=25997541;

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM-UC-2

AC   CVCL_8155

SY   UM-UC2; UMUC2; UC-2; University of Michigan-Urothelial Carcinoma-2

DR   BioSample; SAMN03151953

DR   Cosmic; 846277

DR   Cosmic; 1302357

DR   Cosmic; 2037968

RX   PubMed=3761468;

RX   PubMed=6471236;

RX   PubMed=16469639;

RX   PubMed=18812553;

RX   PubMed=19375735;

RX   PubMed=20143388;

RX   PubMed=24018021;

RX   PubMed=25997541;

RX   PubMed=26621286;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=19375735, PubMed=20143388).

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0554 ! T24

SX   Female

CA   Cancer cell line

//

ID   UM-UC-3

AC   CVCL_1783

SY   UMUC-3; UM-UC3; UMUC3; UC-3; University of Michigan-Urothelial Carcinoma-3

DR   BTO; BTO:0003723

DR   CLO; CLO_0009487

DR   EFO; EFO_0006771

DR   ATCC; CRL-1749

DR   BioSample; SAMN03471418

DR   BioSample; SAMN03473229

DR   CCLE; UMUC3_URINARY_TRACT

DR   CCRID; 3131C0001001200023

DR   ChEMBL-Cells; CHEMBL3307245

DR   ChEMBL-Targets; CHEMBL612799

DR   Cosmic; 715827

DR   Cosmic; 724838

DR   Cosmic; 760478

DR   Cosmic; 845568

DR   Cosmic; 846273

DR   Cosmic; 928818

DR   Cosmic; 943744

DR   Cosmic; 1046684

DR   Cosmic; 1082647

DR   Cosmic; 1285132

DR   Cosmic; 1285995

DR   Cosmic; 1302358

DR   Cosmic; 1927294

DR   Cosmic; 1938480

DR   Cosmic; 1938700

DR   Cosmic; 2050468

DR   Cosmic; 2057446

DR   Cosmic; 2212694

DR   Cosmic; 2444238

DR   Cosmic-CLP; 724838

DR   ECACC; 96020936

DR   GDSC; 724838

DR   GEO; GSM887729

DR   GEO; GSM888824

DR   GEO; GSM1374978

DR   GEO; GSM1574568

DR   GEO; GSM1670567

DR   IGRhCellID; UMUC3

DR   KCB; KCB 2014053YJ

DR   PRIDE; PXD003105

RX   PubMed=8873383;

RX   PubMed=12127398;

RX   PubMed=16469639;

RX   PubMed=18812553;

RX   PubMed=19375735;

RX   PubMed=22460905;

RX   PubMed=23401075;

RX   PubMed=24367658;

RX   PubMed=25485619;

RX   PubMed=25997541;

RX   PubMed=26972028;

RX   PubMed=27141528;

RX   PubMed=27397505;

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: GPI-anchored proteins analysis by proteomics.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11 (ATCC; Cosmic-CLP)

ST   CSF1PO: 10 (ECACC; PubMed=25877200)

ST   D13S317: 8

ST   D16S539: 8,9

ST   D18S51: 14

ST   D21S11: 31

ST   D3S1358: 17,18

ST   D5S818: 12

ST   D7S820: 8,9

ST   D8S1179: 13

ST   FGA: 20,21

ST   Penta D: 13

ST   Penta E: 12

ST   TH01: 6,9

ST   TPOX: 10

ST   vWA: 17

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-UC-3-GFP

AC   CVCL_1R40

DR   BioSample; SAMN03152036

RX   PubMed=19375735;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Misidentified/contaminated. Shown not to be derived from UM-UC-3, its origin is unknow (PubMed=19375735, PubMed=20143388).

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Undefined cell line type

//

ID   UM-UC-4

AC   CVCL_2749

SY   UMUC4; University of Michigan-Urothelial Carcinoma-4

DR   Cosmic; 1938701

DR   ECACC; 08090501

DR   GEO; GSM1574566

DR   GEO; GSM1574569

RX   PubMed=3761468;

RX   PubMed=25997541;

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Doubling time: ~32 hours (ECACC).

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-UC-5

AC   CVCL_2750

SY   UMUC5; University of Michigan-Urothelial Carcinoma-5

DR   BTO; BTO:0004993

DR   Cosmic; 1082648

DR   Cosmic; 1938702

DR   Cosmic; 2037969

DR   ECACC; 08090502

DR   GEO; GSM1574558

RX   PubMed=3761468;

RX   PubMed=24018021;

RX   PubMed=25997541;

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Doubling time: ~19 hours (ECACC).

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UM-UC-6

AC   CVCL_2751

SY   UM-UC6; UMUC6; UC-6; University of Michigan-Urothelial Carcinoma-6

DR   Cosmic; 846278

DR   Cosmic; 1082649

DR   Cosmic; 1302359

DR   Cosmic; 1927295

DR   Cosmic; 1938703

DR   ECACC; 08090503

DR   GEO; GSM1574559

RX   PubMed=3761468;

RX   PubMed=16469639;

RX   PubMed=18812553;

RX   PubMed=19375735;

RX   PubMed=23401075;

RX   PubMed=25997541;

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Doubling time: ~38 hours (ECACC).

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-UC-7

AC   CVCL_2752

SY   UMUC7; University of Michigan-Urothelial Carcinoma-7

DR   Cosmic; 1927296

DR   Cosmic; 1938704

DR   Cosmic; 2037970

DR   ECACC; 08090504

DR   GEO; GSM1574564

RX   PubMed=3761468;

RX   PubMed=18812553;

RX   PubMed=23401075;

RX   PubMed=24018021;

RX   PubMed=25997541;

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Doubling time: ~19 hours (ECACC).

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UM-UC-9

AC   CVCL_2753

SY   UMUC9; UC-9; University of Michigan-Urothelial Carcinoma-9

DR   BTO; BTO:0004990

DR   Cosmic; 846274

DR   Cosmic; 1082650

DR   Cosmic; 2037971

DR   ECACC; 08090505

DR   GEO; GSM1574565

RX   PubMed=16469639;

RX   PubMed=18812553;

RX   PubMed=19375735;

RX   PubMed=24018021;

RX   PubMed=25997541;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: CNV analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UM103-1 PGD

AC   CVCL_HF75

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM11-1 PGD

AC   CVCL_B837

SY   UM11-1PGD

DR   ISCR; 2242

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=497

WW   http://www.ur.umich.edu/update/archives/120614/stemcell

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0153.

DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM112-1 PGD

AC   CVCL_X369

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=703

WW   http://www.freep.com/story/news/local/2015/01/18/embryo-donation-disease-cure/21921281/

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0285.

DI   NCIt; C61252; Adrenoleukodystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM112-2 PGD

AC   CVCL_Z077

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=826

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0307.

DI   NCIt; C61252; Adrenoleukodystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM114-10

AC   CVCL_X368

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=710

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0290.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM121-7

AC   CVCL_X367

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=711

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0291.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM126-2

AC   CVCL_5H74

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=840

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0356.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM134-1 PGD

AC   CVCL_X365

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=704

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0286.

DI   NCIt; C82341; Spinocerebellar ataxia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM139-2 PGD

AC   CVCL_X366

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=712

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0292.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM14-1

AC   CVCL_B914

DR   ISCR; 2243

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=569

WW   http://www.ur.umich.edu/update/archives/120614/stemcell

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0162.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM14-2

AC   CVCL_B915

DR   ISCR; 2244

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=570

WW   http://www.ur.umich.edu/update/archives/120614/stemcell

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0163.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM14-3

AC   CVCL_5H73

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=839

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0355.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM141-6 PGD

AC   CVCL_5H72

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=844

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0360.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM15-4 PGD

AC   CVCL_B838

DR   ISCR; 2245

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=529

WW   http://www.ur.umich.edu/update/archives/120614/stemcell

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0161.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM150-1 PGD

AC   CVCL_HF76

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM150-3 PGD

AC   CVCL_IS75

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM153-1 PGD

AC   CVCL_IS76

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM17-1 PGD

AC   CVCL_B913

DR   ISCR; 2246

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=571

WW   http://www.ur.umich.edu/update/archives/120614/stemcell

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0160.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM22-2

AC   CVCL_E087

DR   ISCR; 2247

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=587

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0209.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM25-2

AC   CVCL_Z076

SY   UM25-2 PGD

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=824

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0305.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM29-2 PGD

AC   CVCL_B916

DR   ISCR; 2248

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=574

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0164.

DI   NCIt; C84563; Aniridia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM29-3 PGD

AC   CVCL_B917

DR   ISCR; 2249

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=575

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0165.

DI   NCIt; C84563; Aniridia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM33-4

AC   CVCL_R781

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=688

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0279.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM38-2 PGD

AC   CVCL_B839

SY   UM38-2PGD

DR   ISCR; 2250

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=534

WW   http://www.ur.umich.edu/update/archives/120614/stemcell

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0155.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM4-11

AC   CVCL_5H75

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=837

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0353.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM4-12

AC   CVCL_5H76

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=838

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0354.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM4-6

AC   CVCL_B840

DR   ISCR; 2251

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=490

WW   http://www.ur.umich.edu/update/archives/120614/stemcell

WW   http://www.uofmhealth.org/news/human-embryonic-stem-cell-line-placed-on-national-registry

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0147.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM4-9

AC   CVCL_5H77

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=836

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0352.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM57-1 PGD

AC   CVCL_E088

DR   ISCR; 2252

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=586

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0208.

DI   NCIt; C3226; Multiple endocrine neoplasia type 2A

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM57-3 PGD

AC   CVCL_HF77

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM59-2 PGD

AC   CVCL_N808

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=685

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0275.

DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM59-4 PGD

AC   CVCL_5H78

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=841

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0357.

DI   NCIt; C75467; Charcot-Marie-Tooth disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM63-1

AC   CVCL_R782

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=686

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0277.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM66-3 PGD

AC   CVCL_HF78

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM76-1 PGS

AC   CVCL_X362

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=709

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0289.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   UM76-2

AC   CVCL_5H68

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=855

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0361.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM77-2

AC   CVCL_R783

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=687

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0278.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM78-2

AC   CVCL_X363

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=706

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0288.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM89-1 PGD

AC   CVCL_N809

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=684

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0276.

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM89-2

AC   CVCL_5H69

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=856

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0362.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM89-3 PGD

AC   CVCL_5H70

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=842

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0358.

DI   NCIt; C75467; Charcot-Marie-Tooth disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM89-4 PGD

AC   CVCL_5H71

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=843

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0359.

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM89-5 PGD

AC   CVCL_HF79

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM9-1 PGD

AC   CVCL_B841

SY   UM9-1PGD

DR   ISCR; 2253

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=496

WW   http://www.ur.umich.edu/update/archives/120614/stemcell

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0154.

DI   NCIt; C26721; Hemophilia B

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM90-12 PGS

AC   CVCL_X364

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=705

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0287.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UM90-14 PGD

AC   CVCL_Z075

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=825

CC   From: University of Michigan; Ann Arbor; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0306.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UMB-SCC-745

AC   CVCL_A093

DR   Cosmic; 1483461

RX   PubMed=16035614;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UMB-SCC-864

AC   CVCL_A094

DR   Cosmic; 1483462

RX   PubMed=16035614;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UMB-SCC-969

AC   CVCL_A095

DR   Cosmic; 1483463

RX   PubMed=16035614;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UMB1949

AC   CVCL_C471

SY   UMBSVtel

DR   ATCC; CRL-4004

DR   BioSample; SAMN03471715

RX   PubMed=17592550;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 12,13

ST   D16S539: 12

ST   D5S818: 11

ST   D7S820: 9,10

ST   TH01: 6,8

ST   TPOX: 12

ST   vWA: 18

DI   NCIt; C3888; Renal angiomyolipoma

DI   NCIt; C75331; Tuberous sclerosis 2

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UMC-11

AC   CVCL_1784

SY   UMC11; NCI-UMC-11

DR   CLO; CLO_0009483

DR   EFO; EFO_0002386

DR   ATCC; CRL-5975

DR   BioSample; SAMN03473023

DR   ChEMBL-Cells; CHEMBL3308343

DR   ChEMBL-Targets; CHEMBL1075606

DR   Cosmic; 687835

DR   Cosmic; 909779

DR   Cosmic; 1879414

DR   Cosmic; 1995662

DR   Cosmic-CLP; 909779

DR   GDSC; 909779

DR   GEO; GSM784236

DR   GEO; GSM827360

DR   GEO; GSM1670566

RX   PubMed=1563005;

RX   PubMed=8806092;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Misspelling: 'UNC-11' in PubMed=1563005.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,13

ST   D16S539: 11,12

ST   D18S51: 14

ST   D21S11: 31.2

ST   D3S1358: 14

ST   D5S818: 11

ST   D7S820: 9,11

ST   D8S1179: 13,15

ST   FGA: 20,24

ST   Penta D: 13

ST   Penta E: 18,19

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 14,15

DI   NCIt; C4038; Lung carcinoid tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UMC-DgE

AC   CVCL_Z423

SY   DgE

RX   PubMed=10950000;

CC   Group: Insect cell line.

OX   NCBI_TaxID=61289; ! Diatraea grandiosella

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UMC-OnE

AC   CVCL_Z424

SY   OnE

RX   PubMed=10950000;

CC   Group: Insect cell line.

OX   NCBI_TaxID=29057; ! Ostrinia nubilalis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UMJF-2

AC   CVCL_M548

RX   PubMed=1649357;

RX   PubMed=10936422;

CC   Problematic cell line: Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10936422).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UML-49

AC   CVCL_D646

DR   BTO; BTO:0005284

RX   PubMed=20413351;

CC   Miscellaneous: Only mentioned as a lymphoblastoid cell line in PubMed=20413351.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   UMMT-ARK-1

AC   CVCL_IW26

RX   PubMed=22498937;

DI   NCIt; C42700; Uterine carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UMMT-ARK-2

AC   CVCL_IW27

RX   PubMed=22498937;

DI   NCIt; C42700; Uterine carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UMN-MDH-1

AC   CVCL_AV47

RX   DOI=10.1111/j.1550-7408.1983.tb05338.x;

CC   Group: Insect cell line.

OX   NCBI_TaxID=40071; ! Malacosoma disstria

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UMN-PIE-1181

AC   CVCL_Z394

RX   DOI=10.1016/0022-2011(85)90147-8;

RX   PubMed=1561320;

CC   Group: Insect cell line.

OX   NCBI_TaxID=58824; ! Plodia interpunctella

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UMNSAH/DF-1

AC   CVCL_0570

SY   UMNSAH-DF-1; UMNSAH-DF 1; UMNSAH-DF1; UMNSAH/DF#1; DF-1; DF1

DR   BTO; BTO:0005956

DR   CLO; CLO_0009484

DR   MCCL; MCC:0000475

DR   ATCC; CRL-12203

DR   BCRJ; 0307

DR   CCLV; CCLV-RIE 1029

DR   CCRID; 3131C0001000400023

DR   IZSLER; BS CL 197

DR   KCB; KCB 2012111YJ

RX   Patent=US5672485;

RX   PubMed=9721238;

RX   PubMed=16313905;

RX   PubMed=18638503;

RX   PubMed=19941903;

WW   http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/cef/cefcells.html

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-546.html

CC   Group: Bird cell line.

CC   Breed/subspecies: East Lansing Line 0 (ELL-0).

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Spontaneously immortalized cell line

//

ID   UMR-104

AC   CVCL_S478

SY   UMR 104

RX   PubMed=6575864;

CC   Breed/subspecies: Sprague-Dawley.

DI   NCIt; C60487; Rat osteosarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_S479 ! UMR-105

OI   CVCL_3617 ! UMR-106

OI   CVCL_3618 ! UMR-108

CA   Cancer cell line

//

ID   UMR-105

AC   CVCL_S479

SY   UMR 105

RX   PubMed=6575864;

CC   Breed/subspecies: Sprague-Dawley.

DI   NCIt; C60487; Rat osteosarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_S478 ! UMR-104

OI   CVCL_3617 ! UMR-106

OI   CVCL_3618 ! UMR-108

CA   Cancer cell line

//

ID   UMR-106

AC   CVCL_3617

SY   UMR 106; UMR106

DR   BTO; BTO:0002576

DR   CLO; CLO_0009485

DR   CLDB; cl4610

DR   ATCC; CRL-1661

DR   BCRC; 60270

DR   BCRJ; 0243

DR   CCRID; 3131C0001001200010

DR   ECACC; 90111314

DR   IZSLER; BS TCL 106

DR   NCBI_Iran; C586

RX   PubMed=6575864;

RX   PubMed=7988420;

CC   Characteristics: Responsive to PTH, prostaglandins and bone-resorbing steroids.

CC   Breed/subspecies: Sprague-Dawley.

DI   NCIt; C60487; Rat osteosarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_S478 ! UMR-104

OI   CVCL_S479 ! UMR-105

OI   CVCL_3618 ! UMR-108

CA   Cancer cell line

//

ID   UMR-106-01

AC   CVCL_D580

SY   UMR 106-01; UMR106-01; UMR 106-1

DR   BTO; BTO:0005173

DR   Lonza; 1311

RX   PubMed=3922597;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-316.html

CC   Breed/subspecies: Sprague-Dawley.

DI   NCIt; C60487; Rat osteosarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3617 ! UMR-106

CA   Cancer cell line

//

ID   UMR-106-06

AC   CVCL_S477

SY   UMR 106-06; UMR106-06

DR   ChEMBL-Cells; CHEMBL3307259

DR   ChEMBL-Targets; CHEMBL613502

RX   PubMed=1659122;

RX   PubMed=3922597;

CC   Breed/subspecies: Sprague-Dawley.

DI   NCIt; C60487; Rat osteosarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3617 ! UMR-106

CA   Cancer cell line

//

ID   UMR-108

AC   CVCL_3618

SY   UMR 108; UMR108

DR   BTO; BTO:0002577

DR   CLO; CLO_0009486

DR   CLDB; cl4611

DR   ATCC; CRL-1663

DR   ECACC; 91060527

DR   IZSLER; BS TCL 107

RX   PubMed=6575864;

RX   PubMed=10457266;

CC   Breed/subspecies: Sprague-Dawley.

DI   NCIt; C60487; Rat osteosarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_S478 ! UMR-104

OI   CVCL_S479 ! UMR-105

OI   CVCL_3617 ! UMR-106

CA   Cancer cell line

//

ID   UMR-201

AC   CVCL_F683

SY   UMR 201; UMR201

RX   PubMed=1659122;

RX   PubMed=3213604;

CC   Doubling time: ~24 hours (PubMed=3213604).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Finite cell line

//

ID   UMR-201-10A

AC   CVCL_IR40

SY   10A

RX   PubMed=1659122;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_F683 ! UMR-201

CA   Transformed cell line

//

ID   UMR-201-10B

AC   CVCL_IR41

SY   UMR 201-10B; 10B

RX   PubMed=1659122;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_F683 ! UMR-201

CA   Transformed cell line

//

ID   UMT2

AC   CVCL_R739

SY   Uveal Melanoma Tubingen 2

DR   Cosmic; 1879475

RX   PubMed=23456173;

CC   Doubling time: 3-4 days (PubMed=23456173).

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UMT26

AC   CVCL_R740

SY   Uveal Melanoma Tubingen 26

DR   Cosmic; 1879477

RX   PubMed=23456173;

CC   Doubling time: 3-4 months (PubMed=23456173).

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UMT33

AC   CVCL_R741

SY   Uveal Melanoma Tubingen 33

DR   Cosmic; 1879479

RX   PubMed=23456173;

CC   Doubling time: 33 days (PubMed=23456173).

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UN-KC-6141

AC   CVCL_1U11

RX   PubMed=24278292;

CC   Breed/subspecies: B6.FVB-Tg(Pdx1-cre)6Tuv/J,LSL-Kras(G12D/+).

DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   UN-KPC-960

AC   CVCL_1U12

RX   PubMed=24278292;

CC   Breed/subspecies: B6.FVB-Tg(Pdx1-cre)6Tuv/J,LSL-Kras(G12D/+),LSL-Trp53(R175H/+).

DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   UN-KPC-961

AC   CVCL_1U13

RX   PubMed=24278292;

CC   Breed/subspecies: B6.FVB-Tg(Pdx1-cre)6Tuv/J,LSL-Kras(G12D/+),LSL-Trp53(R175H/+).

DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   UN7RGB

AC   CVCL_T332

DR   CLO; CLO_0050700

DR   BioSample; SAMN03472186

DR   RCB; GMC0010

DR   RCB; RCB0873

CC   Discontinued: RCB; RCB0873; true.

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,10

ST   D16S539: 10,12

ST   D5S818: 11

ST   D7S820: 12

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 14,20

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   UN8RGB

AC   CVCL_T333

DR   CLO; CLO_0050695

DR   BioSample; SAMN03472159

DR   RCB; GMC0011

DR   RCB; RCB1141

CC   Discontinued: RCB; RCB1141; true.

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,13

ST   D13S317: 8,11

ST   D16S539: 10,11

ST   D5S818: 12,13

ST   D7S820: 12

ST   TH01: 7,9

ST   TPOX: 9,11

ST   vWA: 16

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   UNC-10

AC   CVCL_L890

SY   UNC10

DR   Cosmic; 1122676

RX   PubMed=14732763;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UNC-7

AC   CVCL_L891

SY   UNC7

DR   Cosmic; 1122675

DR   Cosmic; 1530766

RX   PubMed=14732763;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UNEWi001-A

AC   CVCL_9S37

SY   UNEW001Ai

DR   BioSamples; SAMEA2629641

DR   EBiSC; UNEWi001-A

DR   ECACC; 66540039

DR   hPSCreg; UNEWi001-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C85045; Retinitis pigmentosa

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi002-A

AC   CVCL_9S38

SY   PRPF31 AW; UNEW002Ai

DR   BioSamples; SAMEA2629491

DR   EBiSC; UNEWi002-A

DR   ECACC; 66540040

DR   hPSCreg; UNEWi002-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C85045; Retinitis pigmentosa

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi003-A

AC   CVCL_IU01

SY   PRPF31 HD

DR   hPSCreg; UNEWi003-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C85045; Retinitis pigmentosa

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi004-A

AC   CVCL_9S39

SY   PRPF31 SH

DR   BioSamples; SAMEA3275846

DR   EBiSC; UNEWi004-A

DR   ECACC; 66540017

DR   hPSCreg; UNEWi004-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C85045; Retinitis pigmentosa

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi005-A

AC   CVCL_9S40

SY   PRPF31 RH

DR   BioSamples; SAMEA3275904

DR   EBiSC; UNEWi005-A

DR   ECACC; 66540020

DR   hPSCreg; UNEWi005-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C85045; Retinitis pigmentosa

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi017-A

AC   CVCL_II93

DR   BioSamples; SAMEA3142096

DR   EBiSC; UNEWi017-A

DR   ECACC; 66540057

DR   hPSCreg; UNEWi017-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C2870; Aplastic anemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi018-A

AC   CVCL_II94

DR   BioSamples; SAMEA3142165

DR   EBiSC; UNEWi018-A

DR   ECACC; 66540012

DR   hPSCreg; UNEWi018-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C2870; Aplastic anemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi019-A

AC   CVCL_II95

DR   BioSamples; SAMEA3275958

DR   EBiSC; UNEWi019-A

DR   ECACC; 66540021

DR   hPSCreg; UNEWi019-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C2869; Anemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi021-A

AC   CVCL_IT82

SY   F018 13.2

DR   BioSamples; SAMEA4092799

DR   EBiSC; UNEWi021-A

DR   hPSCreg; UNEWi021-A

CC   From: University of Newcastle; Newcastle; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT83 ! UNEWi021-B

OI   CVCL_IT84 ! UNEWi021-C

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi021-B

AC   CVCL_IT83

SY   F018 15.8

DR   BioSamples; SAMEA4092819

DR   EBiSC; UNEWi021-B

DR   hPSCreg; UNEWi021-B

CC   From: University of Newcastle; Newcastle; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT82 ! UNEWi021-A

OI   CVCL_IT84 ! UNEWi021-C

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi021-C

AC   CVCL_IT84

SY   F018 17/8-1

DR   BioSamples; SAMEA4092855

DR   EBiSC; UNEWi021-C

DR   hPSCreg; UNEWi021-C

CC   From: University of Newcastle; Newcastle; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT82 ! UNEWi021-A

OI   CVCL_IT83 ! UNEWi021-B

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi022-A

AC   CVCL_IT85

SY   F181 5.8

DR   BioSamples; SAMEA4092883

DR   EBiSC; UNEWi022-A

DR   hPSCreg; UNEWi022-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT86 ! UNEWi022-B

OI   CVCL_IT87 ! UNEWi022-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi022-B

AC   CVCL_IT86

SY   F181 18.2

DR   BioSamples; SAMEA4092901

DR   EBiSC; UNEWi022-B

DR   hPSCreg; UNEWi022-B

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT85 ! UNEWi022-A

OI   CVCL_IT87 ! UNEWi022-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi022-C

AC   CVCL_IT87

SY   F181 25.7

DR   BioSamples; SAMEA4092914

DR   EBiSC; UNEWi022-C

DR   hPSCreg; UNEWi022-C

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT85 ! UNEWi022-A

OI   CVCL_IT86 ! UNEWi022-B

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi023-A

AC   CVCL_IT88

SY   F343 clone 2

DR   BioSamples; SAMEA4567585

DR   hPSCreg; UNEWi023-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT89 ! UNEWi023-B

OI   CVCL_IT90 ! UNEWi023-C

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi023-B

AC   CVCL_IT89

SY   F343 clone 3

DR   BioSamples; SAMEA4567587

DR   hPSCreg; UNEWi023-B

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT88 ! UNEWi023-A

OI   CVCL_IT90 ! UNEWi023-C

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi023-C

AC   CVCL_IT90

SY   F343 clone 4

DR   BioSamples; SAMEA4567588

DR   hPSCreg; UNEWi023-C

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT88 ! UNEWi023-A

OI   CVCL_IT89 ! UNEWi023-B

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi024-A

AC   CVCL_IT91

SY   F180-1

DR   BioSamples; SAMEA444699

DR   EBiSC; UNEWi024-A

DR   hPSCreg; UNEWi024-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT92 ! UNEWi024-B

OI   CVCL_IT93 ! UNEWi024-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi024-B

AC   CVCL_IT92

SY   F180-2

DR   BioSamples; SAMEA4447006

DR   EBiSC; UNEWi024-B

DR   hPSCreg; UNEWi024-B

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT91 ! UNEWi024-A

OI   CVCL_IT93 ! UNEWi024-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi024-C

AC   CVCL_IT93

SY   F180-3

DR   BioSamples; SAMEA4447024

DR   EBiSC; UNEWi024-C

DR   hPSCreg; UNEWi024-C

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT91 ! UNEWi024-A

OI   CVCL_IT92 ! UNEWi024-B

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi025-A

AC   CVCL_IT94

SY   F324 5.8

DR   BioSamples; SAMEA4447907

DR   EBiSC; UNEWi025-A

DR   hPSCreg; UNEWi025-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT95 ! UNEWi025-B

OI   CVCL_IT96 ! UNEWi025-C

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi025-B

AC   CVCL_IT95

SY   F324 12.8

DR   BioSamples; SAMEA4447908

DR   EBiSC; UNEWi025-B

DR   hPSCreg; UNEWi025-B

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT94 ! UNEWi025-A

OI   CVCL_IT96 ! UNEWi025-C

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi025-C

AC   CVCL_IT96

SY   F324 19.7

DR   BioSamples; SAMEA4447909

DR   EBiSC; UNEWi025-C

DR   hPSCreg; UNEWi025-C

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT94 ! UNEWi025-A

OI   CVCL_IT95 ! UNEWi025-B

SX   Female

CA   Induced pluripotent stem cell

//

ID   UNEWi026-A

AC   CVCL_IT97

SY   SF116 clone 1

DR   BioSamples; SAMEA4567589

DR   hPSCreg; UNEWi026-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT98 ! UNEWi026-B

OI   CVCL_IT99 ! UNEWi026-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi026-B

AC   CVCL_IT98

SY   SF116 clone 2

DR   BioSamples; SAMEA4567590

DR   hPSCreg; UNEWi026-B

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT97 ! UNEWi026-A

OI   CVCL_IT99 ! UNEWi026-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi026-C

AC   CVCL_IT99

SY   SF116 clone K

DR   BioSamples; SAMEA4567591

DR   hPSCreg; UNEWi026-C

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IT97 ! UNEWi026-A

OI   CVCL_IT98 ! UNEWi026-B

SX   Male

CA   Induced pluripotent stem cell

//

ID   UNEWi027-A

AC   CVCL_IU00

SY   F116

DR   BioSamples; SAMEA4458542

DR   hPSCreg; UNEWi027-A

CC   From: University of Newcastle; Newcastle; UK.

DI   NCIt; C85045; Retinitis pigmentosa

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UO-31

AC   CVCL_1911

AS   CVCL_1777

SY   UO.31; UO31; U031

DR   BTO; BTO:0004234

DR   ChEMBL-Cells; CHEMBL3307612

DR   ChEMBL-Cells; CHEMBL3308806

DR   ChEMBL-Targets; CHEMBL614388

DR   ChEMBL-Targets; CHEMBL1075603

DR   Cosmic; 687945

DR   Cosmic; 875869

DR   Cosmic; 897465

DR   Cosmic; 905981

DR   Cosmic; 974304

DR   Cosmic; 1044263

DR   Cosmic; 1092643

DR   Cosmic; 1175853

DR   Cosmic; 1305379

DR   Cosmic; 1998486

DR   Cosmic-CLP; 905981

DR   GDSC; 905981

DR   GEO; GSM50232

DR   GEO; GSM50296

DR   GEO; GSM750841

DR   GEO; GSM799378

DR   GEO; GSM799441

DR   GEO; GSM847169

DR   GEO; GSM844724

DR   GEO; GSM1153451

DR   GEO; GSM1181309

DR   GEO; GSM1181327

DR   GEO; GSM1670553

DR   SKY/M-FISH/CGH; 2808

RX   PubMed=2041050;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=35

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 41.7 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=19372543

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9,11

ST   D16S539: 11,13

ST   D18S51: 14,16

ST   D19S433: 13,16.2

ST   D21S11: 32.2

ST   D2S1338: 23

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 13

ST   FGA: 21,25

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 16,20

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UoC-B1

AC   CVCL_A296

SY   UOC-B1; UOCB1; UoCB1

DR   Cosmic; 1524827

DR   GEO; GSM236810

DR   GEO; GSM236846

RX   PubMed=7849311;

RX   PubMed=8231254;

RX   PubMed=8704231;

RX   PubMed=9108419;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UoC-B10

AC   CVCL_A301

SY   UOC-B10; UOCB10

RX   PubMed=8069867;

RX   PubMed=8704231;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UoC-B11

AC   CVCL_A299

SY   UOC-B11; UOCB11

RX   PubMed=8704231;

RX   PubMed=9108419;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UoC-B12

AC   CVCL_A300

SY   UOC-B12; UOCB12; AT-1; AT1

DR   Cosmic; 1524790

DR   GEO; GSM236778

DR   GEO; GSM236814

RX   PubMed=8704231;

RX   PubMed=12127395;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DI26 ! AT-2

SX   Male

CA   Cancer cell line

//

ID   UoC-B2

AC   CVCL_A302

SY   UOC-B2; UOCB2

RX   PubMed=7687517;

RX   PubMed=8704231;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UoC-B3

AC   CVCL_A298

SY   UOC-B3; UOCB3

RX   PubMed=8231254;

RX   PubMed=8704231;

RX   PubMed=9108419;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A303 ! UoC-B5

SX   Female

CA   Cancer cell line

//

ID   UoC-B4

AC   CVCL_A297

SY   UOC-B4; UOCB4; UoCB4

RX   PubMed=7849311;

RX   PubMed=8231254;

RX   PubMed=8704231;

RX   PubMed=9108419;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A304 ! UoC-B6

SX   Female

CA   Cancer cell line

//

ID   UoC-B5

AC   CVCL_A303

SY   UOC-B5; UOCB5

RX   PubMed=8231254;

RX   PubMed=8704231;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A298 ! UoC-B3

SX   Female

CA   Cancer cell line

//

ID   UoC-B6

AC   CVCL_A304

SY   UOC-B6; UOCB6

RX   PubMed=8231254;

RX   PubMed=8704231;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A297 ! UoC-B4

SX   Female

CA   Cancer cell line

//

ID   UoC-B7

AC   CVCL_A305

SY   UOC-B7; UOCB7

RX   PubMed=8231254;

RX   PubMed=8704231;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UoC-B8

AC   CVCL_A306

SY   UOC-B8; UOCB8

RX   PubMed=8231254;

RX   PubMed=8704231;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UoC-B9

AC   CVCL_A307

SY   UOC-B9; UOCB9

DR   Cosmic; 2491079

RX   PubMed=8231254;

RX   PubMed=8704231;

RX   PubMed=9067587;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UoC-M1

AC   CVCL_A480

SY   UOC-M1; UOCM1

DR   Cosmic; 975311

DR   DSMZ; ACC-775

DR   GEO; GSM1040774

RX   PubMed=9665199;

CC   Doubling time: ~50-60 hours (DSMZ).

CC   Misspelling: 'UCM1' in GEO GSM1040774.

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 11

ST   TH01: 7

ST   TPOX: 9

ST   vWA: 15,16

DI   NCIt; C7965; Adult acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UOFS-CT-1

AC   CVCL_Z828

RX   PubMed=2280394;

CC   Group: Insect cell line.

CC   Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the institution (University of the Orange Free State) and of the species.

OX   NCBI_TaxID=561267; ! Culex theileri

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UOK101

AC   CVCL_B076

SY   UOK-101; UOK 101

DR   CCLE; UOK101_KIDNEY

DR   Cosmic; 972889

RX   PubMed=1345811;

RX   PubMed=7915601;

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 28 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK102

AC   CVCL_B080

SY   UOK-102; UOK 102

DR   Cosmic; 972890

RX   PubMed=1345811;

RX   PubMed=7915601;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK103

AC   CVCL_B081

SY   UOK-103; UOK 103

RX   PubMed=1345811;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK104

AC   CVCL_B082

SY   UOK-104; UOK 104

RX   PubMed=1345811;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK105

AC   CVCL_B083

SY   UOK-105; UOK 105

RX   PubMed=1345811;

RX   PubMed=27993170;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK106

AC   CVCL_B084

SY   UOK-106; UOK 106

RX   PubMed=1345811;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK107

AC   CVCL_B085

SY   UOK-107; UOK 107; UOK 50

RX   PubMed=1345811;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK108

AC   CVCL_B086

SY   UOK-108; UOK 108

RX   PubMed=1345811;

RX   PubMed=9255309;

RX   PubMed=27993170;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK109

AC   CVCL_B087

SY   UOK-109; UOK 109

DR   Cosmic; 1241981

RX   PubMed=1345811;

RX   PubMed=9255309;

RX   PubMed=9393982;

DI   NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B088 ! UOK109LN

SX   Male

CA   Cancer cell line

//

ID   UOK109LN

AC   CVCL_B088

SY   UOK-109LN; UOK 109LN

RX   PubMed=1345811;

RX   PubMed=9255309;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B087 ! UOK109

SX   Male

CA   Cancer cell line

//

ID   UOK110

AC   CVCL_B089

SY   UOK-110; UOK 110

DR   Cosmic; 972891

RX   PubMed=1345811;

RX   PubMed=7915601;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK111

AC   CVCL_B090

SY   UOK-111; UOK 111; UOK 39

DR   Cosmic; 972892

DR   SKY/M-FISH/CGH; 1526

RX   PubMed=1345811;

RX   PubMed=7915601;

RX   PubMed=12759923;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UOK112

AC   CVCL_B091

SY   UOK-112; UOK 112

RX   PubMed=1345811;

RX   PubMed=9255309;

RX   PubMed=9393982;

RX   PubMed=27993170;

DI   NCIt; C6975; Papillary renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UOK113

AC   CVCL_B092

SY   UOK-113; UOK 113

RX   PubMed=1345811;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK114

AC   CVCL_B093

SY   UOK-114; UOK 114

RX   PubMed=1345811;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK115

AC   CVCL_B094

SY   UOK-115; UOK 115

DR   Cosmic; 845932

DR   Cosmic; 972893

DR   SKY/M-FISH/CGH; 1484

RX   PubMed=1345811;

RX   PubMed=7915601;

RX   PubMed=9255309;

RX   PubMed=10723130;

RX   PubMed=12759923;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UOK116

AC   CVCL_B095

SY   UOK-116; UOK 116

RX   PubMed=1345811;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK117

AC   CVCL_B096

SY   UOK-117; UOK 117

DR   Cosmic; 972894

DR   SKY/M-FISH/CGH; 1485

RX   PubMed=1345811;

RX   PubMed=7915601;

RX   PubMed=9255309;

RX   PubMed=12759923;

RX   PubMed=27993170;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UOK117-5

AC   CVCL_IS29

DR   Cosmic; 845927

RX   PubMed=10723130;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B096 ! UOK117

SX   Male

CA   Cancer cell line

//

ID   UOK118

AC   CVCL_B097

SY   UOK-118; UOK 118

DR   Cosmic; 972871

DR   Cosmic; 972895

RX   PubMed=1345811;

RX   PubMed=7915601;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK119

AC   CVCL_B098

SY   UOK-119; UOK 119

RX   PubMed=1345811;

RX   PubMed=9255309;

RX   PubMed=27993170;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK120

AC   CVCL_B099

SY   UOK-120; UOK 120

DR   Cosmic; 1330966

RX   PubMed=1345811;

RX   PubMed=7587394;

RX   PubMed=8872474;

RX   PubMed=9255309;

RX   PubMed=27993170;

DI   NCIt; C6975; Papillary renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UOK121

AC   CVCL_B100

SY   UOK-121; UOK 121; UoK121

DR   SKY/M-FISH/CGH; 1480

RX   PubMed=1345811;

RX   PubMed=9255309;

RX   PubMed=12759923;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B101 ! UOK121LN

SX   Male

CA   Cancer cell line

//

ID   UOK121LN

AC   CVCL_B101

SY   UOK-121LN; UOK 121LN

RX   PubMed=1345811;

RX   PubMed=9255309;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B100 ! UOK121

SX   Male

CA   Cancer cell line

//

ID   UOK122

AC   CVCL_B102

SY   UOK-122; UOK 122

DR   SKY/M-FISH/CGH; 1475

RX   PubMed=1345811;

RX   PubMed=12759923;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B103 ! UOK122LN

SX   Male

CA   Cancer cell line

//

ID   UOK122LN

AC   CVCL_B103

SY   UOK-122LN; UOK 122LN

RX   PubMed=1345811;

RX   PubMed=9255309;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B102 ! UOK122

SX   Male

CA   Cancer cell line

//

ID   UOK123

AC   CVCL_B104

SY   UOK-123; UOK 123

DR   Cosmic; 845926

DR   Cosmic; 972896

RX   PubMed=1345811;

RX   PubMed=7915601;

RX   PubMed=9255309;

RX   PubMed=10723130;

RX   PubMed=27993170;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK124

AC   CVCL_B105

SY   UOK-124; UOK 124

DR   Cosmic; 1330967

RX   PubMed=1345811;

RX   PubMed=7587394;

RX   PubMed=8872474;

RX   PubMed=9255309;

DI   NCIt; C6975; Papillary renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B106 ! UOK124LN

SX   Female

CA   Cancer cell line

//

ID   UOK124LN

AC   CVCL_B106

SY   UOK-124LN; UOK 124LN

RX   PubMed=1345811;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C6975; Papillary renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B105 ! UOK124

SX   Female

CA   Cancer cell line

//

ID   UOK125

AC   CVCL_B107

SY   UOK-125; UOK 125

DR   Cosmic; 845931

RX   PubMed=1345811;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK126

AC   CVCL_B108

SY   UOK-126; UOK 126

RX   PubMed=1345811;

RX   PubMed=9255309;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK127

AC   CVCL_B109

SY   UOK-127; UOK 127

RX   PubMed=1345811;

RX   PubMed=9255309;

RX   PubMed=27993170;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK128

AC   CVCL_B110

SY   UOK-128; UOK 128

RX   PubMed=1345811;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK129

AC   CVCL_B111

SY   UOK-129; UOK 129

RX   PubMed=1345811;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK130

AC   CVCL_B112

SY   UOK-130; UOK 130

DR   Cosmic; 972897

DR   Cosmic; 981000

DR   SKY/M-FISH/CGH; 1527

RX   PubMed=1345811;

RX   PubMed=7915601;

RX   PubMed=12759923;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UOK131

AC   CVCL_B113

SY   UOK-131; UOK 131

RX   PubMed=1345811;

RX   PubMed=9255309;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK132

AC   CVCL_B114

SY   UOK-132; UOK 132

RX   PubMed=9255309;

RX   PubMed=9393982;

DI   NCIt; C6975; Papillary renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UOK133

AC   CVCL_B115

SY   UOK-133; UOK 133

RX   PubMed=9255309;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK134

AC   CVCL_B116

SY   UOK-134; UOK 134

RX   PubMed=9255309;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK135

AC   CVCL_B117

SY   UOK-135; UOK 135

DR   Cosmic; 972898

RX   PubMed=7915601;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK136COL

AC   CVCL_IS28

SY   UOK-136COL; UOK 136COL

RX   PubMed=9255309;

CC   Derived from metastatic site: Colon.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK139

AC   CVCL_B118

SY   UOK-139; UOK 139

DR   Cosmic; 972899

RX   PubMed=7915601;

RX   PubMed=9255309;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK140

AC   CVCL_B119

SY   UOK-140; UOK 140

DR   Cosmic; 972900

DR   Cosmic; 981002

RX   PubMed=7915601;

RX   PubMed=9255309;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK141

AC   CVCL_B120

SY   UOK-141; UOK 141

DR   Cosmic; 972901

RX   PubMed=7915601;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK142

AC   CVCL_B121

SY   UOK-142; UOK 142

DR   Cosmic; 972902

RX   PubMed=7915601;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK143

AC   CVCL_B225

SY   UOK-143; UOK 143; UoK143

DR   SKY/M-FISH/CGH; 1473

RX   PubMed=12759923;

RX   PubMed=9255309;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UOK145

AC   CVCL_B122

SY   UOK-145; UOK 145

DR   Cosmic; 1241980

RX   PubMed=9393982;

RX   PubMed=23628822;

DI   NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UOK146

AC   CVCL_B123

SY   UOK-146; UOK 146

DR   Cosmic; 1330968

RX   PubMed=8872474;

RX   PubMed=9255309;

DI   NCIt; C6975; Papillary renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UOK147

AC   CVCL_B124

SY   UOK-147; UOK 147

DR   Cosmic; 845924

RX   PubMed=9255309;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK150

AC   CVCL_B125

SY   UOK-150; UOK 150

DR   Cosmic; 972903

RX   PubMed=7915601;

RX   PubMed=9255309;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK151

AC   CVCL_B126

SY   UOK-151; UOK 151

DR   Cosmic; 972875

DR   Cosmic; 972904

RX   PubMed=7915601;

RX   PubMed=9255309;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK152

AC   CVCL_B252

SY   UOK-152; UOK 152

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK154

AC   CVCL_B127

SY   UOK-154; UOK 154

DR   Cosmic; 972905

DR   SKY/M-FISH/CGH; 1524

RX   PubMed=7915601;

RX   PubMed=9255309;

RX   PubMed=12759923;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IS27 ! UOK154LN

SX   Female

CA   Cancer cell line

//

ID   UOK154LN

AC   CVCL_IS27

SY   UOK-154LN; UOK 154LN

RX   PubMed=9255309;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B127 ! UOK154

SX   Female

CA   Cancer cell line

//

ID   UOK161

AC   CVCL_B128

SY   UOK-161; UOK 161

DR   Cosmic; 972906

RX   PubMed=7915601;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK162

AC   CVCL_B129

SY   UOK-162; UOK 162

DR   Cosmic; 972907

DR   Cosmic; 981004

RX   PubMed=7915601;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK163

AC   CVCL_B130

SY   UOK-163; UOK 163

DR   Cosmic; 972908

RX   PubMed=7915601;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK164

AC   CVCL_B131

SY   UOK-164; UOK 164

DR   Cosmic; 972909

RX   PubMed=7915601;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOK171

AC   CVCL_B223

SY   UOK-171; UOK 171

DR   SKY/M-FISH/CGH; 1525

RX   PubMed=12759923;

WW   http://www.ott.nih.gov/technology/e-033-2010

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UOK181

AC   CVCL_B224

SY   UOK-181; UOK 181

DR   SKY/M-FISH/CGH; 1483

RX   PubMed=12759923;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UOK257

AC   CVCL_S717

SY   UOK-257; UOK 257

DR   SKY/M-FISH/CGH; 5607

RX   PubMed=17028174;

RX   PubMed=18206534;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-605.html

WW   http://www.bhdsyndrome.org/for-researchers/what-is-bhd/cell-lines-and-model-organisms-for-studying-bhd-syndrome/uok-257-cell-line/

DI   NCIt; C28244; Birt-Hogg-Dube syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UOK257-2

AC   CVCL_1D69

RX   PubMed=17028174;

WW   http://www.bhdsyndrome.org/for-researchers/what-is-bhd/cell-lines-and-model-organisms-for-studying-bhd-syndrome/uok-257-cell-line/

CC   Transfected with: HGNC; 27310; FLCN.

DI   NCIt; C28244; Birt-Hogg-Dube syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S717 ! UOK257

SX   Male

CA   Cancer cell line

//

ID   UOK262

AC   CVCL_1D72

SY   UOK-262; UOK 262

DR   BTO; BTO:0005727

RX   PubMed=19963135;

RX   PubMed=27993170;

WW   http://www.ott.nih.gov/erma/uok-262-hereditary-leiomyomatosis-and-renal-cell-carcinoma-hlrcc-cell-line

CC   Derived from metastatic site: Kidney.

DI   NCIt; C51302; Hereditary leiomyomatosis and renal cell cancer

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UOK268

AC   CVCL_1D73

SY   UOK 268

RX   PubMed=22867999;

RX   PubMed=27993170;

WW   http://www.ott.nih.gov/erma/one-1-vial-uok-268-hereditary-leiomyomatosis-and-renal-cell-carcinoma-hlrcc-human-cell-line

DI   NCIt; C51302; Hereditary leiomyomatosis and renal cell cancer

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UOKCR

AC   CVCL_4Z16

SY   UOK(CR)

RX   PubMed=17509556;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B112 ! UOK130

SX   Male

CA   Cancer cell line

//

ID   UOXFi001-A

AC   CVCL_EE27

SY   MK071-1; iPS.MK071.1; GBA-PD 1#1

DR   BioSamples; SAMEA4453897

DR   EBiSC; UOXFi001-A

DR   ECACC; 66540384

DR   hPSCreg; UOXFi001-A

RX   PubMed=26905200;

CC   From: University of Oxford; Oxford; UK.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE28 ! UOXFi001-B

OI   CVCL_EE29 ! UOXFi001-C

OI   CVCL_EE30 ! UOXFi001-D

SX   Female

CA   Induced pluripotent stem cell

//

ID   UOXFi001-B

AC   CVCL_EE28

SY   MK071-3; iPS.MK071.3; GBA-PD 1#2

DR   BioSamples; SAMEA4453900

DR   EBiSC; UOXFi001-B

DR   ECACC; 66540385

RX   PubMed=26905200;

CC   From: University of Oxford; Oxford; UK.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE27 ! UOXFi001-A

OI   CVCL_EE29 ! UOXFi001-C

OI   CVCL_EE30 ! UOXFi001-D

SX   Female

CA   Induced pluripotent stem cell

//

ID   UOXFi001-C

AC   CVCL_EE29

SY   MK071-5; iPS.MK071.5

DR   BioSamples; SAMEA4453901

DR   EBiSC; UOXFi001-C

DR   ECACC; 66540386

DR   hPSCreg; UOXFi001-C

CC   From: University of Oxford; Oxford; UK.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE27 ! UOXFi001-A

OI   CVCL_EE28 ! UOXFi001-B

OI   CVCL_EE30 ! UOXFi001-D

SX   Female

CA   Induced pluripotent stem cell

//

ID   UOXFi001-D

AC   CVCL_EE30

SY   MK071-6; iPS.MK071.6

DR   BioSamples; SAMEA4454476

DR   EBiSC; UOXFi001-D

DR   ECACC; 66540387

DR   hPSCreg; UOXFi001-D

CC   From: University of Oxford; Oxford; UK.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE27 ! UOXFi001-A

OI   CVCL_EE28 ! UOXFi001-B

OI   CVCL_EE29 ! UOXFi001-C

SX   Female

CA   Induced pluripotent stem cell

//

ID   UOXFi002-A

AC   CVCL_IJ04

SY   MK082-26

DR   BioSamples; SAMEA4458672

DR   EBiSC; UOXFi002-A

DR   ECACC; 66540388

CC   From: University of Oxford; Oxford; UK.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IJ05 ! UOXFi002-B

OI   CVCL_IJ06 ! UOXFi002-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UOXFi002-B

AC   CVCL_IJ05

SY   MK082-30

DR   BioSamples; SAMEA4458549

DR   EBiSC; UOXFi002-B

DR   ECACC; 66540389

DR   hPSCreg; UOXFi002-B

CC   From: University of Oxford; Oxford; UK.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IJ04 ! UOXFi002-A

OI   CVCL_IJ06 ! UOXFi002-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UOXFi002-C

AC   CVCL_IJ06

SY   MK082-31

DR   BioSamples; SAMEA7615168

DR   EBiSC; UOXFi002-C

DR   ECACC; 66540390

CC   From: University of Oxford; Oxford; UK.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IJ04 ! UOXFi002-A

OI   CVCL_IJ05 ! UOXFi002-B

SX   Male

CA   Induced pluripotent stem cell

//

ID   UOXFi003-A

AC   CVCL_EE31

SY   MK088-1; GBA-PD 2#1

DR   BioSamples; SAMEA4454477

DR   EBiSC; UOXFi003-A

DR   ECACC; 66540391

DR   hPSCreg; UOXFi003-A

RX   PubMed=26905200;

CC   From: University of Oxford; Oxford; UK.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE32 ! UOXFi003-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UOXFi003-C

AC   CVCL_EE32

SY   MK088-7

DR   BioSamples; SAMEA4454479

DR   EBiSC; UOXFi003-C

DR   ECACC; 66540392

DR   hPSCreg; UOXFi003-C

CC   From: University of Oxford; Oxford; UK.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE31 ! UOXFi003-A

SX   Male

CA   Induced pluripotent stem cell

//

ID   UOXFi004-A

AC   CVCL_IJ07

SY   OX1-18

DR   BioSamples; SAMEA7615918

DR   EBiSC; UOXFi004-A

DR   ECACC; 66540393

DR   hPSCreg; UOXFi004-A

CC   From: University of Oxford; Oxford; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IJ08 ! UOXFi004-B

SX   Male

CA   Induced pluripotent stem cell

//

ID   UOXFi004-B

AC   CVCL_IJ08

SY   OX1-19

DR   BioSamples; SAMEA4454111

DR   EBiSC; UOXFi004-B

DR   ECACC; 66540394

DR   hPSCreg; UOXFi004-B

CC   From: University of Oxford; Oxford; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IJ07 ! UOXFi004-A

SX   Male

CA   Induced pluripotent stem cell

//

ID   UOXFi005-A

AC   CVCL_EE33

SY   JR053-1

DR   BioSamples; SAMEA4453899

DR   EBiSC; UOXFi005-A

DR   ECACC; 66540395

DR   hPSCreg; UOXFi005-A

CC   From: University of Oxford; Oxford; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE34 ! UOXFi005-B

OI   CVCL_EE35 ! UOXFi005-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UOXFi005-B

AC   CVCL_EE34

SY   JR053-6

DR   BioSamples; SAMEA4454480

DR   EBiSC; UOXFi005-B

DR   ECACC; 66540396

DR   hPSCreg; UOXFi005-B

CC   From: University of Oxford; Oxford; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE33 ! UOXFi005-A

OI   CVCL_EE35 ! UOXFi005-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UOXFi005-C

AC   CVCL_EE35

SY   JR053-7

DR   BioSamples; SAMEA4454481

DR   EBiSC; UOXFi005-C

DR   ECACC; 66540397

DR   hPSCreg; UOXFi005-C

CC   From: University of Oxford; Oxford; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE33 ! UOXFi005-A

OI   CVCL_EE34 ! UOXFi005-B

SX   Male

CA   Induced pluripotent stem cell

//

ID   UOXFi006-A

AC   CVCL_IJ09

SY   OX2-28

DR   BioSamples; SAMEA4458551

DR   EBiSC; UOXFi006-A

DR   ECACC; 66540398

DR   hPSCreg; UOXFi006-A

CC   From: University of Oxford; Oxford; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UP-007

AC   CVCL_AP56

RX   PubMed=25550537;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UP-019

AC   CVCL_AP57

RX   PubMed=24335698;

RX   PubMed=25550537;

ST   Source(s): PubMed=24335698

ST   Amelogenin: X

ST   CSF1PO: 8,11

ST   D13S317: 10,12

ST   D16S539: 11

ST   D21S11: 29

ST   D5S818: 12

ST   D7S820: 9

ST   TH01: 9.3

ST   TPOX: 12

ST   vWA: 17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UP-029

AC   CVCL_AU95

RX   PubMed=24335698;

ST   Source(s): PubMed=24335698

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10,12

ST   D16S539: 10,11

ST   D21S11: 28,30

ST   D5S818: 12

ST   D7S820: 8,12

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UP-032

AC   CVCL_AP58

RX   PubMed=24335698;

RX   PubMed=25550537;

ST   Source(s): PubMed=24335698

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 12,13

ST   D21S11: 30,31

ST   D5S818: 12,13

ST   D7S820: 10

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C9477; Anaplastic astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPAB

AC   CVCL_1R54

SY   University of Portsmouth AB

RX   CelloPub=CLPUB00261;

RX   PubMed=20951163;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPAM

AC   CVCL_1T12

SY   University of Portsmouth AM

RX   PubMed=20951163;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UPCI-SCC-002

AC   CVCL_C024

SY   UPCI:SCC002; SCC002

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-003

AC   CVCL_C025

SY   UPCI:SCC003; UPCISCC003; SCC003

RX   PubMed=17112776;

RX   PubMed=17681875;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-013

AC   CVCL_C026

SY   UPCI:SCC013; SCC013

RX   PubMed=17112776;

DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-016

AC   CVCL_C027

SY   UPCI:SCC016; UPCISCC016; SCC016

RX   PubMed=17112776;

RX   PubMed=17681875;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2221 ! UPCI-SCC-026

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-026

AC   CVCL_2221

SY   UPCI:SCC026; SCC026

DR   BioSample; SAMN03473471

DR   DSMZ; ACC-658

RX   PubMed=17112776;

RX   PubMed=17681875;

CC   Doubling time: ~60 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 13

ST   D7S820: 10

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 15,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C027 ! UPCI-SCC-016

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-029A

AC   CVCL_1855

SY   UPCI-SCC-29A; UPCI:SCC029A; UPCI-SCC-029B; UPCI:SCC029B; UPCI:SCC029; SCC029

DR   BioSample; SAMN03473472

DR   DSMZ; ACC-659

RX   PubMed=17112776;

RX   PubMed=17681875;

CC   Doubling time: ~60 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 8,9

ST   TH01: 6,7

ST   TPOX: 9,11

ST   vWA: 14,17

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-030

AC   CVCL_C028

SY   UPCI:SCC030; SCC030

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-032

AC   CVCL_C029

SY   UPCI:SCC032; SCC032

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-036

AC   CVCL_C030

SY   UPCI:SCC036; SCC036

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C050 ! UPCI-SCC-104

OI   CVCL_C056 ! UPCI-SCC-142

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-040

AC   CVCL_2222

SY   UPCI:SCC040; SCC040

DR   BioSample; SAMN03473474

DR   DSMZ; ACC-660

RX   PubMed=17112776;

RX   PubMed=17681875;

CC   Doubling time: ~70-80 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 11

ST   D5S818: 10,11

ST   D7S820: 9,10

ST   TH01: 6,8

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-044

AC   CVCL_C031

SY   UPCI:SCC044; SCC044

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-045

AC   CVCL_C032

SY   UPCI:SCC045; SCC045

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-051

AC   CVCL_C033

SY   UPCI:SCC051; SCC051

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-052

AC   CVCL_C034

SY   UPCI:SCC052; SCC052

RX   PubMed=17112776;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-053

AC   CVCL_C035

SY   UPCI:SCC053; SCC053

RX   PubMed=17112776;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-056

AC   CVCL_C036

SY   UPCI:SCC056; SCC056

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-062

AC   CVCL_C037

SY   UPCI:SCC062; SCC062

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-065

AC   CVCL_C038

SY   UPCI:SCC065; SCC065

RX   PubMed=17112776;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-066

AC   CVCL_C039

SY   UPCI:SCC066; SCC066

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-068

AC   CVCL_C040

SY   UPCI:SCC068; SCC068

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-070

AC   CVCL_C041

SY   UPCI:SCC070; SCC070

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-072

AC   CVCL_2223

SY   UPCI:SCC072; SCC072

DR   BioSample; SAMN03473421

DR   DSMZ; ACC-667

RX   PubMed=17112776;

RX   PubMed=17681875;

CC   Doubling time: ~120 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 14

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 15

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-074

AC   CVCL_2224

SY   UPCI:SCC074; SCC074

DR   BioSample; SAMN03473478

DR   DSMZ; ACC-664

RX   PubMed=17112776;

RX   PubMed=17681875;

CC   Doubling time: ~60 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 10,11

ST   D16S539: 9,10

ST   D5S818: 11

ST   D7S820: 8,11

ST   TH01: 7,9.3

ST   TPOX: 9,11

ST   vWA: 15,17

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-075

AC   CVCL_C042

SY   UPCI:SCC075; SCC075

RX   PubMed=17112776;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-077

AC   CVCL_C043

SY   UPCI:SCC077; SCC077

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-078

AC   CVCL_C044

SY   UPCI:SCC078; SCC078

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-080

AC   CVCL_C045

SY   UPCI:SCC080; SCC080

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-081

AC   CVCL_C046

SY   UPCI:SCC081; SCC081

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-084

AC   CVCL_C047

SY   UPCI:SCC084; SCC084

DR   Cosmic; 1969497

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-089

AC   CVCL_C048

SY   UPCI:SCC089; SCC089

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-090

AC   CVCL_1899

SY   UPCI:SCC090; UPCI:SCC90; UPCI-SCC090; SCC090; SCC90

DR   ATCC; CRL-3239

DR   BioSample; SAMN03473425

DR   Cosmic; 1122679

DR   Cosmic; 1530750

DR   Cosmic; 2296310

DR   Cosmic-CLP; 1299052

DR   DSMZ; ACC-670

DR   GDSC; 1299052

RX   PubMed=17112776;

RX   PubMed=17681875;

RX   PubMed=25275298;

RX   PubMed=27397505;

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Characteristics: Contains 100-150 copies of the HPV16 genome.

CC   Doubling time: ~120-150 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Omics: Deep exome analysis.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25275298

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 12,13

ST   D18S51: 14,18

ST   D21S11: 29,31

ST   D3S1358: 14

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 12

ST   FGA: 20

ST   Penta D: 11

ST   Penta E: 11,12

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C058 ! UPCI-SCC-152

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-099

AC   CVCL_2225

SY   UPCI:SCC099; SCC099

DR   BioSample; SAMN03473479

DR   DSMZ; ACC-665

RX   PubMed=17112776;

RX   PubMed=17681875;

CC   Doubling time: ~50 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,13

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 7,9,10

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 14,18,19

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-103

AC   CVCL_C049

SY   UPCI:SCC103; SCC103

RX   PubMed=17112776;

RX   PubMed=17681875;

CC   Misspelling: Occasionally 'UPMC-SCC103'.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-104

AC   CVCL_C050

SY   UPCI:SCC104; SCC104

RX   PubMed=17112776;

RX   PubMed=17681875;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C030 ! UPCI-SCC-036

OI   CVCL_C056 ! UPCI-SCC-142

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-105

AC   CVCL_C051

SY   UPCI:SCC105; SCC105

RX   PubMed=17112776;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-111

AC   CVCL_2226

SY   UPCI:SCC111; SCC111; SCC-111

DR   BioSample; SAMN03473480

DR   Cosmic; 927220

DR   Cosmic; 932154

DR   DSMZ; ACC-666

RX   PubMed=17112776;

RX   PubMed=17681875;

CC   Doubling time: ~40 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,13

ST   D16S539: 9,12

ST   D5S818: 12

ST   D7S820: 8,10

ST   TH01: 8,10

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-114

AC   CVCL_2227

SY   UPCI:SCC114; SCC114

DR   BioSample; SAMN03473476

DR   DSMZ; ACC-662

RX   PubMed=17112776;

CC   Doubling time: ~60 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 8,12

ST   TH01: 7,9.3

ST   TPOX: 9,11

ST   vWA: 16,20

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-116

AC   CVCL_2228

SY   UPCI:SCC116; SCC116

DR   BioSample; SAMN03473477

DR   DSMZ; ACC-663

RX   PubMed=17112776;

CC   Doubling time: ~80 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9,11

ST   D16S539: 11,12

ST   D5S818: 9,13

ST   D7S820: 8,12

ST   TH01: 10

ST   TPOX: 8,10

ST   vWA: 15,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-121

AC   CVCL_C052

SY   UPCI:SCC121; SCC121

RX   PubMed=17112776;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-122

AC   CVCL_C053

SY   UPCI:SCC122; SCC122

RX   PubMed=17112776;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-125

AC   CVCL_C054

SY   UPCI:SCC125; UPCISCC125; SCC125

RX   PubMed=17112776;

RX   PubMed=17681875;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-131

AC   CVCL_2229

SY   UPCI:SCC131; SCC131

DR   BioSample; SAMN03473422

DR   DSMZ; ACC-668

RX   PubMed=17112776;

CC   Doubling time: ~50-60 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,13

ST   D16S539: 13

ST   D5S818: 11

ST   D7S820: 11,12

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 15,17

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-136

AC   CVCL_C055

SY   UPCI:SCC136; SCC136

RX   PubMed=17112776;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-142

AC   CVCL_C056

SY   UPCI:SCC142; SCC142

RX   PubMed=17112776;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C030 ! UPCI-SCC-036

OI   CVCL_C050 ! UPCI-SCC-104

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-143

AC   CVCL_C057

SY   UPCI:SCC143; SCC143

RX   PubMed=17112776;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPCI-SCC-152

AC   CVCL_C058

SY   UPCI:SCC152; SCC152

DR   ATCC; CRL-3240

RX   PubMed=17112776;

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 12,13

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1899 ! UPCI-SCC-090

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-153

AC   CVCL_C059

SY   UPCI:SCC153; UPCISCC153; SCC153

RX   PubMed=17112776;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-154

AC   CVCL_2230

SY   UPCI:SCC154; UPCISCC154; SCC154

DR   BioSample; SAMN03473423

DR   DSMZ; ACC-669

DR   IZSLER; BS TCL 245

RX   PubMed=17112776;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~50-60 hours (DSMZ).

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9,12

ST   D16S539: 13

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-172

AC   CVCL_2231

SY   UPCI:SCC172; SCC172

DR   BioSample; SAMN03473475

DR   DSMZ; ACC-661

RX   PubMed=17112776;

CC   Doubling time: ~50 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 10

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-182

AC   CVCL_C060

SY   UPCI:SCC182; SCC182

RX   PubMed=17112776;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-192

AC   CVCL_C061

SY   UPCI:SCC192; SCC192

RX   PubMed=17112776;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPCI-SCC-200

AC   CVCL_2232

SY   UPCI:SCC200; SCC200

DR   BioSample; SAMN03473427

DR   DSMZ; ACC-672

RX   PubMed=17112776;

CC   Doubling time: ~60-80 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,14

ST   D13S317: 13,14

ST   D16S539: 10,12

ST   D5S818: 9,12

ST   D7S820: 10,11

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPES/C

AC   CVCL_1R55

DR   BioSample; SAMN03152029

RX   PubMed=20951163;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from mouse (PubMed=20951163).

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Sex undetermined

CA   Undefined cell line type

//

ID   UPHHJA

AC   CVCL_1R56

DR   BioSample; SAMN03152030

RX   PubMed=20951163;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20951163).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Sex undetermined

CA   Undefined cell line type

//

ID   UPJM

AC   CVCL_1T13

SY   University of Portsmouth JM

RX   CelloPub=CLPUB00261;

RX   PubMed=20951163;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPMC

AC   CVCL_1S99

SY   University of Portsmouth MC

RX   CelloPub=CLPUB00261;

RX   PubMed=20951163;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPMD-1

AC   CVCL_C297

SY   UPMD1; Uveal Primary Melanoma with Disomy-3 1

DR   Cosmic; 1628403

RX   PubMed=19212147;

RX   PubMed=22236444;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UPMD-2

AC   CVCL_C298

SY   UPMD2; Uveal Primary Melanoma with Disomy-3 2

DR   Cosmic; 1628404

RX   PubMed=19212147;

RX   PubMed=22236444;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UPMM-1

AC   CVCL_C299

SY   UPMM1; Uveal Primary Melanoma with Monosomy-3 1

DR   Cosmic; 1628399

RX   PubMed=16750193;

RX   PubMed=19212147;

RX   PubMed=22236444;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPMM-2

AC   CVCL_C294

SY   UPMM2; Uveal Primary Melanoma with Monosomy-3 2

DR   Cosmic; 1628400

RX   PubMed=16750193;

RX   PubMed=19212147;

RX   PubMed=22236444;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UPMM-3

AC   CVCL_C295

SY   UPMM3; Uveal Primary Melanoma with Monosomy-3 3

DR   Cosmic; 1628401

DR   CLDB; cl7223

DR   ICLC; HTL13001

RX   PubMed=19212147;

RX   PubMed=22236444;

ST   Source(s): ICLC

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 8,11

ST   D16S539: 12

ST   D21S11: 28,31.2

ST   D5S818: 10,11

ST   D7S820: 8,11

ST   TH01: 7,9.3

ST   TPOX: 9,10

ST   vWA: 16,17

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPMM-4

AC   CVCL_C296

SY   UPMM4; Uveal Primary Melanoma with Monosomy-3 4

DR   Cosmic; 1628407

RX   PubMed=19212147;

RX   PubMed=22236444;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UPN1

AC   CVCL_A795

SY   UPN-1

DR   Cosmic; 1047109

DR   Cosmic; 2296996

DR   GEO; GSM119542

RX   PubMed=12742154;

RX   PubMed=12970738;

RX   PubMed=16960149;

DI   NCIt; C4337; Mantle cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPN2

AC   CVCL_A796

SY   UPN-2

DR   Cosmic; 2296997

DR   GEO; GSM119504

RX   PubMed=12742154;

RX   PubMed=12970738;

RX   PubMed=16960149;

DI   NCIt; C4337; Mantle cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UPN251

AC   CVCL_DG78

SY   UPN-251

DR   GEO; GSM185162

DR   GEO; GSM185163

RX   PubMed=23415752;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UPS-1

AC   CVCL_T762

DR   RCB; RCB4451

RX   PubMed=7876305;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Urd-A

AC   CVCL_1N54

SY   CHO Urd-A

RX   PubMed=21463;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Urd-B

AC   CVCL_1N55

SY   A204

RX   PubMed=220270;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Urd-C

AC   CVCL_1N56

SY   URD-C; CHO Urd-C

RX   PubMed=7368045;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   UROtsa

AC   CVCL_0571

DR   BTO; BTO:0005004

DR   MCCL; MCC:0000476

DR   Cosmic; 867840

DR   ENCODE; ENCBS268AAA

DR   ENCODE; ENCBS269AAA

RX   PubMed=8788275;

RX   PubMed=11564615;

RX   PubMed=23691160;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/Urothelia_Crawford_protocol.pdf

CC   Problematic cell line: Partially contaminated. Some stocks of UROTsa are contaminated with T24 (PubMed=23691160).

CC   Part of: ENCODE project common cell types; tier 3.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UROtsa/F35

AC   CVCL_M721

RX   PubMed=16102566;

RX   PubMed=23691160;

CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=23691160).

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0554 ! T24

SX   Female

CA   Cancer cell line

//

ID   USASK/DSIL-LHRH-A1

AC   CVCL_F805

DR   CLO; CLO_0009488

DR   ATCC; HB-9094

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   USC-DHL-1

AC   CVCL_DH84

DR   GEO; GSM380152

RX   PubMed=19278952;

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: miRNA expression profiling.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   USC-HN1

AC   CVCL_D656

SY   USC-HNI

DR   ATCC; CRL-3026

RX   PubMed=20175927;

CC   Discontinued: ATCC; CRL-3026; probable.

DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USC-HN2

AC   CVCL_W327

RX   PubMed=21719345;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USH1-hiPSC1

AC   CVCL_C368

SY   USH-hiPSC1; USH.1.H.iPSC.1

DR   RSCB; RSCB0100

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C85217; Usher syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C369 ! USH1-hiPSC2

OI   CVCL_C370 ! USH1-hiPSC3

OI   CVCL_C371 ! USH1-hiPSC4

OI   CVCL_C372 ! USH1-hiPSC5

OI   CVCL_C373 ! USH1-hiPSC6

OI   CVCL_C374 ! USH1-hiPSC7

OI   CVCL_C375 ! USH1-hiPSC8

SX   Female

CA   Induced pluripotent stem cell

//

ID   USH1-hiPSC2

AC   CVCL_C369

SY   USH-hiPSC2; USH.1.H.iPSC.2

DR   RSCB; RSCB0101

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C85217; Usher syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C368 ! USH1-hiPSC1

OI   CVCL_C370 ! USH1-hiPSC3

OI   CVCL_C371 ! USH1-hiPSC4

OI   CVCL_C372 ! USH1-hiPSC5

OI   CVCL_C373 ! USH1-hiPSC6

OI   CVCL_C374 ! USH1-hiPSC7

OI   CVCL_C375 ! USH1-hiPSC8

SX   Female

CA   Induced pluripotent stem cell

//

ID   USH1-hiPSC3

AC   CVCL_C370

SY   USH-hiPSC3; USH.1.H.iPSC.3

DR   RSCB; RSCB0102

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C85217; Usher syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C368 ! USH1-hiPSC1

OI   CVCL_C369 ! USH1-hiPSC2

OI   CVCL_C371 ! USH1-hiPSC4

OI   CVCL_C372 ! USH1-hiPSC5

OI   CVCL_C373 ! USH1-hiPSC6

OI   CVCL_C374 ! USH1-hiPSC7

OI   CVCL_C375 ! USH1-hiPSC8

SX   Female

CA   Induced pluripotent stem cell

//

ID   USH1-hiPSC4

AC   CVCL_C371

SY   USH-hiPSC4; USH.1.H.iPSC.4

DR   RSCB; RSCB0103

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C85217; Usher syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C368 ! USH1-hiPSC1

OI   CVCL_C369 ! USH1-hiPSC2

OI   CVCL_C370 ! USH1-hiPSC3

OI   CVCL_C372 ! USH1-hiPSC5

OI   CVCL_C373 ! USH1-hiPSC6

OI   CVCL_C374 ! USH1-hiPSC7

OI   CVCL_C375 ! USH1-hiPSC8

SX   Female

CA   Induced pluripotent stem cell

//

ID   USH1-hiPSC5

AC   CVCL_C372

SY   USH-hiPSC5; USH.1.H.iPSC.5

DR   RSCB; RSCB0104

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C85217; Usher syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C368 ! USH1-hiPSC1

OI   CVCL_C369 ! USH1-hiPSC2

OI   CVCL_C370 ! USH1-hiPSC3

OI   CVCL_C371 ! USH1-hiPSC4

OI   CVCL_C373 ! USH1-hiPSC6

OI   CVCL_C374 ! USH1-hiPSC7

OI   CVCL_C375 ! USH1-hiPSC8

SX   Female

CA   Induced pluripotent stem cell

//

ID   USH1-hiPSC6

AC   CVCL_C373

SY   USH-hiPSC6; USH.1.H.iPSC.6; RIi011-A

DR   hPSCreg; RIi011-A

DR   RSCB; RSCB0105

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C85217; Usher syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C368 ! USH1-hiPSC1

OI   CVCL_C369 ! USH1-hiPSC2

OI   CVCL_C370 ! USH1-hiPSC3

OI   CVCL_C371 ! USH1-hiPSC4

OI   CVCL_C372 ! USH1-hiPSC5

OI   CVCL_C374 ! USH1-hiPSC7

OI   CVCL_C375 ! USH1-hiPSC8

SX   Female

CA   Induced pluripotent stem cell

//

ID   USH1-hiPSC7

AC   CVCL_C374

SY   USH-hiPSC7; USH.1.H.iPSC.7

DR   RSCB; RSCB0106

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C85217; Usher syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C368 ! USH1-hiPSC1

OI   CVCL_C369 ! USH1-hiPSC2

OI   CVCL_C370 ! USH1-hiPSC3

OI   CVCL_C371 ! USH1-hiPSC4

OI   CVCL_C372 ! USH1-hiPSC5

OI   CVCL_C373 ! USH1-hiPSC6

OI   CVCL_C375 ! USH1-hiPSC8

SX   Female

CA   Induced pluripotent stem cell

//

ID   USH1-hiPSC8

AC   CVCL_C375

SY   USH-hiPSC8; USH.1.H.iPSC.8

DR   RSCB; RSCB0107

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C85217; Usher syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C368 ! USH1-hiPSC1

OI   CVCL_C369 ! USH1-hiPSC2

OI   CVCL_C370 ! USH1-hiPSC3

OI   CVCL_C371 ! USH1-hiPSC4

OI   CVCL_C372 ! USH1-hiPSC5

OI   CVCL_C373 ! USH1-hiPSC6

OI   CVCL_C374 ! USH1-hiPSC7

SX   Female

CA   Induced pluripotent stem cell

//

ID   USP-1

AC   CVCL_Z290

SY   A32

RX   PubMed=12011937;

RX   PubMed=25761219;

CC   Breed/subspecies: 129/Sv.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   USP-13-Med

AC   CVCL_4U90

RX   PubMed=26358937;

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   USP-2

AC   CVCL_Z291

SY   A414

RX   PubMed=12011937;

CC   Breed/subspecies: 129/Sv.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   USP-3

AC   CVCL_Z292

SY   B310

RX   PubMed=12011937;

CC   Breed/subspecies: 129/Sv.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   USP-4

AC   CVCL_Z293

SY   B410

RX   PubMed=12011937;

CC   Breed/subspecies: 129/Sv.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   USP-91

AC   CVCL_H634

RX   PubMed=8400235;

RX   PubMed=15356658;

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   USPC-ARK-1

AC   CVCL_IV72

SY   USPC ARK-1; USPC-ARK1; USC ARK-1; ARK-1

RX   PubMed=19920829;

RX   PubMed=21246534;

RX   PubMed=23891627;

RX   PubMed=26325104;

RX   PubMed=26625219;

CC   Characteristics: Has a PIK3CA p.Glu542Lys mutation.

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-10

AC   CVCL_IV81

SY   USPC-ARK10

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-11

AC   CVCL_IV82

SY   USPC-ARK11

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-12

AC   CVCL_IV83

SY   USPC-ARK12

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-13

AC   CVCL_IV84

SY   USPC-ARK13

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-14

AC   CVCL_IV85

SY   USPC-ARK14

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-15

AC   CVCL_IV86

SY   USPC-ARK15

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-16

AC   CVCL_IV87

SY   USPC-ARK16

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-17

AC   CVCL_IV88

SY   USPC-ARK17

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-18

AC   CVCL_IV89

SY   USPC-ARK18

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-19

AC   CVCL_IV90

SY   USPC-ARK19

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-2

AC   CVCL_IV73

SY   USPC ARK-2; USPC-ARK2; USC ARK-2; ARK-2

RX   PubMed=19920829;

RX   PubMed=21246534;

RX   PubMed=23891627;

RX   PubMed=26325104;

RX   PubMed=26625219;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-20

AC   CVCL_IV91

SY   USPC-ARK20; USC ARK-20; ARK-20

RX   PubMed=23891627;

RX   PubMed=26325104;

RX   PubMed=26625219;

CC   Characteristics: Has a PIK3CA p.His1047Arg mutation.

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-21

AC   CVCL_IV92

SY   USPC-ARK21; USC ARK-21; ARK-21

RX   PubMed=23891627;

RX   PubMed=26325104;

RX   PubMed=26625219;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-22

AC   CVCL_IV93

SY   USPC-ARK22

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-3

AC   CVCL_IV74

SY   USPC ARK-3; USPC-ARK3

RX   PubMed=19920829;

RX   PubMed=21246534;

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-4

AC   CVCL_IV75

SY   USPC ARK-4; USPC-ARK4

RX   PubMed=19920829;

RX   PubMed=21246534;

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-5

AC   CVCL_IV76

SY   USPC ARK-5; USPC-ARK5

RX   PubMed=19920829;

RX   PubMed=21246534;

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-6

AC   CVCL_IV77

SY   USPC ARK-6; USPC-ARK6

RX   PubMed=19920829;

RX   PubMed=21246534;

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-7

AC   CVCL_IV78

SY   USPC-ARK7

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-8

AC   CVCL_IV79

SY   USPC-ARK8

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   USPC-ARK-9

AC   CVCL_IV80

SY   USPC-ARK9

RX   PubMed=23891627;

DI   NCIt; C27838; Endometrial serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-1

AC   CVCL_4332

SY   UT1

DR   CLO; CLO_0009489

DR   CLDB; cl4612

DR   ECACC; 87100701

RX   PubMed=6951166;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   UT-2

AC   CVCL_DC04

SY   UT2

RX   PubMed=6643457;

RX   PubMed=9305924;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   UT-7

AC   CVCL_2233

SY   UT7

DR   BTO; BTO:0000960

DR   CLO; CLO_0009490

DR   CLDB; cl5398

DR   BioSample; SAMN03472875

DR   CCLE; UT7_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   CCRID; 3111C0001CCC000120

DR   ChEMBL-Cells; CHEMBL3307293

DR   ChEMBL-Targets; CHEMBL614057

DR   Cosmic; 787487

DR   Cosmic; 919130

DR   Cosmic; 975312

DR   Cosmic; 1012128

DR   Cosmic; 1281362

DR   Cosmic; 1465951

DR   Cosmic; 2089659

DR   DSMZ; ACC-137

DR   GEO; GSM887730

DR   GEO; GSM888825

DR   GEO; GSM1374979

DR   Lonza; 41

RX   PubMed=1824823;

RX   PubMed=2217443;

RX   PubMed=11021758;

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=23955599;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~70 hours (DSMZ).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 10,12

ST   D18S51: 14,17

ST   D21S11: 31.2

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 8

ST   D8S1179: 11,15

ST   FGA: 23

ST   Penta D: 9,11

ST   Penta E: 16,17

ST   TH01: 6,9

ST   TPOX: 10

ST   vWA: 14,18

DI   NCIt; C7965; Adult acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-7/Epo

AC   CVCL_5202

SY   UT7-Epo

DR   Lonza; 169

RX   PubMed=8329702;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7%2fEpo

DI   NCIt; C7965; Adult acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2233 ! UT-7

SX   Male

CA   Cancer cell line

//

ID   UT-7/GM

AC   CVCL_5203

SY   UT7-GM

DR   Lonza; 170

RX   PubMed=9166841;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7%2fGM

DI   NCIt; C7965; Adult acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2233 ! UT-7

SX   Male

CA   Cancer cell line

//

ID   UT-7/TPO

AC   CVCL_5204

SY   UT7-TPO

DR   Lonza; 171

RX   PubMed=8639823;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7%2fTPO

DI   NCIt; C7965; Adult acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5203 ! UT-7/GM

SX   Male

CA   Cancer cell line

//

ID   UT-EC-1

AC   CVCL_X003

RX   PubMed=1541432;

DI   NCIt; C114656; Endometrial adenosquamous carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-EC-2A

AC   CVCL_X004

RX   PubMed=7821848;

RX   PubMed=8123477;

CC   Doubling time: 40 hours, at 17th passage (PubMed=7821848).

DI   NCIt; C114656; Endometrial adenosquamous carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_X005 ! UT-EC-2B

SX   Female

CA   Cancer cell line

//

ID   UT-EC-2B

AC   CVCL_X005

RX   PubMed=7821848;

RX   PubMed=8123477;

RX   PubMed=17178626;

CC   Doubling time: 30 hours, at 14th passage (PubMed=7821848).

CC   Derived from metastatic site: Supraclavicular fossa lymph node.

DI   NCIt; C114656; Endometrial adenosquamous carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_X004 ! UT-EC-2A

SX   Female

CA   Cancer cell line

//

ID   UT-EC-3

AC   CVCL_X006

RX   PubMed=8123477;

RX   PubMed=17178626;

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-MUC-1

AC   CVCL_A438

DR   Cosmic; 1520948

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=1571132;

RX   PubMed=9187133;

DI   NCIt; C6214; Hard palate mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-MUC-2

AC   CVCL_A439

DR   Cosmic; 1520949

RX   PubMed=16444749;

DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-10

AC   CVCL_7804

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-11

AC   CVCL_7805

SY   UTSCC11

RX   PubMed=9187133;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-110B

AC   CVCL_A091

DR   Cosmic; 1140779

DR   Cosmic; 1219863

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UT-SCC-118

AC   CVCL_7806

SY   UT-SCC118

DR   BTO; BTO:0004873

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UT-SCC-12A

AC   CVCL_7807

DR   Cosmic; 1140772

DR   Cosmic; 1219856

DR   Cosmic; 1351518

RX   PubMed=9187133;

DI   NCIt; C4819; Skin squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7808 ! UT-SCC-12B

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-12B

AC   CVCL_7808

DR   Cosmic; 1140773

DR   Cosmic; 1219857

DI   NCIt; C4819; Skin squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7807 ! UT-SCC-12A

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-13

AC   CVCL_7809

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-14

AC   CVCL_7810

DR   BTO; BTO:0004440

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-15

AC   CVCL_7811

DR   BTO; BTO:0004441

DR   GEO; GSM901099

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-16A

AC   CVCL_7812

DR   Cosmic; 1140774

DR   Cosmic; 1219858

RX   PubMed=9187133;

RX   PubMed=15287027;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7813 ! UT-SCC-16B

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-16B

AC   CVCL_7813

DR   Cosmic; 1140775

DR   Cosmic; 1219859

RX   PubMed=15287027;

CC   Derived from metastatic site: Neck lymph node.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7812 ! UT-SCC-16A

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-17

AC   CVCL_7814

DR   GEO; GSM901097

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-18

AC   CVCL_7815

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-19A

AC   CVCL_7816

SY   UTSCC19A

RX   PubMed=15287027;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7817 ! UT-SCC-19B

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-19B

AC   CVCL_7817

SY   UTSCC19B

RX   PubMed=15287027;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7816 ! UT-SCC-19A

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-1A

AC   CVCL_7818

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=9187133;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7819 ! UT-SCC-1B

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-1B

AC   CVCL_7819

DR   GEO; GSM901092

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7818 ! UT-SCC-1A

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-2

AC   CVCL_7820

DR   BTO; BTO:0003721

DR   GEO; GSM901093

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=9187133;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-20A

AC   CVCL_7821

RX   PubMed=15287027;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7822 ! UT-SCC-20B

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-20B

AC   CVCL_7822

RX   PubMed=15287027;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7821 ! UT-SCC-20A

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-21

AC   CVCL_7823

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-22

AC   CVCL_7824

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-23

AC   CVCL_7825

SY   UT-SCC23

DR   Cosmic; 932292

DR   Cosmic; 932293

DR   GEO; GSM901098

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-24A

AC   CVCL_7826

DR   BTO; BTO:0003722

DR   Cosmic; 1140778

DR   Cosmic; 1219862

DR   Cosmic; 1483464

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7827 ! UT-SCC-24B

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-24B

AC   CVCL_7827

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7826 ! UT-SCC-24A

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-25

AC   CVCL_7828

DR   GEO; GSM901095

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-26A

AC   CVCL_7829

DR   Cosmic; 1483465

RX   PubMed=19414362;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7830 ! UT-SCC-26B

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-26B

AC   CVCL_7830

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7829 ! UT-SCC-26A

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-27

AC   CVCL_7831

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-28

AC   CVCL_7832

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-29

AC   CVCL_7833

SY   UTSCC29

DR   GEO; GSM901096

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-30

AC   CVCL_7834

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-31

AC   CVCL_7835

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-32

AC   CVCL_7836

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-33

AC   CVCL_7837

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-34

AC   CVCL_7838

SY   UTSCC34

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-35

AC   CVCL_7839

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-36

AC   CVCL_7840

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-37

AC   CVCL_7841

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-38

AC   CVCL_7842

SY   UTSCC38

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-39

AC   CVCL_7843

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-4

AC   CVCL_7844

RX   PubMed=9187133;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-40

AC   CVCL_7845

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-41

AC   CVCL_7846

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-42A

AC   CVCL_7847

SY   UTSCC42A

RX   PubMed=15287027;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7848 ! UT-SCC-42B

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-42B

AC   CVCL_7848

RX   PubMed=15287027;

CC   Derived from metastatic site: Neck lymph node.

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7847 ! UT-SCC-42A

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-43A

AC   CVCL_7849

RX   PubMed=15287027;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7850 ! UT-SCC-43B

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-43B

AC   CVCL_7850

RX   PubMed=15287027;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7849 ! UT-SCC-43A

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-44

AC   CVCL_7851

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-45

AC   CVCL_7852

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-46A

AC   CVCL_7853

RX   PubMed=15287027;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7854 ! UT-SCC-46B

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-46B

AC   CVCL_7854

RX   PubMed=15287027;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7853 ! UT-SCC-46A

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-47

AC   CVCL_7855

DR   GEO; GSM901101

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-48

AC   CVCL_7856

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-49

AC   CVCL_7857

SY   UTSCC49

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-5

AC   CVCL_7858

DR   BTO; BTO:0004442

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UT-SCC-50

AC   CVCL_7859

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-51

AC   CVCL_7860

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-52

AC   CVCL_7861

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-53

AC   CVCL_7862

DI   NCIt; C68611; Nasal cavity and paranasal sinus squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-54A

AC   CVCL_7863

RX   PubMed=15287027;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7864 ! UT-SCC-54B

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-54B

AC   CVCL_7864

RX   PubMed=15287027;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7863 ! UT-SCC-54A

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-55

AC   CVCL_7865

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-60A

AC   CVCL_A089

SY   UT-SCC 60 A

DR   Cosmic; 1140776

DR   Cosmic; 1219860

RX   PubMed=15287027;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A090 ! UT-SCC-60B

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-60B

AC   CVCL_A090

SY   UT-SCC 60 B

DR   Cosmic; 1140777

DR   Cosmic; 1219861

RX   PubMed=15287027;

CC   Derived from metastatic site: Neck lymph node.

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A089 ! UT-SCC-60A

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-6A

AC   CVCL_7866

RX   PubMed=15287027;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7867 ! UT-SCC-6B

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-6B

AC   CVCL_7867

RX   PubMed=15287027;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7866 ! UT-SCC-6A

SX   Female

CA   Cancer cell line

//

ID   UT-SCC-7

AC   CVCL_7868

RX   PubMed=9187133;

DI   NCIt; C4819; Skin squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-75

AC   CVCL_A092

SY   UTSCC75

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UT-SCC-8

AC   CVCL_7869

SY   UTSCC8

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCC-9

AC   CVCL_7870

DR   BTO; BTO:0003720

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UT-SCV-1

AC   CVCL_6468

SY   University of Turku-Squamous cell Carcinoma of the Vulva-1

RX   PubMed=15047230;

CC   Doubling time: 38 hours (PubMed=15047230).

CC   Derived from metastatic site: Inguinal lymph node.

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-SCV-2

AC   CVCL_6469

SY   University of Turku-Squamous cell Carcinoma of the Vulva-2

RX   PubMed=15047230;

CC   Doubling time: 56 hours (PubMed=15047230).

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UT-SCV-3

AC   CVCL_6470

SY   University of Turku-Squamous cell Carcinoma of the Vulva-3

RX   PubMed=15047230;

CC   Doubling time: 13 hours (PubMed=15047230).

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UTA-SF2-2

AC   CVCL_AS03

DR   JCRB; NIHS0693

RX   PubMed=21124894;

CC   Discontinued: JCRB; NIHS0693; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UTA-SF3-2

AC   CVCL_AS04

DR   JCRB; NIHS0695

RX   PubMed=21124894;

CC   Discontinued: JCRB; NIHS0695; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UTA1

AC   CVCL_AS02

RX   PubMed=21124894;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   UtE-iPS-1

AC   CVCL_E031

SY   Center; UtE-iPS-A01

DR   SKIP; SKIP000350

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D693 ! UtE1104

SX   Female

CA   Induced pluripotent stem cell

//

ID   UtE-iPS-10

AC   CVCL_E032

SY   Flanker; UtE-iPS-B03

DR   SKIP; SKIP000386

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D693 ! UtE1104

SX   Female

CA   Induced pluripotent stem cell

//

ID   UtE-iPS-11

AC   CVCL_E033

SY   SplitEnd; UtE-iPS-B05

DR   SKIP; SKIP000357

RX   PubMed=21637780;

RX   PubMed=23631808;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D693 ! UtE1104

SX   Female

CA   Induced pluripotent stem cell

//

ID   UtE-iPS-2

AC   CVCL_E034

SY   Guard; UtE-iPS-A02

DR   SKIP; SKIP000383

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D693 ! UtE1104

SX   Female

CA   Induced pluripotent stem cell

//

ID   UtE-iPS-3

AC   CVCL_E035

SY   Tackle; UtE-iPS-A03

DR   SKIP; SKIP000384

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D693 ! UtE1104

SX   Female

CA   Induced pluripotent stem cell

//

ID   UtE-iPS-4

AC   CVCL_E036

SY   TightEnd; UtE-iPS-A04

DR   SKIP; SKIP000349

RX   PubMed=21637780;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D693 ! UtE1104

SX   Female

CA   Induced pluripotent stem cell

//

ID   UtE-iPS-5

AC   CVCL_E037

SY   FullBack; UtE-iPS-A05

DR   SKIP; SKIP000385

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D693 ! UtE1104

SX   Female

CA   Induced pluripotent stem cell

//

ID   UtE-iPS-6

AC   CVCL_E038

SY   TailBack; UtE-iPS-A06

DR   SKIP; SKIP000356

RX   PubMed=21637780;

RX   PubMed=23631808;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D693 ! UtE1104

SX   Female

CA   Induced pluripotent stem cell

//

ID   UtE-iPS-7

AC   CVCL_E039

SY   QuaterBack; UtE-iPS-A07

DR   SKIP; SKIP000358

RX   PubMed=21637780;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D693 ! UtE1104

SX   Female

CA   Induced pluripotent stem cell

//

ID   UtE1104

AC   CVCL_D693

DR   JCRB; JCRB1573

RX   PubMed=21155951;

RX   PubMed=21637780;

RX   PubMed=23631808;

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,9

ST   D16S539: 10,11

ST   D5S818: 12,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   UTHs

AC   CVCL_7871

DR   CLO; CLO_0009491

DR   CLDB; cl4613

CC   Transformant: NCBI_TaxID; 10298; Human herpesvirus 1 (HSV-1).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0579 ! WI-38

SX   Female

CA   Transformed cell line

//

ID   UtLM-hTERT

AC   CVCL_9Z19

RX   PubMed=12065682;

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2T99 ! GM10964

SX   Female

CA   Telomerase immortalized cell line

//

ID   UTMB-460

AC   CVCL_8276

DR   BioSample; SAMN03151622

RX   PubMed=3022081;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0207 ! CCRF-CEM

SX   Female

CA   Cancer cell line

//

ID   UTMC-2

AC   CVCL_4802

SY   UTMC2; University of Tennessee Medical Center-2

DR   Cosmic; 720762

DR   Cosmic; 759911

DR   Cosmic; 760393

DR   Cosmic; 2081410

DR   Cosmic; 2302412

DR   Cosmic; 2367294

DR   Cosmic; 2391804

RX   PubMed=7528862;

RX   PubMed=8943038;

RX   PubMed=10936422;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=UTMC-2

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UTO-EW1

AC   CVCL_W452

RX   PubMed=9573488;

DI   NCIt; C3716; Primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UTOS-1

AC   CVCL_H195

RX   PubMed=19239720;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UTP-2

AC   CVCL_5383

DR   BTO; BTO:0004948

DR   Cosmic; 996289

DR   Cosmic; 998697

DR   Cosmic; 1037707

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-5

AC   CVCL_W267

DR   Cosmic; 721711

RX   CelloPub=CLPUB00111;

RX   PubMed=10071127;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-6

AC   CVCL_W268

DR   Cosmic; 721712

RX   CelloPub=CLPUB00111;

RX   PubMed=10071127;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-DSAL-1

AC   CVCL_0C63

DR   Cosmic; 2089671

RX   PubMed=23955599;

DI   NCIt; C7972; Childhood acute megakaryoblastic leukemia

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-ES1

AC   CVCL_DH85

DR   GEO; GSM393043

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-L10

AC   CVCL_5385

DR   BTO; BTO:0004947

DR   Cosmic; 996288

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-L20

AC   CVCL_5386

DR   Cosmic; 998693

DR   Cosmic; 1037709

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-L3

AC   CVCL_5387

DR   Cosmic; 998739

DI   NCIt; C3171; Acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-L5

AC   CVCL_5388

DR   BTO; BTO:0004946

DR   Cosmic; 996286

DR   Cosmic; 998691

DR   Cosmic; 1037708

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-L51

AC   CVCL_5389

DR   Cosmic; 998690

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-M1

AC   CVCL_5390

DR   Cosmic; 998742

DI   NCIt; C3171; Acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-M2

AC   CVCL_5391

DR   Cosmic; 998741

DI   NCIt; C3171; Acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UTP-N-1

AC   CVCL_DF75

DR   Cosmic; 1153802

DR   GEO; GSM333824

DR   GEO; GSM333826

RX   PubMed=18923524;

CC   Omics: SNP array analysis.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   utr-1

AC   CVCL_U033

DR   ECACC; 10080904

RX   PubMed=2158104;

CC   Monoclonal antibody target: UniProtKB; P20333; Human TNFRSF1B/CD120b.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   utr-4a

AC   CVCL_U034

DR   ECACC; 10080901

RX   PubMed=2158104;

CC   Monoclonal antibody target: UniProtKB; P20333; Human TNFRSF1B/CD120b.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   UTree-O2

AC   CVCL_W195

RX   PubMed=16809887;

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UtSMC-hTERT

AC   CVCL_9Z20

RX   PubMed=12065682;

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Telomerase immortalized cell line

//

ID   UTSW-ACC112

AC   CVCL_Y492

SY   ACC112

DR   EFO; EFO_0007070

DR   ENCODE; ENCBS726UUU

DR   ENCODE; ENCBS827JIC

RX   PubMed=10328235;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UTSW-ACC52

AC   CVCL_Y489

SY   ACC52

RX   PubMed=10328235;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UTSW-CaPA79

AC   CVCL_Y490

SY   CaPA79

RX   PubMed=10328235;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

DI   NCIt; C40410; Salivary gland carcinoma ex pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UTSW-EMC52

AC   CVCL_Y491

RX   PubMed=10328235;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

DI   NCIt; C35701; Salivary gland epithelial myoepithelial carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UTSW-MEC49

AC   CVCL_Y488

SY   MEC49

RX   PubMed=10328235;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

DI   NCIt; C5908; Salivary gland mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UTSW-PA116

AC   CVCL_Y485

RX   PubMed=10328235;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

DI   NCIt; C40409; Salivary gland pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UTSW-PA125

AC   CVCL_Y486

RX   PubMed=10328235;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

DI   NCIt; C40409; Salivary gland pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UTSW-PA37

AC   CVCL_Y487

RX   PubMed=10328235;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

DI   NCIt; C40409; Salivary gland pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UV female 1A

AC   CVCL_4E30

DR   CLO; CLO_0050766

DR   RCB; RCB1993

RX   PubMed=8205558;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6 x BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   UV female 2

AC   CVCL_U951

DR   CLO; CLO_0050223

DR   RCB; RCB1994

RX   PubMed=8205558;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6 x BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   UV male 1d

AC   CVCL_4E31

DR   CLO; CLO_0050765

DR   RCB; RCB1992

RX   PubMed=8205558;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6 x BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   UV-2237-IP3

AC   CVCL_0J66

SY   UV-2237 ip-3; UV2237-IP3

RX   PubMed=2529426;

RX   PubMed=6935459;

CC   Breed/subspecies: C3H/HeN.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_B479 ! UV-2237M

SX   Female

CA   Cancer cell line

//

ID   UV-2237M

AC   CVCL_B479

SY   UV-2237m; UV2237M; UV2237m; UV2237 M; UV-2237

DR   KCLB; 80032

RX   PubMed=679204;

CC   Breed/subspecies: C3H/HeN.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_0J66 ! UV-2237-IP3

SX   Female

CA   Cancer cell line

//

ID   UV-2237M-ADMR

AC   CVCL_D696

SY   UV-2237-ADMR

RX   PubMed=6616446;

RX   PubMed=6831444;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Breed/subspecies: C3H/HeN.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B479 ! UV-2237M

SX   Female

CA   Cancer cell line

//

ID   UV-P3U1-B8

AC   CVCL_U860

DR   CLO; CLO_0050397

DR   RCB; RCB1157

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   UV.B6-1.1

AC   CVCL_4E33

DR   CLO; CLO_0050754

DR   RCB; RCB1997

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.B6-2.1A

AC   CVCL_4E34

DR   CLO; CLO_0050755

DR   RCB; RCB1998

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.B6-4.1

AC   CVCL_4E35

DR   CLO; CLO_0050756

DR   RCB; RCB1999

RX   DOI=10.4051/ibc.2010.2.4.0014;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.B6-5.1

AC   CVCL_4E36

DR   CLO; CLO_0050757

DR   RCB; RCB2000

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-1.1

AC   CVCL_4E37

DR   CLO; CLO_0050730

DR   RCB; RCB1995

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-12.1

AC   CVCL_4E38

DR   CLO; CLO_0050735

DR   RCB; RCB2030

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-13.1

AC   CVCL_4E39

DR   CLO; CLO_0050736

DR   RCB; RCB2031

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-14.2

AC   CVCL_4E40

DR   CLO; CLO_0050737

DR   RCB; RCB2032

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-15.1

AC   CVCL_4E41

DR   CLO; CLO_0050738

DR   RCB; RCB2033

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-16.1

AC   CVCL_4E42

DR   CLO; CLO_0050739

DR   RCB; RCB2034

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-17.1

AC   CVCL_4E43

DR   CLO; CLO_0050740

DR   RCB; RCB2035

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-18.1

AC   CVCL_4E44

DR   CLO; CLO_0050741

DR   RCB; RCB2036

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-19.1A

AC   CVCL_4E45

DR   CLO; CLO_0050742

DR   RCB; RCB2057

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-2.1D

AC   CVCL_4E46

DR   CLO; CLO_0050731

DR   RCB; RCB1996

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-20.1

AC   CVCL_4E47

DR   CLO; CLO_0050743

DR   RCB; RCB2058

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-21.1

AC   CVCL_4E48

DR   CLO; CLO_0050744

DR   RCB; RCB2059

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-23.1

AC   CVCL_4E49

DR   CLO; CLO_0050745

DR   RCB; RCB2060

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-3.3

AC   CVCL_4E50

DR   CLO; CLO_0050747

DR   RCB; RCB2024

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-5.4G

AC   CVCL_4E51

DR   CLO; CLO_0050748

DR   RCB; RCB2025

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-6.1E

AC   CVCL_4E52

DR   CLO; CLO_0050732

DR   RCB; RCB2026

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-7.1

AC   CVCL_4E53

DR   CLO; CLO_0050733

DR   RCB; RCB2027

RX   DOI=10.4051/ibc.2010.2.4.0014;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.BAL-8.1

AC   CVCL_4E54

DR   CLO; CLO_0050734

DR   RCB; RCB2028

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.C3B6-1.1

AC   CVCL_4E55

DR   CLO; CLO_0050728

DR   RCB; RCB2061

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6 x C3H/HeN.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.C3H-3.3

AC   CVCL_4E56

DR   CLO; CLO_0050751

DR   RCB; RCB2053

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C3H/HeN.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.C3H-8.2

AC   CVCL_4E57

DR   CLO; CLO_0050750

DR   RCB; RCB2056

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C3H/HeN.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV.CB6-2.1F

AC   CVCL_4E58

SY   2.1F

DR   CLO; CLO_0050720

DR   RCB; RCB2065

RX   PubMed=8205558;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6 x BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   UV.CB6-3.4B

AC   CVCL_8B28

DR   CLO; CLO_0050719

DR   RCB; RCB2066

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6 x BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   UV.CB6-4.1D

AC   CVCL_8B29

DR   RCB; RCB2067

DR   CLO; CLO_0050721

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6 x BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   UV.CB6-4.1F

AC   CVCL_8B30

DR   CLO; CLO_0050722

DR   RCB; RCB2068

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6 x BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   UV.CB6-5.2B

AC   CVCL_4E59

SY   5.2B

DR   CLO; CLO_0050725

DR   RCB; RCB2071

RX   PubMed=8205558;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6 x BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   UV.CB6-6.1B

AC   CVCL_4E60

SY   6.1B

DR   CLO; CLO_0050724

DR   RCB; RCB2073

RX   PubMed=8205558;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: C57BL/6 x BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   UV.CC3-11.1

AC   CVCL_4E61

DR   CLO; CLO_0050727

DR   RCB; RCB2074

RX   DOI=10.4051/ibc.2010.2.4.0014;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

CC   Breed/subspecies: BALB/c x C3H.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UV135

AC   CVCL_4595

SY   CHO UV-135; UV-135; GM10908

DR   CLO; CLO_0009492

DR   CLO; CLO_0023394

DR   ATCC; CRL-1867

DR   Coriell; GM10908

RX   PubMed=2687628;

RX   PubMed=3919945;

RX   PubMed=8765433;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV152

AC   CVCL_1N44

RX   PubMed=2687628;

RX   PubMed=3919945;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV20

AC   CVCL_4596

SY   UV-20

DR   CLO; CLO_0009493

DR   ATCC; CRL-1862

RX   PubMed=2687628;

RX   PubMed=3919945;

RX   PubMed=6943579;

RX   PubMed=7404270;

RX   PubMed=8765433;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV24

AC   CVCL_4597

SY   UV-24; UV 24; 60-21

DR   CLO; CLO_0009494

DR   ATCC; CRL-1866

DR   BCRC; 60175

RX   PubMed=2687628;

RX   PubMed=3919945;

RX   PubMed=6943579;

RX   PubMed=8765433;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV4

AC   CVCL_S480

SY   UV-4; AA8 / UV4

DR   ChEMBL-Cells; CHEMBL3307475

DR   ChEMBL-Cells; CHEMBL3307896

DR   ChEMBL-Targets; CHEMBL612800

DR   ChEMBL-Targets; CHEMBL614261

RX   PubMed=2687628;

RX   PubMed=3919945;

RX   PubMed=8765433;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV40

AC   CVCL_1N50

SY   361-114-33

RX   PubMed=8765162;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV41

AC   CVCL_4598

SY   UV-41; 361-112-10b

DR   CLO; CLO_0009495

DR   ATCC; CRL-1860

RX   PubMed=2687628;

RX   PubMed=3919945;

RX   PubMed=6943579;

RX   PubMed=8765433;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV46

AC   CVCL_1N45

RX   PubMed=3919945;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV47

AC   CVCL_1N46

RX   PubMed=3919945;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV5

AC   CVCL_4599

SY   UV-5; UV 5

DR   CLO; CLO_0009496

DR   ATCC; CRL-1865

DR   BCRC; 60174

RX   PubMed=2687628;

RX   PubMed=3919945;

RX   PubMed=6943579;

RX   PubMed=7404270;

RX   PubMed=8765433;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV57

AC   CVCL_1N47

RX   PubMed=3919945;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV61

AC   CVCL_1N42

RX   PubMed=2687628;

RX   PubMed=8765433;

RX   PubMed=9806502;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UV78

AC   CVCL_1N48

RX   PubMed=3919945;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Transformed cell line

//

ID   UVE-10

AC   CVCL_4600

DR   CLO; CLO_0009497

DR   ATCC; CRL-6515

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Transformant: NCBI_TaxID; 10533; Adenovirus 1.

CC   Discontinued: ATCC; CRL-6515; true.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   UVL-1

AC   CVCL_DE20

SY   UVL1

RX   PubMed=3129654;

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC   Selected for resistance to: ChEBI; CHEBI:77751; 8-azaadenine.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_DE19 ! CHO-AT3-2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   UVL-10

AC   CVCL_DE21

SY   UVL10

RX   PubMed=3129654;

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC   Selected for resistance to: ChEBI; CHEBI:77751; 8-azaadenine.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_DE19 ! CHO-AT3-2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   UVU1

AC   CVCL_1N43

SY   UVU1-CHO

RX   PubMed=2687628;

RX   PubMed=9258434;

CC   Transformant: NCIt; C17231; Ultraviolet radiation.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_S480 ! UV4

SX   Female

CA   Transformed cell line

//

ID   UW-1

AC   CVCL_8008

DR   GEO; GSM276760

RX   PubMed=9154388;

RX   PubMed=15714118;

RX   PubMed=17487557;

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Spontaneously immortalized cell line

//

ID   UW14

AC   CVCL_8582

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UW15

AC   CVCL_8583

RX   PubMed=19706761;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UW19

AC   CVCL_8584

RX   PubMed=19706761;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UW228

AC   CVCL_8585

SY   UW 228

DR   GEO; GSM919366

RX   PubMed=1292757;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UW228-1

AC   CVCL_4460

DR   BTO; BTO:0004330

RX   PubMed=8674085;

RX   PubMed=8866661;

RX   PubMed=15814657;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8585 ! UW228

SX   Female

CA   Cancer cell line

//

ID   UW228-2

AC   CVCL_0572

DR   BTO; BTO:0004331

DR   MCCL; MCC:0000477

RX   PubMed=8674085;

RX   PubMed=8866661;

RX   PubMed=15814657;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8585 ! UW228

SX   Female

CA   Cancer cell line

//

ID   UW228-3

AC   CVCL_0573

DR   BTO; BTO:0004332

DR   MCCL; MCC:0000478

RX   PubMed=8674085;

RX   PubMed=8866661;

RX   PubMed=15814657;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8585 ! UW228

SX   Female

CA   Cancer cell line

//

ID   UW28

AC   CVCL_8586

RX   PubMed=18505928;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UW281

AC   CVCL_8587

RX   PubMed=18505928;

RX   PubMed=19706761;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UW35

AC   CVCL_8588

RX   PubMed=19706761;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UW402

AC   CVCL_DH81

SY   Uw-402

DR   GEO; GSM482331

RX   PubMed=23325114;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UW426

AC   CVCL_DH82

SY   Uw-426

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UW443

AC   CVCL_M135

RX   PubMed=8674085;

RX   PubMed=8866661;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UW467

AC   CVCL_DG13

RX   PubMed=15814657;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UW473

AC   CVCL_DG14

SY   Uw-473

RX   PubMed=15814657;

RX   PubMed=23325114;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UW479

AC   CVCL_DG15

SY   UW-479

DR   BTO; BTO:0005888

DR   GEO; GSM2197892

DR   GEO; GSM2197893

DR   GEO; GSM2197894

DR   GEO; GSM2197895

DR   GEO; GSM2197896

DR   GEO; GSM2197897

RX   PubMed=15814657;

RX   PubMed=19365568;

CC   Doubling time: 28 hours (PubMed=19365568).

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C9477; Anaplastic astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UW5

AC   CVCL_8589

RX   PubMed=19706761;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UW77iSMA-e.x

AC   CVCL_W563

SY   77iSMA

DR   SKIP; SKIP000318

RX   PubMed=22723941;

DI   NCIt; C98670; Werdnig-Hoffmann disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W562 ! GM09677

SX   Male

CA   Induced pluripotent stem cell

//

ID   UW78

AC   CVCL_8590

RX   PubMed=19706761;

RX   PubMed=18505928;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UW83iCTR-i.8

AC   CVCL_W565

SY   83iCTR

RX   PubMed=22723941;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W557 ! GM02183

SX   Female

CA   Induced pluripotent stem cell

//

ID   UWB1.289

AC   CVCL_B079

SY   UWB1-289

DR   ATCC; CRL-2945

DR   BioSample; SAMN03471702

DR   Cosmic-CLP; 1480374

DR   GDSC; 1480374

DR   GEO; GSM1670568

RX   PubMed=17259345;

RX   PubMed=25230021;

RX   PubMed=27397505;

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25230021

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9

ST   D16S539: 12

ST   D18S51: 19

ST   D21S11: 28,31

ST   D3S1358: 14,15

ST   D5S818: 13

ST   D7S820: 7,10

ST   D8S1179: 12

ST   FGA: 22

ST   Penta D: 10

ST   Penta E: 8

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 16,19

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UWB1.289+BRCA1

AC   CVCL_B078

DR   ATCC; CRL-2946

RX   PubMed=17259345;

RX   PubMed=25230021;

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Transfected with: HGNC; 1100; BRCA1.

ST   Source(s): ATCC; PubMed=25230021

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9

ST   D16S539: 12

ST   D18S51: 19

ST   D21S11: 28,31

ST   D3S1358: 14,15

ST   D5S818: 13

ST   D7S820: 7,10

ST   D8S1179: 12

ST   FGA: 22

ST   Penta D: 10

ST   Penta E: 8

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 16,19

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B079 ! UWB1.289

SX   Female

CA   Cancer cell line

//

ID   UWKOS1

AC   CVCL_X350

RX   PubMed=23489774;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   UWKOS2

AC   CVCL_X351

RX   PubMed=23489774;

CC   Breed/subspecies: Irish Terrier.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   UWKOS3

AC   CVCL_X352

RX   PubMed=23489774;

CC   Breed/subspecies: Mastiff.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   UWKOS6

AC   CVCL_X353

RX   PubMed=23489774;

CC   Breed/subspecies: Labrador Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   UWKOS7

AC   CVCL_X354

RX   PubMed=23489774;

CC   Breed/subspecies: German Shepherd.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   UWKOS8

AC   CVCL_X355

RX   PubMed=23489774;

CC   Breed/subspecies: Border Collie.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   UWOV1

AC   CVCL_9809

RX   PubMed=2351639;

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UWOV2

AC   CVCL_9810

RX   PubMed=2351639;

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UWOV2 Sf

AC   CVCL_9811

RX   PubMed=2351639;

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9810 ! UWOV2

SX   Female

CA   Cancer cell line

//

ID   UWWC1-2DS3

AC   CVCL_EJ80

SY   2DS3

RX   PubMed=23716668;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UWWC1-2DS3.cmsx

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L976 ! GM02504

SX   Male

CA   Induced pluripotent stem cell

//

ID   UWWC1-DS1

AC   CVCL_EJ81

SY   DS1

RX   PubMed=23716668;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UWWC1-DS1.cmsx

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L780 ! AG05397

SX   Male

CA   Induced pluripotent stem cell

//

ID   UWWC1-DS2U

AC   CVCL_EJ82

SY   DS2U

RX   PubMed=23716668;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UWWC1-DS2U.cmsx

CC   Characteristics: Lost the third copy of chromosome 21.

ST   Source(s): PubMed=23716668

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 11,13

ST   D5S818: 10,12

ST   D7S820: 10,12

ST   TH01: 6,9

ST   TPOX: 8,10

ST   vWA: 15,17

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L780 ! AG05397

SX   Male

CA   Induced pluripotent stem cell

//

ID   UWWC1-DS4

AC   CVCL_EJ83

SY   DS4

RX   PubMed=23716668;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UWWC1-DS4.cmsx

ST   Source(s): PubMed=23716668

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 11,13

ST   D5S818: 10,12

ST   D7S820: 10,12

ST   TH01: 6,9

ST   TPOX: 8,10

ST   vWA: 15,17

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L780 ! AG05397

SX   Male

CA   Induced pluripotent stem cell

//

ID   Uyghur-UCSCCL

AC   CVCL_IM36

SY   Uyghur Uterine Cervical Squamous Carcinoma Cell Line

RX   PubMed=22800521;

CC   Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the cell description.

DI   NCIt; C4028; Cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   V-1181N1

AC   CVCL_T435

RX   PubMed=4354152;

RX   PubMed=4370460;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D317 ! 1181N1

SX   Male

CA   Cancer cell line

//

ID   V-3

AC   CVCL_K039

SY   CHO-V3; CHO V3; V3

DR   CLO; CLO_0050428

DR   RCB; RCB2329

RX   PubMed=2573661;

RX   PubMed=7724535;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4386 ! CHO-AA8

SX   Female

CA   Spontaneously immortalized cell line

//

ID   V-B11

AC   CVCL_V246

SY   GM16137

DR   CLO; CLO_0018899

DR   Coriell; GM16137

RX   PubMed=3412364;

RX   PubMed=3587254;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V-C4

AC   CVCL_T044

SY   GM16138

DR   CLO; CLO_0018897

DR   Coriell; GM16138

RX   PubMed=2466555;

RX   PubMed=3587254;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V-C8

AC   CVCL_X405

SY   VC8

RX   PubMed=3587254;

RX   PubMed=7565860;

RX   PubMed=11756561;

RX   PubMed=16643964;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V-E5

AC   CVCL_T045

SY   GM16139

DR   CLO; CLO_0018896

DR   CLO; CLO_0051578

DR   Coriell; GM16139

DR   RCB; RCB2335

RX   PubMed=2466555;

RX   PubMed=3587254;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V-G8

AC   CVCL_T046

SY   GM16140

DR   CLO; CLO_0018895

DR   CLO; CLO_0051579

DR   Coriell; GM16140

DR   RCB; RCB2336

RX   PubMed=2466555;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V-H1

AC   CVCL_V247

SY   GM16141

DR   CLO; CLO_0018894

DR   Coriell; GM16141

RX   PubMed=3587254;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V-H4

AC   CVCL_V248

SY   GM16142

DR   CLO; CLO_0018893

DR   Coriell; GM16142

RX   PubMed=3587254;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V.E.C.

AC   CVCL_E860

DR   dbMHC; 49050

DR   ECACC; 94050309

DR   IHW; IHW9314

DR   IMGT/HLA; 11521

WW   http://bioinformatics.hsanmartino.it/ecbr/cl314.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   V12S-3Y1-2

AC   CVCL_K114

DR   RCB; RCB0381

RX   PubMed=2920374;

CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 [E1A 12S isoform].

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4563 ! 3Y1-B clone 1

SX   Female

CA   Transformed cell line

//

ID   V13S-3Y1-4

AC   CVCL_K115

DR   RCB; RCB0384

RX   PubMed=2920374;

CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 [E1A 13S isoform].

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4563 ! 3Y1-B clone 1

SX   Female

CA   Transformed cell line

//

ID   v17.2

AC   CVCL_6D26

SY   V17.2

RX   PubMed=9054943;

RX   PubMed=9501308;

RX   PubMed=11331774;

RX   PubMed=11441181;

CC   Breed/subspecies: BALB/cTa x 129S4/SvJae.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   v18.6

AC   CVCL_6D27

SY   v 18.6; V18.6

RX   PubMed=10655052;

RX   PubMed=11331774;

RX   PubMed=11441181;

CC   Breed/subspecies: 129S4/SvJae.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   V2387

AC   CVCL_IP02

RX   PubMed=22249266;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   v26.2

AC   CVCL_6D28

SY   V26.2

RX   PubMed=11331774;

RX   PubMed=11441181;

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   v30.30

AC   CVCL_6D30

SY   V30.30

RX   PubMed=11331774;

CC   Breed/subspecies: C57BL/6J x BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   v39.7

AC   CVCL_6D31

SY   V39.7

RX   PubMed=11331774;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   v6.4

AC   CVCL_6D29

SY   V6.4

RX   PubMed=9501308;

CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   v6.5

AC   CVCL_C865

SY   v 6.5; V6.5

DR   EFO; EFO_0006308

DR   GEO; GSM344757

DR   GEO; GSM344758

DR   GEO; GSM1385513

RX   PubMed=10655052;

RX   PubMed=11331774;

RX   PubMed=11441181;

RX   PubMed=15464582;

WW   http://www.novusbio.com/v65-Mouse-embryonic-stem-cells-_NBP1-41162.html

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: C57BL/6 x 129S4/SvJae.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   V79

AC   CVCL_2234

SY   V-79; V 79; Strain V; GM00215; GM16136; UCW 100

DR   BTO; BTO:0001425

DR   CLO; CLO_0009500

DR   CLO; CLO_0018898

DR   CLO; CLO_0025501

DR   CLO; CLO_0051573

DR   CLDB; cl4625

DR   CLDB; cl4626

DR   CLDB; cl4627

DR   CLDB; cl4628

DR   CLDB; cl4952

DR   CCRID; 3131C0001000100006

DR   CCRID; 3153C0001000000026

DR   ChEMBL-Cells; CHEMBL3307528

DR   ChEMBL-Targets; CHEMBL614074

DR   Coriell; GM00215

DR   Coriell; GM16136

DR   DSMZ; ACC-335

DR   ECACC; 86041102

DR   ICLC; AL99002

DR   KCB; KCB 93015YJ

DR   Lonza; 731

DR   RCB; RCB0008

RX   PubMed=3558490;

RX   PubMed=13576097;

CC   Characteristics: Widely used to study DNA damage induced by X-ray, UV radiation and oxidizing agents.

CC   Doubling time: ~16 hours (DSMZ).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79 A3

AC   CVCL_5A61

SY   V-79 A3; V-79 A-3; V79, clone A3; A-3; A3

RX   PubMed=220255;

RX   PubMed=954094;

RX   PubMed=1170021;

RX   PubMed=4345996;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79 clone S

AC   CVCL_7230

DR   CLO; CLO_0009501

DR   CLDB; cl4629

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79 Dtxr-1

AC   CVCL_U412

SY   Dtxr-1

RX   PubMed=117016;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79 Dtxr-2

AC   CVCL_U413

SY   Dtxr-2

RX   PubMed=117016;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79 Dtxr-3

AC   CVCL_U414

SY   Dtxr-3

RX   PubMed=117016;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79 HPRT~

AC   CVCL_8556

SY   T2-14

DR   JCRB; JCRB0707

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79 HRC

AC   CVCL_7231

DR   CLO; CLO_0009502

DR   CLDB; cl4630

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-379A

AC   CVCL_J371

SY   V79 379A; V79.379A; V79-379-A; V-79-379A; V-79-379 A

DR   IFO; IFO50082

RX   PubMed=475817;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-4

AC   CVCL_2796

SY   V-79-4; V 79-4

DR   BTO; BTO:0003719

DR   CLO; CLO_0009504

DR   CLO; CLO_0051576

DR   CLDB; cl4632

DR   ATCC; CCL-93

DR   BCRC; 60183

DR   BCRJ; 0244

DR   ChEMBL-Cells; CHEMBL3307246

DR   ChEMBL-Targets; CHEMBL612801

DR   CLS; 603371/p553_V79-4

DR   ECACC; 93010723

DR   JCRB; JCRB0603

DR   RCB; RCB2332

RX   PubMed=9023109;

CC   Characteristics: Widely used to study DNA damage induced by X-ray, UV radiation and oxidizing agents.

CC   Characteristics: Deficient in TP53 due to two mutations, Q-133 and W-135.

CC   Doubling time: 12-14 hours (ECACC).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-6TG

AC   CVCL_3241

DR   JCRB; JCRB0219

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-8

AC   CVCL_M079

RX   PubMed=658159;

RX   PubMed=6035652;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-8HG-

AC   CVCL_M080

RX   PubMed=658159;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_M079 ! V79-8

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-ETO1

AC   CVCL_5A65

SY   ETO1

RX   PubMed=10606818;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2796 ! V79-4

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-ETO2

AC   CVCL_5A66

SY   ETO2

RX   PubMed=10606818;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2796 ! V79-4

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-ETO3

AC   CVCL_5A67

SY   ETO3

RX   PubMed=10606818;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2796 ! V79-4

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-G7

AC   CVCL_DQ79

SY   G7

RX   PubMed=196202;

RX   PubMed=1027147;

RX   PubMed=6265473;

RX   PubMed=9217999;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-GalK1

AC   CVCL_2797

SY   GalK1; GalK 1; DR2R1610; DR2R 1610; R1610; R 1610

DR   CLO; CLO_0008690

DR   ATCC; CRL-1657

DR   CCRID; 3131C0001000100005

RX   PubMed=1269916;

RX   PubMed=6513922;

CC   Selected for resistance to: ChEBI; CHEBI:27411; 2-deoxy-D-galactose.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-hCYP2E1-hSULT1A1

AC   CVCL_5A60

RX   PubMed=15668106;

CC   Transfected with: HGNC; 2631; CYP2E1.

CC   Transfected with: HGNC; 11453; SULT1A1.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4V36 ! V79MZ

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79-HG04

AC   CVCL_4333

DR   CLO; CLO_0009505

DR   CLDB; cl4633

DR   ECACC; 87020406

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79/380

AC   CVCL_HM61

SY   V79, clone 380

RX   PubMed=291939;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79/380-6

AC   CVCL_HM62

RX   PubMed=6510024;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HM61 ! V79/380

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79/B7

AC   CVCL_7232

SY   V79,B7

DR   CLO; CLO_0009503

DR   CLDB; cl4631

RX   PubMed=2896299;

RX   PubMed=7679200;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79/E36

AC   CVCL_5A58

SY   E36; E-36; E36,HGPRT-

DR   KCB; KCB 87014YJ

RX   PubMed=3049611;

RX   PubMed=4345996;

RX   PubMed=6752155;

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Misspelling: Occasionally 'CHO-E36' or 'CHO E36'. This is incorrect as E36 is not a CHO derivative but rather a V79 derivative.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_5A61 ! V79 A3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79/E36-ts20

AC   CVCL_0215

SY   E36-ts20; E36ts20; TS20; ts20; ts 20

DR   MCCL; MCC:0000104

RX   PubMed=3049611;

RX   PubMed=6752155;

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Misspelling: Occasionally 'CHO-TS20', 'CHO-ts20', 'CHO ts20' or 'CHOTS20'. This is incorrect as V79/E36-ts20 is not a CHO derivative but rather a V79 derivative.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_5A58 ! V79/E36

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79/M12G

AC   CVCL_S250

SY   M12G

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79/SD1

AC   CVCL_GR60

SY   SD1; SD-1

DR   TOKU-E; 4043

RX   PubMed=1441600;

RX   PubMed=1800893;

RX   PubMed=3137560;

RX   PubMed=8596476;

CC   Transfected with: RGD; 2466; Cyp2b1.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4V36 ! V79MZ

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79/UC

AC   CVCL_S170

RX   PubMed=1900371;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_S250 ! V79/M12G

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79B

AC   CVCL_6296

SY   V79b; V79 Brighton; GM16143

DR   CLO; CLO_0018892

DR   CLO; CLO_0051577

DR   Coriell; GM16143

DR   RCB; RCB2337

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79MZ

AC   CVCL_4V36

SY   V79-MZ; V79-Mz; V79 Mainz; V79d MZ

RX   PubMed=1446722;

RX   PubMed=7588408;

RX   PubMed=8293790;

RX   PubMed=8596476;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79MZh11B1

AC   CVCL_4709

DR   BTO; BTO:0003278

RX   PubMed=7588408;

CC   Transfected with: HGNC; 2591; CYP11B1.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4V36 ! V79MZ

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79MZh11B2

AC   CVCL_4710

DR   BTO; BTO:0003279

RX   PubMed=7588408;

CC   Transfected with: HGNC; 2592; CYP11B2.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4V36 ! V79MZ

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79MZh1A1

AC   CVCL_4V37

RX   PubMed=8293790;

CC   Transfected with: HGNC; 2595; CYP1A1.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4V36 ! V79MZ

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79MZh1A2

AC   CVCL_4V39

SY   XEMhIA2-MZ#1; XEMhIA2-MZ

RX   PubMed=1446722;

RX   PubMed=8293790;

CC   Transfected with: HGNC; 2596; CYP1A2.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4V36 ! V79MZ

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79NH

AC   CVCL_4V38

SY   V79-NH

RX   PubMed=1446722;

RX   PubMed=8293790;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_J371 ! V79-379A

SX   Male

CA   Spontaneously immortalized cell line

//

ID   V79NHh1A2

AC   CVCL_4V40

SY   XEMhIA2-NH#1; XEMhIA2NH

RX   PubMed=1446722;

RX   PubMed=8293790;

CC   Transfected with: HGNC; 2596; CYP1A2.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4V38 ! V79NH

SX   Male

CA   Spontaneously immortalized cell line

//

ID   v8.1

AC   CVCL_6D32

SY   V8.1

RX   PubMed=11331774;

RX   PubMed=11441181;

CC   Breed/subspecies: 129S4/SvJae x FVB.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   V9-7A

AC   CVCL_C658

SY   NED5; NED 5

DR   ISCR; 225

RX   PubMed=18371431;

CC   From: StemLifeLine, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   VA-ES-BJ

AC   CVCL_1785

SY   VAESBJ

DR   CLO; CLO_0009509

DR   CLDB; cl4635

DR   CLDB; cl4636

DR   ATCC; CRL-2138

DR   BioSample; SAMN03472555

DR   ChEMBL-Cells; CHEMBL3308888

DR   ChEMBL-Targets; CHEMBL2366259

DR   Cosmic; 688121

DR   Cosmic-CLP; 688121

DR   DSMZ; ACC-328

DR   ECACC; 94092303

DR   GDSC; 688121

DR   GEO; GSM1632462

DR   GEO; GSM1632463

DR   GEO; GSM1632464

DR   GEO; GSM1632465

DR   GEO; GSM1670569

DR   GEO; GSM1676344

DR   GEO; GSM1701675

DR   ICLC; HTL97024

RX   PubMed=21357725;

RX   PubMed=21552805;

RX   PubMed=26351324;

RX   PubMed=26365879;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 36-39 hours (PubMed=21552805); ~32 hours (PubMed=21357725); ~60-90 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; ICLC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D21S11: 27,28

ST   D5S818: 11,13

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C3714; Epithelioid sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VA-N-BR

AC   CVCL_9880

RX   DOI=10.1007/0-306-46872-7_2;

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=1580564;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VA13-TS4

AC   CVCL_U971

DR   BTO; BTO:0003065

RX   PubMed=14701864;

CC   Transfected with: HGNC; 220; ADAMTS4.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2759 ! WI-38 VA13 subline 2RA

SX   Female

CA   Transformed cell line

//

ID   VAB5

AC   CVCL_S600

RX   Patent=US6660276;

RX   PubMed=7681084;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VACO 1

AC   CVCL_5392

SY   VACO1

RX   PubMed=6498841;

CC   Derived from metastatic site: Liver.

DI   NCIt; C2955; Colorectal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VACO 10MS

AC   CVCL_5393

SY   VACO10MS; V10MS; VACO-10M; VACO10M; V10M; VACO 10; VACO10

DR   Cosmic; 948824

DR   Cosmic; 986022

DR   Cosmic; 1223152

DR   Cosmic; 1312319

DR   Cosmic; 2302023

DR   GEO; GSM784050

DR   GEO; GSM1346859

DR   GEO; GSM1374980

RX   PubMed=6498841;

RX   PubMed=7761852;

RX   PubMed=8755562;

RX   PubMed=20606684;

RX   PubMed=24755471;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Visceral (omental).

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5394 ! VACO 10P

SX   Female

CA   Cancer cell line

//

ID   VACO 10P

AC   CVCL_5394

SY   VACO10P

RX   PubMed=6498841;

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5393 ! VACO 10MS

SX   Female

CA   Cancer cell line

//

ID   VACO 143

AC   CVCL_9U74

SY   VACO143; VaCo143

RX   PubMed=9515795;

WW   http://www.seltarbase.org/cgi-bin/cell_lines.cgi?extension=latest

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 206

AC   CVCL_5395

SY   VACO206; Vaco206; V206

RX   PubMed=3567899;

RX   PubMed=7761852;

RX   PubMed=8385345;

RX   PubMed=11314036;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VACO 235

AC   CVCL_5175

SY   VACO235; VACO-235

DR   BTO; BTO:0002739

DR   Cosmic; 736333

DR   Cosmic; 956085

RX   PubMed=3567899;

RX   PubMed=8132740;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VACO 241

AC   CVCL_5396

SY   VACO241; Vaco241; V241

RX   PubMed=3567899;

RX   PubMed=8385345;

RX   PubMed=11314036;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VACO 264

AC   CVCL_8629

SY   Vaco 264; VACO264; V264

RX   PubMed=7761852;

RX   PubMed=8385345;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 3

AC   CVCL_5397

SY   VACO3

RX   PubMed=6498841;

DI   NCIt; C2955; Colorectal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VACO 310

AC   CVCL_5398

SY   VACO310

RX   PubMed=3567899;

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VACO 330

AC   CVCL_5399

SY   VACO330; VACO-330

RX   PubMed=3567899;

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VACO 364

AC   CVCL_8630

SY   VACO364; Vaco364; V364

RX   PubMed=11314036;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 394

AC   CVCL_8631

SY   Vaco 394; VACO394; Vaco394; V394

DR   GEO; GSM784026

RX   PubMed=8385345;

RX   PubMed=11314036;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 400

AC   CVCL_5400

SY   Vaco 400; VACO-400; Vaco-400; VACO400; Vaco400; V400

DR   BTO; BTO:0004764

DR   Cosmic; 1312318

DR   GEO; GSM784046

RX   PubMed=20606684;

WW   http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/VACO400.html

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VACO 410

AC   CVCL_8632

SY   Vaco 410; VACO410; VaCo410; Vaco410; V410

DR   GEO; GSM784047

RX   PubMed=7824277;

RX   PubMed=8385345;

RX   PubMed=11314036;

CC   Derived from metastatic site: Liver.

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VACO 411

AC   CVCL_5176

SY   Vaco 411; VACO-411; VACO411; V411

DR   BTO; BTO:0002739

DR   Cosmic; 736334

DR   GEO; GSM1448221

RX   PubMed=7761852;

RX   PubMed=8132740;

RX   PubMed=12595761;

RX   PubMed=25926053;

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5175 ! VACO 235

SX   Female

CA   Cancer cell line

//

ID   VACO 425

AC   CVCL_8633

SY   VACO425; Vaco 425; Vaco425

RX   PubMed=8385345;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 429

AC   CVCL_5401

SY   Vaco 429; VACO-429; Vaco-429; VACO429; V429

DR   Cosmic; 1312320

DR   GEO; GSM784051

RX   PubMed=7816807;

RX   PubMed=8385345;

RX   PubMed=20606684;

WW   http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/VACO429.html

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VACO 432

AC   CVCL_5402

SY   Vaco 432; VACO432; VaCo432; Vaco432; V432

DR   GEO; GSM1448124

RX   PubMed=7761852;

RX   PubMed=7816807;

RX   PubMed=7824277;

RX   PubMed=8755562;

RX   PubMed=9515795;

RX   PubMed=11314036;

RX   PubMed=25926053;

CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VACO 441

AC   CVCL_5403

SY   VACO441; VaCo441; Vaco441; Vaco 441; V441

RX   PubMed=7816807;

RX   PubMed=8385345;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 444

AC   CVCL_8634

SY   Vaco 444; VACO444; V444

DR   Cosmic; 1090614

RX   PubMed=7761852;

RX   PubMed=8385345;

RX   PubMed=8755562;

RX   PubMed=9515795;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 451

AC   CVCL_8635

SY   Vaco 451; VACO451; Vaco451; V451

RX   PubMed=8385345;

RX   PubMed=11314036;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 456

AC   CVCL_5404

SY   Vaco 456; VACO456; VaCo456; V456

DR   GEO; GSM784052

RX   PubMed=7816807;

RX   PubMed=8385345;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 457

AC   CVCL_9T31

SY   Vaco 457; Vaco-457; VACO457; Vaco457; V457

DR   GEO; GSM1448081

RX   PubMed=7761852;

RX   PubMed=7824277;

RX   PubMed=8755562;

RX   PubMed=9515795;

RX   PubMed=11314036;

RX   PubMed=25926053;

CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Liver.

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VACO 459

AC   CVCL_8636

SY   Vaco 459; VACO459; V459

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 478

AC   CVCL_8637

SY   Vaco 478; VACO478; Vaco478

RX   PubMed=8385345;

RX   PubMed=11314036;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 481

AC   CVCL_8638

SY   Vaco 481; VACO481; Vaco481; V481

DR   Cosmic; 1090615

DR   Cosmic; 1131690

DR   GEO; GSM1448110

RX   PubMed=7761852;

RX   PubMed=8385345;

RX   PubMed=8755562;

RX   PubMed=9515795;

RX   PubMed=11314036;

RX   PubMed=17363507;

RX   PubMed=25926053;

CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 486

AC   CVCL_8639

SY   Vaco 486; VACO486

RX   PubMed=8385345;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 489

AC   CVCL_8640

SY   Vaco 489; VACO489

RX   PubMed=7824277;

RX   PubMed=8385345;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VACO 4A

AC   CVCL_5405

SY   VACO4A

DR   Cosmic; 948843

DR   Cosmic; 985654

DR   Cosmic; 995404

DR   Cosmic; 1043833

DR   Cosmic; 1312321

DR   GEO; GSM1374981

RX   PubMed=6498841;

RX   PubMed=10737795;

RX   PubMed=11226274;

RX   PubMed=20606684;

WW   http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/VACO4A.html

CC   Omics: Transcriptome analysis.

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5406 ! VACO 4S

SX   Male

CA   Cancer cell line

//

ID   VACO 4S

AC   CVCL_5406

SY   VACO-4S; VACO4S

DR   Cosmic; 948849

DR   Cosmic; 986023

DR   Cosmic; 1043834

DR   Cosmic; 2302024

DR   GEO; GSM1346860

DR   GEO; GSM1374982

RX   PubMed=6498841;

RX   PubMed=20606684;

RX   PubMed=24755471;

CC   Omics: Transcriptome analysis.

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5405 ! VACO 4A

SX   Male

CA   Cancer cell line

//

ID   VACO 5

AC   CVCL_5407

SY   Vaco 5; VACO5; Vaco5; V5

DR   Cosmic; 948859

DR   Cosmic; 995385

DR   Cosmic; 1043835

DR   Cosmic; 1090612

DR   Cosmic; 1223153

DR   Cosmic; 1312322

DR   Cosmic; 1479608

DR   GEO; GSM1374983

DR   GEO; GSM1448121

RX   PubMed=6498841;

RX   PubMed=7761852;

RX   PubMed=8385345;

RX   PubMed=8755562;

RX   PubMed=9515795;

RX   PubMed=10737795;

RX   PubMed=11226274;

RX   PubMed=11314036;

RX   PubMed=20606684;

RX   PubMed=25926053;

WW   http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/VACO5.html

CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5409 ! VACO 5A

SX   Female

CA   Cancer cell line

//

ID   VACO 503

AC   CVCL_8641

SY   Vaco 503; VACO503; V503

DR   GEO; GSM784048

RX   PubMed=8385345;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 531

AC   CVCL_DG24

SY   V531

DR   GEO; GSM784053

RX   PubMed=8755562;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 576

AC   CVCL_5408

SY   VACO576; Vaco576; V576

DR   GEO; GSM784049

RX   PubMed=7816807;

RX   PubMed=7824277;

CC   Derived from metastatic site: Liver.

DI   NCIt; C2955; Colorectal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VACO 5A

AC   CVCL_5409

SY   VACO5A

RX   PubMed=6498841;

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5407 ! VACO 5

SX   Female

CA   Cancer cell line

//

ID   VACO 6

AC   CVCL_5410

SY   Vaco 6; VACO6; Vaco6; V6

DR   Cosmic; 1090613

DR   GEO; GSM1448220

RX   PubMed=6498841;

RX   PubMed=7761852;

RX   PubMed=8385345;

RX   PubMed=8755562;

RX   PubMed=9515795;

RX   PubMed=11314036;

RX   PubMed=25926053;

CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VACO 670

AC   CVCL_9T32

SY   Vaco 670; VACO670; Vaco670; V670

RX   PubMed=7761852;

RX   PubMed=11314036;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 703

AC   CVCL_9T33

SY   Vaco 703; VACO703; Vaco703; V703

DR   GEO; GSM1448108

RX   PubMed=7761852;

RX   PubMed=11314036;

RX   PubMed=25926053;

CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 784

AC   CVCL_8642

SY   VACO784; V784

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 786

AC   CVCL_8643

SY   VACO786; V786

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 8

AC   CVCL_5411

SY   Vaco 8; VACO8; V8

RX   PubMed=6498841;

RX   PubMed=7761852;

RX   PubMed=8385345;

RX   PubMed=8755562;

RX   PubMed=11314036;

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VACO 866

AC   CVCL_8644

SY   VACO866; V866

DR   BTO; BTO:0004763

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VACO 9M

AC   CVCL_5412

SY   Vaco 9M; VACO9M; Vaco9M; V9M

DR   GEO; GSM784025

RX   PubMed=6498841;

RX   PubMed=7761852;

RX   PubMed=8385345;

RX   PubMed=8755562;

CC   Derived from metastatic site: Liver.

DI   NCIt; C2955; Colorectal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5413 ! VACO 9P

SX   Male

CA   Cancer cell line

//

ID   VACO 9P

AC   CVCL_5413

AS   CVCL_A437

SY   Vaco 9P; VACO9P; V9P

DR   Cosmic; 711267

DR   Cosmic; 887233

DR   Cosmic; 1132562

DR   Cosmic; 1479634

RX   PubMed=3349466;

RX   PubMed=6498841;

RX   PubMed=9000147;

RX   PubMed=9000572;

RX   PubMed=11526487;

RX   PubMed=24042735;

CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735).

CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained by personal communication of Lind G.E.

ST   Source(s): PubMed=24042735

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 9,12

ST   D16S539: 12,13

ST   D18S51: 13

ST   D19S433: 13

ST   D21S11: 30

ST   D2S1338: 17,20

ST   D3S1358: 13,15

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 13,14

ST   FGA: 23,25

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 19

DI   NCIt; C2955; Colorectal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5412 ! VACO 9M

SX   Male

CA   Cancer cell line

//

ID   VAL

AC   CVCL_1819

DR   BioSample; SAMN03473489

DR   Cosmic; 1086346

DR   Cosmic; 1517631

DR   Cosmic; 1541908

DR   Cosmic; 2276320

DR   Cosmic; 2297002

DR   Cosmic-CLP; 1331048

DR   DSMZ; ACC-586

DR   GDSC; 1331048

DR   GEO; GSM115973

DR   GEO; GSM201349

DR   GEO; GSM1670570

DR   Lonza; 1237

RX   PubMed=8220427;

RX   PubMed=16960149;

RX   PubMed=19358282;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~50-70 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10,14

ST   D16S539: 9,13

ST   D5S818: 11

ST   D7S820: 10

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 14,15

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VAL-1

AC   CVCL_9969

RX   PubMed=15652923;

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VAL-10B

AC   CVCL_9961

SY   ESe020-A

DR   hPSCreg; ESe020-A

DR   ISCR; 2254

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL_10B.pdf

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   VAL-11B

AC   CVCL_V174

DR   ISCR; 2255

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL_11B.pdf

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VAL-2

AC   CVCL_9970

RX   PubMed=15652923;

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VAL-3

AC   CVCL_9962

SY   ESe011-A

DR   hPSCreg; ESe011-A

DR   ISCR; 1415

RX   PubMed=20186513;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/VAL3.pdf

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

CC   Registration: Swiss research registry; BAG-hES-IMP-0021.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   VAL-4

AC   CVCL_9963

SY   ESe012-A

DR   hPSCreg; ESe012-A

DR   ISCR; 1416

RX   PubMed=20186513;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/VAL4.pdf

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

CC   Registration: Swiss research registry; BAG-hES-IMP-0022.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VAL-5

AC   CVCL_9964

SY   ESe013-A

DR   hPSCreg; ESe013-A

DR   ISCR; 1417

RX   PubMed=20186513;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/VAL5.pdf

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

CC   Registration: Swiss research registry; BAG-hES-IMP-0023.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VAL-6M

AC   CVCL_9965

SY   ESe017-A

DR   hPSCreg; ESe017-A

DR   ISCR; 1418

RX   PubMed=20186513;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL_6M_febrero_2008.pdf

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

DI   NCIt; C84679; Dystrophia myotonica 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   VAL-7

AC   CVCL_9966

SY   ESe018-A

DR   hPSCreg; ESe018-A

DR   ISCR; 1419

RX   PubMed=20186513;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL_7_febrero_2008.pdf

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   VAL-8

AC   CVCL_9967

SY   ESe021-A

DR   hPSCreg; ESe021-A

DR   ISCR; 1420

RX   PubMed=20186513;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL8.pdf

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VAL-9

AC   CVCL_9968

SY   Val 9; ESe019-A

DR   hPSCreg; ESe019-A

DR   ISCR; 1421

RX   PubMed=20186513;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL_9.pdf

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC10-45.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   VAL-9-GFP

AC   CVCL_V165

DR   ISCR; 2256

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL-9-GFP.pdf

CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9968 ! VAL-9

SX   Male

CA   Embryonic stem cell

//

ID   ValiScreen human Kv1.3

AC   CVCL_5I79

WW   http://www.perkinelmer.com/Catalog/Product/ID/AX-010-C

CC   Transfected with: HGNC; 6221; KCNA3.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_1977 ! CHO-DXB11

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ValiScreen human TRPC3

AC   CVCL_5I80

WW   http://www.perkinelmer.com/Catalog/Product/ID/AX-011-C

CC   Transfected with: HGNC; 12335; TRPC3.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_1977 ! CHO-DXB11

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ValiScreen human TRPC6

AC   CVCL_5I81

WW   http://www.perkinelmer.com/Catalog/Product/ID/AX-012-C

CC   Transfected with: HGNC; 12338; TRPC6.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_1977 ! CHO-DXB11

SX   Female

CA   Spontaneously immortalized cell line

//

ID   VAMT-1

AC   CVCL_A731

SY   VAMT 1; VAMT

DR   Cosmic; 733834

DR   Cosmic; 1522779

DR   Cosmic; 1541209

DR   GEO; GSM726285

RX   CelloPub=CLPUB00125;

RX   PubMed=21642991;

CC   Omics: SNP array analysis.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VAn2H

AC   CVCL_6E14

SY   VAN2H; Vertebra Acipenser naccarii 2H

RX   DOI=10.1111/j.1439-0426.2010.01408.x;

RX   DOI=10.1111/j.1439-0426.2010.01411.x;

CC   Group: Fish cell line.

OX   NCBI_TaxID=42330; ! Acipenser naccarii

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   VAO1

AC   CVCL_S601

RX   Patent=US6660276;

RX   PubMed=7681084;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VAT-39

AC   CVCL_0U25

RX   PubMed=24481592;

CC   Doubling time: 34 hours, at 50th passage (PubMed=24481592).

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=24481592

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9,12

ST   D21S11: 30

ST   D5S818: 12

ST   D7S820: 12,13

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C95966; Ampulla of Vater hepatoid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VAVY

AC   CVCL_E861

SY   Vavy

DR   dbMHC; 49051

DR   ECACC; 88052023

DR   IHW; IHW9023

DR   IMGT/HLA; 11522

RX   PubMed=7615790;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl23.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   VBD234

AC   CVCL_E862

SY   VBD 234

DR   dbMHC; 49052

DR   ECACC; 94082260

DR   IHW; IHW9160

DR   IMGT/HLA; 11703

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl160.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   VBT2

AC   CVCL_S587

RX   Patent=US6660276;

RX   PubMed=7513255;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_S588 ! VBT2-EBV

SX   Male

CA   Cancer cell line

//

ID   VBT2-EBV

AC   CVCL_S588

RX   PubMed=7513255;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_S587 ! VBT2

SX   Male

CA   Transformed cell line

//

ID   VC1.Ov

AC   CVCL_S371

DR   ATCC; CRL-6266

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6266; true.

OX   NCBI_TaxID=9627; ! Vulpes vulpes

SX   Female

CA   Finite cell line

//

ID   VC312R

AC   CVCL_1R57

DR   BioSample; SAMN03152031

RX   PubMed=20951163;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20951163).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Sex undetermined

CA   Undefined cell line type

//

ID   VC5

AC   CVCL_M545

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VCaP

AC   CVCL_2235

SY   VCAP; Vcap; Vertebral Cancer of the Prostate

DR   BTO; BTO:0003215

DR   ATCC; CRL-2876

DR   BioSample; SAMN03473238

DR   CCLE; VCAP_PROSTATE

DR   Cosmic; 1028646

DR   Cosmic; 1028698

DR   Cosmic; 1043330

DR   Cosmic; 1071482

DR   Cosmic; 1689710

DR   Cosmic; 1995663

DR   Cosmic; 2580131

DR   Cosmic-CLP; 1299075

DR   ECACC; 06020201

DR   GDSC; 1299075

DR   GEO; GSM525805

DR   GEO; GSM648824

DR   GEO; GSM887731

DR   GEO; GSM888826

DR   GEO; GSM1374984

DR   GEO; GSM1440913

DR   GEO; GSM1440914

DR   GEO; GSM1670571

DR   IZSLER; BS TCL 234

RX   PubMed=11317522;

RX   PubMed=14518029;

RX   PubMed=22460905;

RX   PubMed=23671654;

RX   PubMed=25984343;

RX   PubMed=27397505;

WW   http://capcelllines.ca/details.asp?id=159

WW   http://www.addexbio.com/productdetail?pid=73

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 220 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Vertebra.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 9

ST   D18S51: 13

ST   D21S11: 31

ST   D3S1358: 14,15

ST   D5S818: 12

ST   D7S820: 9,12

ST   D8S1179: 12,13

ST   FGA: 21,26

ST   Penta D: 9

ST   Penta E: 10,12

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 18,19

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2025 ! DuCaP

SX   Male

CA   Cancer cell line

//

ID   VCP-#1

AC   CVCL_T897

DR   RCB; HPS0351

DR   SKIP; SKIP000225

DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_T894 ! GM22394

SX   Male

CA   Induced pluripotent stem cell

//

ID   VCP-#2

AC   CVCL_T898

DR   RCB; HPS0352

DR   SKIP; SKIP000226

DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_T894 ! GM22394

SX   Male

CA   Induced pluripotent stem cell

//

ID   VCP-#4

AC   CVCL_T899

DR   SKIP; SKIP000227

DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_T894 ! GM22394

SX   Male

CA   Induced pluripotent stem cell

//

ID   VD-10

AC   CVCL_F806

DR   CLO; CLO_0009520

DR   ATCC; HB-68

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   VE-CL-01

AC   CVCL_Z454

SY   VE-Clp1; Super Sf9-1; superSf9-1

RX   Patent=US7842493;

RX   PubMed=19453763;

WW   http://www.paratechs.com/ve-bevs-cell-lines/

WW   http://www.paratechs.com/ve-bevs-resource-page/

WW   http://oetltd.com/product/super-sf9-1-cells/

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Transfected with: UniProtKB; Q56IA8; Campoletis sonorensis ichnovirus P-vankyrin-1.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_0549 ! Sf9

SX   Female

CA   Spontaneously immortalized cell line

//

ID   VE-CL-02

AC   CVCL_Z455

SY   VE-CL2; Super Sf9-2; superSf9-2

RX   Patent=US7842493;

RX   PubMed=19453763;

WW   http://www.paratechs.com/ve-bevs-cell-lines/

WW   http://www.paratechs.com/ve-bevs-resource-page/

WW   http://oetltd.com/product/super-sf9-2-cells/

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Transfected with: UniProtKB; Q56IA8; Campoletis sonorensis ichnovirus P-vankyrin-1.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_0549 ! Sf9

SX   Female

CA   Spontaneously immortalized cell line

//

ID   VE-CL-03

AC   CVCL_Z456

SY   VE-CL03; Super Sf9-3; superSf9-3

RX   Patent=US7842493;

WW   http://www.paratechs.com/ve-bevs-cell-lines/

WW   http://www.paratechs.com/ve-bevs-resource-page/

WW   http://oetltd.com/product/super-sf9-3-cells/

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Transfected with: UniProtKB; Q56IA8; Campoletis sonorensis ichnovirus P-vankyrin-1.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_0549 ! Sf9

SX   Female

CA   Spontaneously immortalized cell line

//

ID   VEGF-D 293 clone 11

AC   CVCL_W713

DR   IZSLER; BS CL 202

RX   PubMed=11175849;

CC   Transfected with: HGNC; 3708; FIGF.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6974 ! HEK293-EBNA

SX   Female

CA   Transformed cell line

//

ID   VEGF120 fibrosarcoma

AC   CVCL_HG18

DR   Ximbio; 153239

RX   PubMed=18381437;

CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF120.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   VEGF120 fibrosarcoma Luc2/mStrawberry

AC   CVCL_HG19

DR   Ximbio; 152853

CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF120.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Transfected with: mStrawberry; a bright red fluorescent protein derived from mRFP1.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_HG18 ! VEGF120 fibrosarcoma

CA   Cancer cell line

//

ID   VEGF164 fibrosarcoma

AC   CVCL_HG20

DR   Ximbio; 153240

RX   PubMed=18381437;

CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF164.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   VEGF164 fibrosarcoma Luc2/mStrawberry

AC   CVCL_HG21

DR   Ximbio; 152854

CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF164.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Transfected with: mStrawberry; a bright red fluorescent protein derived from mRFP1.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_HG20 ! VEGF164 fibrosarcoma

CA   Cancer cell line

//

ID   VEGF188 fibrosarcoma

AC   CVCL_HG22

DR   Ximbio; 153241

RX   PubMed=18381437;

CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF188.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   VEGF188 fibrosarcoma Luc2/mStrawberry

AC   CVCL_HG23

DR   Ximbio; 152855

CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF188.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Transfected with: mStrawberry; a bright red fluorescent protein derived from mRFP1.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_HG22 ! VEGF188 fibrosarcoma

CA   Cancer cell line

//

ID   VEGFWT fibrosarcoma

AC   CVCL_HG24

DR   Ximbio; 153238

RX   PubMed=18381437;

CC   Characteristics: Control cell line for the Vegfa isoform-specific cell lines.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   VEGFWT fibrosarcoma Luc2/mStrawberry

AC   CVCL_HG25

DR   Ximbio; 152852

RX   PubMed=18381437;

CC   Characteristics: Control cell line for the Vegfa isoform-specific cell lines.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Transfected with: mStrawberry; a bright red fluorescent protein derived from mRFP1.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_HG24 ! VEGFWT fibrosarcoma

CA   Cancer cell line

//

ID   VEN

AC   CVCL_E863

DR   dbMHC; 49053

DR   ECACC; 94022550

DR   IHW; IHW9238

DR   IMGT/HLA; 11525

WW   http://bioinformatics.hsanmartino.it/ecbr/cl238.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   vEPT

AC   CVCL_4626

DR   CLO; CLO_0009523

DR   ATCC; CRL-2087

RX   PubMed=1280703;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: New Zealand white.

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

SX   Male

CA   Transformed cell line

//

ID   Vero

AC   CVCL_0059

SY   VERO; Verda reno

DR   BTO; BTO:0001444

DR   CLO; CLO_0009524

DR   CLO; CLO_0050515

DR   MCCL; MCC:0000480

DR   CLDB; cl4643

DR   CLDB; cl4644

DR   CLDB; cl4645

DR   CLDB; cl4648

DR   CLDB; cl4649

DR   CLDB; cl4650

DR   CLDB; cl4651

DR   CLDB; cl5170

DR   ATCC; CCL-81

DR   ATCC; CCL-81.4

DR   ATCC; CRL-6318

DR   BCRC; 60013

DR   BCRJ; 0245

DR   CCLV; CCLV-RIE 0078

DR   CCRID; 3111C0001CCC000060

DR   CCRID; 3111C0002000000001

DR   CCRID; 3131C0001000400010

DR   CCRID; 3142C0001000000029

DR   CCRID; 3153C0001000000035

DR   ChEMBL-Cells; CHEMBL3307520

DR   ChEMBL-Targets; CHEMBL391

DR   CLS; 605372/p622_VERO

DR   ECACC; 08011101

DR   ECACC; 84113001

DR   ICLC; ATL95005

DR   IFO; IFO50471

DR   IZSLER; BS CL 86

DR   JCRB; JCRB0111

DR   JCRB; JCRB9013

DR   KCB; KCB 92017YJ

DR   KCLB; 10081

DR   Lonza; 173

DR   MeSH; D014709

DR   NCBI_Iran; C101

DR   RCB; RCB0001

DR   TKG; TKG 0280

DR   TOKU-E; 3415

DR   Wikidata; Q3066564

RX   CelloPub=CLPUB00126;

RX   CelloPub=CLPUB00328;

RX   DOI=10.12665/J63.Morgan;

RX   PubMed=4043530;

RX   PubMed=6027511;

RX   PubMed=10403033;

RX   PubMed=10494966;

RX   PubMed=19941903;

RX   PubMed=24975811;

RX   PubMed=25267831;

RX   PubMed=25903999;

WW   https://en.wikipedia.org/wiki/Vero_cell

WW   http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3616b1a.pdf

WW   http://en.vircell.com/products/vero-cell-line/

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/v/cell-lines-detail-60.html

WW   http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/vero/verocells.html

CC   Group: Vaccine production cell line.

CC   Group: Non-human primate cell line.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Biotechnology: Used for the production of the Japanese encephalitis virus (JEV) vaccine Ixiaro.

CC   Biotechnology: Used for the production of the inactivated poliovirus vaccine Imovax Polio.

CC   Biotechnology: Used for the production of the Purified Vero-cell Rabies Vaccine (PVRV) (Trade name: Verorab).

CC   Biotechnology: Used for the production of the Chromatographically Purified Rabies Vaccine (CPRV).

CC   Omics: Genome sequenced.

CC   Anecdotal: Verda reno means green kidney in Esperanto.

CC   Discontinued: ATCC; CCL-81.4; probable.

CC   Discontinued: ATCC; CRL-6318; true.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero 303

AC   CVCL_L035

CC   Group: Vaccine production cell line.

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero 317

AC   CVCL_3863

SY   Vero-317; Vero317

DR   CLO; CLO_0009525

DR   CLO; CLO_0050513

DR   CLDB; cl4652

DR   ECACC; 89070502

DR   RCB; RCB0272

CC   Group: Vaccine production cell line.

CC   Group: Non-human primate cell line.

CC   Discontinued: ECACC; 89070502; probable.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_L035 ! Vero 303

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero 76

AC   CVCL_0603

SY   VERO 76; Vero-76; VERO-76; VERO76; Vero76

DR   BTO; BTO:0004754

DR   CLO; CLO_0009526

DR   CLDB; cl4653

DR   CLDB; cl4654

DR   CLDB; cl4655

DR   ATCC; CRL-1587

DR   BCRC; 60477

DR   CCLV; CCLV-RIE 0228

DR   CCRID; 3111C0002000000007

DR   ECACC; 85020205

DR   IFO; IFO50410

DR   IZSLER; BS CL 101

DR   JCRB; JCRB9007

DR   KCLB; 21587

RX   CelloPub=CLPUB00328;

RX   PubMed=19941903;

WW   https://en.wikipedia.org/wiki/Vero_cell

WW   http://www.rccc.cytspb.rssi.ru/ecellbank/animal/avero_76.htm

CC   Group: Vaccine production cell line.

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero C1008

AC   CVCL_0574

SY   VERO C1008; VeroC1008; VEROC1008; VERO C 1008; Vero 76 clone E6; Vero 76 clone E-6; Vero E6; VERO E6; Vero-E6; VeroE6

DR   BTO; BTO:0004755

DR   CLO; CLO_0009527

DR   MCCL; MCC:0000479

DR   CLDB; cl4656

DR   CLDB; cl4657

DR   ATCC; CRL-1586

DR   BCRC; 60476

DR   CCRID; 3111C0001CCC000388

DR   ECACC; 85020206

DR   GEO; GSM758827

DR   GEO; GSM758828

DR   GEO; GSM758829

DR   GEO; GSM758830

DR   GEO; GSM758831

DR   GEO; GSM758832

DR   GEO; GSM758833

DR   GEO; GSM758834

DR   GEO; GSM758835

DR   GEO; GSM758836

DR   GEO; GSM758837

DR   GEO; GSM758838

DR   GEO; GSM758839

DR   GEO; GSM758840

DR   GEO; GSM758841

DR   GEO; GSM758842

DR   GEO; GSM758843

DR   GEO; GSM758844

DR   IZSLER; BS CL 87

RX   CelloPub=CLPUB00328;

WW   https://en.wikipedia.org/wiki/Vero_cell

WW   http://en.vircell.com/products/vero-e6-cell-line/

CC   Group: Vaccine production cell line.

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0603 ! Vero 76

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero F6

AC   CVCL_L036

SY   F6; F6B2

RX   PubMed=1309250;

WW   https://en.wikipedia.org/wiki/Vero_cell

CC   Group: Non-human primate cell line.

CC   Transfected with: UniProtKB; P08356; HHV-1 strain HFEM glycoprotein H (gH).

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero M

AC   CVCL_EJ70

SY   Vero-M; VERO-M; Vero-MARU

CC   Group: Non-human primate cell line.

CC   From: Middle America Research Unit (MARU); Panama.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero-B4

AC   CVCL_1912

SY   VERO-B4; Vero B4

DR   CLO; CLO_0009528

DR   CLDB; cl4659

DR   CCLV; CCLV-RIE 0929

DR   DSMZ; ACC-33

CC   Group: Vaccine production cell line.

CC   Group: Non-human primate cell line.

CC   Doubling time: ~25 hours (DSMZ).

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero-Hektor

AC   CVCL_4334

SY   Vero Hektor

DR   ECACC; 03092503

CC   Group: Vaccine production cell line.

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero-SF-ACF

AC   CVCL_1K11

DR   ATCC; CCL-81.5

CC   Group: Vaccine production cell line.

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero-SF-adapted

AC   CVCL_AS92

DR   CLS; 605372-SF/p17167_VERO,_SF-adapted

CC   Group: Vaccine production cell line.

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero-SV2neo clone VN5

AC   CVCL_GA12

SY   Vn5; Vero/G418

RX   Patent=US7655406;

RX   PubMed=7745744;

CC   Group: Non-human primate cell line.

CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2659.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero/hSLAM

AC   CVCL_L037

DR   ECACC; 04091501

CC   Group: Non-human primate cell line.

CC   Transfected with: HGNC; 10903; SLAMF1.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero/PPRV H

AC   CVCL_GA11

RX   PubMed=17050742;

CC   Group: Non-human primate cell line.

CC   Transfected with: UniProtKB; Q6Q498; PPRV hemagglutinin (H).

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Vero/SF

AC   CVCL_1K13

SY   VERO/SF

DR   ATCC; CCL-81.1

CC   Group: Vaccine production cell line.

CC   Discontinued: ATCC; CCL-81.1; true.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Veronica-HSA

AC   CVCL_0D02

SY   Veronica

RX   PubMed=19461996;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C122783; Canine hemangiosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   Verots S3

AC   CVCL_T368

DR   CLO; CLO_0050511

DR   RCB; RCB0707

RX   PubMed=1368119;

CC   Group: Vaccine production cell line.

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_3863 ! Vero 317

SX   Female

CA   Transformed cell line

//

ID   Verots S3(SF)

AC   CVCL_T369

DR   CLO; CLO_0050512

DR   RCB; RCB0706

CC   Group: Vaccine production cell line.

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_T368 ! Verots S3

SX   Female

CA   Transformed cell line

//

ID   Vester

AC   CVCL_G707

DR   BTO; BTO:0003757

RX   PubMed=16177958;

CC   Miscellaneous: Only mentioned as a mesothelioma cell line in PubMed=16177958.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   vFOP1-1

AC   CVCL_W549

RX   PubMed=24321451;

DI   NCIt; C3040; Fibrodysplasia ossificans progressiva

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W541 ! GM00513

SX   Female

CA   Induced pluripotent stem cell

//

ID   vFOP1-4

AC   CVCL_W550

DR   SKIP; SKIP000341

RX   PubMed=24321451;

DI   NCIt; C3040; Fibrodysplasia ossificans progressiva

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W541 ! GM00513

SX   Female

CA   Induced pluripotent stem cell

//

ID   vFOP2-1

AC   CVCL_W551

DR   SKIP; SKIP000336

RX   PubMed=24321451;

DI   NCIt; C3040; Fibrodysplasia ossificans progressiva

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W542 ! GM00783

SX   Male

CA   Induced pluripotent stem cell

//

ID   vFOP2-2

AC   CVCL_W552

DR   SKIP; SKIP000335

RX   PubMed=24321451;

DI   NCIt; C3040; Fibrodysplasia ossificans progressiva

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W542 ! GM00783

SX   Male

CA   Induced pluripotent stem cell

//

ID   vFOP4-1

AC   CVCL_W553

SY   CiRA00041

DR   RCB; HPS0376

DR   SKIP; SKIP000339

DR   SKIP; SKIP000635

RX   PubMed=24321451;

CC   From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.

CC   Miscellaneous: Assignment of vFOP4-1 to CiRA00041 by personal communication from CiRA.

DI   NCIt; C3040; Fibrodysplasia ossificans progressiva

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W554 ! vFOP4-3

SX   Male

CA   Induced pluripotent stem cell

//

ID   vFOP4-3

AC   CVCL_W554

SY   CiRA00042

DR   RCB; HPS0377

DR   SKIP; SKIP000338

RX   PubMed=24321451;

DI   NCIt; C3040; Fibrodysplasia ossificans progressiva

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W553 ! vFOP4-1

SX   Male

CA   Induced pluripotent stem cell

//

ID   vFOP5-22

AC   CVCL_W555

SY   CiRA00043

DR   RCB; HPS0378

DR   SKIP; SKIP000340

RX   PubMed=24321451;

DI   NCIt; C3040; Fibrodysplasia ossificans progressiva

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   VG

AC   CVCL_X927

RX   PubMed=7535998;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9556; ! Papio cynocephalus

CA   Transformed cell line

//

ID   VG-1

AC   CVCL_0106

SY   VG1

DR   Cosmic; 1588566

DR   GEO; GSM634741

DR   GEO; GSM710426

DR   GEO; GSM710442

DR   Wikidata; Q16258509

RX   PubMed=10925292;

RX   PubMed=15613351;

RX   PubMed=21685375;

WW   https://en.wikipedia.org/wiki/VG-1

CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).

DI   NCIt; C6915; Primary effusion lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M579 ! B301

SX   Male

CA   Cancer cell line

//

ID   VGE

AC   CVCL_W084

DR   Cosmic; 1522765

DR   GEO; GSM726286

RX   PubMed=21642991;

CC   Omics: SNP array analysis.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VGH-EPY

AC   CVCL_Y107

DR   BCRC; 60374

ST   Source(s): BCRC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10

ST   D16S539: 9,12

ST   D5S818: 9,10

ST   D7S820: 11

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3017; Ependymoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VGH-MED

AC   CVCL_Y106

SY   VGH-Med

DR   BCRC; 60375

DR   GEO; GSM1938722

CC   Discontinued: BCRC; 60375; probable.

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VH-64

AC   CVCL_9672

SY   VH 64; VH64

DR   EFO; EFO_0002870

DR   GEO; GSM510015

RX   PubMed=1320624;

RX   PubMed=8335680;

RX   PubMed=15150091;

RX   PubMed=19787792;

CC   From: Van Valen F.; University of Munster; Germany.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VH-Renal

AC   CVCL_X539

DR   Cosmic; 849369

RX   PubMed=11146448;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VH2

AC   CVCL_4369

SY   VH 2; VH-2; Viper Heart-2

DR   CLO; CLO_0009531

DR   CLO; CLO_0009532

DR   CLDB; cl4662

DR   ATCC; CCL-140

DR   ECACC; 90102539

DR   IZSLER; BS CL 187

RX   PubMed=4358139;

CC   Group: Reptilian cell line.

OX   NCBI_TaxID=31159; ! Daboia russellii

SX   Female

CA   Spontaneously immortalized cell line

//

ID   VHB-1

AC   CVCL_M381

RX   PubMed=2824520;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   vHFF1-iPS4

AC   CVCL_DQ55

SY   vHFF1_iPS_iPS4

RX   PubMed=27345787;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3285 ! HFF-1

SX   Male

CA   Induced pluripotent stem cell

//

ID   VI-2A5-A4

AC   CVCL_U040

SY   B-4; B4

RX   PubMed=8734946;

CC   Monoclonal antibody target: Leishmania panamensis.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   VI-4D10-D12

AC   CVCL_U039

SY   B-3; B3

RX   PubMed=8734946;

CC   Monoclonal antibody target: Leishmania brazilensis and Leishmania panamensis.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Vi-856

AC   CVCL_A440

SY   Vi856; VI856

DR   Cosmic; 1167986

RX   PubMed=18165268;

CC   From: Majdic O.; Institute for Immunology; Vienna; Austria.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VII-II-5G3-F3

AC   CVCL_U041

SY   B-11; B11

RX   PubMed=8734946;

CC   Monoclonal antibody target: Leishmania panamensis.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   VIII-6G10

AC   CVCL_F807

DR   CLO; CLO_0009533

DR   ATCC; HB-10519

RX   Patent=US5206345;

CC   Monoclonal antibody target: UniProtKB; P19320; Human VCAM1/CD106.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Vin Dor

AC   CVCL_U681

DR   ATCC; CRL-1097

CC   Discontinued: ATCC; CRL-1097; true.

DI   NCIt; C34568; Ehlers-Danlos syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   VIP-VIIIC8

AC   CVCL_2236

DR   CLO; CLO_0009534

DR   DSMZ; ACC-479

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   VIPA

AC   CVCL_5177

DR   BTO; BTO:0003111

DR   SKY/M-FISH/CGH; 2649

RX   PubMed=12659655;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VJ-300

AC   CVCL_X217

SY   KB/VJ300

RX   PubMed=2568984;

RX   PubMed=2906349;

CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0372 ! KB

SX   Female

CA   Cancer cell line

//

ID   VK

AC   CVCL_Y578

RX   PubMed=1322234;

RX   PubMed=23882450;

DI   NCIt; C8971; Embryonal rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VK2/E6E7

AC   CVCL_6471

SY   Vk2/E6E7; VK-2/E6E7; VK2 (E6/E7)

DR   BTO; BTO:0005683

DR   CLO; CLO_0009535

DR   ATCC; CRL-2616

DR   BioSample; SAMN03471675

RX   PubMed=9314589;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D16S539: 9

ST   D5S818: 9,10

ST   D7S820: 10,11

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   VL-68

AC   CVCL_B480

DR   Cosmic; 1429647

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VL51

AC   CVCL_3169

SY   SLVL; VL-51

DR   CLO; CLO_0050869

DR   BioSample; SAMN03472064

DR   Cosmic-CLP; 1331032

DR   GDSC; 1331032

DR   GEO; GSM827255

DR   GEO; GSM866167

DR   GEO; GSM1670458

DR   JCRB; JCRB0159

DR   JCRB; NIHS0247

DR   RCB; RCB1702

RX   PubMed=8551798;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: JCRB; NIHS0247; true.

ST   Source(s): Cosmic-CLP; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,10

ST   D16S539: 12

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C35425; Splenic lymphoma with circulating villous lymphocytes

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VLM

AC   CVCL_2237

SY   SV40-VLM

DR   CLO; CLO_0009539

DR   DSMZ; ACC-429

RX   PubMed=4348218;

CC   Doubling time: ~25 hours (DSMZ).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   VLN1F9

AC   CVCL_Z072

DR   ATCC; HB-8635

RX   Patent=US4761377;

RX   PubMed=3621203;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D039 ! UC 729-6

CA   Hybridoma

//

ID   VLN3F10

AC   CVCL_Z073

DR   ATCC; HB-8632

RX   Patent=US4761377;

RX   PubMed=3621203;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D039 ! UC 729-6

CA   Hybridoma

//

ID   VLN3G2

AC   CVCL_8009

DR   CLO; CLO_0009540

DR   ATCC; HB-8636

DR   BioSample; SAMN03471084

RX   Patent=US4761377;

RX   PubMed=3621203;

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D16S539: 11,12,13

ST   D5S818: 11,12,13

ST   D7S820: 9,10,11,14

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 16,17,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D039 ! UC 729-6

CA   Hybridoma

//

ID   VLN5C7

AC   CVCL_Z074

DR   ATCC; HB-8634

RX   Patent=US4761377;

RX   PubMed=3621203;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D039 ! UC 729-6

CA   Hybridoma

//

ID   VLN6H2

AC   CVCL_8010

DR   CLO; CLO_0009541

DR   ATCC; HB-8633

RX   Patent=US4761377;

RX   PubMed=3621203;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D039 ! UC 729-6

CA   Hybridoma

//

ID   VM-2

AC   CVCL_F808

DR   CLO; CLO_0009542

DR   ATCC; HB-8530

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   VM-CUB-1

AC   CVCL_1786

SY   VM-CUB1; VMCUB-1; VMCUB1; VMCub1; VM Cub 1; VM-CUB-I

DR   CLO; CLO_0009545

DR   BioSample; SAMN03473580

DR   CCLE; VMCUB1_URINARY_TRACT

DR   ChEMBL-Cells; CHEMBL3308476

DR   ChEMBL-Targets; CHEMBL1075607

DR   Cosmic; 909780

DR   Cosmic; 925825

DR   Cosmic; 1016889

DR   Cosmic; 1046677

DR   Cosmic; 1285133

DR   Cosmic; 1285992

DR   Cosmic; 2037972

DR   Cosmic; 2050470

DR   Cosmic; 2057461

DR   Cosmic; 2212696

DR   Cosmic; 2444228

DR   Cosmic-CLP; 909780

DR   DSMZ; ACC-400

DR   GDSC; 909780

DR   GEO; GSM827147

DR   GEO; GSM887732

DR   GEO; GSM888827

DR   GEO; GSM1374985

DR   GEO; GSM1574550

DR   GEO; GSM1670572

RX   PubMed=3708594;

RX   PubMed=6244232;

RX   PubMed=6582512;

RX   PubMed=16885334;

RX   PubMed=22460905;

RX   PubMed=24018021;

RX   PubMed=24367658;

RX   PubMed=25997541;

RX   PubMed=26621286;

RX   PubMed=27397505;

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Doubling time: ~30-45 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'VM-CB-1' in Cosmic 1285992.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=11416159

ST   Amelogenin: X

ST   CSF1PO: 11,12 (Cosmic-CLP)

ST   CSF1PO: 11 (DSMZ; PubMed=11416159)

ST   D13S317: 10,12 (Cosmic-CLP)

ST   D13S317: 10 (DSMZ; PubMed=11416159)

ST   D16S539: 9,11,12 (Cosmic-CLP)

ST   D16S539: 11,12 (DSMZ; PubMed=11416159)

ST   D18S51: 16,19,20

ST   D21S11: 31

ST   D5S818: 10,11 (Cosmic-CLP)

ST   D5S818: 11 (DSMZ; PubMed=11416159)

ST   D7S820: 8,11

ST   D8S1179: 12,13

ST   FGA: 22,24

ST   TH01: 6,9 (Cosmic-CLP)

ST   TH01: 9 (DSMZ)

ST   TH01: 9.3 (PubMed=11416159)

ST   TPOX: 8

ST   vWA: 18,19 (Cosmic-CLP; DSMZ)

ST   vWA: 16 (PubMed=11416159)

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VM-CUB-2

AC   CVCL_9829

SY   VM-CUB2; VMCUB-2; VMCUB2; VMCub2; VM Cub 2; VM-CUB-II; VMCUBII

DR   Cosmic; 715728

DR   Cosmic; 760477

DR   Cosmic; 845569

DR   Cosmic; 1046678

DR   Cosmic; 1285134

DR   Cosmic; 1285993

DR   Cosmic; 2050471

DR   Cosmic; 2057462

DR   Cosmic; 2444233

DR   GEO; GSM1574583

RX   PubMed=327080;

RX   PubMed=6244232;

RX   PubMed=6582512;

RX   PubMed=24367658;

RX   PubMed=25997541;

RX   PubMed=26621286;

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VM-CUB-3

AC   CVCL_9830

SY   VM-CUB3; VMCUB-3; VMCUB3; VMCub3; VM Cub 3; VM-CUB-III; VMCUBIII; CUB III; CUBIII

DR   BioSample; SAMN03152040

DR   Cosmic; 925826

DR   Cosmic; 1016888

DR   Cosmic; 1046679

DR   Cosmic; 1285135

DR   Cosmic; 1285994

DR   Cosmic; 1938425

DR   Cosmic; 2050472

DR   Cosmic; 2057463

DR   Cosmic; 2444225

DR   Cosmic; 2212697

DR   GEO; GSM1574580

RX   PubMed=3708594;

RX   PubMed=6244232;

RX   PubMed=7459858;

RX   PubMed=16885334;

RX   PubMed=20143388;

RX   PubMed=24367658;

RX   PubMed=25997541;

RX   PubMed=26621286;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a VM-CUB-1 derivative (PubMed=3708594, PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1786 ! VM-CUB-1

SX   Male

CA   Cancer cell line

//

ID   VM-M2/Fluc

AC   CVCL_0P41

SY   VM-M2

RX   PubMed=18398829;

WW   https://www.kerafast.com/product/1405/highly-systemic-metastatic-cell-lines

CC   Doubling time: 2 days (Kerafast).

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Breed/subspecies: VM/Dk.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   VM-M3/Fluc

AC   CVCL_0P42

SY   VM-M3

RX   PubMed=18398829;

WW   https://www.kerafast.com/product/1405/highly-systemic-metastatic-cell-lines

CC   Doubling time: 2 days (Kerafast).

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Breed/subspecies: VM/Dk.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   VM-NM1/Fluc

AC   CVCL_0P43

SY   VM-NM1

RX   PubMed=18398829;

WW   https://www.kerafast.com/product/1405/highly-systemic-metastatic-cell-lines

CC   Doubling time: 2-5 days (Kerafast).

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Breed/subspecies: VM/Dk.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   VMM1

AC   CVCL_A732

DR   ATCC; CRL-3225

DR   GEO; GSM1572805

DR   GEO; GSM1572806

DR   GEO; GSM1572807

DR   GEO; GSM1572808

DR   GEO; GSM1572809

DR   GEO; GSM1572810

RX   PubMed=7681084;

RX   PubMed=10752474;

RX   PubMed=20856146;

RX   PubMed=21654344;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Brain.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 9,11

ST   D16S539: 10

ST   D5S818: 9

ST   D7S820: 9,12

ST   TH01: 10

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VMM1040

AC   CVCL_A733

RX   PubMed=20856146;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VMM12

AC   CVCL_A734

DR   Cosmic; 890887

RX   PubMed=10752474;

RX   PubMed=15378283;

RX   PubMed=20856146;

WW   http://dartmouth.eagle-i.net/i/0000013e-d775-02e4-6a92-b95280000000

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_F863 ! VMM12-EBV

CA   Cancer cell line

//

ID   VMM12-EBV

AC   CVCL_F863

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A734 ! VMM12

CA   Transformed cell line

//

ID   VMM14

AC   CVCL_A735

RX   PubMed=20856146;

RX   PubMed=21654344;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VMM15

AC   CVCL_A736

DR   ATCC; CRL-3227

RX   PubMed=10752474;

RX   PubMed=20856146;

RX   PubMed=21654344;

WW   http://dartmouth.eagle-i.net/i/0000013e-7bb5-bd54-8e79-05bd80000000

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 12

ST   D5S818: 9,15

ST   D7S820: 10,12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VMM150

AC   CVCL_S583

RX   PubMed=15378283;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VMM17

AC   CVCL_S581

DR   ATCC; CRL-3228

RX   PubMed=10752474;

RX   PubMed=21654344;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 9,10

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VMM18

AC   CVCL_A737

SY   VMM-18

DR   ATCC; CRL-3229

RX   PubMed=10752474;

RX   PubMed=15378283;

RX   PubMed=20856146;

RX   PubMed=21654344;

WW   http://dartmouth.eagle-i.net/i/0000013e-7bb5-fe8b-8e79-05bd80000000

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 10,12

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 9

ST   TH01: 6,9.3

ST   TPOX: 8,10

ST   vWA: 15,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_F862 ! VMM18-EBV

SX   Male

CA   Cancer cell line

//

ID   VMM18-EBV

AC   CVCL_F862

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A737 ! VMM18

SX   Male

CA   Transformed cell line

//

ID   VMM19

AC   CVCL_A738

RX   PubMed=15378283;

RX   PubMed=20856146;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VMM39

AC   CVCL_A739

DR   BTO; BTO:0005447

DR   ATCC; CRL-3230

DR   Cosmic; 890888

DR   Cosmic; 1054848

DR   Cosmic; 1507601

DR   Cosmic; 2233683

DR   GEO; GSM1572823

DR   GEO; GSM1572824

DR   GEO; GSM1572825

DR   GEO; GSM1572826

DR   GEO; GSM1572827

DR   GEO; GSM1572828

RX   PubMed=17308088;

RX   PubMed=20856146;

RX   PubMed=21654344;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 11,13

ST   D5S818: 12

ST   D7S820: 7,12

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VMM425

AC   CVCL_4D07

DR   ATCC; CRL-3231

RX   PubMed=21654344;

CC   Derived from metastatic site: Pelvic soft tissue.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,13

ST   D16S539: 12

ST   D5S818: 11

ST   D7S820: 9

ST   TH01: 8,9.3

ST   TPOX: 8,12

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VMM5A

AC   CVCL_A740

SY   VMM-5A; VMM5

DR   ATCC; CRL-3226

DR   Cosmic; 890886

RX   PubMed=7681084;

RX   PubMed=10752474;

RX   PubMed=15905528;

RX   PubMed=20856146;

RX   PubMed=21654344;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 12

ST   D5S818: 9

ST   D7S820: 9,10

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_S584 ! VMM5B

SX   Male

CA   Cancer cell line

//

ID   VMM5B

AC   CVCL_S584

SY   VMM-5B

RX   PubMed=15905528;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A740 ! VMM5A

SX   Male

CA   Cancer cell line

//

ID   VMM609

AC   CVCL_4D08

RX   PubMed=21654344;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VMM86

AC   CVCL_S582

RX   PubMed=15378283;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VMM917

AC   CVCL_4D09

DR   ATCC; CRL-3232

RX   PubMed=21654344;

CC   Derived from metastatic site: Subcutaneous; right posterior thigh adjacent to buttocks.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 11

ST   D16S539: 12

ST   D5S818: 11

ST   D7S820: 8,10

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VMR-0

AC   CVCL_F849

SY   VMR-O

RX   CelloPub=CLPUB00133;

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   VMR-100-Liv

AC   CVCL_F850

SY   VMR-Liv; VMR-liv; VMRLiv

RX   CelloPub=CLPUB00133;

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F849 ! VMR-0

SX   Female

CA   Cancer cell line

//

ID   VMR-100-Ov

AC   CVCL_F851

SY   VMR-Ov

RX   CelloPub=CLPUB00133;

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F849 ! VMR-0

SX   Female

CA   Cancer cell line

//

ID   VMRC-LCD

AC   CVCL_1787

SY   VMRCLCD; LCD

DR   EFO; EFO_0006773

DR   BioSample; SAMN03471805

DR   CCLE; VMRCLCD_LUNG

DR   CGH-DB; 210-1

DR   CGH-DB; 9168-4

DR   Cosmic; 713869

DR   Cosmic; 801581

DR   Cosmic; 889100

DR   Cosmic; 876140

DR   Cosmic; 917975

DR   Cosmic; 929163

DR   Cosmic; 932928

DR   Cosmic; 1066174

DR   Cosmic; 1089220

DR   Cosmic; 1154600

DR   Cosmic; 1239900

DR   Cosmic; 1571730

DR   Cosmic-CLP; 713869

DR   GDSC; 713869

DR   GEO; GSM784287

DR   GEO; GSM827592

DR   GEO; GSM1670573

DR   JCRB; JCRB0814

RX   PubMed=9290701;

RX   PubMed=11005564;

RX   PubMed=12569360;

RX   PubMed=14581340;

RX   PubMed=15185009;

RX   PubMed=15746151;

RX   PubMed=19472407;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Misspelling: 'RERF-LCD' in PubMed=11005564.

CC   Misspelling: 'VMR-LCD' in Cosmic 889100.

CC   Misspelling: 'VRMC-LCD' in Cosmic 1571730.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=11416159; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 14

ST   D21S11: 30

ST   D3S1358: 15

ST   D5S818: 10

ST   D7S820: 8,10

ST   D8S1179: 13

ST   FGA: 22,24

ST   Penta D: 12

ST   Penta E: 15,16

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VMRC-LCF

AC   CVCL_S848

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VMRC-LCP

AC   CVCL_1788

SY   VMRCLCP; Patton

DR   BioSample; SAMN03470791

DR   CCLE; VMRCLCP_LUNG

DR   CGH-DB; 193-1

DR   CGH-DB; 9177-4

DR   ChEMBL-Cells; CHEMBL3308808

DR   ChEMBL-Targets; CHEMBL1075608

DR   Cosmic; 889101

DR   Cosmic; 930300

DR   Cosmic; 1066175

DR   GEO; GSM827200

DR   GEO; GSM1374986

DR   JCRB; JCRB0103

RX   PubMed=9290701;

RX   PubMed=15185009;

RX   PubMed=14581340;

RX   PubMed=15746151;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'VMR-LCP' in Cosmic 889101.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D16S539: 12

ST   D5S818: 13

ST   D7S820: 10,12

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 18,20

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VMRC-MELG

AC   CVCL_1789

SY   Leggee

DR   BioSample; SAMN03471062

DR   ChEMBL-Cells; CHEMBL3308809

DR   ChEMBL-Targets; CHEMBL1075609

DR   Cosmic; 930301

DR   Cosmic-CLP; 930301

DR   GDSC; 930301

DR   JCRB; JCRB0074

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X (Cosmic-CLP)

ST   Amelogenin: X,Y (JCRB)

ST   CSF1PO: 10

ST   D13S317: 8,11

ST   D16S539: 12

ST   D5S818: 10,13

ST   D7S820: 8,10

ST   TH01: 6,7

ST   TPOX: 9,11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VMRC-PCZ

AC   CVCL_X543

DR   Cosmic; 849371

RX   PubMed=11146448;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VMRC-RCW

AC   CVCL_1790

SY   Thomas Wirts

DR   BTO; BTO:0003714

DR   CLO; CLO_0050893

DR   BioSample; SAMN03470901

DR   BioSample; SAMN03472513

DR   CCLE; VMRCRCW_KIDNEY

DR   Cosmic; 756014

DR   Cosmic; 849370

DR   Cosmic-CLP; 1240224

DR   GDSC; 1240224

DR   GEO; GSM827232

DR   GEO; GSM887733

DR   GEO; GSM888828

DR   JCRB; JCRB0813

DR   RCB; RCB1963

DR   TKG; TKG 0447

RX   PubMed=9290701;

RX   PubMed=11146448;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB; TKG

ST   Amelogenin: X,Y (JCRB; RCB; TKG)

ST   Amelogenin: Y (Cosmic-CLP; PubMed=25877200)

ST   CSF1PO: 11,12

ST   D13S317: 9

ST   D16S539: 11,15

ST   D18S51: 15,16

ST   D19S433: 13

ST   D21S11: 32.2,33.2

ST   D2S1338: 21,22

ST   D3S1358: 18

ST   D5S818: 12

ST   D7S820: 8,10

ST   D8S1179: 12

ST   FGA: 21,22

ST   Penta D: 9,11

ST   Penta E: 11,12

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 14,15

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VMRC-RCZ

AC   CVCL_1791

DR   BTO; BTO:0003715

DR   BioSample; SAMN03472519

DR   CCLE; VMRCRCZ_KIDNEY

DR   ChEMBL-Cells; CHEMBL3308810

DR   ChEMBL-Targets; CHEMBL1075610

DR   Cosmic; 909781

DR   Cosmic-CLP; 909781

DR   GDSC; 909781

DR   GEO; GSM827243

DR   GEO; GSM887734

DR   GEO; GSM888829

DR   GEO; GSM1670574

DR   JCRB; JCRB0827

RX   PubMed=9290701;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 11

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Vn19

AC   CVCL_8538

SY   Vn1919

DR   JCRB; JCRB1361

RX   PubMed=21073635;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   Vn19-15

AC   CVCL_8539

RX   PubMed=21073635;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_8538 ! Vn19

CA   Cancer cell line

//

ID   Vn19-21

AC   CVCL_8540

RX   PubMed=21073635;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_8538 ! Vn19

CA   Cancer cell line

//

ID   Vn19-4

AC   CVCL_8541

SY   Vn1919 cl4

DR   JCRB; JCRB1365

RX   PubMed=21073635;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_8538 ! Vn19

CA   Cancer cell line

//

ID   Vn19-49

AC   CVCL_8542

SY   Vn1919 cl49

DR   JCRB; JCRB1367

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_8538 ! Vn19

CA   Cancer cell line

//

ID   Vn19-59

AC   CVCL_8543

SY   Vn1919 cl59

DR   JCRB; JCRB1368

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_8538 ! Vn19

CA   Cancer cell line

//

ID   vNBS8-iPS-c1

AC   CVCL_9U58

RX   PubMed=26987925;

DI   NCIt; C4692; Nijmegen breakage syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9U59 ! vNBS8-iPS-c2

SX   Male

CA   Induced pluripotent stem cell

//

ID   vNBS8-iPS-c2

AC   CVCL_9U59

RX   PubMed=26987925;

DI   NCIt; C4692; Nijmegen breakage syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9U58 ! vNBS8-iPS-c1

SX   Male

CA   Induced pluripotent stem cell

//

ID   VOA1056_CL

AC   CVCL_V536

RX   PubMed=24023729;

DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VOA1072_CL

AC   CVCL_V537

RX   PubMed=24023729;

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VOA1312_CL

AC   CVCL_V538

RX   PubMed=24023729;

DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VOA1400_CL

AC   CVCL_V539

RX   PubMed=24023729;

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VOA1416_CL

AC   CVCL_V540

RX   PubMed=24023729;

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Vogel

AC   CVCL_L422

DR   GEO; GSM1974800

RX   PubMed=21908323;

RX   PubMed=22916246;

RX   PubMed=27197945;

CC   Part of: FACC canine tumor cell line panel.

CC   Doubling time: 35.9 hours (PubMed=22916246).

CC   Omics: Transcriptome analysis.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   VOO

AC   CVCL_E864

DR   dbMHC; 49054

DR   ECACC; 94022551

DR   IHW; IHW9241

DR   IMGT/HLA; 11528

WW   http://bioinformatics.hsanmartino.it/ecbr/cl241.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   VP185

AC   CVCL_D130

DR   GEO; GSM115103

DR   GEO; GSM217607

RX   PubMed=8877005;

RX   PubMed=15677628;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VP207

AC   CVCL_W115

RX   PubMed=8877005;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VP223

AC   CVCL_W116

RX   PubMed=8877005;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VP229

AC   CVCL_2754

DR   BioSample; SAMN03472874

DR   Cosmic; 1523834

DR   ECACC; 05092804

DR   GEO; GSM115113

DR   GEO; GSM217608

RX   PubMed=8877005;

RX   PubMed=11044355;

RX   PubMed=12800145;

RX   PubMed=15677628;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/VP229.html

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D18S51: 16

ST   D19S433: 13

ST   D21S11: 29

ST   D2S1338: 18,25

ST   D3S1358: 16,18

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 10,13

ST   FGA: 18

ST   Penta D: 10

ST   Penta E: 13,17

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2755 ! VP267

SX   Female

CA   Cancer cell line

//

ID   VP267

AC   CVCL_2755

DR   BioSample; SAMN03472912

DR   ECACC; 05092805

DR   GEO; GSM115114

DR   GEO; GSM217609

RX   PubMed=8877005;

RX   PubMed=11044355;

RX   PubMed=15677628;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/VP267.html

ST   Source(s): ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D18S51: 16

ST   D19S433: 13

ST   D21S11: 29

ST   D2S1338: 25

ST   D3S1358: 16,18

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 10,13

ST   FGA: 18

ST   Penta D: 10

ST   Penta E: 13,17

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2754 ! VP229

SX   Female

CA   Cancer cell line

//

ID   VP298

AC   CVCL_W117

RX   PubMed=8877005;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VP303

AC   CVCL_2756

DR   BioSample; SAMN03472873

DR   ECACC; 05092806

DR   GEO; GSM217610

RX   PubMed=8877005;

RX   PubMed=12800145;

RX   PubMed=15677628;

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 9,12

ST   D18S51: 12,13

ST   D19S433: 13,14

ST   D21S11: 28,29

ST   D2S1338: 25

ST   D3S1358: 17

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   D8S1179: 11

ST   FGA: 22,23

ST   Penta D: 10,13

ST   Penta E: 12

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VP317

AC   CVCL_W118

RX   PubMed=8877005;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VP331

AC   CVCL_W119

RX   PubMed=8877005;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VP342

AC   CVCL_W120

RX   PubMed=8877005;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VP348

AC   CVCL_W180

RX   PubMed=8877005;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VPC-6

AC   CVCL_IP77

RX   CelloPub=CLPUB00252;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VPM 18

AC   CVCL_G164

DR   ECACC; 93113025

CC   Monoclonal antibody target: UniProtKB; W5Q2E5; Sheep PTPRC/CD45.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 19

AC   CVCL_G165

DR   ECACC; 93113026

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 36

AC   CVCL_G166

DR   ECACC; 93113027

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 37

AC   CVCL_G167

DR   ECACC; 93113028

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 38

AC   CVCL_G168

DR   ECACC; 93113029

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 40

AC   CVCL_G169

DR   ECACC; 93113030

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 41

AC   CVCL_G170

DR   ECACC; 93113031

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 43

AC   CVCL_G171

DR   ECACC; 93113032

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 44

AC   CVCL_G172

DR   ECACC; 93113033

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 45

AC   CVCL_G173

DR   ECACC; 93113034

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 46

AC   CVCL_G174

DR   ECACC; 93113035

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 47

AC   CVCL_G175

DR   ECACC; 93113036

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 48

AC   CVCL_G176

DR   ECACC; 93113037

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 5

AC   CVCL_G177

DR   ECACC; 93113022

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 54

AC   CVCL_G178

DR   ECACC; 93113038

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 6

AC   CVCL_G179

DR   ECACC; 93113023

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VPM 8

AC   CVCL_G180

DR   ECACC; 93113024

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   VR09

AC   CVCL_N794

DR   Cosmic; 1840004

RX   PubMed=23285191;

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   VSa13

AC   CVCL_S952

SY   Vertebra Sparus aurata 13

RX   DOI=10.1111/j.1439-0426.2010.01411.x;

RX   PubMed=14762709;

RX   PubMed=15820747;

RX   PubMed=17899405;

RX   PubMed=19002990;

RX   PubMed=21668972;

CC   Group: Fish cell line.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=8175; ! Sparus aurata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   VSa16

AC   CVCL_S953

SY   Vertebra Sparus aurata 16

RX   DOI=10.1111/j.1439-0426.2010.01411.x;

RX   PubMed=14762709;

RX   PubMed=15820747;

RX   PubMed=19002990;

RX   PubMed=21668972;

CC   Group: Fish cell line.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=8175; ! Sparus aurata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   VSW

AC   CVCL_4370

DR   CLO; CLO_0009549

DR   ATCC; CCL-129

RX   PubMed=4358139;

RX   PubMed=5165585;

CC   Group: Reptilian cell line.

OX   NCBI_TaxID=31159; ! Daboia russellii

SX   Female

CA   Spontaneously immortalized cell line

//

ID   VT-E

AC   CVCL_0C28

RX   PubMed=7736387;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   vT{2}

AC   CVCL_4010

DR   CLO; CLO_0009550

DR   ATCC; CRL-2712

CC   Transfected with: HGNC; 700; ARNT.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Breed/subspecies: C57L.

DI   NCIt; C38756; Hepatocellular carcinoma of the mouse

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_9085 ! c4 (B13NBii1)

SX   Female

CA   Cancer cell line

//

ID   VTIS39243

AC   CVCL_6G71

DR   IMGT/HLA; 12637

RX   PubMed=11782282;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   VTIS43878

AC   CVCL_6G72

DR   IMGT/HLA; 12642

RX   PubMed=11782282;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   VTIS45561

AC   CVCL_6G73

DR   IMGT/HLA; 12638

RX   PubMed=11782282;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   VTIS46155

AC   CVCL_6G74

DR   IMGT/HLA; 12643

RX   PubMed=11782282;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   VUB01

AC   CVCL_9838

SY   VUB-01-WT; VUBe001-A

DR   hPSCreg; VUBe001-A

DR   ISCR; 208

RX   PubMed=16284066;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-24.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   VUB02

AC   CVCL_9839

SY   VUBe002-A

DR   hPSCreg; VUBe002-A

DR   ISCR; 209

RX   PubMed=16284066;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   VUB03_DM1

AC   CVCL_9840

SY   VUBe003-A

DR   hPSCreg; VUBe003-A

DR   ISCR; 249

RX   PubMed=16284066;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C84679; Dystrophia myotonica 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB04_CF

AC   CVCL_9841

SY   VUBe004-A

DR   hPSCreg; VUBe004-A

DR   ISCR; 248

RX   PubMed=16284066;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C2975; Cystic fibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB05_HD

AC   CVCL_9842

SY   VUB-05-HD; VUBe005-A

DR   hPSCreg; VUBe005-A

DR   ISCR; 247

RX   PubMed=16284066;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-24.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   VUB06

AC   CVCL_9843

SY   VUBe006-A

DR   hPSCreg; VUBe006-A

DR   ISCR; 246

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB07

AC   CVCL_9844

SY   VUBe007-A

DR   hPSCreg; VUBe007-A

DR   ISCR; 245

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB08_MFS

AC   CVCL_9845

SY   VUBe008-A

DR   hPSCreg; VUBe008-A

DR   ISCR; 244

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB09_FSHD

AC   CVCL_9846

SY   VUBe009-A

DR   hPSCreg; VUBe009-A

DR   ISCR; 243

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C84704; Facioscapulohumeral muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB10_SCA7

AC   CVCL_9847

SY   VUBe010-A

DR   hPSCreg; VUBe010-A

DR   ISCR; 242

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C82341; Spinocerebellar ataxia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB11_FXS

AC   CVCL_9848

SY   VUBe011-A

DR   hPSCreg; VUBe011-A

DR   ISCR; 241

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB13_FXS

AC   CVCL_9849

SY   VUBe012-A

DR   hPSCreg; VUBe012-A

DR   ISCR; 240

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB14

AC   CVCL_9850

SY   VUBe021-A

DR   hPSCreg; VUBe021-A

DR   ISCR; 1422

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB15

AC   CVCL_9851

DR   ISCR; 1285

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   VUB16

AC   CVCL_9852

DR   ISCR; 1286

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   VUB17

AC   CVCL_9853

DR   ISCR; 1423

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB19_DM1

AC   CVCL_9854

SY   VUBe013-A

DR   hPSCreg; VUBe013-A

DR   ISCR; 239

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C84679; Dystrophia myotonica 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB20_CMT1A

AC   CVCL_9855

SY   VUBe014-A

DR   hPSCreg; VUBe014-A

DR   ISCR; 238

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB21_HEMA

AC   CVCL_9856

DR   ISCR; 1289

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   VUB22_CF

AC   CVCL_9857

SY   VUBe015-A

DR   hPSCreg; VUBe015-A

DR   ISCR; 237

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C2975; Cystic fibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB23_OI

AC   CVCL_9858

SY   VUBe016-A

DR   hPSCreg; VUBe016-A

DR   ISCR; 236

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C99003; Osteogenesis imperfecta type I

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   VUB24_DM1

AC   CVCL_9859

SY   VUBe017-A

DR   hPSCreg; VUBe017-A

DR   ISCR; 235

RX   PubMed=20224973;

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB26

AC   CVCL_9860

SY   VUB26_QUATRO; VUBe019-A

DR   hPSCreg; VUBe019-A

DR   ISCR; 234

RX   PubMed=19633307;

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUB27

AC   CVCL_9861

SY   VUB27_PATRU; VUBe020-A

DR   hPSCreg; VUBe020-A

DR   ISCR; 1281

RX   PubMed=19633307;

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   VUB28_HD_MFS

AC   CVCL_9862

SY   VUBe018-A

DR   hPSCreg; VUBe018-A

DR   ISCR; 233

RX   PubMed=20224973;

WW   http://emgerege.vub.ac.be/HESC_2.php

CC   From: Vrije Universiteit Brussel; Brussels; Belgium.

DI   NCIt; C82342; Huntington's disease

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   VUMC-DIPG-A

AC   CVCL_IT43

SY   VU-DIPG-A; VU-DIPG.A; DIPG-A

RX   PubMed=23637844;

RX   PubMed=25939062;

CC   Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).

DI   NCIt; C94764; Diffuse intrinsic pontine glioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VUMC-DIPG-B

AC   CVCL_IT44

SY   VU-DIPG-B; VU-DIPG.B; DIPG-B

RX   PubMed=23637844;

RX   PubMed=25939062;

CC   Characteristics: Has a HIST1H3B p.Lys28Met mutation (H3.1K27M).

DI   NCIt; C94764; Diffuse intrinsic pontine glioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   VUP

AC   CVCL_J307

SY   VUP-1

RX   CelloPub=CLPUB00127;

RX   PubMed=6819484;

RX   PubMed=12098005;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   VUP15

AC   CVCL_J305

RX   Patent=WO2006091868A2;

RX   PubMed=10205165;

CC   Transfected with: HGNC; 6156; ITGB3.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_J307 ! VUP

CA   Cancer cell line

//

ID   VUP20

AC   CVCL_J306

RX   Patent=WO2006091868A2;

CC   Selected for resistance to: ChEBI; CHEBI:17939; Puromycin.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_J307 ! VUP

CA   Cancer cell line

//

ID   VV-1H831

AC   CVCL_EG63

DR   JCRB; JCRB1632

RX   PubMed=3008418;

CC   Monoclonal antibody target: UniProtKB; P08714; Vaccinia virus HA.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   vWTa

AC   CVCL_0G81

DR   SKIP; SKIP000533

RX   PubMed=24321451;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   vWTb

AC   CVCL_0G82

DR   SKIP; SKIP000534

RX   PubMed=24321451;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   Vx2

AC   CVCL_3864

SY   VX2; Vx-2; VX-2

DR   CLO; CLO_0009553

DR   CLDB; cl4673

DR   ATCC; CRL-6503

DR   BCRJ; 0297

DR   CCRID; 3111C0001CCC000320

DR   CLS; 609374/NA

DR   ECACC; 90030912

DR   TKG; TKG 0332

RX   PubMed=6126038;

RX   PubMed=6500159;

RX   PubMed=14955572;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6503; true.

CC   Discontinued: CLS; 609374; true.

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

SX   Male

CA   Cancer cell line

//

ID   Vx7

AC   CVCL_3470

SY   VX7; Vx-7; VX-7

DR   CLO; CLO_0009554

DR   ATCC; CRL-6504

DR   BCRJ; 0246

RX   PubMed=6286852;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6504; true.

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

CA   Cancer cell line

//

ID   VXG3

AC   CVCL_J128

DR   ATCC; CRL-11865

RX   Patent=US5976860;

CC   Discontinued: ATCC; CRL-11865; probable.

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0002 ! HL-60

SX   Female

CA   Cancer cell line

//

ID   W-20-17

AC   CVCL_6529

SY   W-20 clone 17

DR   CLO; CLO_0009556

DR   ATCC; CRL-2623

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   W-2K-11

AC   CVCL_6E69

RX   PubMed=195084;

RX   PubMed=6262522;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [777].

CC   Breed/subspecies: C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6E66 ! C3H2K-C4

CA   Transformed cell line

//

ID   W-3Y-23

AC   CVCL_6E71

RX   PubMed=195084;

RX   PubMed=6262522;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [777].

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_E147 ! 3Y1-B clone 1-6

SX   Female

CA   Transformed cell line

//

ID   W-98

AC   CVCL_DG19

DR   GEO; GSM114602

RX   PubMed=16966431;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   W-ES

AC   CVCL_W528

DR   Cosmic; 1381110

RX   PubMed=2486606;

RX   PubMed=2731119;

RX   PubMed=8221663;

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   W-V

AC   CVCL_E079

DR   CLO; CLO_0050644

DR   BioSample; SAMN03472349

DR   RCB; RCB0252

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,13

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 15,18

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   W1

AC   CVCL_0C64

DR   Cosmic; 2089679

RX   PubMed=7769852;

RX   PubMed=8182949;

RX   PubMed=23955599;

DI   NCIt; C7463; Acute myelomonocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   W10-1A

AC   CVCL_C706

DR   ISCR; 1602

RX   PubMed=19222349;

CC   From: StemLifeLine, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   W12 [Human keratinocytes]

AC   CVCL_T290

RX   PubMed=2467886;

RX   PubMed=16505361;

CC   Characteristics: Derived from a low-grade squamous intraepithelial lesion (LG-SIL).

CC   Characteristics: At early passages contains about 100 HPV16 episomes per cell.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   W12 [Mouse ESC]

AC   CVCL_Y631

RX   PubMed=11084865;

CC   Breed/subspecies: 129S9/SvEvH.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   W13-1C

AC   CVCL_C707

DR   ISCR; 1603

RX   PubMed=19222349;

CC   From: StemLifeLine, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   W14-1A

AC   CVCL_C708

DR   ISCR; 1604

RX   PubMed=19222349;

CC   From: StemLifeLine, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   W162

AC   CVCL_3807

DR   CLO; CLO_0009555

DR   ATCC; CRL-2783

DR   ATCC; JHU-66

RX   PubMed=6310575;

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5 [E4].

CC   Discontinued: ATCC; CRL-2783; true.

CC   Discontinued: ATCC; JHU-66; true.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_0059 ! Vero

SX   Female

CA   Transformed cell line

//

ID   W2

AC   CVCL_Y632

RX   PubMed=11084865;

CC   Breed/subspecies: 129S9/SvEvH.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   W20C6

AC   CVCL_Z823

DR   DGRC; 159

RX   PubMed=1905427;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   W3

AC   CVCL_Y633

RX   PubMed=11084865;

CC   Breed/subspecies: 129S9/SvEvH.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   W3/13

AC   CVCL_G185

DR   ECACC; 84112001

RX   PubMed=88272;

CC   Monoclonal antibody target: UniProtKB; P13838; Rat Spn.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   W3/15

AC   CVCL_G186

SY   W3/15 HLK

DR   ECACC; 88051305

RX   PubMed=88272;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   W3/25

AC   CVCL_G187

SY   W3/25 HL

DR   ECACC; 84112002

RX   PubMed=88272;

CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   W3C4E11

AC   CVCL_IQ37

RX   Patent=US20080038272;

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2668.

CC   Monoclonal antibody target: UniProtKB; O60353; Human FZD6.

CC   Monoclonal antibody target: UniProtKB; O00144; Human FZD9.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   W3D2B10

AC   CVCL_IQ38

RX   Patent=US20080038272;

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2669.

CC   Monoclonal antibody target: UniProtKB; O75084; Human FZD7.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   W3UF

AC   CVCL_X940

DR   CGH-DB; 333-2

DR   CGH-DB; 9355-4

RX   PubMed=10457904;

RX   PubMed=11330945;

RX   PubMed=12417041;

RX   PubMed=17671176;

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A620 ! HUOCA-II

SX   Female

CA   Cancer cell line

//

ID   W4 [Mouse ESC]

AC   CVCL_Y634

RX   PubMed=11084865;

CC   Breed/subspecies: 129S6/SvEvTac.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   W4 [Mouse lymphoma]

AC   CVCL_H588

DR   ChEMBL-Cells; CHEMBL3308050

DR   ChEMBL-Targets; CHEMBL613708

RX   PubMed=7689176;

CC   Transfected with: MGI; MGI:95484; Fas.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4338 ! WR19L

SX   Female

CA   Cancer cell line

//

ID   W4F.5B

AC   CVCL_F809

DR   CLO; CLO_0009557

DR   ATCC; HB-9282

RX   Patent=US4845026;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   W5

AC   CVCL_Y635

RX   PubMed=11084865;

CC   Breed/subspecies: 129S9/SvEvH.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   W5-6

AC   CVCL_0U29

DR   ATCC; CRL-9267

DR   BioSample; SAMN03471214

RX   Patent=US6004761;

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 11

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0608 ! Calu-1

SX   Male

CA   Cancer cell line

//

ID   W6/1

AC   CVCL_U056

SY   W6/1 HLK

DR   ECACC; 13082201

RX   PubMed=88272;

RX   PubMed=667938;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   W6/32

AC   CVCL_7872

SY   HB95

DR   CLO; CLO_0009558

DR   ATCC; HB-95

DR   CCRID; 3111C0001CCC000389

DR   CCRID; 3142C0001000000123

DR   ECACC; 84112003

DR   IZSLER; BS Hy 32

DR   PRIDE; PXD000394

RX   PubMed=88272;

RX   PubMed=667938;

RX   PubMed=25576301;

CC   Omics: HLA class I peptidome analysis by proteomics.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   W6/32HK

AC   CVCL_G134

DR   ECACC; 86012801

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7872 ! W6/32

CA   Hybridoma

//

ID   W6/32HL

AC   CVCL_G135

DR   ECACC; 85102222

DR   NCBI_Iran; H127

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7872 ! W6/32

CA   Hybridoma

//

ID   W8-8A

AC   CVCL_C705

DR   ISCR; 1605

RX   PubMed=19222349;

CC   From: StemLifeLine, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   Wa Fen

AC   CVCL_3279

DR   CLO; CLO_0009559

DR   ATCC; CRL-1271

CC   Discontinued: ATCC; CRL-1271; true.

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Wa-2

AC   CVCL_M847

SY   Wa2

DR   Cosmic; 802253

RX   PubMed=2180563;

DI   NCIt; C6586; Extrarenal rhabdoid tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WA-C3CD5+

AC   CVCL_Y438

SY   WaC3 CD5+; WaC3CD5+; WaC3CD5; WAC3CD5+; WAC3-CD5; WAC-CD5+; Wa C3,CD5+; Waco3-CD5

DR   DSMZ; ACC-769

DR   NCBI_Iran; C547

RX   PubMed=8127151;

RX   PubMed=19358282;

RX   PubMed=23297799;

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): DSMZ; NCBI_Iran

ST   Amelogenin: X,Y

ST   CSF1PO: 9,10

ST   D13S317: 9

ST   D16S539: 8,11 (NCBI_Iran)

ST   D16S539: 9,12 (DSMZ)

ST   D18S51: 11,18

ST   D21S11: 29,30

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 8,10

ST   D8S1179: 10,13

ST   FGA: 19,20

ST   TH01: 8,9 (NCBI_Iran)

ST   TH01: 8,9.3 (DSMZ)

ST   TPOX: 7,11 (NCBI_Iran)

ST   TPOX: 8,11 (DSMZ)

ST   vWA: 18

DI   NCIt; C3163; Chronic lymphocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y549 ! WA-OSEL

SX   Male

CA   Transformed cell line

//

ID   WA-hT

AC   CVCL_8766

DR   CLO; CLO_0050041

DR   BioSample; SAMN03471949

DR   RCB; RCB2279

RX   PubMed=16142338;

RX   PubMed=22576795;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 9,10

ST   vWA: 17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WA-mFib

AC   CVCL_U894

DR   CLO; CLO_0050749

DR   RCB; RCB1925

RX   PubMed=16142338;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   WA-OSEL

AC   CVCL_Y549

SY   WA-osel; Wa osel

DR   DSMZ; ACC-767

RX   PubMed=8127151;

RX   PubMed=23297799;

CC   Doubling time: ~40 hours (DSMZ).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 9,10

ST   D13S317: 9

ST   D16S539: 9,12

ST   D5S818: 12

ST   D7S820: 8,10

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3163; Chronic lymphocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y438 ! WA-C3CD5+

SX   Male

CA   Transformed cell line

//

ID   WA01

AC   CVCL_9771

SY   WA 01; WA1; H1; H1-hESC; ESC H1; GE01; WAe001-A; WICELLe001-A

DR   EFO; EFO_0003042

DR   BioSample; SAMN03471895

DR   BioSamples; SAMEA7768168

DR   ENCODE; ENCBS001VRA

DR   ENCODE; ENCBS011NFB

DR   ENCODE; ENCBS019EUF

DR   ENCODE; ENCBS040WGM

DR   ENCODE; ENCBS051SJH

DR   ENCODE; ENCBS055BDT

DR   ENCODE; ENCBS055DBZ

DR   ENCODE; ENCBS060CKC

DR   ENCODE; ENCBS081AUS

DR   ENCODE; ENCBS083WOY

DR   ENCODE; ENCBS086PQW

DR   ENCODE; ENCBS103ZIA

DR   ENCODE; ENCBS111ENC

DR   ENCODE; ENCBS131GSD

DR   ENCODE; ENCBS153GON

DR   ENCODE; ENCBS215WGD

DR   ENCODE; ENCBS244HDB

DR   ENCODE; ENCBS262EHC

DR   ENCODE; ENCBS270AGK

DR   ENCODE; ENCBS282MUP

DR   ENCODE; ENCBS285QSX

DR   ENCODE; ENCBS299BNQ

DR   ENCODE; ENCBS299NOL

DR   ENCODE; ENCBS309DZE

DR   ENCODE; ENCBS345JIP

DR   ENCODE; ENCBS368BPP

DR   ENCODE; ENCBS380OBH

DR   ENCODE; ENCBS409PYK

DR   ENCODE; ENCBS440MTS

DR   ENCODE; ENCBS479XUT

DR   ENCODE; ENCBS428NIG

DR   ENCODE; ENCBS484NGW

DR   ENCODE; ENCBS497CZZ

DR   ENCODE; ENCBS513BIK

DR   ENCODE; ENCBS534NMZ

DR   ENCODE; ENCBS559QNR

DR   ENCODE; ENCBS568FYY

DR   ENCODE; ENCBS570AYT

DR   ENCODE; ENCBS582QGL

DR   ENCODE; ENCBS614LXI

DR   ENCODE; ENCBS626BQK

DR   ENCODE; ENCBS649THQ

DR   ENCODE; ENCBS661AAA

DR   ENCODE; ENCBS665AAA

DR   ENCODE; ENCBS668AAA

DR   ENCODE; ENCBS670AAA

DR   ENCODE; ENCBS704NOS

DR   ENCODE; ENCBS706WYC

DR   ENCODE; ENCBS708BLT

DR   ENCODE; ENCBS711AAA

DR   ENCODE; ENCBS716AAA

DR   ENCODE; ENCBS716FMR

DR   ENCODE; ENCBS717WTB

DR   ENCODE; ENCBS718AAA

DR   ENCODE; ENCBS720AAA

DR   ENCODE; ENCBS731AAA

DR   ENCODE; ENCBS732AAA

DR   ENCODE; ENCBS733AAA

DR   ENCODE; ENCBS734AAA

DR   ENCODE; ENCBS739PSV

DR   ENCODE; ENCBS740OND

DR   ENCODE; ENCBS780AAA

DR   ENCODE; ENCBS780WAB

DR   ENCODE; ENCBS797AAA

DR   ENCODE; ENCBS802AAA

DR   ENCODE; ENCBS803AAA

DR   ENCODE; ENCBS819TBN

DR   ENCODE; ENCBS820AAA

DR   ENCODE; ENCBS847AAA

DR   ENCODE; ENCBS854AAA

DR   ENCODE; ENCBS855AAA

DR   ENCODE; ENCBS874KZJ

DR   ENCODE; ENCBS887ZGJ

DR   ENCODE; ENCBS899KQD

DR   ENCODE; ENCBS899NYB

DR   ENCODE; ENCBS929BKG

DR   ENCODE; ENCBS945MCY

DR   ENCODE; ENCBS977TKX

DR   ENCODE; ENCBS982HXP

DR   ENCODE; ENCBS984IPH

DR   GEO; GSM347921

DR   GEO; GSM409307

DR   GEO; GSM409308

DR   GEO; GSM409312

DR   GEO; GSM410807

DR   GEO; GSM410808

DR   GEO; GSM428286

DR   GEO; GSM428289

DR   GEO; GSM428291

DR   GEO; GSM428295

DR   GEO; GSM428296

DR   GEO; GSM429321

DR   GEO; GSM429322

DR   GEO; GSM429323

DR   GEO; GSM432392

DR   GEO; GSM432685

DR   GEO; GSM432686

DR   GEO; GSM433167

DR   GEO; GSM433170

DR   GEO; GSM433171

DR   GEO; GSM433174

DR   GEO; GSM433176

DR   GEO; GSM433177

DR   GEO; GSM433179

DR   GEO; GSM434762

DR   GEO; GSM434776

DR   GEO; GSM434785

DR   GEO; GSM438361

DR   GEO; GSM438362

DR   GEO; GSM450236

DR   GEO; GSM450239

DR   GEO; GSM450266

DR   GEO; GSM450268

DR   GEO; GSM450270

DR   GEO; GSM466732

DR   GEO; GSM466734

DR   GEO; GSM466737

DR   GEO; GSM466739

DR   GEO; GSM469971

DR   GEO; GSM484408

DR   GEO; GSM537679

DR   GEO; GSM537680

DR   GEO; GSM537681

DR   GEO; GSM537682

DR   GEO; GSM537683

DR   GEO; GSM537684

DR   GEO; GSM537685

DR   GEO; GSM543005

DR   GEO; GSM579898

DR   GEO; GSM579899

DR   GEO; GSM602251

DR   GEO; GSM602252

DR   GEO; GSM602253

DR   GEO; GSM816632

DR   GEO; GSM856729

DR   GEO; GSM1040242

DR   GEO; GSM1040312

DR   GEO; GSM1153529

DR   GEO; GSM1489248

DR   GEO; GSM1489459

DR   hPSCreg; WAe001-A

DR   IGRhCellID; H1%20p61

DR   ISCR; 87

DR   PRIDE; PXD003903

RX   PubMed=9804556;

RX   PubMed=14745950;

RX   PubMed=16388305;

RX   PubMed=16919167;

RX   PubMed=17572666;

RX   PubMed=21714037;

RX   PubMed=21983960;

RX   PubMed=22514597;

RX   PubMed=22802639;

RX   PubMed=23117585;

RX   PubMed=23325432;

RX   PubMed=24259714;

RX   PubMed=24374290;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=29

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa01.cmsx

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa01-matched-research-bank.cmsx

WW   https://stemcelldb.nih.gov/cellLineDetails.do?id=12

WW   http://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/

CC   Part of: ENCODE project common cell types; tier 1.

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0043.

CC   Registration: Swiss research registry; BAG-hES-IMP-0001.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-06.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: H3K27ac ChIP-seq epigenome analysis.

CC   Omics: H3K27me3 ChIP-seq epigenome analysis.

CC   Omics: H3K36me3 ChIP-seq epigenome analysis.

CC   Omics: H3K4me1 ChIP-seq epigenome analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Omics: H3K9ac ChIP-seq epigenome analysis.

CC   Omics: H3K9me3 ChIP-seq epigenome analysis.

CC   Omics: Transcriptome analysis.

CC   Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.

ST   Source(s): PubMed=16919167; PubMed=24374290; WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 8,11

ST   D16S539: 9,13

ST   D18S51: 17,18

ST   D21S11: 28,32.2

ST   D3S1358: 15

ST   D5S818: 9,11

ST   D7S820: 8,12

ST   D8S1179: 12,13

ST   FGA: 20,24

ST   Penta D: 10,13

ST   Penta E: 10,12

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 15,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WA07

AC   CVCL_9772

SY   WA 07; WA7; H7; H7 GE07; hESC; H7-hESC; ES-WA7; WAe002-A; WICELLe002-A; WAe007-A

DR   EFO; EFO_0005904

DR   BioSample; SAMN03471896

DR   ENCODE; ENCBS017AOD

DR   ENCODE; ENCBS052WSJ

DR   ENCODE; ENCBS058YII

DR   ENCODE; ENCBS068KXI

DR   ENCODE; ENCBS291AAA

DR   ENCODE; ENCBS292AAA

DR   ENCODE; ENCBS293AAA

DR   ENCODE; ENCBS297CQV

DR   ENCODE; ENCBS311AAZ

DR   ENCODE; ENCBS465FZV

DR   ENCODE; ENCBS559YVY

DR   ENCODE; ENCBS611ORI

DR   ENCODE; ENCBS624XJG

DR   ENCODE; ENCBS721YNV

DR   ENCODE; ENCBS851RDN

DR   ENCODE; ENCBS884CKU

DR   ENCODE; ENCBS920PVU

DR   ENCODE; ENCBS962QAF

DR   GEO; GSM347922

DR   GEO; GSM510581

DR   GEO; GSM537623

DR   GEO; GSM537639

DR   GEO; GSM537640

DR   GEO; GSM537641

DR   GEO; GSM537657

DR   GEO; GSM580005

DR   GEO; GSM621347

DR   GEO; GSM621353

DR   GEO; GSM669896

DR   GEO; GSM669926

DR   GEO; GSM856730

DR   GEO; GSM945183

DR   GEO; GSM945184

DR   GEO; GSM945185

DR   GEO; GSM945186

DR   GEO; GSM981283

DR   GEO; GSM1008596

DR   GEO; GSM1215275

DR   GEO; GSM1215276

DR   hPSCreg; WAe007-A

DR   IGRhCellID; H7%20p91

DR   ISCR; 88

RX   PubMed=9804556;

RX   PubMed=14745950;

RX   PubMed=15345125;

RX   PubMed=16388305;

RX   PubMed=16919167;

RX   PubMed=17572666;

RX   PubMed=21983960;

RX   PubMed=23117585;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=413

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/H7-hESC_StamAndCrawford_protocol.pdf

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa07.cmsx

WW   https://stemcelldb.nih.gov/cellLineDetails.do?id=3

WW   http://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/

CC   Part of: ENCODE project common cell types; tier 3.

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0061.

CC   Registration: Swiss research registry; BAG-hES-IMP-0034.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-18.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: H3K27me3 ChIP-seq epigenome analysis.

CC   Omics: H3K36me3 ChIP-seq epigenome analysis.

CC   Omics: H3K4me1 ChIP-seq epigenome analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Omics: H3K9ac ChIP-seq epigenome analysis.

CC   Omics: Transcriptome analysis.

CC   Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.

ST   Source(s): PubMed=16919167; WiCell

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 14,15

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WA09

AC   CVCL_9773

SY   WA 09; WA9; H9; H9.hESCs; H9 ESC; H9 hES; H9ES; GE09; WAe003-A; WICELLe003-A; WAe009-A

DR   BioSample; SAMN03471903

DR   BioSamples; SAMEA7769668

DR   ENCODE; ENCBS013BRF

DR   ENCODE; ENCBS061KRP

DR   ENCODE; ENCBS140HIH

DR   ENCODE; ENCBS277KDR

DR   ENCODE; ENCBS298AAA

DR   ENCODE; ENCBS299AAA

DR   ENCODE; ENCBS300AAA

DR   ENCODE; ENCBS315DEY

DR   ENCODE; ENCBS375GFI

DR   ENCODE; ENCBS377MXB

DR   ENCODE; ENCBS399JWQ

DR   ENCODE; ENCBS417MAQ

DR   ENCODE; ENCBS477SFO

DR   ENCODE; ENCBS532LWE

DR   ENCODE; ENCBS616QKE

DR   ENCODE; ENCBS656LSW

DR   ENCODE; ENCBS692FVF

DR   ENCODE; ENCBS703ZDS

DR   ENCODE; ENCBS741LLD

DR   ENCODE; ENCBS769EPD

DR   ENCODE; ENCBS808UWK

DR   ENCODE; ENCBS853WXF

DR   GEO; GSM347923

DR   GEO; GSM579901

DR   GEO; GSM579902

DR   GEO; GSM603054

DR   GEO; GSM603055

DR   GEO; GSM605307

DR   GEO; GSM605310

DR   GEO; GSM605314

DR   GEO; GSM605316

DR   GEO; GSM605324

DR   GEO; GSM616127

DR   GEO; GSM616128

DR   GEO; GSM616129

DR   GEO; GSM665037

DR   GEO; GSM667608

DR   GEO; GSM667609

DR   GEO; GSM667610

DR   GEO; GSM667611

DR   GEO; GSM667612

DR   GEO; GSM667613

DR   GEO; GSM667616

DR   GEO; GSM667619

DR   GEO; GSM667620

DR   GEO; GSM667621

DR   GEO; GSM667622

DR   GEO; GSM667623

DR   GEO; GSM667625

DR   GEO; GSM667626

DR   GEO; GSM667628

DR   GEO; GSM667629

DR   GEO; GSM667630

DR   GEO; GSM667631

DR   GEO; GSM667632

DR   GEO; GSM667633

DR   GEO; GSM667634

DR   GEO; GSM667635

DR   GEO; GSM667636

DR   GEO; GSM667637

DR   GEO; GSM667638

DR   GEO; GSM667639

DR   GEO; GSM667640

DR   GEO; GSM667643

DR   GEO; GSM669899

DR   GEO; GSM669901

DR   GEO; GSM670053

DR   GEO; GSM674603

DR   GEO; GSM706044

DR   GEO; GSM706059

DR   GEO; GSM706060

DR   GEO; GSM706061

DR   GEO; GSM706062

DR   GEO; GSM706063

DR   GEO; GSM706064

DR   GEO; GSM706066

DR   GEO; GSM706071

DR   GEO; GSM706076

DR   GEO; GSM816629

DR   GEO; GSM856731

DR   GEO; GSM1040243

DR   GEO; GSM1040313

DR   GEO; GSM1215278

DR   GEO; GSM1215279

DR   GEO; GSM1227088

DR   GEO; GSM1489249

DR   GEO; GSM1489460

DR   hPSCreg; WAe009-A

DR   IGRhCellID; H9%20p25-2

DR   IGRhCellID; H9%20p34

DR   ISCR; 89

DR   PRIDE; PXD003903

DR   TOKU-E; 4223

DR   Wikidata; Q27555433

RX   PubMed=9804556;

RX   PubMed=14745950;

RX   PubMed=16388305;

RX   PubMed=16919167;

RX   PubMed=17572666;

RX   PubMed=21983960;

RX   PubMed=22514597;

RX   PubMed=22802639;

RX   PubMed=23117585;

RX   PubMed=24259714;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=414

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/BG02ES_and_H9ES_Myers_protocols.pdf

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=88

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa09.cmsx

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa09-cgmp-material.cmsx

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa09-matched-research.cmsx

WW   https://stemcelldb.nih.gov/cellLineDetails.do?id=13

WW   http://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/

CC   Group: Clinical grade hESC cell line.

CC   Part of: ENCODE project common cell types; tier 3.

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0062.

CC   Registration: Swiss research registry; BAG-hES-IMP-0016.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-06.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

CC   Omics: H2AK5ac ChIP-seq epigenome analysis.

CC   Omics: H2BK12ac ChIP-seq epigenome analysis.

CC   Omics: H2BK15ac ChIP-seq epigenome analysis.

CC   Omics: H2BK5ac ChIP-seq epigenome analysis.

CC   Omics: H3K18ac ChIP-seq epigenome analysis.

CC   Omics: H3K23ac ChIP-seq epigenome analysis.

CC   Omics: H3K23me2 ChIP-seq epigenome analysis.

CC   Omics: H3K27ac ChIP-seq epigenome analysis.

CC   Omics: H3K27me3 ChIP-seq epigenome analysis.

CC   Omics: H3K36me3 ChIP-seq epigenome analysis.

CC   Omics: H3K4ac ChIP-seq epigenome analysis.

CC   Omics: H3K4me1 ChIP-seq epigenome analysis.

CC   Omics: H3K4me2 ChIP-seq epigenome analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Omics: H3K56ac ChIP-seq epigenome analysis.

CC   Omics: H3K79me1 ChIP-seq epigenome analysis.

CC   Omics: H3K79me2 ChIP-seq epigenome analysis.

CC   Omics: H3K9ac ChIP-seq epigenome analysis.

CC   Omics: H3K9me3 ChIP-seq epigenome analysis.

CC   Omics: H4K20me1 ChIP-seq epigenome analysis.

CC   Omics: H4K5ac ChIP-seq epigenome analysis.

CC   Omics: H4K8ac ChIP-seq epigenome analysis.

CC   Omics: H4K91ac ChIP-seq epigenome analysis.

CC   Omics: Transcriptome analysis.

CC   Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.

ST   Source(s): PubMed=16919167; WiCell

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9

ST   D16S539: 12,13

ST   D18S51: 13

ST   D21S11: 30

ST   D3S1358: 13,16

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 8,14

ST   FGA: 26,28

ST   Penta D: 11,13

ST   Penta E: 11,14

ST   TH01: 9.3

ST   TPOX: 10,11

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WA09 MIXL1-2A-eGFP

AC   CVCL_GQ06

SY   MIXL1-2A-eGFP

RX   PubMed=27558609;

CC   Characteristics: TALEN-engineered line where the stop codon of MIXL1 was replaced with a 2A-eGFP cassette, thus, creating a MIXL1-2A-eGFP allele.

ST   Source(s): PubMed=27558609

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9

ST   D16S539: 12,13

ST   D18S51: 13

ST   D21S11: 30

ST   D3S1358: 13,16

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 8,14

ST   FGA: 26,28

ST   Penta D: 9,13

ST   Penta E: 11,14

ST   TH01: 9.3

ST   TPOX: 10,11

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9773 ! WA09

SX   Female

CA   Induced pluripotent stem cell

//

ID   WA13

AC   CVCL_9774

SY   WA 13; H13; GE13; WAe004-A; WICELLe004-A; WAe013-A

DR   BioSample; SAMN03471898

DR   GEO; GSM347924

DR   GEO; GSM856732

DR   hPSCreg; WAe013-A

DR   ISCR; 92

RX   PubMed=9804556;

RX   PubMed=17572666;

RX   PubMed=23117585;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=415

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa13.cmsx

WW   https://stemcelldb.nih.gov/cellLineDetails.do?id=4

WW   http://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0063.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18.

CC   Omics: Transcriptome analysis.

CC   Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 14,15

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WA14

AC   CVCL_9775

SY   WA 14; H14; GE14; WAe005-A; WICELLe005-A; WAe014-A

DR   BioSample; SAMN03471899

DR   GEO; GSM347925

DR   GEO; GSM856733

DR   hPSCreg; WAe014-A

DR   ISCR; 93

RX   PubMed=9804556;

RX   PubMed=14745950;

RX   PubMed=16388305;

RX   PubMed=17572666;

RX   PubMed=21983960;

RX   PubMed=23117585;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=416

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa14.cmsx

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa14-cgmp-material.cmsx

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa14-matched-research.cmsx

WW   https://stemcelldb.nih.gov/cellLineDetails.do?id=29

WW   http://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/

CC   Group: Clinical grade hESC cell line.

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0064.

CC   Registration: Swiss research registry; BAG-hES-IMP-0033.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-18.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Transcriptome analysis.

CC   Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,13

ST   D18S51: 12,14

ST   D21S11: 30,31

ST   D3S1358: 15,16

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   D8S1179: 13,14

ST   FGA: 21

ST   Penta D: 12,13

ST   Penta E: 13,20

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 15,16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WA15

AC   CVCL_9776

SY   WISCe001-A

DR   hPSCreg; WISCe001-A

DR   ISCR; 1668

RX   PubMed=16388305;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=473

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa15.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0096.

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,12

ST   D16S539: 11,12

ST   D5S818: 9,13

ST   D7S820: 11,12

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WA16

AC   CVCL_9777

SY   WISCe002-A

DR   hPSCreg; WISCe002-A

DR   ISCR; 1669

RX   PubMed=16388305;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=474

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa16.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0097.

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 10,12

ST   D16S539: 9,11

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C34752; Klinefelter syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WA17

AC   CVCL_9778

DR   ISCR; 1831

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=475

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa17.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0098.

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 8

ST   D16S539: 11,13

ST   D5S818: 12

ST   D7S820: 8,12

ST   TH01: 6,7

ST   TPOX: 11

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WA18

AC   CVCL_9779

DR   ISCR; 1832

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=476

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa18.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0099.

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 9,12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 12,13

ST   D7S820: 8,11

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 15,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WA19

AC   CVCL_9780

DR   ISCR; 1833

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=477

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa19.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0100.

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D16S539: 13

ST   D5S818: 11

ST   D7S820: 9,10

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WA20

AC   CVCL_9781

DR   ISCR; 1834

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=478

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa20.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0101.

ST   Source(s): WiCell

ST   Amelogenin: X

ST   CSF1PO: 11,14

ST   D13S317: 13,14

ST   D16S539: 9,11

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 16,20

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WA21

AC   CVCL_9782

DR   ISCR; 1835

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=479

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa21.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0102.

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 11,12

ST   D16S539: 11

ST   D5S818: 11

ST   D7S820: 9

ST   TH01: 8,9

ST   TPOX: 8,12

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WA22

AC   CVCL_9783

SY   WAe022-A

DR   hPSCreg; WAe022-A

DR   ISCR; 1836

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=480

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa22.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0103.

ST   Source(s): WiCell

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 11,14

ST   D5S818: 13

ST   D7S820: 10,11

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WA23

AC   CVCL_9784

DR   ISCR; 1837

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=481

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa23.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0104.

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 12,13

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WA24

AC   CVCL_9785

DR   ISCR; 1838

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=482

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa24.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0105.

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 10,12

ST   D16S539: 9,12

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 15,16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WA25

AC   CVCL_E080

DR   ISCR; 2001

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=582

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa25.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0196.

ST   Source(s): WiCell

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 11,12

ST   D16S539: 8,14

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WA26

AC   CVCL_E081

DR   ISCR; 2021

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=583

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa26.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0197.

ST   Source(s): WiCell

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 12,14

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 7,10

ST   TPOX: 8,11

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WA27

AC   CVCL_E082

DR   ISCR; 2022

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=584

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa27.cmsx

CC   From: University of Wisconsin; Madison; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0198.

ST   Source(s): WiCell

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 11

ST   D16S539: 12,13

ST   D5S818: 11,12

ST   D7S820: 10

ST   TH01: 6,8

ST   TPOX: 8,10

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WAC2

AC   CVCL_0575

SY   WAC-2; WAC 2

DR   MCCL; MCC:0000481

RX   PubMed=2364393;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0522 ! SH-EP007

SX   Female

CA   Cancer cell line

//

ID   WAF

AC   CVCL_1H00

SY   Wallago Attu Fin

RX   PubMed=24381102;

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=5

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC005.

OX   NCBI_TaxID=36718; ! Wallago attu

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WAG

AC   CVCL_1H01

SY   Wallago Attu Gill

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=48

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC048.

OX   NCBI_TaxID=36718; ! Wallago attu

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WaGa

AC   CVCL_E998

SY   WAGA

DR   Cosmic; 1699819

DR   Cosmic; 2273918

RX   PubMed=20444890;

CC   Characteristics: Contains a Merkel cell polyomavirus (MCPyV) genome.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WAI,DL

AC   CVCL_E865

SY   WAI, DL

DR   dbMHC; 49055

DR   IHW; IHW9204

DR   IMGT/HLA; 11745

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl204.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   Waji

AC   CVCL_W202

SY   WAJI

RX   PubMed=3164747;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WAL,FD

AC   CVCL_E866

SY   WAL, FD

DR   dbMHC; 49056

DR   ECACC; 94082228

DR   IHW; IHW9129

DR   IMGT/HLA; 11672

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl129.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   Walker-256-TC

AC   CVCL_4984

SY   Walker256-TC

DR   CLO; CLO_0051604

DR   RCB; RCB2909

DR   TKG; TKG 0565

DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3537 ! LLC-WRC 256

SX   Female

CA   Cancer cell line

//

ID   Walvax-2

AC   CVCL_5J50

SY   WALVAX-2; WALVAX 2; WALVAX2

RX   Patent=CN103525770A;

RX   PubMed=25803132;

CC   Group: Vaccine production cell line.

CC   Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201055.

CC   Characteristics: Maintains excellent capabilities for growth and proliferation until PDL 50 (max PDL is 58).

CC   Anecdotal: Is causing an outrage in some pro-lifer circles because it is a cell line originating from an aborted (for medical reasons) 3-month old female fetus.

ST   Source(s): PubMed=25803132

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D18S51: 15,18

ST   D21S11: 29,30

ST   D3S1358: 15,16

ST   D5S818: 10,11

ST   D7S820: 8,12

ST   D8S1179: 13,15

ST   FGA: 21,24

ST   Penta D: 10,11

ST   Penta E: 5,18

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WAM

AC   CVCL_1H02

SY   Wallago Attu Muscle

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=47

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC047.

OX   NCBI_TaxID=36718; ! Wallago attu

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Wan-BL

AC   CVCL_M654

SY   WAN-BL; WAN BL; Wan.BL; WAN; Wan

RX   PubMed=1356511;

RX   PubMed=2824665;

RX   PubMed=2898508;

RX   PubMed=2943927;

RX   PubMed=2985508;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WAPS 12.2

AC   CVCL_F810

SY   WAPS12.2

DR   CLO; CLO_0009560

DR   ATCC; HB-299

CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   WART

AC   CVCL_8011

SY   Wart

RX   PubMed=9551745;

RX   PubMed=9615717;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WASMC

AC   CVCL_9500

DR   CLO; CLO_0009561

DR   CLDB; cl4677

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

SX   Male

CA   Finite cell line

//

ID   WATANABE

AC   CVCL_E867

SY   WATANABI

DR   dbMHC; 49057

DR   ECACC; 94082225

DR   IHW; IHW9126

DR   IMGT/HLA; 11669

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl126.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Watanabe

AC   CVCL_W437

RX   PubMed=8721091;

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WAZ-2T

AC   CVCL_5G88

SY   WAZ-2t; WAZ2T

RX   PubMed=7306960;

RX   PubMed=7371012;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   WB-F344

AC   CVCL_9806

SY   WB F344; WBF344

DR   BTO; BTO:0004318

DR   EFO; EFO_0002871

DR   JCRB; JCRB0193

RX   PubMed=6468534;

RX   PubMed=9846981;

RX   PubMed=20140209;

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   WB2054

AC   CVCL_4335

SY   WB-2054

CC   Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).

CC   Breed/subspecies: Wistar Furth x Brown Norway.

DI   NCIt; C63866; Adenocarcinoma of the rat colon

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   WB2054M

AC   CVCL_4336

DR   CLO; CLO_0009562

DR   CLDB; cl4678

DR   ECACC; 91011802

RX   PubMed=2910247;

CC   Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).

CC   Breed/subspecies: Wistar Furth x Brown Norway.

DI   NCIt; C63866; Adenocarcinoma of the rat colon

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4335 ! WB2054

CA   Cancer cell line

//

ID   WB311

AC   CVCL_X199

SY   WB-311

DR   BTO; BTO:0004319

RX   PubMed=2774059;

RX   PubMed=20140209;

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_9806 ! WB-F344

SX   Male

CA   Transformed cell line

//

ID   WB-5-11

AC   CVCL_DN33

RX   PubMed=2862991;

RX   PubMed=2862992;

RX   PubMed=3970142;

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_9806 ! WB-F344

SX   Male

CA   Transformed cell line

//

ID   WB6a

AC   CVCL_Y636

RX   PubMed=11084865;

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   WB6b

AC   CVCL_Y637

RX   PubMed=11084865;

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   WB6d

AC   CVCL_Y638

RX   PubMed=11084865;

RX   PubMed=17828574;

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   WBC264-9C

AC   CVCL_8981

SY   WBC264-9

DR   CLO; CLO_0009563

DR   ATCC; HB-8902

RX   Patent=US4970162;

RX   PubMed=3741419;

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_1P00 ! RAW264-TG3

CA   Hybrid cell line

//

ID   WBD001088

AC   CVCL_E868

DR   dbMHC; 49058

DR   ECACC; 94082253

DR   IHW; IHW9153

DR   IMGT/HLA; 11696

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl153.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   WBD001816

AC   CVCL_E869

DR   dbMHC; 49059

DR   ECACC; 94082254

DR   IHW; IHW9154

DR   IMGT/HLA; 11697

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl154.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   WBE

AC   CVCL_5604

SY   White Bass Embryo

DR   CLO; CLO_0009564

DR   ATCC; CRL-2773

RX   PubMed=12892524;

CC   Group: Fish cell line.

OX   NCBI_TaxID=46259; ! Morone chrysops

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WBS-A

AC   CVCL_0G88

DR   SKIP; SKIP000557

RX   PubMed=23283491;

DI   NCIt; C85232; Williams syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0G89 ! WBS-B

OI   CVCL_0G90 ! WBS-C

OI   CVCL_0G91 ! WBS-I

SX   Male

CA   Induced pluripotent stem cell

//

ID   WBS-B

AC   CVCL_0G89

DR   SKIP; SKIP000558

RX   PubMed=23283491;

DI   NCIt; C85232; Williams syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0G88 ! WBS-A

OI   CVCL_0G90 ! WBS-C

OI   CVCL_0G91 ! WBS-I

SX   Male

CA   Induced pluripotent stem cell

//

ID   WBS-C

AC   CVCL_0G90

DR   SKIP; SKIP000559

RX   PubMed=23283491;

DI   NCIt; C85232; Williams syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0G88 ! WBS-A

OI   CVCL_0G89 ! WBS-B

OI   CVCL_0G91 ! WBS-I

SX   Male

CA   Induced pluripotent stem cell

//

ID   WBS-I

AC   CVCL_0G91

DR   SKIP; SKIP000560

RX   PubMed=23283491;

DI   NCIt; C85232; Williams syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0G88 ! WBS-A

OI   CVCL_0G89 ! WBS-B

OI   CVCL_0G90 ! WBS-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   WC-1

AC   CVCL_4555

SY   WC 1

DR   CLO; CLO_0009565

DR   CLDB; cl4679

DR   IZSLER; BS TCL 65

RX   DOI=10.1139/f80-139;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Cancer cell line

//

ID   WC005i-FX11-7

AC   CVCL_EJ76

SY   FX11-7

RX   PubMed=24654675;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WC005i-FX11-7.cmsx

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ77 ! WC006i-FX11-9U

SX   Male

CA   Induced pluripotent stem cell

//

ID   WC006i-FX11-9U

AC   CVCL_EJ77

SY   FX11-9U

RX   PubMed=24654675;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WC006i-FX11-9U.cmsx

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ76 ! WC005i-FX11-7

SX   Male

CA   Induced pluripotent stem cell

//

ID   WC007i-FX13-2

AC   CVCL_EJ78

SY   FX13-2

RX   PubMed=24654675;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WC007i-FX13-2.cmsx

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   WC009i-FX08-01

AC   CVCL_EJ79

SY   FX08-1

RX   PubMed=24654675;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WC009i-FX08-01.cmsx

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   WCH-17

AC   CVCL_3471

SY   WCH17

DR   CLO; CLO_0009566

DR   ATCC; CRL-2082

DR   NCBI_Iran; C573

RX   PubMed=2839596;

CC   From: Fernie B.; Georgetown University; Rockville; USA.

DI   NCIt; C124251; Woodchuck hepatocellular carcinoma

OX   NCBI_TaxID=9995; ! Marmota monax

CA   Cancer cell line

//

ID   WCL2

AC   CVCL_DC12

SY   WCL-2

RX   PubMed=2019585;

RX   PubMed=2243084;

CC   Transfected with: MGI; MGI:95824; Nr3c1.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_1977 ! CHO-DXB11

SX   Female

CA   Spontaneously immortalized cell line

//

ID   WCMC-1

AC   CVCL_V488

SY   WMC 1; WMC1

RX   CelloPub=CLPUB00245;

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WCMC-10

AC   CVCL_V493

SY   WCMC 10; WMC 10

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=849

CC   From: Weill Cornell Medical College; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0367.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-11

AC   CVCL_V494

SY   WCMC 11; WMC 11

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=848

CC   From: Weill Cornell Medical College; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0366.

DI   NCIt; C36100; BRCA1 syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-12

AC   CVCL_V495

SY   WMC 12

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-13

AC   CVCL_V496

SY   WCMC 13; WMC 13

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=847

CC   From: Weill Cornell Medical College; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0365.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-14

AC   CVCL_V497

SY   WMC 14

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C34375; Thalassemia major

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-15

AC   CVCL_V498

SY   WMC 15

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C82342; Huntington's disease

DI   NCIt; C36529; Trisomy 13

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-16

AC   CVCL_V499

SY   WMC 16

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-17

AC   CVCL_V500

SY   WMC 17

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C2975; Cystic fibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-18

AC   CVCL_V501

SY   WMC 18

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-19

AC   CVCL_V502

SY   WMC 19

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-2

AC   CVCL_B922

SY   WMC 2; WMC-2; WMC2

RX   CelloPub=CLPUB00245;

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-14.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WCMC-20

AC   CVCL_V503

SY   WMC 20

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-21

AC   CVCL_V504

SY   WMC 21

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-22

AC   CVCL_V505

SY   WMC 22

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-23

AC   CVCL_V506

SY   WCMC 23; WMC 23

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=846

CC   From: Weill Cornell Medical College; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0364.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-24

AC   CVCL_V507

SY   WMC 24

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-25

AC   CVCL_V508

SY   WMC 25

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-26

AC   CVCL_V509

SY   WMC 26

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-27

AC   CVCL_V510

SY   WMC 27

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C27146; Hemophilia A

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-28

AC   CVCL_V511

SY   WMC 28

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C34345; Achondroplasia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-29

AC   CVCL_V512

SY   WMC 29

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-3

AC   CVCL_V489

SY   WMC 3; WMC3

RX   CelloPub=CLPUB00245;

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WCMC-30

AC   CVCL_V513

SY   WMC 30

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C118780; Autosomal dominant torsion dystonia 1

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-31

AC   CVCL_V514

SY   WMC 31

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-32

AC   CVCL_V515

SY   WMC 32

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C34345; Achondroplasia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-33

AC   CVCL_V516

SY   WMC 33

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C34345; Achondroplasia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-34

AC   CVCL_V517

SY   WMC 34

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C36529; Trisomy 13

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-35

AC   CVCL_V518

SY   WMC 35

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-36

AC   CVCL_V519

SY   WMC 36

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C37865; Trisomy 17

DI   NCIt; C36626; Trisomy 18

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-37

AC   CVCL_B919

SY   WCMC 37; WCMC37; WMC 37

DR   ISCR; 2257

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=573

CC   From: Weill Cornell Medical College; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0211.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WCMC-38

AC   CVCL_V520

SY   WMC 38

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C114765; Trisomy 22

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-39

AC   CVCL_V521

SY   WCMC 39; WMC 39

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=845

CC   From: Weill Cornell Medical College; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0363.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-4

AC   CVCL_V490

SY   WMC 4; WMC4

RX   CelloPub=CLPUB00245;

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V491 ! WCMC-5

SX   Male

CA   Embryonic stem cell

//

ID   WCMC-40

AC   CVCL_V522

SY   WMC 40

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C34345; Achondroplasia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-41

AC   CVCL_V523

SY   WMC 41

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C61268; Gaucher disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-42

AC   CVCL_V524

SY   WMC 42

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

DI   NCIt; C36529; Trisomy 13

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-43

AC   CVCL_V525

SY   WMC 43

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-5

AC   CVCL_V491

SY   WMC 5; WMC5

RX   CelloPub=CLPUB00245;

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V490 ! WCMC-4

SX   Male

CA   Embryonic stem cell

//

ID   WCMC-6

AC   CVCL_V492

SY   WCMC 6; WMC 6; WMC6

RX   CelloPub=CLPUB00245;

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V419 ! WCMC-7

SX   Male

CA   Embryonic stem cell

//

ID   WCMC-7

AC   CVCL_V419

SY   WCMC 7; WMC 7; WMC7

RX   CelloPub=CLPUB00245;

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

CC   From: Weill Cornell Medical College; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V492 ! WCMC-6

SX   Male

CA   Embryonic stem cell

//

ID   WCMC-8

AC   CVCL_B920

SY   WCMC 8; WMC 8; WMC8

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=851

CC   From: Weill Cornell Medical College; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0369.

DI   NCIt; C36101; BRCA2 syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCMC-9

AC   CVCL_B921

SY   WCMC 9; WMC 9; WMC9

WW   http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=850

CC   From: Weill Cornell Medical College; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0368.

DI   NCIt; C36101; BRCA2 syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WCQH-9801

AC   CVCL_X186

RX   PubMed=21310132;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WD PaCa

AC   CVCL_8435

SY   WDPaCa; Well-Differentiated Pancreatic adenoCarcinoma; WD

RX   PubMed=3971476;

RX   PubMed=6435863;

RX   PubMed=6805945;

RX   PubMed=8863680;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

CA   Cancer cell line

//

ID   WD39

AC   CVCL_Y528

DR   SKIP; SKIP000514

RX   PubMed=23039195;

RX   PubMed=24936452;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   WDC-1

AC   CVCL_R803

RX   PubMed=10721940;

DI   NCIt; C7889; Duodenal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WDS3

AC   CVCL_A741

DR   Cosmic; 1006171

RX   PubMed=10201537;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WDV

AC   CVCL_E870

AS   CVCL_F296

SY   WVB; GM06816; GM17002

DR   CLO; CLO_0018043

DR   CLO; CLO_0036533

DR   Coriell; GM06816

DR   Coriell; GM17002

DR   dbMHC; 49060

DR   ECACC; 88052062

DR   IHW; IHW9062

DR   IMGT/HLA; 11555

RX   PubMed=6417008;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl62.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Part of: Human variation panel.

CC   Population: Northern European.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Misspelling: 'WVD' in Coriell GM06816.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WE

AC   CVCL_5M23

RX   PubMed=4735239;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

OI   CVCL_5M20 ! KF

OI   CVCL_5M21 ! MB

OI   CVCL_5M22 ! TD

CA   Cancer cell line

//

ID   WE-68

AC   CVCL_9717

SY   WE 68; WE68

DR   EFO; EFO_0002872

DR   GEO; GSM510016

RX   PubMed=1320624;

RX   PubMed=8335680;

RX   PubMed=15150091;

RX   PubMed=19787792;

CC   From: Van Valen F.; University of Munster; Germany.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9718 ! WE-M1-68

OI   CVCL_9719 ! WE-M2-68

SX   Female

CA   Cancer cell line

//

ID   WE-afin8e

AC   CVCL_AZ93

SY   Wall Eye-anal fin 8e

RX   CelloPub=CLPUB00324;

RX   PubMed=25424833;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WE-brain3

AC   CVCL_AZ94

SY   Wall Eye-brain 3

RX   CelloPub=CLPUB00324;

RX   PubMed=25424833;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WE-brain5

AC   CVCL_AZ95

SY   Wall Eye-brain 5

RX   CelloPub=CLPUB00324;

RX   PubMed=25424833;

RX   PubMed=26251287;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WE-cfin11e

AC   CVCL_AZ96

SY   Wall Eye-caudal fin 11e; WECF11e; Wall Eye Caudal Fine 11e

RX   CelloPub=CLPUB00324;

RX   PubMed=23891577;

RX   PubMed=25424833;

RX   PubMed=25643858;

RX   PubMed=26251287;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WE-cfin11f

AC   CVCL_AZ97

SY   Wall Eye-caudal fin 11f

RX   CelloPub=CLPUB00324;

RX   PubMed=25424833;

RX   PubMed=25589167;

RX   PubMed=25643858;

RX   PubMed=26251287;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WE-heart1

AC   CVCL_AZ98

SY   Wall Eye-heart 1

RX   CelloPub=CLPUB00324;

RX   PubMed=25424833;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WE-heart6

AC   CVCL_AZ99

SY   Wall Eye-heart 6

RX   CelloPub=CLPUB00324;

RX   PubMed=25424833;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WE-liver3

AC   CVCL_BA00

SY   Wall Eye-liver 3

RX   CelloPub=CLPUB00324;

RX   PubMed=26251287;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WE-M1-68

AC   CVCL_9718

RX   PubMed=1320624;

CC   From: Van Valen F.; University of Munster; Germany.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9717 ! WE-68

OI   CVCL_9719 ! WE-M2-68

SX   Female

CA   Cancer cell line

//

ID   WE-M2-68

AC   CVCL_9719

RX   PubMed=1320624;

CC   From: Van Valen F.; University of Munster; Germany.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9717 ! WE-68

OI   CVCL_9718 ! WE-M1-68

SX   Female

CA   Cancer cell line

//

ID   WE-skin11f

AC   CVCL_BA01

SY   Wall Eye-skin 11f

RX   CelloPub=CLPUB00324;

RX   PubMed=25424833;

RX   PubMed=26251287;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WE-spleen6

AC   CVCL_BA02

SY   Wall Eye-spleen 6; WE-spleen

RX   CelloPub=CLPUB00324;

RX   PubMed=25424833;

RX   PubMed=25701636;

RX   PubMed=26251287;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WE17/10

AC   CVCL_X625

SY   We17/10

DR   NIH-ARP; 462-168

RX   CelloPub=CLPUB00150;

RX   PubMed=2144349;

CC   Characteristics: IL2 dependent.

DI   NCIt; C3466; T-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Factor-dependent cell line

//

ID   WEBA

AC   CVCL_BA03

SY   Wall Eye Bulbus Arteriosus

RX   CelloPub=CLPUB00324;

RX   PubMed=25424833;

RX   PubMed=25461487;

RX   PubMed=26251287;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WEG-1

AC   CVCL_8012

RX   PubMed=8536610;

WW   http://www2.kumc.edu/soalab/LabLinks/cell%20lines/weg1.htm

WW   https://www.researchgate.net/post/Does_anyone_know_of_an_established_mouse_uterine_epithelial_cell_line_in_existence

CC   Breed/subspecies: CF-1.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   WEGLI-11

AC   CVCL_7873

SY   WEGLI 11; WEGLI11; Wegli 11

RX   PubMed=7684623;

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybrid cell line

//

ID   WEGLI-13

AC   CVCL_7874

SY   WEGLI 13; WEGLI13

RX   PubMed=7684623;

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybrid cell line

//

ID   WEGLI-16

AC   CVCL_7875

SY   WEGLI 16; WEGLI16

RX   PubMed=7684623;

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybrid cell line

//

ID   WEGLI-18

AC   CVCL_7876

SY   WEGLI 18; WEGLI18

DR   BTO; BTO:0001927

RX   PubMed=7684623;

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybrid cell line

//

ID   WEGLI-20

AC   CVCL_7877

SY   WEGLI 20; WEGLI20

RX   PubMed=7684623;

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybrid cell line

//

ID   WEGLI-22

AC   CVCL_7878

SY   WEGLI 22; WEGLI22

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybrid cell line

//

ID   WEGLI-3

AC   CVCL_7879

SY   WEGLI 3; WEGLI3

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybrid cell line

//

ID   WEGLI-9

AC   CVCL_7880

SY   WEGLI 9; WEGLI9

RX   PubMed=7684623;

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybrid cell line

//

ID   WEHI-105.7

AC   CVCL_F528

SY   WEHI 105.7

RX   PubMed=4630643;

CC   Breed/subspecies: NZB.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   WEHI-13VAR

AC   CVCL_3619

SY   WEHI-13var

DR   CLO; CLO_0009572

DR   ATCC; CRL-2148

DR   CCRID; 3111C0002000000029

RX   PubMed=7590904;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0J47 ! WEHI-164 clone 13

CA   Cancer cell line

//

ID   WEHI-164

AC   CVCL_2251

SY   WEHI 164; WEHI164

DR   CLO; CLO_0009567

DR   CLO; CLO_0009573

DR   CLDB; cl4680

DR   CLDB; cl4681

DR   CLDB; cl4683

DR   ATCC; CRL-1751

DR   BCRJ; 0247

DR   CCRID; 3142C0001000000111

DR   ChEMBL-Cells; CHEMBL3308344

DR   ChEMBL-Targets; CHEMBL614227

DR   CLS; 400438/p944_WEHI-164

DR   ECACC; 87022501

DR   ICLC; ATL96004

DR   IZSLER; BS TCL 195

DR   KCLB; 21751

DR   NCBI_Iran; C200

RX   PubMed=9753870;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=WEHI-164

CC   Breed/subspecies: BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   WEHI-164 clone 13

AC   CVCL_0J47

SY   WEHI 164 clone 13; WEHI 164(13)

RX   PubMed=3782828;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2251 ! WEHI-164

CA   Cancer cell line

//

ID   WEHI-164R

AC   CVCL_4561

SY   WEHI 164R; WEHI164R

DR   CLO; CLO_0050182

DR   RCB; RCB2904

DR   TKG; TKG 0281

CC   Breed/subspecies: BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2251 ! WEHI-164

CA   Cancer cell line

//

ID   WEHI-164S

AC   CVCL_2238

SY   WEHI 164S; WEHI164S

DR   CLO; CLO_0009574

DR   CLO; CLO_0050183

DR   CLDB; cl4682

DR   DSMZ; ACC-25

DR   RCB; RCB2905

DR   TKG; TKG 0282

CC   Doubling time: ~30-50 hours (DSMZ).

CC   Breed/subspecies: BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2251 ! WEHI-164

CA   Cancer cell line

//

ID   WEHI-22.1

AC   CVCL_2248

SY   WEHI 22.1

DR   CLO; CLO_0009568

DR   ATCC; TIB-54

RX   PubMed=4630643;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   WEHI-231

AC   CVCL_0577

SY   WEHI 231; WEHI231

DR   BTO; BTO:0001093

DR   CLO; CLO_0009575

DR   MCCL; MCC:0000483

DR   CLDB; cl4687

DR   ATCC; CRL-1702

DR   CCRID; 3131C0001000300013

DR   ECACC; 85022107

DR   Lonza; 756

DR   PRIDE; PRD000029

DR   TOKU-E; 3440

RX   PubMed=3495708;

RX   PubMed=6170720;

RX   PubMed=6969756;

CC   Breed/subspecies: BALB/c x NZB.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   WEHI-265.1

AC   CVCL_3620

SY   WEHI 265.1; WEHI265.1; WEHI:265

DR   CLO; CLO_0009576

DR   ATCC; TIB-204

DR   ChEMBL-Cells; CHEMBL3307249

DR   ChEMBL-Targets; CHEMBL612805

RX   PubMed=6170720;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   WEHI-274.1

AC   CVCL_3621

SY   Wehi-274.1; WEHI 274.1; WEHI:274

DR   CLO; CLO_0009577

DR   CLDB; cl4688

DR   ATCC; CRL-1679

DR   ECACC; 91061231

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   WEHI-279

AC   CVCL_3278

DR   CLO; CLO_0009578

DR   CLDB; cl4689

DR   ATCC; CRL-1704

DR   ECACC; 94110901

DR   Lonza; 1131

CC   Breed/subspecies: NZC.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   WEHI-3

AC   CVCL_3622

SY   WEHI 3; WEHI3; Wehi-3

DR   BTO; BTO:0000295

DR   CLO; CLO_0009579

DR   CLO; CLO_0051420

DR   CLDB; cl4691

DR   ATCC; TIB-68

DR   BCRC; 60176

DR   CCRID; 3111C0001CCC000029

DR   CLS; 400381/p827_WEHI-3

DR   JCRB; JCRB9093

DR   KCB; KCB 2012094YJ

DR   RCB; RCB0035

RX   PubMed=3792703;

RX   PubMed=6170720;

WW   http://www.infarktforschung.de/macrophages_cell_lines.html

CC   Misspelling: Occasionally 'WEIHI3'.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   WEHI-3B

AC   CVCL_2239

SY   WEHI-3b; WEHI 3B; WEHI3B

DR   BTO; BTO:0005282

DR   CLO; CLO_0009569

DR   CLO; CLO_0009580

DR   CLO; CLO_0050196

DR   CLDB; cl4684

DR   CLDB; cl4685

DR   CLDB; cl4686

DR   CLDB; cl4937

DR   BCRJ; 0248

DR   ChEMBL-Cells; CHEMBL3307352

DR   ChEMBL-Targets; CHEMBL614249

DR   CLS; 400376/p545_WEHI-3b

DR   DSMZ; ACC-26

DR   ECACC; 86013003

DR   ICLC; ATL99003

DR   IFO; IFO50296

DR   RCB; RCB2853

DR   TKG; TKG 0584

RX   PubMed=3792703;

RX   PubMed=17635523;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=WEHI-3B

CC   Doubling time: ~20-30 hours (DSMZ).

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3622 ! WEHI-3

CA   Cancer cell line

//

ID   WEHI-3B D+

AC   CVCL_4357

SY   WEHI-3B(D+); WEHI-3BD; WEHI 3BD

DR   CLO; CLO_0009570

DR   CLO; CLO_0009581

DR   CLDB; cl4693

DR   CLDB; cl4694

DR   ECACC; 92110401

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2239 ! WEHI-3B

CA   Cancer cell line

//

ID   WEHI-3B/CPX

AC   CVCL_3430

SY   WEHI-3B/CPXRES

DR   CLO; CLO_0009582

DR   CLDB; cl4938

DR   ICLC; ATL99004

RX   CelloPub=CLPUB00272;

RX   PubMed=17635523;

CC   Selected for resistance to: ChEBI; CHEBI:100241; Ciprofloxacin.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4357 ! WEHI-3B D+

CA   Cancer cell line

//

ID   WEHI-3B/CTRES

AC   CVCL_4Y52

SY   WEHI-3B/CT/REV

RX   PubMed=12083375;

RX   PubMed=16541129;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4357 ! WEHI-3B D+

CA   Cancer cell line

//

ID   WEHI-3B/NOVO

AC   CVCL_9260

RX   PubMed=1316227;

CC   Selected for resistance to: ChEBI; CHEBI:28368; Novobiocin.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4357 ! WEHI-3B D+

CA   Cancer cell line

//

ID   WEHI-3B/S

AC   CVCL_9261

RX   PubMed=1316227;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4357 ! WEHI-3B D+

CA   Cancer cell line

//

ID   WEHI-5

AC   CVCL_0J46

SY   WEHI 5

RX   PubMed=3495708;

RX   PubMed=6170720;

CC   Breed/subspecies: BALB/c x NZB.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   WEHI-7

AC   CVCL_F526

SY   WEHI 7; WEHI7

RX   PubMed=2019585;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   WEHI-7.1

AC   CVCL_0576

SY   W7; WEHI 7.1; WEHI7.1; Wehi 7.1

DR   CLO; CLO_0009571

DR   MCCL; MCC:0000482

DR   ATCC; TIB-53

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F526 ! WEHI-7

CA   Cancer cell line

//

ID   WEHI-7.2

AC   CVCL_3950

SY   WEHI 7.2; WEHI7.2

DR   BTO; BTO:0003181

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F526 ! WEHI-7

CA   Cancer cell line

//

ID   WEHI-7TG

AC   CVCL_F527

SY   WEHI7TG

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F526 ! WEHI-7

CA   Cancer cell line

//

ID   WERC

AC   CVCL_7881

RX   PubMed=4107530;

CC   Breed/subspecies: Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Spontaneously immortalized cell line

//

ID   WERI

AC   CVCL_2757

DR   ECACC; 06070602

CC   From: Gallie B.; Toronto Hospital for Sick Children; Toronto; Canada.

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WERI-Rb-1

AC   CVCL_1792

SY   WERI-RB-1; WERI-Rb1; WERI-RB1; WERI Rb-1

DR   CLO; CLO_0009583

DR   CLO; CLO_0009584

DR   CLO; CLO_0051563

DR   EFO; EFO_0005715

DR   CLDB; cl4695

DR   ATCC; HTB-169

DR   BioSample; SAMN03472730

DR   CCRID; 3131C0001001200012

DR   Cosmic; 688119

DR   Cosmic; 909782

DR   DSMZ; ACC-90

DR   ENCODE; ENCBS087YAE

DR   ENCODE; ENCBS270AAA

DR   ENCODE; ENCBS282DQM

DR   ENCODE; ENCBS283KOW

DR   ENCODE; ENCBS283WND

DR   ENCODE; ENCBS679NMZ

DR   GEO; GSM824870

DR   GEO; GSM945263

DR   GEO; GSM945318

DR   IGRhCellID; WERIRb1

DR   IZSLER; BS TCL 231

DR   Lonza; 1147

DR   RCB; RCB2146

DR   TKG; TKG 0601

RX   DOI=10.5795/jjscc.24.451;

RX   PubMed=844036;

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/WERI-Rb-1_Stam_protocol.pdf

CC   Part of: ENCODE project common cell types; tier 3.

CC   Doubling time: ~49 hours (DSMZ).

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

ST   Source(s): ATCC; DSMZ; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10,12,13 (ATCC; DSMZ; RCB)

ST   CSF1PO: 10 (TKG)

ST   D13S317: 14

ST   D16S539: 13

ST   D5S818: 11,12

ST   D7S820: 10,13

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WERI-Rb24

AC   CVCL_S609

SY   W-24

RX   PubMed=2391623;

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WERI-Rb27

AC   CVCL_S610

SY   WERI-RB27; W-27

RX   PubMed=1679230;

RX   PubMed=2391623;

CC   Problematic cell line: Contaminated. Shown to be a Y-79 derivative (PubMed=1679230).

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1893 ! Y-79

SX   Female

CA   Cancer cell line

//

ID   WErpe

AC   CVCL_BA04

SY   Wall Eye retinal pigment epithelium

RX   PubMed=26251287;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WES

AC   CVCL_4337

SY   Ad12-SV40 WES

DR   CLO; CLO_0009585

DR   CLDB; cl4696

DR   ATCC; CRL-1609

DR   ECACC; 91011612

DR   KCB; KCB 93006YJ

RX   PubMed=1335029;

RX   PubMed=6264437;

CC   Group: Non-human primate cell line.

CC   Transformant: Ad12-SV40.

CC   Discontinued: ATCC; CRL-1609; true.

OX   NCBI_TaxID=9598; ! Pan troglodytes

CA   Transformed cell line

//

ID   WEWAK1

AC   CVCL_E871

DR   dbMHC; 49061

DR   ECACC; 94022553

DR   IHW; IHW9219

DR   IMGT/HLA; 11558

WW   http://bioinformatics.hsanmartino.it/ecbr/cl219.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   WF-1

AC   CVCL_R857

SY   Wakasaki Fin-1

RX   DOI=10.1577/1548-8667(1993)005<0137:EACOSC>2.3.CO;2;

RX   DOI=10.3147/jsfp.28.27;

CC   Group: Fish cell line.

OX   NCBI_TaxID=240830; ! Hypomesus olidus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WF2

AC   CVCL_4556

SY   WF 2; WF-2; Walleye Fry-2

DR   CLO; CLO_0009586

DR   CLDB; cl4697

DR   IZSLER; BS CL 88

RX   DOI=10.1111/j.1749-7345.2005.tb00402.x;

CC   Group: Fish cell line.

OX   NCBI_TaxID=283036; ! Sander vitreus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WF215-200

AC   CVCL_V387

DR   IMGT/HLA; 14463

RX   PubMed=16948657;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   WFL3C6.1

AC   CVCL_9240

SY   3C6

DR   CLO; CLO_0009587

DR   ATCC; HB-8157

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   WFL4F12.3

AC   CVCL_9241

SY   4F12

DR   CLO; CLO_0009588

DR   ATCC; HB-8156

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Wg-1A

AC   CVCL_0F72

SY   WG-1A; Wg1A; Wg1a; CH-WG-1A

RX   PubMed=762193;

RX   PubMed=4359531;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_3472 ! Don

SX   Male

CA   Spontaneously immortalized cell line

//

ID   WG-59

AC   CVCL_FA28

RX   PubMed=27110824;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): PubMed=27110824

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 12,13

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 14,15

DI   NCIt; C128803; Bicuspid aortic valve

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WG0915

AC   CVCL_0E55

SY   WG915

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C121563; Lysinuric protein intolerance

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   WG0919

AC   CVCL_0E56

SY   WG919

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C121563; Lysinuric protein intolerance

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   WG1077

AC   CVCL_0E57

SY   WG 1077

RX   PubMed=1437403;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C85029; Prolidase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   WG1130

AC   CVCL_0F56

SY   WG 1130

RX   PubMed=7909321;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C98986; Methylmalonic acidemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WG1264

AC   CVCL_0E58

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WG1265

AC   CVCL_0E59

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C121563; Lysinuric protein intolerance

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WG1269

AC   CVCL_0E60

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C121563; Lysinuric protein intolerance

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   WG1270

AC   CVCL_0E61

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WG1271

AC   CVCL_0E62

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C121563; Lysinuric protein intolerance

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WG1273

AC   CVCL_0E63

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C121563; Lysinuric protein intolerance

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   WG1288

AC   CVCL_0E65

RX   PubMed=3478720;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C84664; Cystinuria

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WG1534

AC   CVCL_5I47

SY   PWSdel1; PWS-1

RX   PubMed=20876107;

RX   PubMed=24816254;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C75463; Prader-Willi syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WG1625

AC   CVCL_0E64

SY   WG 1625

RX   PubMed=1437403;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C85029; Prolidase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WG1631

AC   CVCL_5I46

SY   ASdel2

RX   PubMed=20876107;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C75462; Angelman syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   WG1681

AC   CVCL_0D81

SY   WG 1681

RX   PubMed=7909321;

CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.

DI   NCIt; C98986; Methylmalonic acidemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   WGA

AC   CVCL_0578

DR   MCCL; MCC:0000484

RX   PubMed=15572372;

DI   NCIt; C3728; Hepatoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0027 ! Hep-G2

SX   Male

CA   Cancer cell line

//

ID   Wgd5

AC   CVCL_3808

DR   CLO; CLO_0009589

DR   CLDB; cl4698

DR   ATCC; CRL-1817

DR   ECACC; 95082908

CC   Discontinued: ECACC; 95082908; probable.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3433 ! WOP

CA   Transformed cell line

//

ID   WH

AC   CVCL_0C39

DR   Cosmic; 2057464

DR   Cosmic; 2444235

RX   PubMed=2296606;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Wh-Ir

AC   CVCL_S392

DR   ATCC; CRL-6562

CC   Group: Cetacean cell line.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6562; true.

OX   NCBI_TaxID=9770; ! Balaenoptera physalus

SX   Sex undetermined

CA   Finite cell line

//

ID   WH19-4

AC   CVCL_H783

RX   PubMed=1316607;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [U19tsa].

CC   Breed/subspecies: Wistar Kyoto.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   WH257GE10

AC   CVCL_4Z95

RX   PubMed=3905560;

DI   NCIt; C124251; Woodchuck hepatocellular carcinoma

OX   NCBI_TaxID=9995; ! Marmota monax

CA   Cancer cell line

//

ID   WH44KA

AC   CVCL_4Z96

RX   DOI=10.2957/kanzo.29.272;

RX   PubMed=2453497;

DI   NCIt; C124251; Woodchuck hepatocellular carcinoma

OX   NCBI_TaxID=9995; ! Marmota monax

CA   Cancer cell line

//

ID   WHN2

AC   CVCL_0G08

SY   WHN-2

RX   PubMed=8390425;

RX   PubMed=9738977;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WHO NP192

AC   CVCL_E872

SY   WHONP192

DR   dbMHC; 49062

DR   ECACC; 94082240

DR   IHW; IHW9140

DR   IMGT/HLA; 11683

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl140.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WHO NP199

AC   CVCL_E873

SY   WHONP199

DR   dbMHC; 49063

DR   ECACC; 94082233

DR   IHW; IHW9134

DR   IMGT/HLA; 11677

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl134.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WHO NP439

AC   CVCL_E874

SY   WHONP439

DR   dbMHC; 49064

DR   ECACC; 94082239

DR   IHW; IHW9139

DR   IMGT/HLA; 11682

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl139.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WI-1003

AC   CVCL_4557

SY   WI 1003

DR   CLO; CLO_0009590

DR   CLO; CLO_0009592

DR   CLDB; cl4699

DR   CLDB; cl4700

DR   ATCC; CCL-154

DR   IZSLER; BS CL 108

RX   PubMed=7065527;

RX   PubMed=14315085;

CC   Discontinued: ATCC; CCL-154; true.

CC   Discontinued: IZSLER; BS CL 108; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WI-25

AC   CVCL_V827

SY   WI 25

RX   PubMed=13905658;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WI-26

AC   CVCL_V826

SY   WI 26

DR   ATCC; CCL-95

DR   BioSample; SAMN03471292

RX   PubMed=7065527;

RX   PubMed=14315085;

CC   Discontinued: ATCC; CCL-95; true.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 9,11

ST   D5S818: 11,12

ST   D7S820: 10,13

ST   TH01: 6,7

ST   TPOX: 10,11

ST   vWA: 17,20

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   WI-26 VA4

AC   CVCL_2758

SY   WI 26 VA4; WI 26 VA 4; WI-26; WI26 VA4; VA-4

DR   BTO; BTO:0003482

DR   CLO; CLO_0009593

DR   CLDB; cl4701

DR   CLDB; cl4702

DR   ATCC; CCL-95.1

DR   ECACC; 89101301

DR   GEO; GSM827466

DR   IZSLER; BS CL 89

DR   JCRB; JCRB9042

DR   KCLB; 10095.1

RX   DOI=10.1002/jcp.1030650110;

RX   PubMed=7065527;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): ATCC; JCRB; KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 9,11

ST   D3S1358: 14,16

ST   D5S818: 11,12

ST   D7S820: 10,13

ST   FGA: 25

ST   TH01: 6,7

ST   TPOX: 10,11

ST   vWA: 17,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_V826 ! WI-26

SX   Male

CA   Transformed cell line

//

ID   WI-38

AC   CVCL_0579

SY   WI 38; WI38; Wistar Institute-38; AG06814-J; AG06814-M; AG06814-N

DR   BTO; BTO:0000458

DR   CLO; CLO_0009591

DR   CLO; CLO_0009594

DR   CLO; CLO_0035526

DR   CLO; CLO_0035534

DR   EFO; EFO_0001260

DR   MCCL; MCC:0000485

DR   CLDB; cl4703

DR   CLDB; cl4704

DR   CLDB; cl4705

DR   ATCC; CCL-75

DR   ATCC; CRL-7728

DR   BioSample; SAMN01821606

DR   BioSample; SAMN01821721

DR   BioSample; SAMN03471285

DR   CCRID; 3111C0001CCC000210

DR   CCRID; 3111C0002000000067

DR   CCRID; 3131C0001000200008

DR   CCRID; 3142C0001000000016

DR   ChEMBL-Cells; CHEMBL3307614

DR   ChEMBL-Targets; CHEMBL614391

DR   Coriell; AG06814-J

DR   Coriell; AG06814-M

DR   Coriell; AG06814-N

DR   ECACC; 90020107

DR   GEO; GSM827323

DR   IFO; IFO50075

DR   IGRhCellID; WI38

DR   IZSLER; BS CL 90

DR   JCRB; JCRB9017

DR   KCB; KCB 200556YJ

DR   KCLB; 10075

DR   Lonza; 495

DR   RCB; RCB0702

DR   RCB; RCB0704

DR   TKG; TKG 0360

DR   Wikidata; Q7950532

RX   DOI=10.1038/498407a;

RX   DOI=10.1038/498422a;

RX   PubMed=4203458;

RX   PubMed=5834207;

RX   PubMed=7065527;

RX   PubMed=14315085;

RX   PubMed=22984048;

RX   PubMed=25903999;

WW   https://en.wikipedia.org/wiki/WI-38

WW   http://ascb.org/the-story-of-wi-38-the-other-famous-cell-line/

WW   http://www.bioedge.org/index.php/bioethics/bioethics_article/10637

CC   Group: Vaccine production cell line.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Biotechnology: Used for the production of RA27/3 - the first rubella virus vaccine.

CC   Biotechnology: Used for the production of live oral adenovirus type 4 and type 7 vaccine.

CC   Characteristics: Life expectancy of 50 +- 10 population doublings.

CC   Doubling time: ~24 hours (ECACC).

CC   Discontinued: ATCC; CRL-7728; true.

CC   Discontinued: JCRB; JCRB9017; true.

CC   Discontinued: KCLB; 10075; probable.

ST   Source(s): ATCC; ECACC; JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 10

ST   D7S820: 9,11

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 19,20

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WI-38 CT-1

AC   CVCL_L281

SY   CT-1

RX   PubMed=7418975;

CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0579 ! WI-38

SX   Female

CA   Transformed cell line

//

ID   WI-38 KTr

AC   CVCL_5605

DR   CLO; CLO_0009596

DR   CLDB; cl4710

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0579 ! WI-38

SX   Female

CA   Finite cell line

//

ID   WI-38 VA13 subline 2RA

AC   CVCL_2759

SY   WI 38 VA13 subline 2RA; WI 38 VA-13 subline 2RA; WI 38VA13 subline 2RA; WI-38 VA13 sub 2 RA; WI38-VA13 subline 2RA; WI38 VA13/2RA; WI-38 VA13; WI 38 VA 13; WI38/VA13; WI38VA13; VA-13; VA13; AG07217; AG7217

DR   BTO; BTO:0003066

DR   CLO; CLO_0009597

DR   CLO; CLO_0009598

DR   CLO; CLO_0009599

DR   CLO; CLO_0035575

DR   CLO; CLO_0050044

DR   CLDB; cl4711

DR   CLDB; cl4712

DR   CLDB; cl4713

DR   CLDB; cl4714

DR   ATCC; CCL-75.1

DR   BCRC; 60504

DR   BioSample; SAMN03471286

DR   CCRID; 3111C0001CCC000390

DR   CCRID; 3142C0001000000095

DR   ChEMBL-Cells; CHEMBL3308010

DR   ChEMBL-Targets; CHEMBL612807

DR   CLS; 300421/p574_Wi-38_VA-13_2RA

DR   Coriell; AG07217

DR   ECACC; 85062512

DR   GEO; GSM784286

DR   IZSLER; BS CL 91

DR   JCRB; JCRB9057

DR   KCLB; 10075.1

DR   RCB; RCB0251

DR   TOKU-E; 3451

RX   PubMed=3413074;

RX   PubMed=4290661;

RX   PubMed=7065527;

RX   PubMed=9175740;

RX   PubMed=24116068;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): ATCC; CLS; JCRB; KCLB; PubMed=24116068; RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 16,18

ST   D19S433: 13,16.2

ST   D21S11: 30,30.2

ST   D2S1338: 19,25

ST   D3S1358: 16,17

ST   D5S818: 10

ST   D7S820: 9,11

ST   D8S1179: 14

ST   FGA: 22,24

ST   Penta D: 13

ST   Penta E: 13,14

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 19,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0579 ! WI-38

SX   Female

CA   Transformed cell line

//

ID   WI-38-30

AC   CVCL_2812

SY   WI 38-30; WI-38 PDL 30

DR   JCRB; JCRB0517

CC   Discontinued: JCRB; JCRB0517; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0579 ! WI-38

SX   Female

CA   Finite cell line

//

ID   WI-38-40

AC   CVCL_2813

SY   WI 38-40; WI-38 PDL 40

DR   JCRB; JCRB0518

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0579 ! WI-38

SX   Female

CA   Finite cell line

//

ID   WI-38/hTERT/GFP-RAF-ER

AC   CVCL_N806

DR   ENCODE; ENCBS070MZP

DR   ENCODE; ENCBS157XHV

DR   ENCODE; ENCBS601ENJ

DR   ENCODE; ENCBS606ENC

DR   ENCODE; ENCBS607ENC

DR   ENCODE; ENCBS608ENC

DR   ENCODE; ENCBS715PYA

DR   ENCODE; ENCBS787LHJ

DR   GEO; GSM651580

DR   GEO; GSM651581

DR   GEO; GSM651582

DR   GEO; GSM651583

DR   GEO; GSM945215

DR   GEO; GSM945223

DR   GEO; GSM945245

DR   GEO; GSM945265

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/WI38_Stam_protocol.pdf

CC   Part of: ENCODE project common cell types; tier 3.

CC   Characteristics: Transfected with a construct that is composed of EGFP at the N-terminus, the catalytic domain of RAF1 (with 340-DD-341) in the middle and the hormone-binding domain of ESR1 at the C-terminus. Protein kinase activity is activated by estrogen or analogs such as 4-hydroxy-tamoxifen.

CC   Characteristics: Cells can be senesced after exposure for 72 hours with 4-hydroxy-tamoxifen.

CC   Transfected with: HGNC; 9829; RAF1 (catalytic domain with D-340 and D-341).

CC   Transfected with: HGNC; 3467; ESR1 (hormone-binding domain).

CC   Transfected with: HGNC; 11730; TERT.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0579 ! WI-38

SX   Female

CA   Telomerase immortalized cell line

//

ID   WI-L2-729HF2

AC   CVCL_6741

SY   WI-L2-729-HF2; WI-L2-729 HF2

DR   CLO; CLO_0009603

DR   ATCC; CRL-8062

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ATCC; CRL-8062; probable.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 17,20

DI   NCIt; C97074; Hereditary spherocytosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6544 ! WIL2

SX   Male

CA   Transformed cell line

//

ID   WI-MN-1

AC   CVCL_F811

DR   CLO; CLO_0009607

DR   ATCC; HB-8672

RX   Patent=US5654408;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   WIBR1

AC   CVCL_9765

SY   WIBR 1; WIBRe003-A

DR   BioSamples; SAMEA185109

DR   GEO; GSM523596

DR   GEO; GSM523597

DR   GEO; GSM529408

DR   GEO; GSM529411

DR   GEO; GSM529414

DR   GEO; GSM529417

DR   hPSCreg; WIBRe003-A

DR   ISCR; 1424

RX   PubMed=20471072;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=417

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0074.

CC   Omics: H3K27me3 ChIP-seq epigenome analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WIBR2

AC   CVCL_9766

SY   WIBR 2; WIBRe002-A

DR   BioSamples; SAMEA2660497

DR   GEO; GSM523598

DR   GEO; GSM523599

DR   GEO; GSM529409

DR   GEO; GSM529412

DR   GEO; GSM529415

DR   GEO; GSM529418

DR   hPSCreg; WIBRe002-A

DR   ISCR; 1425

RX   PubMed=20471072;

RX   PubMed=25090446;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=418

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0075.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-58.

CC   Omics: H3K27me3 ChIP-seq epigenome analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WIBR3

AC   CVCL_9767

SY   WIBR 3; WIBR38; WIBRe001-A

DR   BioSample; SAMN00010935

DR   GEO; GSM523600

DR   GEO; GSM523601

DR   GEO; GSM529410

DR   GEO; GSM529413

DR   GEO; GSM529416

DR   GEO; GSM529419

DR   hPSCreg; WIBRe001-A

DR   ISCR; 1426

RX   PubMed=20471072;

RX   PubMed=25090446;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=419

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0079.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-58.

CC   Omics: H3K27me3 ChIP-seq epigenome analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WIBR3 Oct4-2A-GFP

AC   CVCL_IU05

SY   WIBRe001-A-2

DR   BioSamples; SAMEA103887531

DR   hPSCreg; WIBRe001-A-2

RX   PubMed=25090446;

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9767 ! WIBR3

SX   Female

CA   Embryonic stem cell

//

ID   WIBR3 Oct4-deltaPE-GFP

AC   CVCL_IU04

SY   WIBRe001-A-1

DR   BioSamples; SAMEA103887532

DR   hPSCreg; WIBRe001-A-1

RX   PubMed=25090446;

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9767 ! WIBR3

SX   Female

CA   Embryonic stem cell

//

ID   WIBR4

AC   CVCL_9768

SY   WIBR 4

DR   ISCR; 1427

RX   PubMed=20471072;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=432

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0080.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WIBR5

AC   CVCL_9769

SY   WIBR 5

DR   ISCR; 1428

RX   PubMed=20471072;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=433

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0081.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   WIBR6

AC   CVCL_9770

SY   WIBR 6

DR   ISCR; 1429

RX   PubMed=20471072;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=434

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0082.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WIC04i-127-33

AC   CVCL_EJ72

SY   iPS-R306C-WT

RX   PubMed=21074045;

RX   PubMed=21966470;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WIC04i-127-33.cmsx

DI   NCIt; C75488; Rett syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F181 ! GM11270

SX   Female

CA   Induced pluripotent stem cell

//

ID   WIC05i-127-325

AC   CVCL_EJ73

SY   iPS-R306C-MT

RX   PubMed=21074045;

RX   PubMed=21966470;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WIC05i-127-325.cmsx

DI   NCIt; C75488; Rett syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F181 ! GM11270

SX   Female

CA   Induced pluripotent stem cell

//

ID   WIC06i-07982-2

AC   CVCL_EJ74

SY   iPS-V247X-WT

RX   PubMed=21966470;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WIC06i-07982-2.cmsx

DI   NCIt; C75488; Rett syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_V341 ! GM07982

SX   Female

CA   Induced pluripotent stem cell

//

ID   WIC07i-07982-4

AC   CVCL_EJ75

SY   iPS-V247X-MT

RX   PubMed=21966470;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WIC07i-07982-4.cmsx

DI   NCIt; C75488; Rett syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_V341 ! GM07982

SX   Female

CA   Induced pluripotent stem cell

//

ID   WiDr

AC   CVCL_2760

SY   WiDR; WIDR; WiDr-TC; WiDrTC; LED-WiDr; Led-WiDr

DR   BTO; BTO:0001483

DR   CLO; CLO_0009600

DR   EFO; EFO_0002389

DR   CLDB; cl4715

DR   CLDB; cl4988

DR   ATCC; CCL-218

DR   BCRC; 60157

DR   BioSample; SAMN03151797

DR   ChEMBL-Cells; CHEMBL3307674

DR   ChEMBL-Targets; CHEMBL614647

DR   CLS; 300377/p484_WiDr

DR   Cosmic; 738928

DR   Cosmic; 887216

DR   Cosmic; 897740

DR   Cosmic; 905002

DR   Cosmic; 1066213

DR   Cosmic; 1122336

DR   Cosmic; 1132695

DR   Cosmic; 1184091

DR   Cosmic; 1187326

DR   Cosmic; 1218881

DR   Cosmic; 1466826

DR   Cosmic; 1479615

DR   Cosmic; 1609498

DR   Cosmic; 1676736

DR   ECACC; 85111501

DR   GEO; GSM784020

DR   GEO; GSM827327

DR   GEO; GSM1374987

DR   GEO; GSM1374988

DR   GEO; GSM1448091

DR   ICLC; HTL00003

DR   IFO; IFO50043

DR   IGRhCellID; WIDR

DR   JCRB; JCRB0224

DR   KCLB; 10218

DR   LINCS; 50049

DR   RCB; RCB1908

DR   TKG; TKG 0513

DR   TKG; TKG 0516

RX   PubMed=90012;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=1389533;

RX   PubMed=3472642;

RX   PubMed=4203458;

RX   PubMed=9290701;

RX   PubMed=10674020;

RX   PubMed=11414198;

RX   PubMed=20143388;

RX   PubMed=24042735;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=26537799;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=3472642, PubMed=20143388).

CC   Doubling time: 15 hours (PubMed=90012).

CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=24042735; PubMed=25926053).

CC   Omics: Deep glycome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: RCB; RCB1908; true.

ST   Source(s): ATCC; CLS; ECACC; JCRB; KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12 (ATCC; ECACC; KCLB)

ST   D13S317: 11 (CLS; JCRB)

ST   D16S539: 11,12

ST   D18S51: 13

ST   D21S11: 29,30

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 10

ST   FGA: 20,22

ST   Penta D: 11,13

ST   Penta E: 14,16

ST   TH01: 6,9 (ATCC; ECACC; JCRB; KCLB)

ST   TH01: 6 (CLS)

ST   TPOX: 8,9

ST   vWA: 17,19

DI   NCIt; C43584; Rectosigmoid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0320 ! HT-29

SX   Female

CA   Cancer cell line

//

ID   WiDr/R

AC   CVCL_2N03

RX   CelloPub=CLPUB00271;

RX   PubMed=2894893;

CC   Problematic cell line: Contaminated. The parent cell line (WiDr) had been shown to be a HT-29 derivative.

CC   Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.

DI   NCIt; C43584; Rectosigmoid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2760 ! WiDr

SX   Female

CA   Cancer cell line

//

ID   Wien 133

AC   CVCL_6958

SY   WIEN 133; Wien-133; Wien133; WIEN133; W133

DR   CCRID; 3111C0002000000061

DR   Cosmic; 2297026

DR   GEO; GSM115810

RX   PubMed=3496952;

RX   PubMed=7849311;

RX   PubMed=16960149;

CC   Characteristics: EBV-negative.

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WIF-B

AC   CVCL_A050

DR   BTO; BTO:0005889

RX   PubMed=7506266;

RX   PubMed=8056838;

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_A051 ! WIF12-1

CA   Hybrid cell line

//

ID   WIF12-1

AC   CVCL_A051

RX   PubMed=1955480;

RX   PubMed=8056838;

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0269 ! Fao

HI   CVCL_0579 ! WI-38

CA   Hybrid cell line

//

ID   WIL,M

AC   CVCL_E875

SY   WIL, M

DR   dbMHC; 49065

DR   ECACC; 94082213

DR   IHW; IHW9114

DR   IMGT/HLA; 11659

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl114.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WIL1

AC   CVCL_6747

SY   WIL-1; WI-L1

RX   PubMed=4323138;

RX   PubMed=5673231;

DI   NCIt; C9265; Mycosis fungoides and Sezary syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WIL2

AC   CVCL_6544

SY   WIL-2; WI-L2

DR   BTO; BTO:0001523

DR   ChEMBL-Cells; CHEMBL3307818

DR   ChEMBL-Cells; CHEMBL3308011

DR   ChEMBL-Cells; CHEMBL3308575

DR   ChEMBL-Targets; CHEMBL612809

DR   ChEMBL-Targets; CHEMBL613549

DR   ChEMBL-Targets; CHEMBL614862

RX   PubMed=4323138;

RX   PubMed=5673231;

RX   PubMed=6600440;

RX   PubMed=8316623;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Misspelling: 'W1-L2' in ChEMBL CHEMBL613549 and CHEMBL3307818.

CC   Misspelling: 'WI-L' in ChEMBL CHEMBL614862 and CHEMBL3308575.

DI   NCIt; C97074; Hereditary spherocytosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WIL2 NS

AC   CVCL_2761

SY   WIL2-NS; WIL-2NS; WIL-2-NS; WI-L2 NS

DR   BTO; BTO:0001524

DR   CLO; CLO_0009601

DR   CLO; CLO_0009604

DR   CLDB; cl4717

DR   ATCC; CRL-8155

DR   BioSample; SAMN03471196

DR   BioSample; SAMN03472416

DR   ChEMBL-Cells; CHEMBL3308012

DR   ChEMBL-Targets; CHEMBL612810

DR   Cosmic-CLP; 1331049

DR   ECACC; 90112121

DR   GDSC; 1331049

DR   GEO; GSM827461

DR   GEO; GSM1670575

DR   IMGT/HLA; 11561

DR   JCRB; JCRB9063

DR   RCB; RCB2285

RX   Patent=US4806476;

RX   PubMed=27397505;

CC   Group: Hybridoma fusion partner cell line.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: RCB; RCB2285; true.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 9,12

ST   TH01: 8,9.3 (ATCC; Cosmic-CLP; ECACC; RCB)

ST   TH01: 8,10 (JCRB)

ST   TPOX: 8,11

ST   vWA: 17,20

DI   NCIt; C97074; Hereditary spherocytosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6544 ! WIL2

SX   Male

CA   Transformed cell line

//

ID   WIL2 S

AC   CVCL_3809

SY   WIL2-S; WIL2S

DR   BTO; BTO:0001525

DR   CLO; CLO_0009605

DR   ATCC; CRL-8885

DR   CCRID; 3111C0002000000032

DR   Lonza; 966

RX   Patent=US4806476;

WW   http://www.addexbio.com/productdetail?pid=4890

CC   Group: Hybridoma fusion partner cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   F13A01: 6,7

ST   F13B: 10

ST   FESFPS: 11,12

ST   LPL: 9,10

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 17,20

DI   NCIt; C97074; Hereditary spherocytosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6544 ! WIL2

SX   Male

CA   Transformed cell line

//

ID   WIL2.NS.6TG

AC   CVCL_2762

SY   Wil2.NS.6TG

DR   CLO; CLO_0009602

DR   CLDB; cl4718

DR   ECACC; 93031001

DR   NCBI_Iran; C148

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C97074; Hereditary spherocytosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2761 ! WIL2 NS

SX   Male

CA   Transformed cell line

//

ID   WIL2:RD1694

AC   CVCL_Y425

RX   PubMed=7537518;

CC   Selected for resistance to: ChEBI; CHEBI:5847; ICI D1694 (Tomudex; ZD1694).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C97074; Hereditary spherocytosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6544 ! WIL2

SX   Male

CA   Transformed cell line

//

ID   WILCL

AC   CVCL_2763

DR   CLO; CLO_0009606

DR   CLDB; cl4719

DR   ECACC; 89120565

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E340 ! LUDLU-23

CA   Transformed cell line

//

ID   WILF 7C11

AC   CVCL_9Q57

SY   WILF-7C11; WILF7C11

RX   PubMed=2542153;

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0F71 ! MB63

CA   Hybrid cell line

//

ID   WILF 7C9

AC   CVCL_9Q58

SY   WILF7C9

DR   ATCC; CRL-2790

RX   PubMed=2542153;

CC   Discontinued: ATCC; CRL-2790; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0F71 ! MB63

CA   Hybrid cell line

//

ID   WILL-1

AC   CVCL_1900

SY   WILL1

DR   BioSample; SAMN03473464

DR   DSMZ; ACC-651

DR   GEO; GSM1374989

RX   PubMed=18972186;

CC   Doubling time: ~30-50 hours, but 50-70 hours after recovery from liquid nitrogen freezing (DSMZ).

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 9,11

ST   D16S539: 9,11

ST   D5S818: 10

ST   D7S820: 11,12

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WILL-2

AC   CVCL_1901

SY   WILL2

DR   BioSample; SAMN03473465

DR   DSMZ; ACC-652

DR   GEO; GSM1374990

RX   PubMed=19330555;

CC   Doubling time: ~36-48 hours (DSMZ).

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,9

ST   D16S539: 9,13

ST   D5S818: 9,12

ST   D7S820: 10,11

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WILTU-1

AC   CVCL_B481

SY   Wiltu-1; WIL-TU-1; WILTU1

DR   ATCC; HTB-50

RX   PubMed=833871;

RX   PubMed=6244232;

CC   Discontinued: ATCC; HTB-50; probable.

DI   NCIt; C40407; Renal Wilms tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WIN

AC   CVCL_E876

DR   dbMHC; 49066

DR   ECACC; 94092814

DR   IHW; IHW9095

DR   IMGT/HLA; 11565

WW   http://bioinformatics.hsanmartino.it/ecbr/cl95.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Win Mec

AC   CVCL_3277

DR   CLO; CLO_0009608

DR   ATCC; CRL-1172

RX   PubMed=225015;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WIN-1

AC   CVCL_Y311

SY   WIN1; Whitehead Institute Naive-1

RX   PubMed=25090446;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=713

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0299.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   WIN-2

AC   CVCL_Y312

SY   WIN2; Whitehead Institute Naive-2

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=768

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0300.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WIN-3

AC   CVCL_Y313

SY   WIN3; Whitehead Institute Naive-3

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=769

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0301.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WIN-4

AC   CVCL_Y314

SY   WIN4; Whitehead Institute Naive-4

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=770

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0302.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WIN-5

AC   CVCL_Y315

SY   WIN5; Whitehead Institute Naive-5

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=771

CC   From: Whitehead Institute for Biomedical Research; Boston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0303.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   WISH

AC   CVCL_1909

SY   Wistar Institute, Susan Hayflick

DR   BTO; BTO:0000069

DR   CLO; CLO_0009609

DR   CLDB; cl4720

DR   CLDB; cl4721

DR   CLDB; cl4723

DR   CLDB; cl4724

DR   ATCC; CCL-25

DR   ATCC; CRL-7727

DR   BioSample; SAMN03151764

DR   CCRID; 3111C0001CCC000088

DR   CCRID; 3131C0001000200011

DR   CCRID; 3142C0001000000040

DR   ChEMBL-Cells; CHEMBL3308013

DR   ChEMBL-Targets; CHEMBL612811

DR   ECACC; 88102403

DR   IFO; IFO50004

DR   IZSLER; BS CL 92

DR   KCLB; 10025

DR   Lonza; 1163

RX   CelloPub=CLPUB00262;

RX   DOI=10.1007/978-1-4757-1647-4_13;

RX   PubMed=566722;

RX   PubMed=1246601;

RX   PubMed=6451928;

RX   PubMed=13712490;

RX   PubMed=20143388;

RX   PubMed=23925245;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=WISH

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722, PubMed=1246601, PubMed=6451928, PubMed=20143388). Originally thought to originate from cells of the amniotic sac of Susan Hayflick, the daughter of Leonard Hayflick.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Omics: Genome sequenced (low read coverage).

CC   Discontinued: ATCC; CRL-7727; true.

ST   Source(s): ATCC; JCRB; KCLB

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 13.3 (ATCC; JCRB; KCLB)

ST   D13S317: 14 (ECACC)

ST   D16S539: 9,10

ST   D3S1358: 15,18

ST   D5S818: 11,12

ST   D7S820: 8,12 (ATCC; JCRB; KCLB)

ST   D7S820: 12 (ECACC)

ST   FGA: 21

ST   TH01: 7

ST   TPOX: 8,12

ST   vWA: 16,18

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   WISH-PC2

AC   CVCL_4907

SY   Weizmann Institute Sheba Hospital - Prostate Cancer 2

RX   PubMed=11118033;

WW   http://capcelllines.ca/details.asp?id=109

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WISi005-A

AC   CVCL_IU02

DR   BioSamples; SAMEA103992707

DR   hPSCreg; WISi005-A

CC   From: Weizmann Institute of Science; Rehovot; Israel.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   WISi006-A

AC   CVCL_IU03

SY   FX1 iPSC

DR   BioSamples; SAMEA103992705

DR   hPSCreg; WISi006-A

CC   From: Weizmann Institute of Science; Rehovot; Israel.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   WiT49

AC   CVCL_0583

SY   WiT 49

DR   MCCL; MCC:0000489

DR   Cosmic; 1196557

RX   PubMed=14506735;

RX   PubMed=19824073;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/w/cell-lines-detail-622.html

DI   NCIt; C40407; Renal Wilms tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Wittier

AC   CVCL_M734

RX   PubMed=7680730;

DI   NCIt; C3844; Gallbladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WIV-BS-02

AC   CVCL_Z703

RX   DOI=10.13242/j.cnki.bingduxuebao.000368;

CC   Group: Insect cell line.

OX   NCBI_TaxID=1049282; ! Biston suppressaria

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WIV-BS-481

AC   CVCL_Z701

CC   Group: Insect cell line.

OX   NCBI_TaxID=1049282; ! Biston suppressaria

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WIV-BS-484

AC   CVCL_Z702

SY   BS-484; Bs-484

RX   CelloPub=CLPUB00201;

CC   Group: Insect cell line.

OX   NCBI_TaxID=1049282; ! Biston suppressaria

SX   Female

CA   Spontaneously immortalized cell line

//

ID   WJ1

AC   CVCL_W352

RX   PubMed=17703357;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WJR076

AC   CVCL_E877

DR   dbMHC; 49067

DR   ECACC; 88052012

DR   IHW; IHW9012

DR   IMGT/HLA; 11567

WW   http://bioinformatics.hsanmartino.it/ecbr/cl12.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WK

AC   CVCL_W800

DR   Cosmic; 706111

RX   PubMed=9692547;

RX   PubMed=10766161;

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WK-1

AC   CVCL_GR57

WW   http://license.umn.edu/technologies/z04191_avian-cell-lines-a-rapidly-growing-immortal-chicken-embryo-fibroblast-cell-line-wk-1

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Sex undetermined

CA   Undefined cell line type

//

ID   WK2

AC   CVCL_HF83

RX   PubMed=24627082;

CC   Doubling time: 32 hours (PubMed=24627082).

DI   NCIt; C8171; Lower gingival squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_HF84 ! WK3F

SX   Male

CA   Cancer cell line

//

ID   WK3F

AC   CVCL_HF84

RX   PubMed=24627082;

CC   Doubling time: 24 hours (PubMed=24627082).

CC   Derived from metastatic site: Cervical lymph node.

DI   NCIt; C8171; Lower gingival squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_HF83 ! WK2

SX   Male

CA   Cancer cell line

//

ID   WKD

AC   CVCL_2764

SY   Wong-Kilbourne Derivative; Wong-Kilbourne

DR   CLO; CLO_0009610

DR   CLDB; cl4725

DR   BioSample; SAMN03151765

DR   BioSample; SAMN03151766

DR   ECACC; 93120839

RX   PubMed=1246601;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   WKPT-0293 Cl.2

AC   CVCL_R947

RX   PubMed=8807581;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Wistar Kyoto.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R948 ! WKPT-0293 Cl.3

SX   Male

CA   Transformed cell line

//

ID   WKPT-0293 Cl.3

AC   CVCL_R948

RX   PubMed=8807581;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Wistar Kyoto.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R947 ! WKPT-0293 Cl.2

SX   Male

CA   Transformed cell line

//

ID   WKPT-1292 Cl.10

AC   CVCL_R949

RX   PubMed=8807581;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Wistar Kyoto.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R951 ! WKPT-1292 Cl.3

OI   CVCL_R952 ! WKPT-1292 Cl.4

OI   CVCL_R953 ! WKPT-1292 Cl.8

OI   CVCL_R950 ! WKPT-1292 Cl.16

SX   Male

CA   Transformed cell line

//

ID   WKPT-1292 Cl.16

AC   CVCL_R950

RX   PubMed=8807581;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Wistar Kyoto.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R951 ! WKPT-1292 Cl.3

OI   CVCL_R952 ! WKPT-1292 Cl.4

OI   CVCL_R953 ! WKPT-1292 Cl.8

OI   CVCL_R949 ! WKPT-1292 Cl.10

SX   Male

CA   Transformed cell line

//

ID   WKPT-1292 Cl.3

AC   CVCL_R951

RX   PubMed=8807581;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Wistar Kyoto.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R952 ! WKPT-1292 Cl.4

OI   CVCL_R953 ! WKPT-1292 Cl.8

OI   CVCL_R949 ! WKPT-1292 Cl.10

OI   CVCL_R950 ! WKPT-1292 Cl.16

SX   Male

CA   Transformed cell line

//

ID   WKPT-1292 Cl.4

AC   CVCL_R952

RX   PubMed=8807581;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Wistar Kyoto.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R951 ! WKPT-1292 Cl.3

OI   CVCL_R953 ! WKPT-1292 Cl.8

OI   CVCL_R949 ! WKPT-1292 Cl.10

OI   CVCL_R950 ! WKPT-1292 Cl.16

SX   Male

CA   Transformed cell line

//

ID   WKPT-1292 Cl.8

AC   CVCL_R953

RX   PubMed=8807581;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Wistar Kyoto.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R951 ! WKPT-1292 Cl.3

OI   CVCL_R952 ! WKPT-1292 Cl.4

OI   CVCL_R949 ! WKPT-1292 Cl.10

OI   CVCL_R950 ! WKPT-1292 Cl.16

SX   Male

CA   Transformed cell line

//

ID   WL-E

AC   CVCL_0C29

DR   Cosmic; 2239084

RX   PubMed=1311980;

RX   PubMed=7736387;

RX   PubMed=9559344;

RX   PubMed=9815546;

RX   PubMed=10037197;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WLC-3

AC   CVCL_5A04

RX   PubMed=2888713;

CC   Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).

OX   NCBI_TaxID=9995; ! Marmota monax

SX   Male

CA   Transformed cell line

//

ID   WLNA6

AC   CVCL_H618

RX   PubMed=6604917;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D039 ! UC 729-6

CA   Hybridoma

//

ID   WM 1043

AC   CVCL_4602

DR   CLO; CLO_0009611

DR   ATCC; CRL-6466

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6466; true.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   WM1 [Human Waldenstrom macroglobulinemia]

AC   CVCL_M088

RX   PubMed=6288575;

RX   PubMed=22950966;

DI   NCIt; C80307; Waldenstrom macroglobulinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WM1 [Mouse hybridoma]

AC   CVCL_J776

DR   ECACC; 92021211

DR   NCBI_Iran; H126

CC   Monoclonal antibody target: UniProtKB; P01024; Human C3.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   WM1-LCL-PI 13

AC   CVCL_9V71

DR   NCBI_Iran; C215

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C80307; Waldenstrom macroglobulinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WM1026

AC   CVCL_AP84

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51626

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 8,11

ST   D13S317: 9,11

ST   D16S539: 9,13

ST   D18S51: 13,16

ST   D19S433: 14

ST   D21S11: 28,31

ST   D2S1338: 18,25

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 12,14

ST   FGA: 21,22

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM115

AC   CVCL_0040

SY   WM-115; WM 115; WM115F; WM115-mel; WM115mel; WC00079

DR   BTO; BTO:0003075

DR   CLO; CLO_0009613

DR   EFO; EFO_0002390

DR   CLDB; cl4727

DR   CLDB; cl4728

DR   ATCC; CRL-1675

DR   CCLE; WM115_SKIN

DR   CGH-DB; 9323-4

DR   ChEMBL-Cells; CHEMBL3308813

DR   ChEMBL-Targets; CHEMBL1075611

DR   Coriell; WC00079

DR   Cosmic; 886835

DR   Cosmic; 888868

DR   Cosmic; 897480

DR   Cosmic; 905236

DR   Cosmic; 909784

DR   Cosmic; 932717

DR   Cosmic; 972277

DR   Cosmic; 1155268

DR   Cosmic; 1155547

DR   Cosmic; 1238102

DR   Cosmic; 1238104

DR   Cosmic-CLP; 909784

DR   ECACC; 91061232

DR   ESTDAB; ESTDAB-066

DR   GDSC; 909784

DR   GEO; GSM827472

DR   GEO; GSM887735

DR   GEO; GSM888830

DR   GEO; GSM1670576

DR   IGRhCellID; WM115

DR   IZSLER; BS TCL 74

DR   LINCS; 50567

RX   PubMed=3020539;

RX   PubMed=3856042;

RX   PubMed=15009714;

RX   PubMed=15467732;

RX   PubMed=18632627;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.proteinatlas.org/learn/cellines

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

WW   http://www.rockland-inc.com/Product.aspx?id=51634

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'WH115mel' in CGH-DB 9323-4.

CC   Discontinued: Coriell; WC00079; probable.

CC   Discontinued: ECACC; 91061232; probable.

ST   Source(s): ATCC; Cosmic-CLP; ESTDAB; Wistar

ST   Amelogenin: X

ST   CSF1PO: 12 (ATCC; Cosmic-CLP; ESTDAB)

ST   CSF1PO: 11,12 (Wistar)

ST   D13S317: 12,13

ST   D16S539: 11,12

ST   D18S51: 17

ST   D19S433: 13

ST   D21S11: 29

ST   D3S1358: 15,18

ST   D5S818: 13

ST   D7S820: 8

ST   D8S1179: 8,13

ST   FGA: 21,23

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L033 ! WM165-1

OI   CVCL_6795 ! WM239A

OI   CVCL_2765 ! WM266-4

SX   Female

CA   Cancer cell line

//

ID   WM1158

AC   CVCL_6785

SY   WM-1158; WM 1158; WC00046

DR   Coriell; WC00046

DR   Cosmic; 686407

DR   Cosmic; 888849

DR   Cosmic; 897486

DR   Cosmic; 928686

DR   Cosmic; 1155287

DR   Cosmic; 1507610

DR   Cosmic; 2233684

DR   GDSC; 1299077

DR   GEO; GSM185164

DR   GEO; GSM185165

RX   PubMed=15009714;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi

WW   http://www.rockland-inc.com/Product.aspx?id=51651

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00046; probable.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 9,12

ST   D16S539: 12,14

ST   D18S51: 12,13

ST   D19S433: 13,15

ST   D21S11: 31.2,33

ST   D2S1338: 22,25

ST   D3S1358: 17,18

ST   D5S818: 12

ST   D7S820: 9,13

ST   D8S1179: 10,15

ST   FGA: 21

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM1193C

AC   CVCL_C265

SY   WM-1193C; WM 1193C

DR   GEO; GSM185166

DR   GEO; GSM185167

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM122

AC   CVCL_DG74

SY   WM 122

DR   GEO; GSM186467

DR   GEO; GSM186468

DR   GEO; GSM188230

DR   GEO; GSM188260

DR   GEO; GSM188319

RX   PubMed=2068080;

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Misspelling: 'MW122' in PubMed=2068080, material and method.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WM1232

AC   CVCL_6786

SY   WM-1232; WM 1232; WC00084

DR   Coriell; WC00084

DR   Cosmic; 2233685

DR   GEO; GSM185168

DR   GEO; GSM185169

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51660

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00084; probable.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 14

ST   D19S433: 13,14

ST   D21S11: 28,29

ST   D2S1338: 20,25

ST   D3S1358: 18

ST   D5S818: 10,12

ST   D7S820: 11,12

ST   D8S1179: 13,14

ST   FGA: 23

ST   TH01: 7,9.3

ST   TPOX: 11,12

ST   vWA: 16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM1321

AC   CVCL_W887

SY   WM-1321

DR   Cosmic; 1155566

RX   PubMed=18632627;

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM1341B

AC   CVCL_A396

SY   WM-1341B; WM 1341B

DR   Cosmic; 1303062

RX   PubMed=2068080;

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6787 ! WM1341D

SX   Male

CA   Cancer cell line

//

ID   WM1341D

AC   CVCL_6787

SY   WM1341-D; WM-1341D; WM 1341D; WC00096

DR   Coriell; WC00096

DR   Cosmic; 1477407

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

WW   http://www.rockland-inc.com/Product.aspx?id=51691

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00096; probable.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 11

ST   D18S51: 14,15

ST   D19S433: 12,14

ST   D21S11: 31.2,32.2

ST   D2S1338: 16,18

ST   D3S1358: 15

ST   D5S818: 10

ST   D7S820: 9,11

ST   D8S1179: 12,14

ST   FGA: 19,22

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A396 ! WM1341B

SX   Male

CA   Cancer cell line

//

ID   WM1346

AC   CVCL_W886

SY   WM-1346; WM 1346; WC00121

DR   Coriell; WC00121

DR   Cosmic; 1155538

DR   GEO; GSM185170

DR   GEO; GSM185171

DR   GEO; GSM185172

DR   GEO; GSM185173

RX   PubMed=18632627;

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00121; probable.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM1361A

AC   CVCL_6788

SY   WM-1361A; WM 1361A; WC00075; EST69

DR   Coriell; WC00075

DR   Cosmic; 686402

DR   Cosmic; 1047649

DR   Cosmic; 1155284

DR   Cosmic; 1155540

DR   Cosmic; 1303063

DR   Cosmic; 1507599

DR   Cosmic; 1669263

DR   Cosmic; 2163799

DR   Cosmic; 2233686

DR   ESTDAB; ESTDAB-069

DR   GEO; GSM156022

DR   GEO; GSM185174

DR   GEO; GSM185175

DR   GEO; GSM185176

DR   GEO; GSM185177

DR   GEO; GSM952593

RX   PubMed=2068080;

RX   PubMed=17260012;

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

WW   http://www.rockland-inc.com/Product.aspx?id=51698

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Array-based CGH.

CC   Omics: Transcriptome analysis.

CC   Discontinued: Coriell; WC00075; probable.

ST   Source(s): ESTDAB; Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 14

ST   D19S433: 13,14

ST   D21S11: 30,31.2

ST   D2S1338: 25

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 12,13

ST   FGA: 22,25

ST   TH01: 7,8 (ESTDAB)

ST   TH01: 7 (Wistar)

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6993 ! WM1361B

OI   CVCL_6994 ! WM1361C

SX   Male

CA   Cancer cell line

//

ID   WM1361B

AC   CVCL_6993

SY   WM-1361B; WM 1361B

DR   Cosmic; 686403

DR   Cosmic; 1155555

RX   PubMed=18632627;

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Skin.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6788 ! WM1361A

OI   CVCL_6994 ! WM1361C

SX   Male

CA   Cancer cell line

//

ID   WM1361C

AC   CVCL_6994

SY   WM-1361C; WM 1361C

DR   Cosmic; 686404

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Skin.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6788 ! WM1361A

OI   CVCL_6993 ! WM1361B

SX   Male

CA   Cancer cell line

//

ID   WM1366

AC   CVCL_6789

SY   WM-1366; WM 1366; WC00078; EST70

DR   Coriell; WC00078

DR   Cosmic; 1047650

DR   Cosmic; 1155539

DR   Cosmic; 1665010

DR   Cosmic; 2163800

DR   ESTDAB; ESTDAB-070

DR   GEO; GSM185178

DR   GEO; GSM185179

DR   GEO; GSM185180

DR   GEO; GSM185181

DR   GEO; GSM188064

DR   GEO; GSM188116

DR   GEO; GSM188189

DR   GEO; GSM188204

DR   GEO; GSM188217

DR   GEO; GSM188231

DR   GEO; GSM188261

DR   GEO; GSM188280

DR   GEO; GSM188289

DR   GEO; GSM188320

DR   GEO; GSM952594

DR   SKY/M-FISH/CGH; 4947

RX   PubMed=17260012;

RX   PubMed=18632627;

RX   PubMed=28196595;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51722

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Array-based CGH.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'Wn1366' in Cosmic 1665010.

CC   Discontinued: Coriell; WC00078; probable.

ST   Source(s): ESTDAB; Wistar

ST   Amelogenin: X

ST   CSF1PO: 12 (ESTDAB)

ST   CSF1PO: 11,12 (Wistar)

ST   D13S317: 8,13

ST   D16S539: 12,13

ST   D18S51: 12,16

ST   D19S433: 14,15

ST   D21S11: 28,30

ST   D2S1338: 20,22

ST   D3S1358: 15,18

ST   D5S818: 13 (ESTDAB)

ST   D5S818: 12,13 (Wistar)

ST   D7S820: 12 (ESTDAB)

ST   D7S820: 11,12 (Wistar)

ST   D8S1179: 13,14

ST   FGA: 21,22

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM1382

AC   CVCL_6790

SY   WM-1382; WM 1382; WC00055

DR   Coriell; WC00055

DR   Cosmic; 1155542

DR   Cosmic; 1669264

RX   PubMed=18632627;

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00055; probable.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM139

AC   CVCL_C266

SY   WM-139; WM 139; EST71

DR   Cosmic; 1047651

DR   Cosmic; 2163801

DR   ESTDAB; ESTDAB-071

DR   GEO; GSM156024

RX   PubMed=17260012;

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Array-based CGH.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9

ST   D3S1358: 14,17

ST   D5S818: 9,11

ST   D7S820: 9,11

ST   FGA: 20,25

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM1552C

AC   CVCL_6472

SY   WM-1552C; WM 1552C; WM-1552; WM1552; EST73

DR   CLO; CLO_0009614

DR   ATCC; CRL-2808

DR   BioSample; SAMN03471792

DR   Cosmic; 886833

DR   Cosmic; 1047652

DR   Cosmic; 1303064

DR   Cosmic; 1995664

DR   Cosmic; 2159426

DR   Cosmic; 2163802

DR   Cosmic-CLP; 1299078

DR   ESTDAB; ESTDAB-073

DR   GDSC; 1299078

DR   GEO; GSM156020

DR   GEO; GSM186469

DR   GEO; GSM186470

DR   GEO; GSM555186

DR   GEO; GSM952582

DR   GEO; GSM1670577

DR   LINCS; 50568

RX   PubMed=17260012;

RX   PubMed=27397505;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50673

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: ATCC; CRL-2808; true.

ST   Source(s): ATCC; Cosmic-CLP; ESTDAB; Wistar

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12,14 (ATCC)

ST   D13S317: 12 (Cosmic-CLP; ESTDAB; Wistar)

ST   D16S539: 9,11

ST   D18S51: 15

ST   D19S433: 14

ST   D21S11: 30

ST   D2S1338: 24,25

ST   D3S1358: 14

ST   D5S818: 12

ST   D7S820: 10,11,12 (ATCC)

ST   D7S820: 10,12 (Cosmic-CLP; ESTDAB; Wistar)

ST   D8S1179: 11,12

ST   FGA: 22

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM1575

AC   CVCL_L027

SY   WM-1575; WM 1575

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM1617

AC   CVCL_6791

SY   WM-1617; WM 1617; WC00076

DR   Coriell; WC00076

DR   Cosmic; 686409

DR   GEO; GSM952583

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00076; probable.

CC   Derived from metastatic site: Right axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6473 ! WM278

SX   Female

CA   Cancer cell line

//

ID   WM164

AC   CVCL_7928

SY   WM-164; WM 164

DR   Cosmic; 888857

DR   Cosmic; 897481

DR   Cosmic; 928684

DR   Cosmic; 1155550

DR   Cosmic; 1187586

DR   Cosmic; 1303065

DR   GEO; GSM186471

DR   GEO; GSM186472

DR   GEO; GSM952584

DR   PRIDE; PXD004343

RX   PubMed=2156614;

RX   PubMed=2918552;

RX   PubMed=8342600;

RX   PubMed=15009714;

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi

WW   http://www.rockland-inc.com/Product.aspx?id=50688

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Deep proteome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 13

ST   D18S51: 12,21

ST   D19S433: 13

ST   D21S11: 28,31.2

ST   D2S1338: 19

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 13,14

ST   FGA: 20

ST   TH01: 9

ST   TPOX: 8,10

ST   vWA: 14,15

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM165-1

AC   CVCL_L033

SY   WM-165-1; WM 165-1

RX   PubMed=3856042;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50693

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 15,17

ST   D19S433: 13

ST   D21S11: 29

ST   D2S1338: 19

ST   D3S1358: 15,18

ST   D5S818: 13

ST   D7S820: 8

ST   D8S1179: 13,15

ST   FGA: 21,23

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0040 ! WM115

OI   CVCL_6795 ! WM239A

OI   CVCL_2765 ! WM266-4

SX   Female

CA   Cancer cell line

//

ID   WM1650

AC   CVCL_D555

SY   WM-1650; WM 1650

DR   ATCC; CRL-2810

RX   PubMed=2068080;

RX   PubMed=8342600;

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: ATCC; CRL-2810; true.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM1716

AC   CVCL_AP82

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50715

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 12,13

ST   D18S51: 14

ST   D19S433: 13,13.2

ST   D21S11: 31,32

ST   D2S1338: 19,24

ST   D3S1358: 16

ST   D5S818: 10

ST   D7S820: 10,11

ST   D8S1179: 13,15

ST   FGA: 22

ST   TH01: 7

ST   TPOX: 8,12

ST   vWA: 18,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM1727A

AC   CVCL_A339

SY   WM-1727A; WM 1727A

DR   Cosmic; 1155559

DR   Cosmic; 1303066

DR   GEO; GSM186473

DR   GEO; GSM186474

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50723

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D18S51: 14

ST   D19S433: 14

ST   D21S11: 28,33.2

ST   D2S1338: 20,23

ST   D3S1358: 16,18

ST   D5S818: 11,12

ST   D7S820: 11,13

ST   D8S1179: 13,14

ST   FGA: 22

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM1789

AC   CVCL_6792

SY   WM-1789; WM 1789; WC00080

DR   Coriell; WC00080

DR   Cosmic; 686395

DR   Cosmic; 1477416

DR   GEO; GSM186475

DR   GEO; GSM186476

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51724

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00080; probable.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D16S539: 11,13

ST   D21S11: 29,30

ST   D5S818: 9,13

ST   D7S820: 8,9

ST   TH01: 7

ST   TPOX: 10,11

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM1791A

AC   CVCL_C267

SY   WM-1791A; WM 1791A; WM 1791-A; EST74

DR   Cosmic; 1047653

DR   ESTDAB; ESTDAB-074

DR   GEO; GSM156013

RX   PubMed=17260012;

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Array-based CGH.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,12

ST   D3S1358: 16,17

ST   D5S818: 10,11

ST   D7S820: 10

ST   FGA: 19,22

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6793 ! WM1791C

SX   Male

CA   Cancer cell line

//

ID   WM1791C

AC   CVCL_6793

SY   WM-1791C; WM 1791C; WM 1791-C; WC00086

DR   Coriell; WC00086

DR   GEO; GSM952585

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51737

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00086; probable.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 8,12

ST   D16S539: 11,13

ST   D18S51: 17

ST   D19S433: 12,16.2

ST   D21S11: 30

ST   D2S1338: 17,25

ST   D3S1358: 16,17

ST   D5S818: 10,11

ST   D7S820: 10

ST   D8S1179: 13,14

ST   FGA: 19,22

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C267 ! WM1791A

SX   Male

CA   Cancer cell line

//

ID   WM1799

AC   CVCL_A341

SY   WM-1799; WM 1799

DR   CCLE; WM1799_SKIN

DR   Cosmic; 888851

DR   Cosmic; 1155560

DR   Cosmic; 1303067

DR   GEO; GSM186477

DR   GEO; GSM186478

DR   GEO; GSM887736

DR   GEO; GSM888831

RX   PubMed=15009714;

RX   PubMed=18632627;

RX   PubMed=22460905;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50734

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 11

ST   D18S51: 13,16

ST   D19S433: 16,16.2

ST   D21S11: 30

ST   D2S1338: 18

ST   D3S1358: 14,15

ST   D5S818: 11

ST   D7S820: 9

ST   D8S1179: 12,14

ST   FGA: 19,24

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM1819

AC   CVCL_0B65

SY   WM-1819

DR   Cosmic; 1303068

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50760

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,14

ST   D16S539: 11,14

ST   D18S51: 12,16

ST   D19S433: 15

ST   D21S11: 29

ST   D2S1338: 17,18

ST   D3S1358: 14,15

ST   D5S818: 11,13

ST   D7S820: 10

ST   D8S1179: 11,12

ST   FGA: 23

ST   TH01: 8

ST   TPOX: 8,9

ST   vWA: 18,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM1852

AC   CVCL_0L86

SY   WM-1852

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi

WW   http://www.rockland-inc.com/Product.aspx?id=50775

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 9,13

ST   D13S317: 8,12

ST   D16S539: 11

ST   D18S51: 13

ST   D19S433: 14,15

ST   D21S11: 28,33.2

ST   D2S1338: 17,25

ST   D3S1358: 16,17

ST   D5S818: 12

ST   D7S820: 9,13

ST   D8S1179: 12,15

ST   FGA: 21,23

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM1862

AC   CVCL_C268

SY   WM-1862; WM 1862; EST75

DR   Cosmic; 972270

DR   Cosmic; 1047654

DR   Cosmic; 2163803

DR   ESTDAB; ESTDAB-075

DR   GEO; GSM156010

RX   PubMed=17260012;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50784

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Array-based CGH.

ST   Source(s): ESTDAB; Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D16S539: 13

ST   D18S51: 12,17

ST   D19S433: 13,14

ST   D21S11: 28,29

ST   D2S1338: 24,25

ST   D3S1358: 16,18

ST   D5S818: 11,14

ST   D7S820: 10

ST   D8S1179: 13,14

ST   FGA: 20,21

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM1922

AC   CVCL_6794

SY   WM-1922; WM 1922; WC00093

DR   Coriell; WC00093

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00093; probable.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM1942

AC   CVCL_DI27

SY   WM-1942; WM 1942

DR   GEO; GSM482482

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WM1960

AC   CVCL_AP76

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50796

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Left axillary lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 8

ST   D18S51: 19

ST   D19S433: 13,14

ST   D21S11: 29

ST   D2S1338: 18,21

ST   D3S1358: 14,18

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 10,16

ST   FGA: 22,24

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AP77 ! WM2013

OI   CVCL_6796 ! WM3060

SX   Male

CA   Cancer cell line

//

ID   WM1963

AC   CVCL_0B66

DR   GEO; GSM952603

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50822

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9,11

ST   D16S539: 9,11

ST   D21S11: 28,30

ST   D5S818: 10,11

ST   D7S820: 9,12

ST   TH01: 9

ST   TPOX: 9

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM1985

AC   CVCL_0B67

DR   GEO; GSM185182

DR   GEO; GSM185183

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50819

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 12

ST   D21S11: 28,30

ST   D5S818: 9,12

ST   D7S820: 8,10

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM2013

AC   CVCL_AP77

DR   GEO; GSM952595

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50837

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Left axillary lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 8,12

ST   D18S51: 19

ST   D19S433: 13,14

ST   D21S11: 29

ST   D2S1338: 18,21

ST   D3S1358: 14,18

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 10,16

ST   FGA: 22,24

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AP76 ! WM1960

OI   CVCL_6796 ! WM3060

SX   Male

CA   Cancer cell line

//

ID   WM2032

AC   CVCL_0B68

DR   GEO; GSM952596

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50848

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D16S539: 8,11

ST   D18S51: 25

ST   D19S433: 13,15

ST   D21S11: 28,30

ST   D2S1338: 17,23

ST   D3S1358: 15

ST   D5S818: 11,13

ST   D7S820: 9,11

ST   D8S1179: 12

ST   FGA: 20,21

ST   TH01: 10

ST   TPOX: 11

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AP86 ! WM3000

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM2044

AC   CVCL_0B69

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50862

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 12,13

ST   D18S51: 20

ST   D19S433: 14,15

ST   D21S11: 29,30

ST   D2S1338: 18

ST   D3S1358: 16,17

ST   D5S818: 11

ST   D7S820: 9

ST   D8S1179: 13

ST   FGA: 23,24

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM2067

AC   CVCL_0L85

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM209

AC   CVCL_C269

SY   WM-209; WM 209

DR   GEO; GSM952604

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi

WW   http://www.rockland-inc.com/Product.aspx?id=50900

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 10,13

ST   D21S11: 28,31

ST   D5S818: 10,11

ST   D7S820: 10,11

ST   TH01: 8,9.3

ST   TPOX: 8,10

ST   vWA: 17,20

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM2090

AC   CVCL_0B70

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50892

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 12,16

ST   D19S433: 13,14

ST   D21S11: 30,31

ST   D2S1338: 24,25

ST   D3S1358: 14,15

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 12,13

ST   FGA: 23

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM218

AC   CVCL_L029

SY   WM-218; WM 218

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM239A

AC   CVCL_6795

SY   WM-239A; WM-239-A; WM 239-A; WM 239A; WM-239; WM239; WM 239; WC00044

DR   BTO; BTO:0003474

DR   Coriell; WC00044

DR   Cosmic; 888850

DR   Cosmic; 928690

DR   Cosmic; 972260

DR   Cosmic; 1155288

DR   Cosmic; 1155564

DR   Cosmic; 1303069

DR   Cosmic; 1477413

DR   GDSC; 1240225

DR   GEO; GSM188232

DR   GEO; GSM188262

DR   GEO; GSM188321

RX   PubMed=3020539;

RX   PubMed=3856042;

RX   PubMed=15009714;

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51751

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

CC   Discontinued: Coriell; WC00044; probable.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D21S11: 28,29

ST   D5S818: 12,13

ST   D7S820: 7,8

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0040 ! WM115

OI   CVCL_L033 ! WM165-1

OI   CVCL_2765 ! WM266-4

SX   Female

CA   Cancer cell line

//

ID   WM245

AC   CVCL_J513

SY   WM-245; WM 245

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM262

AC   CVCL_AP85

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50906

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,9

ST   D16S539: 9,11

ST   D18S51: 20,25

ST   D19S433: 12.2,13

ST   D21S11: 28,29,32.2

ST   D2S1338: 23,24

ST   D3S1358: 17

ST   D5S818: 13

ST   D7S820: 8,11

ST   D8S1179: 15,16

ST   FGA: 20

ST   TH01: 6,9

ST   TPOX: 9,12

ST   vWA: 14,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM266-4

AC   CVCL_2765

SY   WM-266-4; WM 266-4; WM-2664; WM2664; WM 2664; WM266; WM-266-mel; WM266mel; WC00097

DR   BTO; BTO:0001595

DR   CLO; CLO_0009612

DR   CLO; CLO_0009615

DR   EFO; EFO_0006774

DR   CLDB; cl4726

DR   ATCC; CRL-1676

DR   CCLE; WM2664_SKIN

DR   CGH-DB; 9312-4

DR   Coriell; WC00097

DR   Cosmic; 687444

DR   Cosmic; 905225

DR   Cosmic; 932718

DR   Cosmic; 972276

DR   Cosmic; 1022277

DR   Cosmic; 1054856

DR   Cosmic; 1155273

DR   Cosmic; 1238103

DR   Cosmic; 1295343

DR   Cosmic; 1303070

DR   Cosmic; 1458970

DR   Cosmic; 1459638

DR   Cosmic; 1477409

DR   Cosmic; 1507624

DR   Cosmic; 1949557

DR   Cosmic; 2163804

DR   Cosmic; 2233687

DR   ECACC; 91061233

DR   ESTDAB; ESTDAB-076

DR   GEO; GSM827418

DR   GEO; GSM887737

DR   GEO; GSM888832

DR   GEO; GSM1138792

DR   GEO; GSM1670578

DR   KCLB; 21676

DR   Lonza; 1375

RX   PubMed=3020539;

RX   PubMed=3856042;

RX   PubMed=15467732;

RX   PubMed=17308088;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51768

WW   http://tcpaportal.org/mclp/

CC   Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: Coriell; WC00097; probable.

CC   Discontinued: ECACC; 91061233; probable.

CC   Derived from metastatic site: Right thigh skin.

ST   Source(s): ATCC; ESTDAB; KCLB; Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12,13

ST   D16S539: 11,12

ST   D18S51: 21

ST   D19S433: 13

ST   D21S11: 29

ST   D2S1338: 19

ST   D3S1358: 15,18

ST   D5S818: 13

ST   D7S820: 8

ST   D8S1179: 13,15

ST   FGA: 21,23

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0040 ! WM115

OI   CVCL_L033 ! WM165-1

OI   CVCL_6795 ! WM239A

SX   Female

CA   Cancer cell line

//

ID   WM278

AC   CVCL_6473

SY   WM-278; WM 278; WC00054

DR   BTO; BTO:0005480

DR   CLO; CLO_0009616

DR   ATCC; CRL-2809

DR   BioSample; SAMN03471796

DR   Coriell; WC00054

DR   Cosmic; 686401

DR   Cosmic; 972271

DR   Cosmic; 1155544

DR   Cosmic; 1995665

DR   Cosmic; 2159427

DR   Cosmic; 2163805

DR   Cosmic-CLP; 1240226

DR   ESTDAB; ESTDAB-077

DR   GDSC; 1240226

DR   GEO; GSM186479

DR   GEO; GSM186480

DR   GEO; GSM555172

DR   GEO; GSM1670579

RX   PubMed=18632627;

RX   PubMed=27397505;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

WW   http://www.rockland-inc.com/Product.aspx?id=51777

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-2809; true.

CC   Discontinued: Coriell; WC00054; probable.

ST   Source(s): ATCC; Cosmic-CLP; ESTDAB; Wistar

ST   Amelogenin: X

ST   CSF1PO: 9

ST   D13S317: 12

ST   D16S539: 10,13

ST   D18S51: 12,15

ST   D19S433: 15,16

ST   D21S11: 27,30

ST   D2S1338: 19,25

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 12,13

ST   FGA: 19,22

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18,20

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6791 ! WM1617

SX   Female

CA   Cancer cell line

//

ID   WM28

AC   CVCL_L034

SY   WM-28; WM 28

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3000

AC   CVCL_AP86

DR   GEO; GSM185184

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50922

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D16S539: 8,11

ST   D18S51: 14,16

ST   D19S433: 13,15

ST   D21S11: 28,30

ST   D2S1338: 17,23

ST   D3S1358: 15

ST   D5S818: 11,13

ST   D7S820: 9,11

ST   D8S1179: 12

ST   FGA: 20,21

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0B68 ! WM2032

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3004

AC   CVCL_DG75

SY   WM 3004

DR   GEO; GSM185185

DR   GEO; GSM185186

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WM3060

AC   CVCL_6796

SY   WM-3060; WM 3060; WC00126

DR   Coriell; WC00126

DR   Cosmic; 2159440

DR   Cosmic; 2230118

DR   GEO; GSM186481

DR   GEO; GSM186482

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51811

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Misspelling: 'VM3060' in Cosmic 2230118.

CC   Discontinued: Coriell; WC00126; probable.

CC   Derived from metastatic site: Left axillary lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 8,12

ST   D18S51: 19

ST   D19S433: 13,14

ST   D21S11: 29

ST   D2S1338: 18,21

ST   D3S1358: 14,18

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 10,16

ST   FGA: 22

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AP76 ! WM1960

OI   CVCL_AP77 ! WM2013

SX   Male

CA   Cancer cell line

//

ID   WM3061

AC   CVCL_AP87

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51546

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3066

AC   CVCL_C270

SY   WM-3066; WM 3066

DR   GEO; GSM185187

DR   GEO; GSM185188

DR   GEO; GSM952597

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3077

AC   CVCL_DG76

SY   WM 3077

DR   GEO; GSM185189

DR   GEO; GSM186483

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WM3130

AC   CVCL_C271

SY   WM-3130; WM 3130

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WM3152

AC   CVCL_A340

SY   WM-3152; WM 3152

DR   Cosmic; 1477414

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3208V

AC   CVCL_L028

SY   WM-3208V; WM 3208V; WM3208; WM 3208

DR   GEO; GSM185190

DR   GEO; GSM185191

DR   GEO; GSM185192

DR   GEO; GSM185193

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3211

AC   CVCL_6797

SY   WM-3211; WM 3211; WC00045; EST79

DR   Coriell; WC00045

DR   Cosmic; 972286

DR   Cosmic; 1047655

DR   Cosmic; 1155289

DR   Cosmic; 1155541

DR   Cosmic; 1284919

DR   Cosmic; 1303071

DR   Cosmic; 2144978

DR   Cosmic; 2159443

DR   Cosmic; 2163806

DR   ESTDAB; ESTDAB-079

DR   GEO; GSM156008

DR   GEO; GSM185194

DR   GEO; GSM185195

DR   GEO; GSM188070

DR   GEO; GSM188122

DR   GEO; GSM188195

DR   GEO; GSM188210

DR   GEO; GSM188216

DR   GEO; GSM188233

DR   GEO; GSM188263

DR   GEO; GSM188286

DR   GEO; GSM188295

DR   GEO; GSM188322

RX   PubMed=17260012;

RX   PubMed=18632627;

RX   PubMed=22578220;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51798

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: Coriell; WC00045; probable.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB; Wistar

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 12

ST   D19S433: 13,14

ST   D21S11: 29,31.2

ST   D2S1338: 20,24

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 10,11

ST   FGA: 20

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 14,17

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3214

AC   CVCL_0L87

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3246

AC   CVCL_AP88

DR   GEO; GSM952605

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50958

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Adrenal gland.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 13,14

ST   D16S539: 11,14

ST   D18S51: 13,22

ST   D19S433: 14

ST   D21S11: 29

ST   D2S1338: 20,22

ST   D3S1358: 14

ST   D5S818: 13

ST   D7S820: 11,12

ST   D8S1179: 13

ST   FGA: 20,23

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3248

AC   CVCL_6798

SY   WM-3248; WM 3248; WC00081

DR   Coriell; WC00081

DR   Cosmic; 1155546

DR   Cosmic; 1303073

DR   GEO; GSM185196

DR   GEO; GSM185197

DR   GEO; GSM188066

DR   GEO; GSM188118

DR   GEO; GSM188191

DR   GEO; GSM188206

DR   GEO; GSM188215

DR   GEO; GSM188234

DR   GEO; GSM188264

DR   GEO; GSM188282

DR   GEO; GSM188291

DR   GEO; GSM188323

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51826

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Misspelling: 'WM-3428' in Cosmic 1303073.

CC   Discontinued: Coriell; WC00081; probable.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM3258

AC   CVCL_0L88

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3268

AC   CVCL_L031

SY   WM-3268; WM 3268; WM3268V; WM-3268V; WM 3268V; WM3268A

DR   Cosmic; 1155561

DR   Cosmic; 1303072

DR   GEO; GSM185198

DR   GEO; GSM185199

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

WW   http://www.rockland-inc.com/Product.aspx?id=50952

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,13

ST   D16S539: 11

ST   D18S51: 15,18

ST   D19S433: 12,13

ST   D21S11: 29,32.2

ST   D2S1338: 17,18

ST   D3S1358: 13,16

ST   D5S818: 9,10

ST   D7S820: 9,12

ST   D8S1179: 13,14

ST   FGA: 22,23

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3282

AC   CVCL_0B71

SY   WM 3282

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50973

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,14

ST   D16S539: 11,13

ST   D18S51: 13

ST   D19S433: 13,14

ST   D21S11: 29,33.2

ST   D2S1338: 25

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 12

ST   D8S1179: 12,14

ST   FGA: 25,26

ST   TH01: 7,9.3

ST   TPOX: 9,11

ST   vWA: 20

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3301

AC   CVCL_AP89

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=50998

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10

ST   D16S539: 11,12

ST   D18S51: 12,16

ST   D19S433: 14,15

ST   D21S11: 29,30

ST   D2S1338: 17

ST   D3S1358: 16,18

ST   D5S818: 9,13

ST   D7S820: 12,13

ST   D8S1179: 13,16

ST   FGA: 21

ST   TH01: 8,9

ST   TPOX: 8,9

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3311

AC   CVCL_0B72

SY   WM-3311; WM 3311

DR   GEO; GSM952606

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51008

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D18S51: 11,17

ST   D19S433: 12,14

ST   D21S11: 31

ST   D2S1338: 19,23

ST   D3S1358: 14,17

ST   D5S818: 12,13

ST   D7S820: 12

ST   D8S1179: 13

ST   FGA: 23,25

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 15,16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3406

AC   CVCL_AP90

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51028

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 12,14

ST   D16S539: 11,13

ST   D18S51: 16

ST   D19S433: 13,16

ST   D21S11: 30.2

ST   D2S1338: 19,26

ST   D3S1358: 16

ST   D5S818: 10,11

ST   D7S820: 13

ST   D8S1179: 14,15

ST   FGA: 25

ST   TH01: 6,9

ST   TPOX: 8,12

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3438

AC   CVCL_C272

SY   WM-3438; WM 3438

DR   GEO; GSM952607

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51025

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8

ST   D16S539: 12,14

ST   D18S51: 12,14

ST   D19S433: 14,14.2

ST   D21S11: 32.2

ST   D2S1338: 17,19

ST   D3S1358: 14

ST   D5S818: 13

ST   D7S820: 9,11

ST   D8S1179: 13,15

ST   FGA: 21,23

ST   TH01: 9.3

ST   TPOX: 10,11

ST   vWA: 16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3451

AC   CVCL_C273

SY   WM-3451; WM 3451

DR   Cosmic; 1303074

DR   GEO; GSM482483

DR   GEO; GSM952598

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,11

ST   D16S539: 10,11

ST   D18S51: 12,13

ST   D19S433: 12,12.2

ST   D21S11: 29,30

ST   D2S1338: 20,26

ST   D3S1358: 12,16

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   D8S1179: 13,15

ST   FGA: 21,23

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AP91 ! WM3456

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3456

AC   CVCL_AP91

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51060

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,11

ST   D16S539: 10,11

ST   D18S51: 12,13

ST   D19S433: 13,14

ST   D21S11: 29,30

ST   D2S1338: 20,26

ST   D3S1358: 16,17

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   D8S1179: 13,15

ST   FGA: 21,23

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C273 ! WM3451

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3482

AC   CVCL_AP92

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51075

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,13

ST   D16S539: 11,13

ST   D18S51: 13,14

ST   D19S433: 15

ST   D21S11: 27

ST   D2S1338: 25

ST   D3S1358: 14,15

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 9,13

ST   FGA: 21,22

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM35

AC   CVCL_0580

SY   WM-35; WM 35; WC00060

DR   BTO; BTO:0003475

DR   CLO; CLO_0009617

DR   MCCL; MCC:0000486

DR   ATCC; CRL-2807

DR   BioSample; SAMN03471793

DR   Coriell; WC00060

DR   Cosmic; 686396

DR   Cosmic; 886834

DR   Cosmic; 1155548

DR   Cosmic; 1187584

DR   Cosmic; 1247866

DR   Cosmic; 1303075

DR   Cosmic; 1507600

DR   Cosmic; 1995666

DR   Cosmic; 2159431

DR   Cosmic-CLP; 1299080

DR   GDSC; 1299080

DR   GEO; GSM186484

DR   GEO; GSM186485

DR   GEO; GSM188068

DR   GEO; GSM188120

DR   GEO; GSM188193

DR   GEO; GSM188208

DR   GEO; GSM188213

DR   GEO; GSM188284

DR   GEO; GSM188293

DR   GEO; GSM555188

DR   GEO; GSM952586

DR   GEO; GSM1670580

DR   Lonza; 583

RX   PubMed=2068080;

RX   PubMed=18632627;

RX   PubMed=23039341;

RX   PubMed=27087056;

RX   PubMed=27397505;

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-2807; true.

CC   Discontinued: Coriell; WC00060; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=27087056; Wistar

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 12,13

ST   D18S51: 20

ST   D19S433: 15,16

ST   D21S11: 29,32.2

ST   D2S1338: 18,25

ST   D3S1358: 16,18

ST   D5S818: 11,12

ST   D7S820: 10,13

ST   D8S1179: 11,13

ST   FGA: 19

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM35-P1N1

AC   CVCL_A806

SY   35-P1-N1

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0580 ! WM35

SX   Female

CA   Cancer cell line

//

ID   WM35-P1N2

AC   CVCL_A807

SY   35-P1-N2

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0580 ! WM35

SX   Female

CA   Cancer cell line

//

ID   WM35-P1N3

AC   CVCL_A808

SY   35-P1-N3

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0580 ! WM35

SX   Female

CA   Cancer cell line

//

ID   WM35-P2N1

AC   CVCL_A809

SY   35-P2-N1

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0580 ! WM35

SX   Female

CA   Cancer cell line

//

ID   WM35-P2N2

AC   CVCL_A810

SY   35-P2-N2

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0580 ! WM35

SX   Female

CA   Cancer cell line

//

ID   WM35-P2N3

AC   CVCL_A811

SY   35-P2-N3

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0580 ! WM35

SX   Female

CA   Cancer cell line

//

ID   WM3506

AC   CVCL_AP93

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51091

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 12,13

ST   D18S51: 14,18

ST   D19S433: 13,14

ST   D21S11: 30

ST   D2S1338: 19,23

ST   D3S1358: 16

ST   D5S818: 11,13

ST   D7S820: 10,12

ST   D8S1179: 14,15

ST   FGA: 24,25

ST   TH01: 8

ST   TPOX: 8,9

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM3533

AC   CVCL_0B73

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51088

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 9,12

ST   D18S51: 13,16

ST   D19S433: 13,14.2

ST   D21S11: 30

ST   D2S1338: 25,26

ST   D3S1358: 15,17

ST   D5S818: 10,12

ST   D7S820: 9,12

ST   D8S1179: 10,15

ST   FGA: 22,24

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 15,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3540

AC   CVCL_AP94

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51108

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 9

ST   D13S317: 9

ST   D16S539: 12

ST   D19S433: 12,13

ST   D21S11: 27,32

ST   D2S1338: 17,19

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 11,12

ST   D8S1179: 9,13

ST   FGA: 20,24

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM3618F

AC   CVCL_0B74

SY   WM3618

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51135

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Right axillary lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 13

ST   D18S51: 13,14

ST   D19S433: 13,14

ST   D21S11: 28,31

ST   D2S1338: 20,25

ST   D3S1358: 16

ST   D5S818: 11,13

ST   D7S820: 10,13

ST   D8S1179: 10,15

ST   FGA: 20

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0B81 ! WM3772F

SX   Female

CA   Cancer cell line

//

ID   WM3619

AC   CVCL_0B75

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51136

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8

ST   D16S539: 12

ST   D18S51: 12,15

ST   D19S433: 13

ST   D21S11: 28,32.2

ST   D2S1338: 20,21

ST   D3S1358: 15,17

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 9,14

ST   FGA: 23

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 14

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3622

AC   CVCL_AP95

DR   GEO; GSM952599

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51149

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,11

ST   D16S539: 11

ST   D18S51: 10,19

ST   D19S433: 14

ST   D21S11: 28,33.2

ST   D2S1338: 17,25

ST   D3S1358: 14,15

ST   D5S818: 12

ST   D7S820: 7,8

ST   D8S1179: 12,14

ST   FGA: 21

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 16,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3623

AC   CVCL_C274

SY   WM-3623; WM 3623

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51156

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Right lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12,13

ST   D16S539: 11

ST   D21S11: 28

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM3629

AC   CVCL_C275

SY   WM-3629; WM 3629; WC00117; WC00117A

DR   Coriell; WC00117

DR   Cosmic; 1812179

RX   PubMed=28196595;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51178

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Discontinued: Coriell; WC00117; probable.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 12,13

ST   D16S539: 9,12

ST   D18S51: 11,12

ST   D19S433: 13,15

ST   D21S11: 31,32

ST   D2S1338: 32

ST   D3S1358: 15

ST   D5S818: 10,11

ST   D7S820: 10

ST   D8S1179: 8,13

ST   FGA: 22

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 18,20

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3630

AC   CVCL_0B76

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51548

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9,13

ST   D16S539: 9,11

ST   D18S51: 14

ST   D19S433: 13,14

ST   D21S11: 28,31.2

ST   D2S1338: 24,25

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 13

ST   FGA: 19

ST   TH01: 7,8

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3670

AC   CVCL_6799

SY   WM-3670; WM 3670; WC00119; WC00119A

DR   Coriell; WC00119

DR   Cosmic; 1812180

DR   Cosmic; 2159436

RX   PubMed=28196595;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=52026

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Discontinued: Coriell; WC00119; probable.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D18S51: 14,19

ST   D19S433: 14,17

ST   D21S11: 30

ST   D2S1338: 17,25

ST   D3S1358: 16,18

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 13

ST   FGA: 18,19

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3681

AC   CVCL_C276

SY   WM-3681; WM 3681

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51200

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Liver.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 13

ST   D16S539: 11

ST   D18S51: 13,19

ST   D19S433: 13,14

ST   D21S11: 29,33.2

ST   D2S1338: 19,25

ST   D3S1358: 14,15

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   D8S1179: 13

ST   FGA: 24,25

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3682

AC   CVCL_AP78

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51217

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12,14

ST   D16S539: 13,14

ST   D18S51: 14,15

ST   D19S433: 14,15

ST   D21S11: 28,29

ST   D2S1338: 17,23

ST   D3S1358: 14,17

ST   D5S818: 13

ST   D7S820: 9,10

ST   D8S1179: 11,12

ST   FGA: 22

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0B77 ! WM3702

OI   CVCL_AP79 ! WM3758

SX   Male

CA   Cancer cell line

//

ID   WM3702

AC   CVCL_0B77

DR   Cosmic; 2159432

DR   GEO; GSM952600

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51235

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12,14

ST   D16S539: 13,14

ST   D18S51: 14,15

ST   D19S433: 14,15

ST   D21S11: 28,29

ST   D2S1338: 17,23

ST   D3S1358: 14,17

ST   D5S818: 12,13

ST   D7S820: 9,10

ST   D8S1179: 11,12

ST   FGA: 22

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AP78 ! WM3682

OI   CVCL_AP79 ! WM3758

SX   Male

CA   Cancer cell line

//

ID   WM3704

AC   CVCL_0B78

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51242

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12,14

ST   D13S317: 13

ST   D16S539: 13

ST   D18S51: 21

ST   D19S433: 13

ST   D21S11: 31.2

ST   D2S1338: 16,19

ST   D3S1358: 15,17

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 13,15

ST   FGA: 22

ST   TH01: 7,9.3

ST   TPOX: 8,12

ST   vWA: 16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM373

AC   CVCL_C277

SY   WM-373; WM 373

DR   Cosmic; 928687

RX   PubMed=3856042;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51267

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Skin.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 12,13

ST   D18S51: 14,16

ST   D19S433: 12,14

ST   D21S11: 29

ST   D2S1338: 17

ST   D3S1358: 14

ST   D5S818: 11

ST   D7S820: 8

ST   D8S1179: 13

ST   FGA: 20

ST   TH01: 6

ST   TPOX: 9,11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7156 ! WM75

SX   Male

CA   Cancer cell line

//

ID   WM3734

AC   CVCL_6800

SY   WM-3734; WM 3734; WC00090

DR   Coriell; WC00090

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51895

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00090; probable.

CC   Derived from metastatic site: Brain.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 13

ST   D21S11: 30

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3743

AC   CVCL_0B79

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51285

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 8,11

ST   D18S51: 16,18

ST   D19S433: 13,14

ST   D21S11: 31,31.2

ST   D2S1338: 19,21

ST   D3S1358: 14,16

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   D8S1179: 8,12

ST   FGA: 21,26

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 14,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM3749

AC   CVCL_AP80

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51280

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 14

ST   D16S539: 12

ST   D18S51: 16,17

ST   D19S433: 14,15

ST   D21S11: 30.2

ST   D2S1338: 24,25

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 8,9

ST   D8S1179: 13,14

ST   FGA: 20,24

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM3755

AC   CVCL_0B80

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51287

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 12

ST   D16S539: 11,13

ST   D18S51: 15

ST   D19S433: 13,16

ST   D21S11: 29

ST   D2S1338: 17,20

ST   D3S1358: 16,17

ST   D5S818: 11

ST   D7S820: 12

ST   D8S1179: 11,13

ST   FGA: 23

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 97及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。